United States

Securities and Exchange Commission

Washington, D.C. 20549

Form 10-K

[X] ANNUAL REPORT UNDERPURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31 2020, 2022

[  ]

or

TRANSITION REPORT UNDERPURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to .__________.

Commission file number: 001-33899

Digital Ally, Inc.Digital Ally, Inc.

(Exact name of registrant as specified in its charter)

Nevada20-0064269

(State or other jurisdiction of


incorporation or organization)

(I.R.S. Employer


Identification No.)

15612 College Blvd, 14001 Marshall Drive, Lenexa, KS6621966215
(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code: (913)814-7774

Securities registered underpursuant to Section 12(b) of the Exchange Act:

Common Stock, $0.001 par valueDGLY The NASDAQ Stock Market LLC
(Title of class)(Trading Symbol) (Name of each exchange on which registered)

Securities registered underpursuant to Section 12(g) of the Exchange Act: None.

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes [  ] No [X] ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes [  ] No [X] ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] ☒ No [  ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] ☒ No [  ]

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [X]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [  ]Accelerated filer [  ]
Non-accelerated filer [X]Smaller reporting company [X]
Emerging growth company [  ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. [  ]

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b).

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes [  ] No [X] ☒

As of June 30, 2020,2022, the aggregate market value of the Company’s common equityvoting and non-voting stock held by non-affiliates computed by reference to the closing price ($3.14) of the registrant’s most recently completed second fiscal quarter, computed by reference to the closing price ($15.80), was: $75,239,600.34,496,434, which have been adjusted for the Reverse Split (as defined below).

The number of shares of our common stock outstanding as of March 31, 20212023 was: 51,521,191.

Documents Incorporated by Reference: Portions of2,755,224 as adjusted for the Registrant’s definitive proxy statement,Company’s 1-for-20 reverse stock split, which the Company expects to file no later than 120 days after December 31, 2020, are incorporated by reference into Part III ofwas effective on February 6, 2023 (the “Reverse Split”). All share and price per share information in this Annual Report on Form 10-K.10-K has been adjusted to reflect the Reverse Split.

Documents Incorporated by Reference: None.

 

 
 

 

FORM 10-K

DIGITAL ALLY, INC.

DECEMBER 31, 20202022

Table of Contents

Page
PART I
Item 1.Business3
Item 1A.Risk Factors1312
Item 1B.Unresolved Staff Comments1312
Item 2.Properties13
Item 3.Legal Proceedings13
Item 4.Mine Safety Disclosures1514
PART II
Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities1615
Item 6.[Reserved]Selected Financial Data1815
Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations1815
Item 7a.Quantitative and Qualitative Disclosures About Market Risk4238
Item 8.Financial Statements and Supplementary Data4238
Item 9.Changes In and Disagreements With Accountants on Accounting and Financial Disclosure4238
Item 9AControls and Procedures4338
Item 9B.Other Information4439
Item 9C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections39
PART III
PART III
Item 10.Directors, Executive Officers and Corporate Governance4440
Item 11.Executive Compensation4447
Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters4456
Item 13.Certain Relationships and Related Transactions, and Director Independence4457
Item 14.Principal Accountant Fees and Services4457
PART IV
Item 15.Exhibits and Financial Statement Schedules4558
SIGNATURES
Signatures4860

2
 

Note Regarding Forward Looking Statements

This annual report on Form 10-K contains forward-looking statements as that term is defined in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” “intends,” and other variations of these words or comparable words. In addition, any statements that refer to expectations, projections or other characterizations of events, circumstances or trends and that do not relate to historical matters are forward-looking statements. These forward-looking statements are based largely on our expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond our control. Therefore, actual results could differ materially from the forward-looking statements contained in this document, and readers are cautioned not to place undue reliance on such forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this report. Except as required by law, we do not undertake to update or revise any of the forward-looking statements to conform these statements to actual results, whether as a result of new information, future events or otherwise.

As used in this annual report, “Digital Ally,” the “Company,” “we,” “us,” or “our” refer to Digital Ally, Inc., unless otherwise indicated.

Part I

Item 1.Business.

Overview

We produce digital video imaging, storage products and disinfectant and related safety products for use in law enforcement, security and commercial applications. Our current products include, in-car digital video/audio recorders contained in a rear-view mirror for use in law enforcement and commercial fleets; a system that provides its law enforcement customers with audio/video surveillance from multiple vantage points and hands-free automatic activation of body-worn cameras and in-car video systems; a miniature digital video system designed to be worn on an individual’s body; and cloud storage solutions. Additionally, the Company has recently added two new lines of branded products: (1) the ThermoVu™ which is a line of self-contained temperature monitoring stations that provides alerts and controls facility access when an individual’s temperature exceeds a pre-set threshold and (2) our Shield™ disinfectants and cleansers which are for use against viruses and bacteria. The Company began offering its Shield™ disinfectants and cleansers to its law enforcement and commercial customers late in the second quarter of 2020. We have active research and development programs to adapt our technologies to other applications. We can integrate electronic, radio, computer, mechanical, and multi-media technologies to create unique solutions to address needs in a variety of other industries and markets, including mass transit, school bus, taxicab and the military. We sell our products to law enforcement agencies, private security customers and organizations and consumer and commercial fleet operators through direct sales domestically and third-party distributors internationally.

Corporate History

We were incorporated in Nevada on December 13, 2000 as Vegas Petra, Inc. From that date until November 30, 2004, when we entered into a Plan of Merger with Digital Ally, Inc., a Nevada corporation which was formerly known as Trophy Tech Corporation (the “Acquired Company”“Predecessor Registrant”), we had not conducted any operations and were a closely-held company. In conjunction with the merger, we were renamed Digital Ally, Inc.

3

The Acquired Company, which was incorporated on May 16, 2003, engaged in the design, development, marketing and sale of bow hunting-related products. Its principal product was a digital video recording system for use in the bow hunting industry. We changed its business plan in 2004 to adapt its digital video recording system for use in the law enforcement and security markets. We began shipments of our in-car digital video rear view mirror in March 2006.

On January 2, 2008, we commenced trading on the Nasdaq Capital Market under the symbol “DGLY.” We conduct our business from 15612 College Blvd,14001 Marshall Drive, Lenexa, Kansas 66219.66215. Our telephone number is (913) 814-7774.

COVID – 19 Pandemic

Our website address is www.digitalallyinc.com. The COVID-19 pandemic represents a fluid situation that presents a wide rangecontents of, potential impacts of varying durations for different global geographies, including locations where we have offices, employees, customers, vendors and other suppliers and business partners.

Like most US-based businesses, the COVID-19 pandemic and efforts to mitigate the same began to have impacts onor information accessible through, our business in March 2020. By that time, much of our first fiscal quarter was completed. During the remainder of the year ended December 31, 2020, we observed recent decreases in demand from certain customers, including primarily our law-enforcement and commercial customers.

Given the fact that our products are sold through a variety of distribution channels, we expect our sales will experience more volatility as a result of the changing and less predictable operational needs of many customers as a result of the COVID-19 pandemic. We are aware that many companies, including many of our suppliers and customers, are reporting or predicting negative impacts from COVID-19 on future operating results. Although we observed significant declines in demand for our products from certain customers during the year ended December 31, 2020, we believe that it remains too early for us to know the exact impact COVID-19 will have on the long-term demand for our products. We also cannot be certain how demand may shift over time as the impacts of the COVID-19 pandemic may go through several phases of varying severity and duration.

In light of broader macro-economic risks and already known impacts on certain industries that use our products and services, we have taken, and continue to take targeted steps to lower our operating expenses because of the COVID-19 pandemic. We continue to monitor the impacts of COVID-19 on our operations closely and this situation could change based on a significant number of factors thatwebsite are not entirely within our control and are discussed in this and other sectionspart of this Annual Report on Form 10-K. We do not expect theremake our filings with the SEC, including our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and all amendments to be material changes to our assetsthose reports, as well as beneficial ownership filings available free of charge on our balance sheetwebsite as soon as reasonably practicable after we file such reports with, or our abilityfurnish such reports to, timely account for those assets. Further,the SEC. Our filings with the SEC are available to the public through the SEC’s website at www.sec.gov.

On August 23, 2022 (the “Effective Time”), the Predecessor Registrant merged with and into its wholly owned subsidiary, DGLY Subsidiary Inc., a Nevada corporation (the “Registrant”), pursuant to an agreement and plan of merger, dated as of August 23, 2022 (the “Merger Agreement”), between the Predecessor Registrant and the Registrant, with the Registrant as the surviving corporation in the merger (such transaction, the “Merger”). At the Effective Time, Articles of Merger were filed with the Secretary of State of the State of Nevada, pursuant to which the Registrant was renamed “Digital Ally, Inc.” and, by operation of law, succeeded to the assets, continued the business and assumed the rights and obligations of the Predecessor Registrant immediately prior to the Merger. Under the Nevada Revised Statutes, shareholder approval was not required in connection with the preparationMerger Agreement or the transactions contemplated thereby.

At the Effective Time, pursuant to the Merger Agreement, (i) each outstanding share of Predecessor Registrant’s common stock, par value $0.001 per share (the “Predecessor Common Stock”) automatically converted into one share of common stock, par value $0.001 per share, of the Registrant (“Registrant Common Stock”), (ii) each outstanding option, right or warrant to acquire shares of Predecessor Common Stock converted into an option, right or warrant, as applicable, to acquire an equal number of shares of Registrant Common Stock under the same terms and conditions as the original options, rights or warrants, and (iii) the directors and executive officers of the Predecessor Registrant were appointed as directors and executive officers, as applicable, of the Registrant, each to serve in the same capacity and for the same term as such person served with the Predecessor Registrant immediately before the Merger.

For the purposes of this Annual Report on Form 10-K, we reviewedunless the potential impacts ofcontext otherwise requires, (i) the COVID-19 pandemic on goodwill and intangible assets and have determined there to be no material impact at this time. We have also reviewed the potential impacts on future risksterm “our,” or “us” refers to the business as it relates to collections, returnsPredecessor Registrant and other business-related items.

To date, travel restrictions and border closures have not materially impacted our ability to obtain inventory or manufacture or deliver products or services to customers. However, if such restrictions become more severe, they could negatively impact those activities in a way that would harm our business over the long term. Travel restrictions impacting people can restrain our ability to assist our customers and distributors as well as impact our ability to develop new distribution channels, but at present we do not expect these restrictions on personal travel to be material to our business operations or financial results. We have taken steps to restrain and monitor our operating expenses and therefore we do not expect any such impacts to materially change the relationship between costs and revenues.

Like most companies, we have taken a range of actionsits subsidiaries with respect to how we operatethe period prior to assure we comply with government restrictions and guidelines as well as best practices to protect the health and well-being of our employees and our ability to continue operating our business effectively. To date, we have been able to operate our business effectively using these measuresEffective Time and to maintain internal controlsthe Registrant and its subsidiaries with respect to the period on and after the Effective Time; (ii) as documentedof any period prior to the Effective Time, references to the “directors” mean the directors of the Predecessor Registrant, and, posted. Weas of any period at and after the Effective Time, the directors of the Registrant, (iii) as of any period prior to the Effective Time, references to “stockholders” mean the holders of Predecessor Common Stock, and, as of any period at and after the Effective Time, the holders of Registrant Common Stock, and (iv) as of any period prior to the Effective Time, references to “Common Stock” means the Predecessor Common Stock, and, as of any period at and after the Effective Time, Registrant Common Stock.

The business of the Registrant, Digital Ally, Inc. (with its wholly-owned subsidiaries, Digital Ally International, Inc., Shield Products, LLC, Digital Ally Healthcare, LLC, TicketSmarter, Inc., Worldwide Reinsurance, Ltd., Digital Connect, Inc., BirdVu Jets, Inc., Kustom 440, Inc., and its majority-owned subsidiary Nobility Healthcare, LLC, collectively, “Digital Ally,” “Digital,” and the “Company”), is divided into three reportable operating segments: 1) the Video Solutions Segment, 2) the Revenue Cycle Management Segment and 3) the Entertainment Segment. The Video Solutions Segment is our legacy business that produces digital video imaging, storage products, disinfectant and related safety products for use in law enforcement, security and commercial applications. This segment includes both service and product revenues through our subscription models offering cloud and warranty solutions, and hardware sales for video and health safety solutions. The Revenue Cycle Management Segment provides working capital and back-office services to a variety of healthcare organizations throughout the country, as a monthly service fee. The Entertainment Segment acts as an intermediary between ticket buyers and sellers within our secondary ticketing platform, ticketsmarter.com, and we also have not experienced challengesacquire tickets from primary sellers to then sell through various platforms. The accounting guidance on Segment Reporting establishes standards for reporting information regarding operating segments in maintaining business continuityannual financial statements and do not expectrequires selected information of those segments to incur material expenditures to do so. However,be presented in financial statements. The following table sets forth the impacts of COVID-19Company’s total revenue and efforts to mitigate the same have remained unpredictable and it remains possible that challenges may arise in the future.revenue derived from each reportable operating segment:

  Years Ended December 31, 
  2022  2021 
Net Revenues:        
Video Solutions $8,252,288  $9,073,626 
Revenue Cycle Management  7,886,107   1,630,048 
Entertainment  20,871,500   10,709,760 
Total Net Revenues $37,009,895  $21,413,434 

43
 

The actions

Additional information regarding each reportable operating segment is also included in Note 23 entitled Segment Data of “Notes to Consolidated Financial Statements”.

Video Solutions Operating Segment

Within our video solutions operating segment we have taken so far during the COVID-19 pandemic include, but are not limited to:

requiring all employees who can work from home to work from home;
increasing our IT networking capability to best assure employees can work effectively outside the office; and
for employees who must perform essential functions in one of our offices:
having employees maintain a distance of at least six feet from other employees whenever possible;
having employees work in dedicated shifts to lower the risk all employees who perform similar tasks might become infected by COVID-19;
having employees stay segregated from other employees in the office with whom they require no interaction; and
requiring employees to wear masks while they are in the office whenever possible.

We currently believe revenue for the year ending December 31, 2021 may decline year over year due to the conditions noted. In April 2020, we implemented a COVID-19 mitigation plan designed to further reduce our operating expenses during the pandemic. Actions taken to date include work hour and salary reductions for senior management. These cost reductions are in addition to the significant restructuring actions we initiated in the first quarter of 2020. Based on our current cash position, our projected cash flow from operations and our cost reduction and cost containment efforts to date, we believe that we will have sufficient capital and or have access to sufficient capital through public and private equity and debt offerings to sustain operations for a period of one year following the date of this filing. If business interruptions resulting from the COVID-19 pandemic were to be prolonged or expanded in scope, our business, financial condition, results of operations and cash flows would be negatively impacted. We will continue to actively monitor this situation and will implement actions necessary to maintain business continuity.

Our Products

We supply technology-based products utilizing our portable digital video and audio recording capabilities for the law enforcement and security industries and for the commercial fleet and mass transit markets. We have the ability to integrate electronic, radio, computer, mechanical, and multi-media technologies to create positive solutions to our customers’ requests. Our products include: the EVO-HD, DVM-800 and DVM-800 Lite, which are in-car digital video mirror systems for law enforcement;enforcement and commercial markets; the FirstVUFirstVu body-worn camera line, consisting of the FirstVu Pro, FirstVu II, and the FirstVU HD, which are body-worn cameras;FirstVu HD; our patented and revolutionary VuLink product which integrates our body-worn cameras with our in-car systems by providing hands-free automatic activation for both law enforcement and commercial markets; the FLT-250, DVM-250, and DVM-250 Plus, which are our commercial line of digital video mirrors that serve as “event recorders” for the commercial fleet and mass transit markets; and FleetVUFleetVu and VuLink, which are our cloud-based evidence management systems. We introduced the EVO-HD product in the second quarter of 2019further diversified and began full-scale deliveries in the third quarter 2019, which continued into 2020. The EVO-HD is designed and built on a new and highly advanced technology platform that will become the platform for a new family of in-car video solution products for the law enforcement and commercial markets. We believe that the launch of these new products will help to reinvigorate our in-car and body-worn systems revenues while diversifying and broadening the market forbroadened our product offerings. Additionally, we introducedofferings in 2020, by introducing two new lines of branded products: (1) the ThermoVu™ThermoVu® which is a line of self-contained temperature monitoring stations that provides alerts and controls facility access when an individual’s temperature exceeds a pre-set threshold and (2) our Shield™ disinfectants and cleansers which are for use against viruses and bacteria. We began offering our Shield™ disinfectants

Our video solutions segment revenue encompasses video recording products and cleansers toservices for our law enforcement and commercial customers and the sale of ShieldTM disinfectant and personal protective products. This segment generates revenues through our subscription models offering cloud and warranty solutions, and hardware sales for video and personal protective safety products and solutions. Revenues for product sales are recognized upon delivery of the product, and revenues from our cloud and warranty subscription plans are deferred over the term of the subscription, typically 3 or 5 years.

Revenue Cycle Management Operating Segment

We entered the revenue cycle management business late in the second quarter of 2020. The following describes2021 with the formation of our product portfolio.wholly owned subsidiary, Digital Ally Healthcare, Inc. and its majority-owned subsidiary Nobility Healthcare, LLC (“Nobility Healthcare”). Nobility Healthcare completed its first acquisition on June 30, 2021, when it acquired a private medical billing company, and has since completed three more acquisitions of private medical billing companies, in which we assist in providing working capital and back-office services to healthcare organizations throughout the country. Our assistance consists of insurance and benefit verification, medical treatment documentation and coding, and collections. Through our expertise and experience in this field, we aim to maximize our customers’ service revenues collected, leading to substantial improvements in their operating margins and cash flows.

54
 

Our revenue cycle management segment consists of our medical billing subsidiaries. Revenues of this segment are recognized after we perform the obligations of our revenue cycle management services. Our revenue cycle management services are services, performed and charged monthly, generally based on a contractual percentage of total customer collections, for which we recognize our net service fees.

Entertainment Operating Segment

We have also entered into live entertainment and events ticketing services through the formation of our wholly owned subsidiary, TicketSmarter, Inc. (“TicketSmarter”) and its completed acquisitions of Goody Tickets, LLC and TicketSmarter, LLC, on September 1, 2021. TicketSmarter provides ticket sales, partnerships, and mainly, ticket resale services through its online ticketing marketplace for live events, TicketSmarter.com. TicketSmarter offers tickets for over 125,000 live events through its platform, for a wide range of events, including concerts, sporting events, theatres, and performing arts, throughout the country.

Our entertainment operating segment consists of ticketing services provided through TicketSmarter and its online platform, TicketSmarter.com. Revenues of this segment include ticketing service charges generally determined as a percentage of the face value of the underlying ticket and ticket sales from our ticket inventory which are recognized when the underlying tickets are sold. Ticketing direct expenses include the cost of tickets purchased for resale by the Company and held as inventory, credit card fees, ticketing platform expenses, website maintenance fees, along with other administrative costs.

Our Video Operating Segment Products and Services

Through our video operating segment we supply technology-based products utilizing our portable digital video and audio recording capabilities for the law enforcement and security industries and for the commercial fleet and mass transit markets. We have the ability to integrate electronic, radio, computer, mechanical, and multi-media technologies to create positive solutions to our customers’ requests. Our products include: the EVO-HD, DVM-800 and DVM-800 Lite, which are in-car digital video systems for law enforcement and commercial markets; the FirstVu body-worn camera line, consisting of the FirstVu Pro, FirstVu, and the FirstVu HD; our patented and revolutionary VuLink product integrates our body-worn cameras with our in-car systems by providing hands-free automatic activation for both law enforcement and commercial markets; the FLT-250, DVM-250, and DVM-250 Plus, which are our commercial line of digital video mirrors that serve as “event recorders” for the commercial fleet and mass transit markets; and FleetVu and VuLink, which are our cloud-based evidence management systems. We further diversified and broadened our product offerings in 2020, by introducing two new lines of branded products: (1) the ThermoVu® which is a line of self-contained temperature monitoring stations that provides alerts and controls facility access when an individual’s temperature exceeds a pre-set threshold and (2) our Shield™ disinfectants and cleansers which are for use against viruses and bacteria.

In-Car Digital Video Mirror System for law enforcementLaw Enforcement – EVO-HD, DVM-800 and DVM-800 Lite

In-car video systems for patrol cars are now a necessity and have generally become standard. Current systems are primarily digital based systems with cameras mounted on the windshield and the recording device generally in the trunk, headliner, dashboard, console or under the seat of the vehicle. Most manufacturers have developed and transitioned completely to digital video, and some have offered full high definition (“HD”) level recordings, which is currently state-of-art for the industry.

Our digital video rear-view mirror unit is a self-contained video recorder, microphone and digital storage system that is integrated into a rear-view mirror, with a monitor, global positioning system (“GPS”) and 900 megahertz (“MHz”) audio transceiver. Our system is more compact and unobtrusive than certain of our competitors because it requires no recording equipment to be located in other parts of the vehicle.

Our in-car digital video rear-view mirror has the following features:

wide angle zoom color camera;

standards-based video and audio compression and recording;
system is concealed in the rear-view mirror, replacing factory rear-view mirror;
monitor in rear-view mirror is invisible when not activated;
easily installed in any vehicle;
ability to integrate with body-worn cameras including auto-activation of either system;
archives audio/video data to the cloud, computers (wirelessly) and compact flash memory, or file servers;
900 MHz audio transceiver with automatic activation;
marks exact location of incident with integrated GPS;
playback using Windows Media Player;
optional wireless download of stored video evidence;
proprietary software protects the chain of custody; and
records to rugged and durable solid-state memory.

The Company launched its in-car digital video platform under the name EVO-HD during the second quarter of 2019. The EVO-HD is a next generationrevolutionary in-car system that offers a multiple HD in-car camera solution system with built-in patented VuLink auto-activation technology. The EVO-HD is built on a newdelivers versatility and highly advanced technology platform that enables many new and revolutionary features, including auto activation beyond the car and body camera. We believe that no other provider can offer built-in patented VuLink auto-activation technology. The EVO-HD providesreliability for law enforcement officers with an easier to use, faster and more advanced system for capturing video evidence and uploading than the Company’s competitors. Additional features include:enforcement.

a remote cloud trigger feature that allows dispatchers to remotely start recordings;
simultaneous audio/video play back;
cloud connectivity via cell modem, including the planned deployment of the new 5G network;
near real-time mapping and system health monitoring;

65
 

body-camera connectivity with built-in auto activation technology; and
128 gigabyte internal storage and, up to 2 terabyte external solid-state drive storage.

TheWith built-in, patented auto-activation technology, EVO-HD is designedcaptures multiple recording angles in sync from a FirstVu PRO or FirstVu HD body-worn camera and built on a new and highly advanced technology platform that is expected to become the platform for a new family of in-car video solution products for law enforcement. The innovative EVO-HD technology replaces the current in-car mirror-based systems with a miniaturized system that can be custom-mounted in the vehicle while offering numerous hardware configurations to meet the varied needs and requirements of our law enforcement customers. The EVO-HD can support up to four HD in-car cameras – all from a single trigger. The EVO-HD maximizes space and offers top-end reliability when paired with two cameras having pre-event and evidence capture assurance (“ECA”) capabilities to allow agencies to review entire shifts.remote service capabilities. An internal cell modem will allow for connectivity to the VuVault.net cloud, powered by Amazon Web Services (“AWS”) and real time metadata when in the field.

The Company offers the DVM-800, a continuation in the family of highly successful digital video mirrored (DVM) systems developed by the Company. The DVM-800 is a time-tested, compact, powerful and easy-to-use solution designed for law enforcement. The DVM-800 system has built-in road and driver facing cameras and can record up to two external HD cameras. The DVM-800 is compatible with the patented VuLink® auto-activation technology and can be paired with a FirstVu HD body-worn camera.

The Company also offers the DVM-800 Lite, an entry level system is a self-contained video recorder, microphone and digital storage system that is integrated into a rear-view mirror and is designed for law enforcement. The system can record up to two internal HD cameras.

In-Car Digital Video “Event Recorder” System – DVM-250 Plus and FLT-250 for Commercial Fleets

Digital Ally provides commercial fleets and commercial fleet managers with the digital video tools that they need to increase driver safety, track assets in real-time and minimize the company’s liability risk while enabling fleet managers to operate the fleet at an optimal level. We market a product designed to address these commercial fleet markets with our DVM-250 Plus and FLT-250 event recorders that provide various types of commercial fleets with features and capabilities that are fully-customizable and consistent with their specific application and inherent risks.

The DVM-250 Plus is a rear-view mirror basedpart of the DVM family and is designed for commercial fleets featuring built-in digital audio and video recording system with many, but nottechnology and other features to provide commercial fleet managers unmatched driver and asset management – all while aiming to deliver the return on investment that matters most: the safety and security of the features of our DVM-800 law enforcement mirror systems, which we sell at a lower price point.drivers and passengers. The DVM-250 Plus is designed to capture events, such as wrecks and erratic driving or other abnormal occurrences, for evidentiary or training purposes. The commercial fleet markets may find our units attractive from both a feature and a cost perspective compared to other providers. We believe that, dueDue to our marketing efforts, commercial fleets are adoptingbeginning to adopt this technology, and in particular, the ambulance and taxi-cab markets.

In the first quarter of 2021, Digital Ally released the FLT-250, offering the same great features of the DVM-250 Plus in a new compact, non-mirrored form factor that allows for multiple mounting options in any vehicle type for commercial fleets. We believe that, due to non-mirror-based aspect of this product, the FLT-250 will become more attractive for our potential customers, as it is a much simpler plug and play option compared to mirror-based products.

Digital Ally offers a suite of data management web-based tools to assist fleet managers in the organization, archival, and management of videos and telematics information. Within the suite, there are powerful mapping and reporting tools that are intended to optimize efficiency, serve as training tools for teams on safety, and, ultimately, generate a significant return on investment for the organization.

 

The Company’s management expectsWe expect the EVO-HD to become the platform for a new family of in-car video solution products for the commercial markets. The innovative EVO-HD technology is expected to replace the current in-car mirror-based systems with a miniaturized system that can be custom-mounted in the vehicle, while offering numerous hardware configurations to meet the varied needs and requirements of the Company’sour commercial customers. In its commercial market application, the EVO-HD can support up to four HD cameras, with two cameras having pre-event and ECA capabilities to allow customers to review entire shifts. An internal cell modem will allow for connectivity to the FleetVUFleetVu Manager cloud-based system for commercial fleet tracking and monitoring, which is powered by AWS and real time metadata when in the field.

Miniature Body-Worn Digital Video System – FirstVUFirstVu Pro, FirstVu II, and FirstVu HD for Law Enforcement and Private Security

During 2021, Digital Ally launched two next generation body-worn cameras and docking stations, refreshing the Company’s complete ecosystem of evidence recording devices. The latest body worn camera launched by the Company is the FirstVu Pro, the Company’s flagship product in its family of next generation of technology. The light weight, one-piece unit captures full HD video and audio, while offering industry leading features such as live streaming, a full-color touchscreen display, an advanced image sensor with IR LEDs, proprietary image distortion reduction, IP67 rated resisting dust and wind and is water submersible for 30 minutes at a depth of 3 feet. It is also MIL-STD-810G compliant capable of handling drops, shock, and vibration, and will function flawlessly in a wide temperature range.

6

In addition to the FirstVu Pro, Digital Ally also added the FirstVu II to its family of next generation technology. The FirstVu II is a one-piece device offering industry leading technology such as an articulating camera head, a full-color display, an advanced image sensor, and GPS. It can be used in law enforcement, private and event security and commercial segments.

Digital Ally still carries the FirstVu HD, the two-piece body-worn camera which allows for multiple mounting options while minimizing space and weight. It can be used in law enforcement, private and event security

and commercial segments. This system is also a derivative of our in-car video systems, but is much smaller and lighter and more rugged and water-resistant to handle a hostile outdoor environment. These systemsThe FirstVu HD can be used in many applications in addition to law enforcement and private security and areis designed specifically to be clipped to an individual’s pocket or other outer clothing. The unit is self-contained and requires no external battery or storage devices. Current systems offered by competitors are digital based, but generally require a battery pack and/or storage device to be connected to the camera by wire or other means. We believe that our FirstVU HD product is more desirable for potential users than our competitors’ offerings because of its video quality, small size, shape and lightweight characteristics. Our FirstVU HD integrates with our in-car video systems through our patented VuLink system allowing for automatic activation of both systems.

7

With the newly introduced body-worn cameras, Digital Ally also introduced two new QuickVu docking stations compatible with the FirstVu PRO and FirstVu II body-worn cameras. The QuickVu docking stations provide a comprehensive and elegant solution for storing and charging body cameras while uploading video evidence to the cloud. QuickVu also allows for rapid reviewing of footage right from the interactive touchscreen display, and is available in eight or twenty-four individual docking bays. For docking with the FirstVu HD body-worn cameras, Digital Ally offers a 12-bay docking station and Mini-Docks. The 12-bay docking station includes a 1TB local memory hard drive which simultaneously upload 4 hours of video from 12 FirstVu HD cameras within a 15-minute shift change and push configuration updates. The Mini-Dock is a single unit, portable smart dock that uploads video evidence to VuVault from a FirstVu HD body camera.

Auto-activation and Interconnectivity between in-car video systemsBetween In-car Video Systems and FirstVU HD body worn camera productsBody-worn Camera Products – VuLink for law enforcement applicationsLaw Enforcement

Recognizing a critical limitation in law enforcement camera technology, we pioneered the development of our VuLink ecosystem that provides intuitive auto-activation functionality as well as coordination between multiple recording devices. The United States Patent and Trademark Office (the “USPTO”) has recognized these pioneering efforts by granting us multiple patents with claims covering numerous features, such as automatically activating an officer’s cameras when the light bar is activateda variety of triggers, including emergency lights and sirens, extreme acceleration or when a data-recording device such as a smart weapon is activated.braking, g-force or any 12-volt relay. Additionally, the awarded patent claims cover automatic coordination between multiple recording devices. Prior to this work,our VuLink ecosystem, officers were forcedhad to manually activate each device while responding to emergency scenarios, a requirement that both decreased the usefulness of the existing camera systems and diverted officers’ attention during critical moments. Our FirstVU HD integrates with our in-car video systems through our patented VuLink system allowing for automatic activation of both systems.

VuVault.netEVO Web and FleetVUFleetVu Manager

VuVault.netEVO Web is a cost-effective, fully expandable, law enforcement cloud storage solutionweb-based software, powered by and hosted on the AWS GovCloud platform, that enables police departments and security agencies to manage digital video evidence quickly and easily. EVO Web is capable of playing back, reviewing, downloading, archiving, unit configuration and management, running customizable reports and maintaining a chain of custody logs. AWS is the most secure cloud platform on the market with features that go beyond simply storing and reviewing video evidence. AWS GovCloud platform is trusted by the Department of Justice, Defense Digital Services for the US Air Force, U.S. Department of Treasury, and U.S. Department of Homeland Security. Our products that are compatible with EVO Web include: FirstVu Pro, FirstVu II, FirstVu HD, QuickVu, EVO-HD, DVM-800 and DVM-800 Lite.

FleetVu Manager is a web-based software that provides redundant and security-enhanced storage of all uploaded videos that complycommercial fleet managers with the United States Federal Bureau of Investigation’s Criminal Justice Information Services Division requirements.

FleetVUtools to increase driver safety, track assets in real-time and minimize their companies’ liability risks. FleetVu Manager is our web-based software forable to generate driver reports, identify at risk behaviors before an incident takes place, and enable commercial fleet trackingmanagers to manage the entire fleet through a single, easy to use platform. Our products compatible with FleetVu Manager include: DVM-250 and monitoringFLT-250.

7

ShieldTM Heath Protection Products

The Company’s ShieldTM brand offers a variety of products to help keep you safe, including; Shield Cleansers, ThermoVu, Shield Electrostatic Sprayer, Shied Disinfectant, and a variety of personal protection equipment including masks, gloves and sanitizer wipes.

Shield Cleansers is a full line of safe and effective hypochlorous acid (HOCl) based products - and is free of toxic bleach, ammonia, methanol, ethanol, and alcohol ingredients. Shield Disinfectant is EPA approved and has shown effectiveness against SARS-COV-2, the virus that featurescauses the novel COVID-19 disease. Other products in the Shield brand include animal wellness products, wound care, and manages video captured by our video event data recorders of incidents requiring attention, such as accidents. This software solution features our cloud-based web portal that utilizes many of the features of our VuVault.net law-enforcement cloud-based storage solution.household cleaning solutions.

ThermoVu and Shield Disinfectants

ThermoVu is a non-contact temperature-screening instrument that measures temperature through the wrist and controls entry to facilities when temperature measurements exceed pre-determined parameters. ThermoVu has optional features such as facial recognition to improve facility security by restricting access based on temperature and/or facial recognition reasons. ThermoVu provides an instant pass/fail audible tone with its temperature display and controls access to facilities based on such results.

Shield DisinfectantsElectrostatic Sprayer is a compact and Cleansers consists of a disinfectantlightweight disinfecting sprayer utilizing electrostatic induction. The charged particles repel each other and cleanser line, whichaffix to surfaces more evenly, eliminating large droplets for better disinfecting coverage. It is ideal for use against virusesin office buildings, schools, and bacteria, that is less harsh than many of the traditional products now widely distributed. Shield Disinfectants and Cleansers is offered in a variety of sizes and quantities.other populated areas.

The Company has also begunbeen distributing other personal protective equipment and supplies, since the second quarter of 2021, such as masks and gloves to supplement its Shield brand of products to health care workers as well as other consumers.consumers, consisting of vinyl and nitrile gloves, level 3 and N95 NIOSH certified face masks, and disposable wipes.

OtherOur Revenue Management Operating Segment Products and Services

DuringThrough our revenue cycle management segment, we provide assistance in providing working capital and back-office services to healthcare organizations throughout the last year,country. Our RCM operating segment services consist of insurance and benefit verification, medical treatment documentation and coding, and collections. Through our expertise and experience in this field, we focusedmaximize our researchcustomers’ service revenues collected, leading to substantial improvements in their operating margins and development effortscash flows. We generally receive a service fee based on a percentage of the service revenues collected by our customers.

Our Entertainment Operating Segment Products and Services

Through our entertainment segment, we provide customers with access to meet the varying needsonline live event ticketing marketplace through our online platform - TicketSmarter.com. Offering over 48 million tickets for sale for over 125,000 live events, TicketSmarter is a national ticket marketplace offering tickets for live events featuring sports, concerts and theatre. TicketSmarter is the official ticket resale partner of ourmore than 35 collegiate conferences, over 300 universities, and hundreds of events and venues.

Our entertainment operating segment primarily receives compensation for its services generally determined as a percentage of the face-value of the tickets being purchased. Our entertainment operating segment also provides customers enhance our existing products and commence development of new products and product categories. Our research and development efforts are intendedwith access to maintain and enhance our competitivenesstickets which it has purchased or received in return for its sponsorship or partnership from the market niche we have carved out, as well as positioning us to compete in diverse markets outside of law enforcement. In December 2019, we announced a partnership with Pivot International for design and manufacture of a new and innovative Breathalyzer Device utilizing our recently issued patent. With this new technology, when an officer is conducting a field sobriety test and the breathalyzer is activated, the digital video recording device will automatically start a recording, later embedding the meta-data captured onto the recorded video. The U.S. Patent No. 10,390,732 (the “‘732 Patent’”) was granted by the U.S. Patent Office in August 2019 and is an expansion of our patented VuLink automatic activation technology.venue, event or owner.

8

Market and Industry Overview – Video Solutions Operating Segment

Historically, ourOur video solutions segment has historically had a primary market has beenof domestic and international law enforcement agencies. In 2012, weWe have since expanded our scope by pursuing the commercial fleet vehicle and mass transit markets. Recently,Additionally, we have expanded into event security services wherebywhere we provide the hardware and software to supplement private security for NASCAR races, football and other sporting events, concerts and other events where people gather. In the future, given sufficient capital and market opportunity, we mayWe continue to further expand orour focus on private security, homeland security, mass transit, healthcare, general retail, educational, general consumer and other commercial markets. In that regard, we have several installations involving private security on cruise ships and similar markets. Our view isWe believe there are many potential private uses of our product offerings. We continue to have sales in the commercial fleet and the ambulance service provider market, confirming that our DVM-250 Plus product and FleetVUFLT-250 products and FleetVu Manager can become a significant revenue producer for us.

Law Enforcement

We believe that Additionally, our body-worn cameras have applications in law enforcement, already recognizes a valuable use of our various digital audio/video products foralong with private and event security, as well as commercial segments. With the recording of roadside sobriety tests. Without some form of video or audio recording, court proceedings usually consist ofrecent acquisitions we completed in 2021, we hope to utilize the police officer’s word against that of the suspect. Records show that conviction rates increase substantially where there is video evidenceconnections we now have to back up officer testimony. Video evidence also helps to protect police departments against frivolous lawsuits.live events, stadiums, and arenas, as well as new medical connections.

An important source of police video evidence today is in-car video. Some police cars still do not have in-car video, and in those that do, the camera usually points forward rather than to the side of the road where the sobriety test takes place. The in-car video is typically of little use for domestic violence investigations, burglary or theft investigations, disorderly conduct calls or physical assaults. In virtually all of these cases, the FirstVU HD may provide recorded evidence of the suspect’s actions and reactions to police intervention.

Additionally, motorcycle patrolmen rarely have video systems. Our FirstVU body camera is well suited as a mobile application of our digital video recording system that can be used by motorcycle police and water patrol.

Crime scene investigations, including detailed photography, are typically a large part of the budgets of metropolitan police forces. The FirstVU may record a significant portion of such evidence at a much lower cost for gathering, analyzing and storing data and evidence.

Commercial and Other Markets

There are numerous potential applications for our digital audio/video camera products. We believe that other potential markets for our digital video systems, including the derivatives currently being developed, include private investigators, SWAT team members, over-the-road trucking fleets, airport security, municipal fire departments, and the U.S. military. Other potential commercial markets for our digital video systems include sporting venues and arenas.

Schools

We believe our products and offerings may be of benefit in kindergarten through twelve grade school systems. We are assessing our entry into this potential market through several pilot tests. Preliminary results of our exploration of this market have been mixed, but we believe it may represent a new addressable market for our mobile audio/video recording products in the future. Recent tragic events at schools have heightened the need for providing a “safer” environment in general for schools. Additionally, we believe this market would heavily utilize our new ThermoVu and Shield lines as the economy continues to deal with the Covid-19 pandemic.

98
 

Market and Industry Overview – Revenue Cycle Management Operating Segment

Private Security Companies

There are thousandsOur revenue cycle management segment consists of private security agenciesend-to-end revenue cycle management services that focuses on claim reimbursement billing, verification, and related services to medical providers throughout the country. We offer agreements with customers in which we provide our services and bill the customers monthly for our services. The healthcare industry in the United States employingrepresents a large numberstrong portion of guards. Police forces use video systems for proof of correct conduct by officers, but private security services usually have no such tool. We believe that the FirstVU HD is an excellent management toolUnited States’ economy, offering a robust market for these companiesservices. Our current market includes many diverse specialties, including radiology, oncology, orthopedics, pediatrics, internal medicine, and cardiology. We continue to monitor conductinvestigate ways to expand our market reach, although can make no assurances in that regard.

Market and timing of security rounds. In additionIndustry Overview – Entertainment Operating Segment

Our entertainment segment refers to the FirstVU HD,sale of event tickets primarily through our online and mobile platforms. We will buy inventory of event ticket to then sell tickets through various platforms, including our own. Our resale services refer to the digital video security camera can provide fill-in security when guards have large areassale of tickets by a holder, who originally obtained the tickets directly from a venue or entity, through our platform in which we then collect services fees on the transaction. This is commonly referred to coveras secondary ticketing. We work directly with consumers looking to buy or in areas that do not have to be monitored around the clock.

Event Security

Recently, we have expanded intosell event security services whereby we provide the hardware and software to supplement private securitytickets for NASCAR races, footballparticular shows, concerts, games, and other sporting events, concertsallowing a simple and similar events where people gather. In this regard, we have obtained new customers including the Kansas City Chiefs, Met-Life Stadium, NASCAR and a number of other customers who have a need for event security for specific dates rather than 100% of the time. Additionally, we believe this market would heavily utilize our new ThermoVu and Shield lines as the economy continueseffective platform to deal with the Covid-19 pandemic. We believe that this area will be a productive source of future revenues.

Homeland Security Market

In addition to the government, U.S. corporations are spending heavily for protection against potential terrorist attacks. Public and private-sector outlays for antiterrorism measures and for protection against other forms of violence are significant. These are potential markets for our products.

Manufacturing

We have entered into contracts with manufacturers for the assembly of the printed circuit boards used in our products. Dedicated circuit board manufacturers are well-suited to the assembly of circuit boards with the complexity found in our products. Dedicated board manufacturers can spread the extensive capital equipment costs of circuit board assembly among multiple projects and customers. Such manufacturers also have the volume to enable the frequent upgrade to state-of-the-art equipment. We have identified multiple suppliers who meet our quality, cost, and performance criteria.move tickets. We also usecurrently partner with more than one source for circuit board assembly to ensure a reliable supply35 collegiate conferences, over time. We use contract manufacturers to manufacture our component subassemblies300 universities, and may eventually use them to perform final assemblyhundreds of events and testing. Due to the complexity of our products, we believe that it is important to maintain a core of knowledgeable production personnel for consistent quality and to limit the dissemination of sensitive intellectual property, and we expect to continue this practice. In addition, such technicians are valuable in our service and repair business to support our growing installed customer base.venues.

We also contract with two manufacturers that have manufacturing facilities in the Philippines and South Korea to produce our DVM-250 Plus, DVM-800 and DVM-800 HD products. The contracts are general in nature addressing confidentiality and other matters, have no minimum purchase requirements and require the acceptance of specific purchase orders to support any product supply acquisitions. We are using additional contract manufacturers based in the United States for these product lines to further mitigate any supply disruption risk and ensure competitive pricing. We typically perform final assembly, testing and quality control functions for these products in our Lenexa, Kansas facility.

Sales and Marketing

We have an employee-based, direct sales force for domestic selling efforts that enables us to control and monitor its daily activities and independent distributors for international sales. Our sales force is organized in seven territories. The direct territory sales team is supported by a team of five inside sales representatives, a tele-sales specialist and a pre-sales solution design team. We also have a bid specialist to coordinate large bid opportunities. We believe our employee-based model encourages our sales personnel in lower performing territories to improve their efforts and, consequently, their sales results. Our executive team also supports sales agents with significant customer opportunities by providing pricing strategies and customer presentation assistance. Our technical support personnel may also provide sales agents with customer presentations and product specifications in order to facilitate sales activities.

10

We use our direct sales force and international distributors to market our products. Our key promotional activities include:

attendance at industry trade shows and conventions;
direct sales, with a force of industry-specific sales individuals who identify, call upon and build on-going relationships with key purchasers and targeted industries;
support of our direct sales with passive sales systems, including inside sales and e-commerce;
print advertising in journals with specialized industry focus;
direct mail campaigns targeted to potential customers;
web advertising, including supportive search engines and website and registration with appropriate sourcing entities;
our NASCAR relationship is supportive of developing new business opportunities by and between the sponsors at NASCAR sponsored events in addition to the races;
public relations, industry-specific venues, as well as general media, to create awareness of our brand and our products, including membership in appropriate trade organizations; and
brand identification through trade names associated with us and our products.

Competition - Video Solutions Operating Segment

TheOur video solutions segment, consisting of law enforcement and security surveillance markets, areis extremely competitive. Competitive factors in these industries include ease of use, quality, portability, versatility, reliability, accuracy and cost. There are direct competitors with technology and products in the law enforcement and surveillance markets for all of our products, including those that are in development. Many of these competitors have significant advantages over us, including greater financial, technical, marketing and manufacturing resources, more extensive distribution channels, larger customer bases and faster response times to adapt new or emerging technologies and changes in customer requirements. Our primary competitors in the in-car video systems market include L-3 Mobile-Vision, Inc., Coban Technologies, Inc., Enforcement Video, LLC d/b/a WatchGuard Video (“WatchGuard”), Kustom Signals, Panasonic System Communications Company, International Police Technologies, Inc. and a number of other competitors who sell, or may in the future sell, in-car video systems to law enforcement agencies. Our primary competitors in the body-worn camera market include Axon Enterprises, Inc. (“Axon”), Reveal Media, WatchGuard, and VieVU, Inc., which was acquired by Axon in 2018. We face similar and intense competitive factors for our event recorders in the mass transitcommercial fleet and private security markets as we do in the law enforcement and security surveillance markets. We will also compete with any company making surveillance devices for commercial use. There can be no assurance that we will be able to compete successfully in these markets. Further, there can be no assurance that new and existing companies will not enter the law enforcement and security surveillance markets in the future.

The commercial fleet security and surveillance markets likewise are also very competitive. There are direct competitors for our FLT-250 and DVM-250 Plus “event recorders,” which may have greater financial, technical marketing, and manufacturing resources than we do. Our primary competitors in the commercial fleet sector include Lytx, Inc. (previously DriveCam, Inc.) and SmartDrive Systems.Systems, among others.

 

9

Competition – Revenue Cycle Management Operating Segment

Our revenue cycle management segment is a highly competitive market that is only intensifying as the market continues to grow. We face competition from a variety of sources, including internal revenue cycle management departments within healthcare organizations, as these organizations are beginning to make internal investments in these departments to keep these services in house. Additionally, other revenue cycle management providers exist and offer similar services through software vendors, traditional consultants, and information technology sources.

Competition – Entertainment Operating Segment

Our entertainment segment faces robust competition from several sources throughout the industry. As the online and mobile ticketing market continues to increase, it has allowed for more technology-based companies to offer ticketing services and systems. The online environment consists of numerous other websites and platforms for all markets. With the market continuing to grow, resale marketplaces and websites can reach a vastly larger audience with more convenient access to tickets for a wide variety of events. We continue to build our brand and recognition, through the numerous partnerships and sponsorships throughout the country, in attempt to become a preferred platform for consumers.

Worldwide Reinsurance Ltd.

In December 2021, the Company formed a wholly-owned subsidiary, Worldwide Reinsurance Ltd. (“Worldwide Re”), a Bermuda incorporated captive insurance company that will provide primarily liability insurance coverage to the Company for which insurance may not be currently available or economically feasible in today’s insurance marketplace.

Worldwide Re is subject to capital and other regulatory requirements imposed by the Bermuda Monetary Authority (“BMA”). Although these capital requirements are generally less constraining than U.S. capital requirements, failure to satisfy these requirements could result in regulatory actions from the BMA or loss of or modification of Worldwide Re’s Class 1 insurer license, which could adversely impact our ability to support our insurance needs and to grow this business into another line of business for our holding company. To date, our captive’s relatively immature claims history limits the predictive value of estimating the costs of incurred and future claims. Accordingly, the captive could continue to incur significant fluctuations in financial results as the captive provides insurance coverage to Digital Ally and its affiliated businesses and seeks to expand beyond our affiliated companies to offer coverage for third parties.

Intellectual Property – Video Solutions Operating Segment

Our video solutions operating segment’s ability to compete effectively will depend on our success in protecting our proprietary technology, both in the United States and abroad. We have filed for patent protection in the United States and certain other countries to cover certain design aspects of our products.

11

Some of our patent applications are still under review by the USPTO and, therefore, we have not yet been issued all the patents that we applied for in the United States. We were issued several patents in recent years, including a patent on our VuLink product that provides automatic triggering of our body-worn camera and our in-car video systems. No assurance can be given which, or any, of the patents relating to our existing technology will be issued from the United States or any foreign patent offices. Additionally, no assurance can be given that we will receive any patents in the future based on our continued development of our technology, or that our patent protection within and/or outside of the United States will be sufficient to deter others, legally or otherwise, from developing or marketing competitive products utilizing our technologies.

We have entered into supply and distribution agreements with several companies that produce certain of our products, including our DVM-250 and DVM-800 products. These supply and distribution agreements contain certain confidentiality provisions that protect our proprietary technology, as well as that of the third-party manufacturers.

In addition to seeking patent protection, we rely on trade secrets, know-how and continuing technological advancement to seek to achieve and thereafter maintain a competitive advantage. Although we have entered into or intend to enter into confidentiality and invention agreements with our employees, consultants and advisors, no assurance can be given that such agreements will be honored or that we will be able to effectively protect our rights to our unpatented trade secrets and know-how. Moreover, no assurance can be given that others will not independently develop substantially equivalent proprietary information and techniques or otherwise gain access to our trade secrets and know-how.

10

Intellectual Property – Revenue Cycle Management Operating Segment

Our revenue cycle management’s operating segment’s ability to compete effectively primarily depends on our trade secrets and know-how and does not depend heavily on any proprietary technology or patents.

Intellectual Property – Entertainment Operating Segment

Our entertainment operating segment’s ability to compete effectively primarily depends on our trade secrets and know-how and does not depend heavily on any proprietary technology or patents.

Human Capital

As of December 31, 2020,2022, Digital Ally, and its subsidiaries, had approximately 201 full-time 86 employees spread throughout the country, representing the core values and objectives of the Company. These employees are spread amongst our operating segments as follows:

As of
December 31,
2022
Employee headcount:
Video Solutions109
Revenue Cycle Management [1]78
Entertainment14
Total Employee Headcount201

[1] Our revenue cycle management operating segment has no direct employees. Nobility Healthcare, our minority interest partner provides all human capital resources to manage and operate the Company’s revenue cycle management operating segment.

Our employees are our most important assets and they set the foundation for our ability to achieve our strategic objectives. All of our employees contribute to Digital Ally’s success and, in particular, the employees in our manufacturing, sales, research and development, and quality assurance departments are instrumental in driving operational execution and strong financial performance, advancing innovation and maintaining a strong quality and compliance program.

Our employees are not covered by any collective bargaining agreement, and we have never experienced a work stoppage. We strive to create a culture and work environment that enables us to attract, train, promote, and retain a diverse group of talented employees who together can help us gain a competitive advantage. Our key programs and initiatives that are focused to attract, develop and retain our diverse workforce include:

Compensation Programs and Employee Benefits: the main objective of Digital Ally’s compensation program is to provide a compensation package that will attract, retain, motivate and reward superior employees who must operate in a highly competitive and technologically challenging environment. We seek to do this by linking annual changes in compensation to overall Company performance, as well as each individual’s contribution to the results achieved. The emphasis on overall Company performance is intended to align the employee’s financial interests with the interests of shareholders. Digital Ally also seeks fairness in total compensation with reference to external comparisons, internal comparisons and the relationship between management and non-management remuneration. The structure of our compensation programs balances incentive earnings for both short-term and long-term performance. Specifically:

11
 

We provide employee wages that are competitive and consistent with employee positions, skill levels, experience, knowledge and geographic location.
We align our executives’ long-term equity compensation with our shareholders’ interests by linking realizable pay with stock performance.
Annual increases and incentive compensation are based on merit, which is communicated to employees at the time of hiring and documented through our talent management process as part of our annual review procedures and upon internal transfer and/or promotion.
All employees are eligible for health insurance, paid and unpaid leaves, short-term disability, worker’s compensation, long-term disability, a retirement plan and life and disability/accident coverage. We also offer a variety of voluntary benefits that allow employees to select the options that meet their needs.

12

Item 1A.Employee Health and Safety: the health and safety of our employees are top priorities, which was emphasized this year amidst the global COVID-10 pandemic. Digital Ally is committed to operating in a safe, secure and responsible manner for the benefit of its employees, customers and communities Digital Ally serves. Our safety focus is evident in our response to the COVID-19 pandemic:Risk Factors.

Expanding work from home flexibility;
Initiating regular communication regarding impacts of the COVID-19 pandemic, including health and safety protocols and procedures;
Implementing temperature screening of employees at the majority of our manufacturing facilities;
Increasing cleaning protocols across all locations;
Providing additional personal protective equipment and cleaning supplies;
Implementing protocols to address actual and suspected COVID-19 cases and potential exposure; and
Requiring masks to be worn in all locations.

Item 1A.Risk Factors.

Not applicable.

Item 1B.Unresolved Staff Comments.

None.

12

Item 2.Properties.

On May 13, 2020, the Company entered into an operating lease for new warehouse and office space which hashad served as its new principal executive office and primary business location, since June 15, 2020. Ourprior to the completed building purchase. The Company plans to relocate the entertainment operating segment operations to this existing leased facility in 2023. This facility contains approximately 16,531 square feet and is located at 15612 College Blvd, Lenexa, Kansas 66219. The lease terms, as amended, include no base rent for the first nine months and monthly payments ranging from $12,398 to $14,741 thereafter, with a termination date of December 31, 2026.

On February 24,April 30, 2021, the Company entered into a contractclosed on the purchase and sale agreement to purchaseacquire a 71,361 square footfeet commercial office building located in Lenexa, Kansas which is intended to serve as the Company’s future office and warehouse needs.needs for executive offices and for management and warehouse operations for the video solutions operating segment. The building contains approximately 30,000 square footfeet of office space and the remainder warehouse space. The total purchase price iswas approximately $5.3 millionmillion. The Company funded the purchase price with cash on hand, without the addition of external debt or other financing.

On June 30, 2021, the Company completed the acquisition of a private medical billing company, through Nobility Healthcare, a majority owned subsidiary. Upon completion of this acquisition, Nobility Healthcare became responsible for the operating lease for the seller’s office space. The lease terms include monthly payments ranging from $2,648 to $2,774 and is expectedterminate in July 2024. The Company plans to close onrelocate the revenue cycle management operating segment acquired operations to existing owned or around Mayleased facilities upon termination of this operating lease.

On August 31, 2021, the Company completed the acquisition of another private medical billing company, through Nobility Healthcare. Upon completion of this acquisition, Nobility Healthcare became responsible for the operating lease for the seller’s office space. The lease terms include monthly payments ranging from $11,579 to $11,811 and terminate in March 2023. The Company plans to relocate the revenue cycle management operating segment acquired operations to existing owned or leased facilities upon termination of this operating lease.

On September 1, 2021.2021, the Company completed the acquisition of Goody Tickets, LLC and TicketSmarter, LLC, through TicketSmarter. Upon completion of this acquisition, the Company became responsible for the operating lease for the TicketSmarter office space. The lease terms included monthly payments ranging from $7,211 to $7,364 and expired in December 2022. The Company signed a six month extension through June 2023, and plans to relocate the entertainment operating segment operations at that time.

 

On January 1, 2022, the Company completed the acquisition of another private medical billing company, through Nobility Healthcare. Upon completion of this acquisition, Nobility Healthcare became responsible for the operating lease for the seller’s office space. The lease terms include monthly payments ranging from $4,233 to $4,626 and terminate in June 2025. The Company plans to relocate the revenue cycle management operating segment acquired operations to existing owned or leased facilities upon termination of this operating lease.

Item 3.Legal Proceedings.

The Company is subject to various legal proceedings arising from normal business operations. Although there can be no assurances, based on the information currently available, management believes that it is probable that the ultimate outcome of each of the actions will not have a material adverse effect on the consolidated financial statement of the Company. However, an adverse outcome in certain of the actions could have a material adverse effect on the financial results of the Company in the period in which it is recorded.

Axon

The Company owns U.S. Patent No. 9,253,452 (the “‘452 Patent’”), which generally covers the automatic activation and coordination of multiple recording devices in response to a triggering event, such as a law enforcement officer activating the light bar on the vehicle.

13

The Company filed suit on January 15, 2016 in the U.S. District Court for the District of Kansas (Case No: 2:16-cv-02032) against Axon, alleging willful patent infringement against Axon’s body camera product line and Signal auto-activation product. The Company is seeking both monetary damages and a permanent injunction against Axon for infringement of the ‘452 Patent.

In December 2016 and January 2017, Axon filed two petitions for Inter Partes Review (“IPR”) against the ‘452 Patent. The USPTO rejected both of Axon’s petitions. Axon is now statutorily precluded from filing any more IPR petitions against the ‘452 Patent.

The District Court litigation in Kansas was temporarily stayed following the filing of the petitions for IPR. However, on November 17, 2017, the Federal District Court of Kansas rejected Axon’s request to maintain the stay. With this significant ruling, the parties will now proceed towards trial. Since litigation has resumed, the Court has issued a claim construction order (also called a Markman Order) where it sided with the Company on all disputes and denied Axon’s attempts to limit the scope of the claims. Following the Markman Order, the Court set all remaining deadlines in the case. Fact discovery closed on October 8, 2018, and a Final Pretrial Conference took place on January 16, 2019. The parties filed motions for summary judgment on January 31, 2019.

On June 17, 2019, the Court granted Axon’s motion for summary judgment that Axon did not infringe on the Company’s patent and dismissed the case. Importantly, the Court’s ruling did not find that Digital’s ‘452 Patent was invalid. It also did not address any other issue, such as whether Digital’s requested damages were appropriate, and it did not impact the Company’s ability to file additional lawsuits to hold other competitors accountable for patent infringement. This ruling solely related to an interpretation of the claims as they relate to Axon and was unrelated to the supplemental briefing Digital recently filed on its damages claim and the WatchGuard settlement. Those issues are separate and the judge’s ruling on summary judgment had nothing to do with Digital’s damages request.

The Company filed an opening appeal brief on August 26, 2019 with the U.S. Court of Appeals for the Tenth Circuit (the “Court of Appeals”), appealing the U.S. District Court’s granting of Axon’s motion for summary judgment. Axon responded by filing a responsive brief on November 6, 2019 and we then filed a reply brief responding to Axon on November 27, 2019. The Court of Appeals scheduled oral arguments on our appeal of the U.S. District Court’s summary judgment ruling on April 6, 2020. This appeal was intended to address the Company’s position that the U.S. District Court incorrectly dismissed our claims against Axon. If the Court of Appeals overturns the ruling of the U.S. District Court, the case will be remanded to the U.S District Court before a new judge. On March 12, 2020, the panel of judges for the Court of Appeals issued an order cancelling the oral arguments previously set for April 6, 2020, having determined that the appeal will be decided solely based on the parties’ briefs. On April 22, 2020, a three-judge panel of the United States Court of Appeals denied our appeal and affirmed the District Court’s previous decision to grant Axon summary judgment. On May 22, 2020, we filed a petition for panel rehearing requesting that we be granted a rehearing of our appeal of the U.S. District Court’s summary judgment ruling. Furthermore, we filed a motion requesting that we be given an opportunity to make our case through oral argument in front of the three-judge panel of the Court of Appeals, which motion was denied on June 9, 2020. The Company had until November 7, 2020 to decide whether it would appeal the U.S. District Court’s and Court of Appeals’ decisions to the United States Supreme Court. The Company has abandoned its right to any further appeals.

WatchGuard

On May 27, 2016, the Company filed suit against WatchGuard, (Case No. 2:16-cv-02349-JTM-JPO) alleging patent infringement based on WatchGuard’s VISTA Wi-Fi and 4RE In-Car product lines.

On May 13, 2019, the parties resolved the dispute and executed a settlement agreement in the form of a Release and License Agreement. The litigation has been dismissed as a result of this settlement.

The Release and License Agreement encompasses the following key terms:

WatchGuard paid Digital Ally a one-time, lump settlement payment of $6,000,000.
Digital Ally granted WatchGuard a perpetual covenant not to sue if WatchGuard’s products incorporate agreed-upon modified recording functionality. Digital Ally also granted WatchGuard a license to the ‘292 Patent and the ‘452 Patent (and related patents, now existing and yet-to-issue) through December 31, 2023. The parties agreed to negotiate in good faith to attempt to resolve any alleged infringement that occurs after the license period expires.
The parties further agreed to release each other from all claims or liabilities pre-existing the settlement.
As part of the settlement, the parties agreed that WatchGuard made no admission that it infringed any of Digital Ally’s patents.

Upon receipt of the $6,000,000 the parties filed a joint motion to dismiss the lawsuit with the court, which was granted.

14

General

From time to time, we are notified that we may be a party to a lawsuit or that a claim is being made against us. It is our policy to not disclose the specifics of any claim or threatened lawsuit until the summons and complaint are actually served on us. After carefully assessing the claim, and assuming we determine that we are not at fault or we disagree with the damages or relief demanded, we vigorously defend any lawsuit filed against us. We record a liability when losses are deemed probable and reasonably estimable. When losses are deemed reasonably possible but not probable, we determine whether it is possible to provide an estimate of the amount of the loss or range of possible losses for the claim, if material for disclosure. In evaluating matters for accrual and disclosure purposes, we take into consideration factors such as our historical experience with matters of a similar nature, the specific facts and circumstances asserted, the likelihood of our prevailing, the availability of insurance, and the severity of any potential loss. We reevaluate and update accruals as matters progress over time.

 

13

While the ultimate resolution is unknown, we do not expect that these lawsuits will individually, or in the aggregate, have a material adverse effect to our results of operations, financial condition or cash flows. However, the outcome of any litigation is inherently uncertain and there can be no assurance that any expense, liability or damages that may ultimately result from the resolution of these matters will be covered by our insurance or will not be in excess of amounts recognized or provided by insurance coverage and will not have a material adverse effect on our operating results, financial condition or cash flows.

Culp McCauley

On May 31, 2022, the Company filed a lawsuit against Culp McAuley, Inc. (“defendant”) in the United States District Court for the District of Kansas. The lawsuit arises from the defendant’s multiple breaches of its obligations to the Company. The Company seeks monetary damages and injunctive relief based on certain conduct by the defendant. On July 18, 2022, the defendant filed its Answer to the Company’s Verified Complaint and included Counterclaims alleging breach of contract and seeking monetary damages. On August 8, 2022, the Company filed its Reply and Affirmative Defenses to the Counterclaims by, among other things, denying the allegations and any and all liability. We have not concluded that a material loss related to the allegations is probable, nor have we accrued a liability related to these claims. Although we believe a loss could be reasonably possible (as defined in ASC 450), we do not have sufficient information to determine the amount or range of reasonably possible loss with respect to the potential damages given that the dispute is yet to enter the discovery process. We will continue to vigorously pursue these claims, and we continue to believe that we have valid grounds for recovery of the disputed deliverables. However, there can be no assurances as to the outcome of the dispute.

Item 4.Mine Safety Disclosures.

Not applicable.

1514
 

PART II

Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Market Prices

Our common stock, par value $0.001 per share (“Common Stock”), commenced trading on the Nasdaq Capital Market on January 2, 2008 under the symbol “DGLY,” and continues to do so. From July 2007 until we became listed on the Nasdaq Capital Market, our Common Stock was traded on the OTC Bulletin Board and prior to that it was quoted in the “Pink Sheets.”

Holders of Common Stock

 

As of March 31, 2021,2023, we had approximately 158170 shareholders of record for our Common Stock.

Dividend Policy

To date, we have not declared or paid cash dividends on our shares of Common Stock. The holders of our Common Stock will be entitled to non-cumulative dividends on the shares of Common Stock, when and as declared by our board of directors (the “Board(“Board of Directors” or the “Board”), in its discretion. We intend to retain all future earnings, if any, for our business and do not anticipate paying cash dividends in the foreseeable future.

Any future determination to pay cash dividends will be at the discretion of our Board and will be dependent upon our financial condition, results of operations, capital requirements, general business conditions and such other factors as our Board may deem relevant.

Securities Authorized for Issuance under Equity Compensation Plans

Our Board of Directors adopted the 2005 Stock Option and Restricted Stock Plan (the “2005 Plan”) on September 1, 2005. The 2005 Plan authorized us to reserve 312,500 shares of our Common Stock for issuance upon exercise of options and grant of restricted stock awards. The 2005 Plan terminated in 2015 with 19,678 shares of Common Stock reserved for awards that are now unavailable for issuance. Stock options granted under the 2005 Plan that remain unexercised and outstanding as of December 31, 2020 total 7,563.

On January 17, 2006, our Board adopted the 2006 Stock Option and Restricted Stock Plan (the “2006 Plan”). The 2006 Plan authorizes us to reserve 187,500 shares of Common Stock for future grants under it. The 2006 Plan terminated in 2016 with 25,849 shares of Common Stock reserved for awards that are now unavailable for issuance. Stock options granted under the 2006 Plan that remain unexercised and outstanding as of December 31, 2020 total 39,750.

On January 24, 2007, our Board adopted the 2007 Stock Option and Restricted Stock Plan (the “2007 Plan”). The 2007 Plan authorizes us to reserve 187,500 shares of Common Stock for future grants under it. The 2007 Plan terminated in 2017 with 89,651 shares of Common Stock reserved for awards that are now unavailable for issuance. Stock options granted under the 2007 Plan that remain unexercised and outstanding as of December 31, 2020 total 5,000.

On January 2, 2008, our Board adopted the 2008 Stock Option and Restricted Stock Plan (the “2008 Plan”). The 2008 Plan authorizes us to reserve 125,000 shares of Common Stock for future grants under it. The 2008 Plan terminated in 2018 with 9,249 shares of Common Stock reserved for awards that are now unavailable for issuance. Stock options granted under the 2008 Plan that remain unexercised and outstanding as of December 31, 2020 total 31,250.

On March 18, 2011, our Board adopted the 2011 Stock Option and Restricted Stock Plan (the “2011 Plan”). The 2011 Plan authorizes us to reserve 62,500 shares of Common Stock for future grants under it. At December 31, 2020, there were 726 shares of Common Stock reserved for awards available for issuance under the 2011 Plan. Stock options granted under the 2011 Plan that remain unexercised and outstanding as of December 31, 2020 total 9,750.

On March 22, 2013, our Board adopted the 2013 Stock Option and Restricted Stock Plan (the “2013 Plan”). The 2013 Plan was amended on March 28, 2014 and November 14, 2014 to increase the number of shares of Common Stock authorized and reserved for issuance under the 2013 Plan to a total of 300,000. At December 31, 2020, there were 100 shares of Common Stock reserved for awards available for issuance under the 2013 Plan. Stock options granted under the 2013 Plan that remain unexercised and outstanding as of December 31, 2020 total 20,000.

16

On March 27, 2015, our Board of Directors adopted the 2015 Stock Option and Restricted Stock Plan (the “2015 Plan”). The 2015 Plan was amended on February 25, 2016 and May 31, 2017 to increase the number of shares of Common Stock authorized and reserved for issuance under the 2015 Plan to a total of 1,250,000. At December 31, 2020, there were 3,686 shares of Common Stock reserved for awards available for issuance under the 2015 Plan, as amended. Stock options granted under the 2015 Plan that remain unexercised and outstanding as of December 31, 2020 total 130,000.

On April 12, 2018, our Board of Directors adopted the 2018 Stock Option and Restricted Stock Plan (the “2018 Plan”). The 2018 Plan was amended on May 21, 2019 to increase the number of shares of Common Stock authorized and reserved for issuance under the 2018 Plan to a total of 1,750,000. At December 31, 2020, there were 625,500 shares of Common Stock reserved for awards available for issuance under the 2018 Plan. Stock options granted under the 2018 Plan that remain unexercised and outstanding as of December 31, 2020 total 340,000.

On September 9, 2020, our board of directors adopted the 2020 Stock Option and Restricted Stock Plan (the “2020 Plan”). The 2020 Plan authorizes us to reserve 1,500,000 shares of Common Stock for future grants under it. At December 31, 2020, there were 408,341 shares of Common Stock reserved for awards available for issuance under the 2020 Plan. Stock options granted under the 2020 Plan that remain unexercised and outstanding as of December 31, 2020 total 255,000.

The 2005 Plan, 2006 Plan, 2007 Plan, 2008 Plan, 2011 Plan, 2013 Plan, 2015 Plan, 2018 Plan, and 2020 Plan are collectively referred to as the “Plans.”

The Plans authorize us to grant (i) to the key employees incentive stock options (except for the 2007 Plan) to purchase shares of Common Stock and non-qualified stock options to purchase shares of Common Stock and restricted stock awards, and (ii) to non-employee directors and consultants’ non-qualified stock options and restricted stock. The Compensation Committee of our Board (the “Compensation Committee”) administers the Plans by making recommendations to the Board or determinations regarding the persons to whom options or restricted stock should be granted and the amount, terms, conditions and restrictions of the awards.

The Plans allow for the grant of incentive stock options (except for the 2007 Plan), non-qualified stock options and restricted stock awards. Incentive stock options granted under the Plans must have an exercise price at least equal to 100% of the fair market value of the Common Stock as of the date of grant. Incentive stock options granted to any person who owns, immediately after the grant, stock possessing more than 10% of the combined voting power of all classes of our stock, or of any parent or subsidiary corporation, must have an exercise price at least equal to 110% of the fair market value of the Common Stock on the date of grant. Non-statutory stock options may have exercise prices as determined by our Compensation Committee.

The Compensation Committee is also authorized to grant restricted stock awards under the Plans. A restricted stock award is a grant of shares of the Common Stock that is subject to restrictions on transferability, risk of forfeiture and other restrictions and that may be forfeited in the event of certain terminations of employment or service prior to the end of a restricted period specified by the Compensation Committee.

We have filed various registration statements on Form S-8 and amendments to previously filed Form S-8’s with the Securities and Exchange Commission (the “SEC”), which registered a total of 5,675,000 shares of Common Stock issued or to be issued upon exercise of the stock options underlying Plans.

The following table sets forth certain information regarding the Plans as of December 31, 2020:

Equity Compensation Plan Information

Plan category Number of securities to be issued upon exercise of outstanding options, warrants and rights (a)  Weighted-average exercise price of outstanding options, warrants and rights (b)  Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (c) 
Equity compensation plans approved by stockholders  833,313  $3.15   1,064,346 
Equity compensation plans not approved by stockholders  5,000  $11.36    
Total all plans  838,313  $3.20   1,064,346 

17

Recent Sales of Unregistered Securities

Except as previously reported by the Company on its Quarterly Reports on Form 10-Q or its Current Reports on Form 8-K, as applicable, we did not sell any securities during the period covered by this Annual Report on Form 10-K that were not registered under the Securities Act.

Item 6.Selected Financial Data.[Reserved].

Not applicable.

Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operation.

This Reportdiscussion contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “may,” “should,” “could,” “will,” “plan,” “future,” “continue,” and other expressions that are predictions of or indicate future events and trends and that do not relate to historical matters identify forward-looking statements. These forward-looking statements are based largely on our expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond our control. Therefore, actual results could differ materially from the forward-looking statements contained in this document, and readers are cautioned not to place undue reliance on such forward-looking statements.

We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. A wide variety of factors could cause or contribute to such differences and could adversely impact revenues, profitability, cash flows and capital needs. There can be no assurance that the forward-looking statements contained in this document will, in fact, transpire or prove to be accurate.

Factors that could cause or contribute to our actual results differing materially from those discussed herein or for our stock price to be adversely affected include, but are not limited to: (1) our losses in recent years, including fiscal 2020years 2022 and 2019;2021; (2) economic and other risks for our business from the effects of the COVID-19 pandemic, including the impacts on our law-enforcement and commercial customers, suppliers and employees and on our ability to raise capital as required; (3) our ability to increase revenues, increase our margins and return to consistent profitability in the current economic and competitive environment; (4) our operation in developing markets and uncertainty as to market acceptance of our technology and new products; (5) the availability of funding from federal, state and local governments to facilitate the budgets of law enforcement agencies, including the timing, amount and restrictions on such funding; (6) our ability to deliver our new product offerings as scheduled in 2020, such as the Shield™ disinfectant/sanitizers products2023, and ThermoVU™ temperature screening systems, whether such new products perform as planned or advertised and whether they will help increase our revenues; (7) whether we will be able to increase the sales, domestically and internationally, for our products in the future; (8) our ability to maintain or expand our share of the market for our products in the domestic and international markets in which we compete, including increasing our international revenues; (9) our ability to produce our products in a cost-effective manner; (10) competition from larger, more established companies with far greater economic and human resources; (11) our ability to attract and retain quality employees; (12) risks related to dealing with governmental entities as customers; (13) our expenditure of significant resources in anticipation of sales due to our lengthy sales cycle and the potential to receive no revenue in return; (14) characterization of our market by new products and rapid technological change; (15) our dependence on sales of our EVO-HD, DVM-800, FirstVU HD and DVM-250 products; (16) that stockholders may lose all or part of their investment if we are unable to compete in our markets and return to profitability; (17)(16) defects in our products that could impair our ability to sell our products or could result in litigation and other significant costs; (18)(17) our dependence on key personnel; (19)(18) our reliance on third-party distributors and sales representatives for part of our marketing capability; (20)(19) our dependence on a few manufacturers and suppliers for components of our products and our dependence on domestic and foreign manufacturers for certain of our products; (21)(20) our ability to protect technology through patents and to protect our proprietary technology and information, such as trade secrets, through other similar means; (22)(21) our ability to generate more recurring cloud and service revenues; (23)(22) risks related to our license arrangements; (24)(23) our revenues and operating results may fluctuate unexpectedly from quarter to quarter; (25)(24) sufficient voting power by coalitions of a few of our larger stockholders, including directors and officers, to make corporate governance decisions that could have a significant effect on us and the other stockholders; (26)(25) the sale of substantial amounts of our Common Stock that may have a depressive effect on the market price of the outstanding shares of our Common Stock; (27)(26) the possible issuance of Common Stock subject to options and warrants that may dilute the interest of stockholders; (28)(27) our nonpayment of dividends and lack of plans to pay dividends in the future; (29)(28) future sale of a substantial number of shares of our Common Stock that could depress the trading price of our common stock, lower our value and make it more difficult for us to raise capital; (30)(29) our additional securities available for issuance, which, if issued, could adversely affect the rights of the holders of our Common Stock; (31)(30) our stock price is likely to be highly volatile due to a number of factors, including a relatively limited public float; (32) whether our patented VuLink technology is becoming the de-facto “standard” for agencies engaged in deploying state-of-the-art body-worn and in-car camera systems, which might impact our revenues; (33)(31) whether such technology will have a significant impact on our revenues in the long-term; (34)(32) whether we will be able to meet the standards for continued listing on the Nasdaq Capital Market; and (35)(33) indemnification of our officers and directors.

1815
 

Current Trends and Recent Developments for the Company

Overview

WeVideo Solutions Operating Segment – Within our video solutions operating segment we supply technology-based products utilizing our portable digital video and audio recording capabilities for the law enforcement and security industries and for the commercial fleet and mass transit markets. We have the ability to integrate electronic, radio, computer, mechanical, and multi-media technologies to create uniquepositive solutions to our customers’ requests. Our products includeinclude: the EVO-HD, DVM-800 and DVM-800 Lite, which are in-car digital video mirror systems for law enforcement;enforcement and commercial markets; the FirstVU body-worn camera line, consisting of the FirstVu Pro, FirstVu, and the FirstVU HD, which are body-worn cameras,HD; our patented and revolutionary VuLink product which integrates our body-worn cameras with our in-car systems by providing hands-free automatic activation for both law enforcement and commercial markets; the FLT-250, DVM-250, and DVM-250 Plus, which are aour commercial line of digital video mirrors that serve as “event recorders” for the commercial fleet and mass transit markets; and FleetVUFleetVu and VuLink, which are our cloud-based evidence management systems. We introduced the EVO-HD product in late June 2019further diversified and began full-scale deployments in the third quarter 2019. It is designed and built on a new and advanced technology platform that is expected to become the platform for a new family of in-car video solution products for the law enforcement and commercial markets. We believe that the launch of these new products will help to reinvigorate our in-car and body-worn systems revenues while diversifying and broadening the market forbroadened our product offerings as circumstances normalize in a post-COVID-19 economy, although we can offer no assurance in this regard. The Company has recently added2020, by introducing two new lines of branded products: (1) the ThermoVu™,ThermoVu® which is a line of self-contained temperature monitoring stations that provides alerts and controls facility access when an individual’s temperature exceeds a pre-set threshold and (2) our Shield™ disinfectants and cleansers which are for use against viruses and bacteria. The Company began offering its Shield™ disinfectants and cleansers to its law enforcement and commercial customers

Revenue Cycle Management Operating Segment - We entered the revenue cycle management business late in the second quarter of 2020.2021 with the formation of our wholly owned subsidiary, Digital Ally Healthcare, Inc. and its majority-owned subsidiary Nobility Healthcare. Nobility Healthcare completed its first acquisition in June 2021, when it acquired a private medical billing company, and have since completed three additional acquisitions of private medical billing companies, in which we will assist in providing working capital and back-office services to healthcare organizations throughout the country. Our assistance consists of insurance and benefit verification, medical treatment documentation and coding, and collections. Through our expertise and experience in this field, we maximize our customers’ service revenues collected, leading to substantial improvements in their operating margins and cash flows.

Entertainment Operating Segment - We also entered into live entertainment and events ticketing services through the formation of our wholly owned subsidiary, TicketSmarter and its completed acquisitions of Goody Tickets, LLC and TicketSmarter, LLC, on September 1, 2021. TicketSmarter provides ticket sales, partnerships, and mainly, ticket resale services through its online ticketing marketplace for live events, TicketSmarter.com. TicketSmarter offers tickets for over 125,000 live events through its platform, for a wide range of events, including concerts, sporting events, theatres, and performing arts, throughout the country.

Segment Overview

Our reportable segments are: 1) video solutions, 2) revenue cycle management, and 3) entertainment.

Video Solutions Operating Segment

Our video solutions segment revenue encompasses video recording products and services for our law enforcement and commercial customers and the sale of Shield disinfectant and personal protective products. This segment generates revenues our subscription models offering cloud and warranty solutions, and hardware sales for video and personal protective safety products and solutions. Revenues for product sales are recognized upon delivery of the product, and revenues from our cloud and warranty subscription plans are deferred over the term of the subscription, typically 3 or 5 years.

16

To judge the health of our video solutions segment, we review the current active subscriptions and deferred service revenues, along with the quantity and gross margins generated by our video solutions hardware sales.

Revenue Cycle Management Operating Segment

Our revenue cycle management segment consists of our medical billing subsidiaries. Revenues of this segment are recognized after we perform our obligations of our revenue cycle management services. Our revenue cycle management segment is services performed and such services are charged monthly, generally based on a contractual percentage of total customer collections, for which we recognize our net service fees.

To judge the health of our revenue cycle management segment, we review the collection success rate and collection timing. In addition, we review the associated costs incurred to assist our customers, and any changes in operating margins and cash flows.

Entertainment Operating Segment

Our entertainment operating segment consists of ticketing services provided through TicketSmarter and its online platform, TicketSmarter.com. Revenues of this segment include ticketing service charges generally determined as a percentage of the face value of the underlying ticket and ticket sales from our ticket inventory which are recognized when the underlying tickets are sold. Ticketing direct expenses include the cost of tickets purchased for resale by the Company and holds as inventory, credit card fees, ticketing platform expenses, website maintenance fees, along with other administrative costs.

To judge the health of our entertainment operating segment, we review the gross transaction value, which represents the total value related to a ticket sale and includes the face value of the ticket as well as the service charge. In addition, we review the number of visits to our websites, cost of customer acquisition, the purchase conversion rate, the overall number of customers in our database, and the number and percentage of tickets sold via the website and mobile app.

Summary Financial Data

Summarized financial information for the Company’s reportable business segments is provided for the years ended December 31, 2022, and 2021:

  Years Ended December 31, 
  2022  2021 
Net Revenues:        
Video Solutions $8,252,288  $9,073,626 
Revenue Cycle Management  7,886,107   1,630,048 
Entertainment  20,871,500   10,709,760 
Total Net Revenues $37,009,895  $21,413,434 
         
Gross Profit (loss):        
Video Solutions $(1,250,277) $2,002,345 
Revenue Cycle Management  3,303,477   521,047 
Entertainment  268,741   3,140,383 
Total Gross Profit $2,321,941  $5,663,775 
         
Operating Income (loss):        
Video Solutions $(9,278,721) $(4,497,196)
Revenue Cycle Management  357,705   93,763 
Entertainment  (7,369,241)  235,432 
Corporate  (13,443,001)  (10,592,909)
Total Operating Income (Loss) $(29,733,258) $(14,760,910)
         
Depreciation and Amortization:        
Video Solutions $769,228  $395,361
Revenue Cycle Management  128,082    
Entertainment  1,279,369   427,128 
Total Depreciation and Amortization $

2,176,679

  $822,489 
         
Assets (net of eliminations):        
Video Solutions $28,509,706  $25,983,348 
Revenue Cycle Management  2,201,570   934,095 
Entertainment  11,190,491   12,260,780 
Corporate  14,766,295   43,810,974 
Total Identifiable Assets $56,668,062  $82,989,197 

17

Segment net revenues reported above represent only sales to external customers. Segment gross profit represents net revenues less cost of revenues. Segment operating income (loss), which is used in management’s evaluation of segment performance, represents net revenues, less cost of revenues, less all operating expenses. Identifiable assets are those assets used by each segment in its operations. Corporate assets primarily consist of cash, property, plant and equipment, accounts receivable, inventories, and other assets.

Consolidated Results of Operations

We experienced operating losses for all quarters during 20202022 and 2019 except for third quarter 2020 which was aided by the launch of our ThermoVU™ and the Shield™ line, and second quarter 2019 which was aided by a patent litigation settlement.2021. The following is a summary of our recent operating results on a quarterly basis:

 For the Three Months Ended:  For the Three Months Ended: 
 December 31,
2020
 September 30,
2020
 June 30,
2020
 March 31,
2020
 December 31,
2019
 September 30,
2019
 June 30,
2019
 March 31,
2019
  December 31, 2022 September 30, 2022 June 30,
2022
 March 31,
2022
 December 31, 2021 September 30, 2021 June 30,
2021
 March 31,
2021
 
Total revenue $      2,798,291  $     3,558,640  $1,732,192  $2,425,745  $      2,420,437  $     2,923,148  $2,546,983  $2,550,796  $8,879,504  $8,484,153  $9,351,457  $10,294,781  $11,744,112  $4,639,822  $2,493,671  $2,535,829 
Gross profit  1,182,160   1,222,648   392,758   1,265,028   (88,185)  1,188,262   950,812   1,181,740   (1,932,256)  595,500   1,719,078   1,939,619   2,190,523   1,400,570   1,260,800   811,882 
Gross profit margin percentage  43%  34.1%  22.7%  52.2%  (3.6%)  40.7%  37.3%  46.3%  (21.8)%  7.0%  18.4%  18.8%  18.7%  30.2%  50.6%  32.0%
Total selling, general and administrative expenses  2,931,334   3,066,606   2,535,912   3,192,396   3,145,633   3,468,709   (1,616,830)  4,267,898   7,769,389   7,162,523   8,380,330   8,742,957   7,869,883   4,999,543   3,877,684   3,677,575 
Operating loss  (1,749,174)  (1,843,958)  (2,143,154)  (1,927,368)  (3,233,819)  (2,280,447)  2,567,643   (3,086,158)  (9,701,645)  (6,567,023)  (6,661,252)  (6,803,338)  (5,679,360)  (3,598,973)  (2,616,884)  (2,865,693)
Operating loss percentage  (63.2)%  (51.4)%  (123.7)%  (79.5)%  (133.6)%  (78.0)%  100.8%  (121.0)%  (109.3)%  (77.4)%  (71.2)%  (66.1)%  (48.4)%  (77.6)%  (104.9)%  (113.0)%
Net income/(loss) $(321,318) $527,442  $(497,894) $(2,334,110) $(3,426,984) $(2,985,825) $(387,730) $(3,205,174) $(9,574,258) $(1,919,071) $(682,187) $(6,698,242) $1,122,791  $8,068,799  $(5,382,487) $21,721,858 

19

Our business is subject to substantial fluctuations on a quarterly basis as reflected in the significant variations in revenues and operating results in the above table. These variations result from various factors, including but not limited to: (1) the timing of large individual orders; (2) the traction gained by products, such as the recently released FirstVu Pro, FirstVu II, FLT-250, EVO HD, the ThermoVU™ThermoVu™ and the Shield™ line;lines; (3) production, quality and other supply chain issues affecting our cost of goods sold; (4) unusual increases in operating expenses, such as the timing of trade shows and stock-based and bonus compensation; (5) the timing of patent infringement litigation settlements (5)(6) ongoing patent and other litigation and related expenses respecting outstanding lawsuits; and (6) most recently,(7) the impactcompletion of COVID-19 oncorporate acquisitions including the economyrecent purchases in the revenue cycle management and our business.entertainment operating segments. We reported an operatingnet loss of $321,318$9,574,258 on revenues of $2,798,291$8,879,504 for the fourth quarter 2020. The income recognized in the third quarter 2020 and second quarter 2019 ended a series of quarterly losses resulting from competitive pressures, supply chain problems, increases in inventory reserves as our current product suite ages, product quality control issues, product warranty issues, and litigation expenses relating to patent infringement claims.2022.

18

The factors and trends affecting our recent performance include:

On May 13, 2019, we reached a resolution of the pending patent infringement litigation with WatchGuard and executed a settlement agreement that resulted in the dismissal of this case. As part of the settlement agreement, we received a one-time $6,000,000 payment and granted WatchGuard a perpetual covenant to not sue WatchGuard if its products incorporate agreed-upon modified recording functionality. Additionally, we granted it license to U.S. Patent No. 8,781,292 (“‘292 Patent’”) and the ‘452 Patent through December 31, 2023. As part of the settlement, the parties agree that WatchGuard made no admission that it infringed any of our patents. The Company does not anticipate any future recoveries from Watchguard or its successorsformed two new operating segments in 2021 and assigns relative to WatchGuard’s use of the ‘292 Patent or the ‘452 Patent. See Note 12, Commitments and Contingencies,” to our consolidating financial statements for the details respecting the settlement.
On July 20, 2020, the Company and Brickell Key Investments LP (“BKI”) executed a Termination Agreement and Mutual Release (the “Termination Agreement”). Under the terms of the Termination Agreement, the Company made a payment in the amount of $1,250,000 to BKI, and the parties agreed to terminate a Proceeds Investment Agreement (the “PIA”), which they previously entered into on July 31, 2018, and to release each other from any further liability under the PIA. As a result, any obligations under the PIA have been extinguished and a $5,250,000 change in fair value was assessed for the year ended December 31, 2020.
Revenuesrevenues increased in the first through third quarter 2020 to $3,558,640quarters of 2022 compared to the previous quarters.same quarters in 2021. The primary reason for the revenue increase in the third quarter 20202022 is the noticeable demand forcompletion of three acquisitions in 2021, being TicketSmarter which is included in our entertainment operating segment and two acquisitions of medical billing companies through our revenue cycle management operating segment, paired with two further acquisitions within the revenue cycle management operating segment in the first quarter of 2022. The new ThermoVu line, as it accounted for $1,087,740entertainment operating segment generated $20,871,500 in revenue in 2022, and our revenue cycle management operating segment generated $7,886,107 in revenues for such quarter.2022. We expect to continue to experience improved results due tofrom our two new operating segments and their recent acquisitions, along with improved results from the introduction of our new product lines.video solutions segment as the recurring revenue model expands.
Our objective is to expand our video solutions segment’s recurring service revenue to help stabilize our revenues on a quarterly basis. Revenues from cloud storages have been increasing in recent quarters and reached approximately $228,724$431,167 in the fourth quarter 2020,of 2022, an increase of $23,010 (11%$128,533 (42%) over the fourth quarter 2019.of 2021. Overall, cloud revenues increased to approximately $937,000 in 2020$1,471,860 for the year ended December 31, 2022 compared to approximately $750,000 in 2019,$1,055,965 for the year ended December 31, 2021, an increase of $187,000,$415,895, or 25%39%. We are pursuing several new market channels that do not involveoutside of our traditional law enforcement and private security customers, such assimilar to our NASCAR affiliation and event security solutions,customers, which we believe will help expand the appeal of our products and service capabilities to new commercial markets. If successful, we believe that these new market channels could yield recurring service revenues for us in the future.

20

We have a multi-year official partnership with NASCAR, naming us “A Preferred Technology Provider of NASCAR.” As part of the relationship, we will provide cameras that will beare mounted in the Monster Energy NASCAR Cup Series garage throughout the season, bolstering both NASCAR’s commitment to safety at every racetrack, as well as enhancing its officiating process through technology. Our relationship with NASCAR has yielded many new opportunities with NASCAR related sponsors. We believe this partnership with NASCAR will demonstratedemonstrates the flexibility of our product offerings and will help expand the appeal of our products and service capabilities to new commercial markets. We also have an affiliation with the Indy series races and, in particular, the RLL Team (Rahal,Rahal Letterman Lanigan & Letterman)Racing team which has several cars in most Indy style races. These relationships provide us with access to many potential customers through the various programs supported by both the NASCAR and Indy-Style car race series.

Our international revenues decreased to $89,374 (less than 1% of total revenues) during the year ended December 31, 2020, compared to $190,105 (approximately 2% of total revenues) during the year ended December 31, 2019. Political macro-economic tensions including illegal immigration and import/export tariffs between the United States and many countries that have been our customers in the past have made it a difficult climate for our international sales. The international sales cycle generally takes longer than domestic business and we continue to provide bids to a number of international customers. We are actively marketing many of our products, including but not limited to, the EVO-HD, DVM-800, DVM-750, DVM-500+, FleetVu driver monitoring and management service and the FirstVU HD, internationally. We saw a decline in our international sales activity in 2020, largely due in part to the Covid-19 pandemic restricting travel, causing budgetary restraints for customers, and increased shipping delays.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet debt, nor did we have any transactions, arrangements, obligations (including contingent obligations) or other relationships with any unconsolidated entities or other persons that may have a material current or future effect on financial conditions, changes in the financial conditions, results of operations, liquidity, capital expenditures, capital resources, or significant components of revenue or expenses.

We are a party to operating leases and license agreements that represent commitments for future payments (described in Note 11,15, “Commitments and Contingencies,” to our consolidated financial statements) and we have issued purchase orders in the ordinary course of business that represent commitments to future payments for goods and services.

2119
 

For the Years Ended December 31, 20202022 and 20192021

Results of Operations

Summarized immediately below and discussed in more detail in the subsequent sub-sections is an analysis of our operating results for the years ended December 31, 20202022 and 2019,2021, represented as a percentage of total revenues for each respective year:

 Years Ended December 31,  Years Ended December 31, 
 2020  2019  2022 2021 
Revenue  100%  100%  100%  100%
Cost of revenue  61%  69%  94%  74%
                
Gross profit  39%  31%  6%  26%
        
Selling, general and administrative expenses:                
Research and development expense  18%  19%  6%  9%
Selling, advertising and promotional expense  25%  35%  25%  27%
Stock-based compensation expense  14%  20%
General and administrative expense  55%  72%  55%  60%
Patent litigation settlement  0%  (57)%
                
Total selling, general and administrative expenses  112%  89%  87%  96%
                
Operating loss  (73)%  (58)%  (80)%  (69)%
Change in fair value of secured convertible notes  %  (5)%
Change in fair value of note payable  (12)%  (20)%
Change in fair value of proceeds investment agreement  50%  (32)%
        
Change in fair value of derivative liabilities  18%  171%
Change in fair value of contingent consideration promissory notes and earn-out agreements  1%  17%
Warrant modification expense  %  (1)%
Change in fair value of short-term investments  %  %
Gain on extinguishment of warrant derivative liability  10%  %
Gain on extinguishment of debt  13%  %  %  %
Secured convertible note payable issuance expenses  (1)%  (1)%
Other income and interest expense, net  %  %
Loss before income tax benefit  (25)%  (96)%
Gain on sale of property, plant and equipment  1%  %
Interest income (expense) and other income, net  (1)%  1%
        
Income (loss) before income tax benefit  (51)%  119%
Income tax expense (benefit)  %  %  %  %
                
Net loss  (25)%  (96)%
Net income (loss)  (51)%  119%
                
Net loss per share information:        
Net loss attributable to noncontrolling interests of consolidated subsidiary  (1)%  %
Loss on redemption – Series A & B convertible redeemable preferred stock  

(6

)%  %
        
Net income (loss) attributable to common stockholders  (59)%  119%
        
Net income (loss) per share information:        
Basic $(0.12) $(0.87) $(8.50) $10.14 
Diluted $(0.12) $(0.87) $(8.50) $10.14 

Revenues

Revenues by Type and by Operating Segment

Our operating segments generate two types of revenues:

Product revenues primarily includes video operating segment hardware sales of in-car and body-worn cameras, along with sales of our ThermoVuTM units, disinfectants, and personal protective equipment. Additionally, product revenues also include the sale of tickets by our entertainment operating segment that have been purchased or received through our sponsorships and partnerships and held in inventory by our entertainment segment until their sale.

2220
 

RevenuesService and other revenues consist of cloud and warranty services revenues from our subscription plan and storage offerings of our video solutions segment. Our entertainment operating segments’ secondary ticketing marketplace revenues are included in service revenue. We recognize service revenue from sales generated through its secondary ticketing marketplace as we collect net services fees on secondary ticketing marketplace transactions. Lastly, our revenue cycle management segment revenues are included in the service revenues for services provided to medical providers throughout the country.

Our current product offerings include the following:The following table presents revenues by type and segment:

ProductDescription
EVO-HDAn in-car digital audio/video system which records in 1080P high definition video and is designed for law enforcement and commercial fleet customers. This system includes two cameras and can use up to four external cameras for a total of four video streams. This system includes integrated, patented VuLink technology, internal GPS, and an internal Wi-Fi Module. The system includes the choice between a Wireless Microphone Kit or the option to use the FirstVu HD Body Camera as the wireless microphone. This system also includes a three-year Advanced Exchange Warranty. We offer a cloud storage solution to manage the recorded evidence and charge a monthly device license fee for our cloud storage.
DVM-750An in-car digital audio/video system that is integrated into a rear-view mirror primarily designed for law enforcement customers. We offer local storage as well as cloud storage solutions to manage the recorded evidence. We charge a monthly storage fee for our cloud storage option and a one-time fee for the local storage option. This product is being discontinued and phased out of our product line but the Company is supporting existing customers with new products and repair and parts.
DVM-100An in-car digital audio/video system that is integrated into a rear-view mirror primarily designed for law enforcement customers. This system uses an integrated fixed focus camera. This product is being discontinued and phased out of our product line but the Company is supporting existing customers with new products and repair and parts.
DVM-400An in-car digital audio/video system that is integrated into a rear-view mirror primarily designed for law enforcement customers. This system uses an external zoom camera. This product is being discontinued and phased out of our product line but the Company is supporting existing customers with new products and repair and parts.
DVM-250 PlusAn in-car digital audio/video system that is integrated into a rear-view mirror primarily designed for commercial fleet customers. We offer a web-based, driver management and monitoring analytics package for a monthly service fee that is available for our DVM-250 customers.
DVM-800An in-car digital audio/video system which records in 480P standard definition video that is integrated into a rear-view mirror primarily designed for law enforcement customers. This system can use an internal fixed focus camera or two external cameras for a total of four video streams. This system also includes the Premium Package which has additional warranty. We offer local storage as well as cloud storage solutions to manage the recorded evidence. We charge a monthly storage fee for our cloud storage option and a one-time fee for the local storage option.
DVM-800 LiteAn in-car digital audio/video system which records in 480P standard definition video that is integrated into a rear view mirror primarily designed for law enforcement customers. This system can use an internal fixed focus camera or two external cameras for a total of four video streams. We offer local storage as well as cloud storage solutions to manage the recorded evidence. We charge a monthly storage fee for our cloud storage option and a one-time fee for the local storage option. This system is replacing the DVM-100 and DVM-400 product offerings and allows the customer to configure the system to their needs.
FirstVU HDA body-worn digital audio/video camera system primarily designed for law enforcement customers. We also offer a cloud based evidence storage and management solution for our FirstVU HD customers for a monthly service fee.
VuLinkAn in-car device that enables an in-car digital audio/video system and a body worn digital audio/video camera system to automatically and simultaneously start recording.
ThermoVuTMA non-contact temperature-screening instrument that measures temperature through the wrist and controls entry to facilities when temperature measurements exceed pre-determined parameters
ShieldTM lineDisinfectant and cleanser line, which is for use against viruses and bacteria, that is less harsh than many of the traditional products now widely distributed. Offered in a variety of sizes and quantities.
  Year Ended December 31, 
  2022  % Change  2021 
Product revenues:            
Video solutions $5,401,089   (15.5)% $6,393,050 
Entertainment  5,598,803   100.9%  2,787,237 
Total product revenues  10,999,892   19.8%  9,180,287 
Service and other revenues:            
Video solutions  2,851,199   6.4%  2,680,576 
Entertainment  15,272,697   92.8%  7,922,523 
Revenue cycle management  7,886,107   384.0%  1,630,048 
Total service and other revenues  26,010,003   112.6%  12,233,147 
Total revenues $37,009,895   72.8% $21,413,434 

2321
 

We sellOur video operating segment sells our products and services to law enforcement and commercial customers in the following manner:

Sales to domestic customers are made directly to the end customer (typically a law enforcement agency or a commercial customer) through our sales force, comprised of our employees. Revenue is recorded when the product is shipped to the end customer.
Sales to international customers are made through independent distributors who purchase products from us at a wholesale price and sell to the end user (typically law enforcement agencies or a commercial customer) at a retail price. The distributor retains the margin as its compensation for its role in the transaction. The distributor generally maintains product inventory, customer receivables and all related risks and rewards of ownership. Revenue is recorded when the product is shipped to the distributor consistent with the terms of the distribution agreement.
   
Repair parts and services for domestic and international customers are generally handled by our inside customer service employees. Revenue is recognized upon shipment of the repair parts and acceptance of the service or materials by the end customer.

Our revenue cycle management operating segment sells its services to customers in the following manner:

Our revenue cycle management operating segment generates service revenues through relationships with medium to large healthcare organizations, in which the underlying service revenue is recognized upon execution of services. Service revenues are generally determined as a percentage of the dollar amount of medical billings collected by the customer.

Our entertainment operating segment sells our products and services to customers in the following manner:

Our entertainment operating segment generates product revenues from the sale of tickets directly to consumers for a particular event that the entertainment operating segment has previously purchased and held in inventory for ultimate resale to the end consumer. Service sales through TicketSmarter, are driven largely in part to the usage of the TicketSmarter.com marketplace by buyers and sellers, in which the Company collects service fees for each transaction completed through this platform.

We may discount our prices on specific orders based upon the size of the order, the specific customer and the competitive landscape.

The COVID-19 pandemic had an impact on our 2020 revenues and a negative impact generally on our legacy products and, in particular, our commercial event recorder hardware (DVM-250 Plus) and in-car hardware for law enforcement (DVM-800) during the quarter. The COVID-19 pandemic had a positive impact generally on our new ShieldTM disinfectant/sanitizer and ThermoVUTM product lines.

Revenues for the years ended December 31, 2020 and 2019 were derived from the following sources:

  Years ended December 31, 
  2020  2019 
DVM-800 and DVM 800HD  24%  36%
ThermoVuTM  14%  %
ShieldTM disinfectants/sanitizers  2%  %
FirstVu HD  13%  12%
DVM-250 Plus  3%  11%
Cloud service revenue  9%  7%
DVM-750  0%  1%
VuLink  2%  1%
EVO  9%  3%
Repair and service  13%  15%
Accessories and other revenues  11%  14%
   100%  100%

24

Product revenues for the years ended December 31, 20202022 and 20192021 were $8,029,457$10,999,892 and $7,732,796,$9,180,287, respectively, an increase of $296,661 (3%$1,819,605 (20%), due to the following factors:

Revenues generated by the new entertainment operating segment began with the Company’s acquisition of TicketSmarter on September 1, 2021. The Companynew entertainment operating segment generated revenues totaling over $1,643,434 during the years ended December 31, 2020 compared to $-0- for the same period$5,598,803 in 2019 from its new product lines. Late in the second quarter of 2020, the Company launched two product lines in direct response to the increased safety precautions that organizations and individuals are taking due to the COVID-19 pandemic. ThermoVu™ was launched as a non-contact temperature-screening instrument that measures temperature through the wrist and controls entry to facilities when temperature measurements exceed pre-determined parameters. ThermoVu™ has optional features such as facial recognition to improve facility security by restricting access based on temperature and/or facial recognition reasons. ThermoVu™ provides an instant pass/fail audible tone with its temperature display and controls access to facilities based on such results. We believe that it can be widely applied in schools, office buildings, subway stations, airports and other public venues. The Company also launched its Shield™ disinfectant/sanitizer product lines to fulfill demand by current customers and others for a disinfectant and sanitizer that is less harsh than many of the traditional products now widely distributed. The Shield™ Cleanser product line contains a cleanser with no harsh chemicals or fumes.

The Company began offering the Shield™ line of disinfecting products to its first responder customers including police, fire and paramedics late in the second quarter of 2020. Commercial customers such as cruise lines, taxi-cab and para transit may also be good candidates for the products. The Company is considering enhancing the line of disinfectant products for additional related products including hardware to efficiently and effectively dispense the disinfectants. The Company is hopeful that its law enforcement and commercial customers will adopt this new product offering to combat the spread of the COVID-19 virus as well as other bacteria and viruses.

We shipped four individual orders in excess of $100,000, for a total of approximately $903,910 in revenuerevenues for the year ended December 31, 2020,2022, compared to five individual orders$2,787,237 for the fiscal year ended December 31, 2021. This largely relates to the Company having a full year of activity in excess2022, in comparison to just four months of $100,000, for a total of approximately $951,734activity post-acquisition in revenue2021.
The Company’s video solutions operating segment generated product revenues totaling $5,401,089 during the year ended December 31, 2022 compared to $6,393,050 for the year ended December 31, 2019. Our average order size decreased to approximately $1,902 in the year ended December 31, 2020 from $2,259 during the year ended December 31, 2019. For certain opportunities that involve multiple units and/or multi-year contracts, we have occasionally discounted our products to gain or retain market share and revenues.
2021. In general, we haveour video solutions operating segment has experienced pressure on ourits product revenues as our in-car and body-worn systems are facing increased competition because our competitors have released new products with advanced features. Additionally, our law enforcement revenues declined over the prior periodyear ended December 31, 2022 due to price-cutting and competitive actions by our competitors, adverse marketplace effects related to our patent litigation proceedings and our recent financial condition. We introduced our EVO-HD late in the second quarter of 2019 with the goal of enhancing our product line features to meet these competitive challenges and we started to see traction in late 2019. We expect customers and potential customers to review and test the EVO-HD prior to committing to this new product platform, all of which has been delayed due to the COVID-19 pandemic.

The COVID-19 pandemic delayed the shipment of law enforcement orders in the third quarter 2020 as police forces and governments dealt with its impact. In addition, our salesmen were generally unable to meet with and demonstrate our products to our law enforcement customers because of travel and other restrictions imposed by cities and states due to the COVID-19 pandemic. In person demonstration of our products to potential customers is generally important in order to obtain new customers or upgrade existing customers. Our product sales to law enforcement decreased substantially in the third quarter 2020 compared to 2019 primarily due to the impact of the COVID-19 pandemic.

The COVID-19 pandemic impacted the shipment of commercial orders in the third quarter 2020 as cruise lines, taxi cabs, paratransit and other commercial customers dealt with its impact. In addition, our salesmen were generally unable to meet with and demonstrate our products to our commercial customers because of travel and other restrictions imposed by cities and states due to the COVID-19 pandemic. In person demonstration of our products to potential customers is generally required in order to obtain new customers or upgrade existing customers. Our product sales to commercial customers decreased substantially in the third quarter 2020 compared to 2019 primarily due to the impact of the COVID-19 pandemic.

2522
 

ManagementOur video solutions operating segment management has been focusingcontinued to focus on migrating customers, and in particular commercial customers, from a “hardware sale”hardware sale to a service fee model. Therefore, we expect a reduction in commercial hardware sales (principally DVM-250’s, FLT-250’s, and FirstVU’s)a portion of our body-worn camera line) as we convert these customers to a service model under which we provide the hardware as part of a recurring monthly service fee. In that respect, we introduced a monthly subscription agreement plan for our body worn cameras and related equipment during the second quarter of 2020 that allowed law enforcement agencies to pay a monthly service fee to obtain body worn cameras without incurring a significant upfront capital outlay. This program has gained some traction, resulting in decreased product revenues and increasing our service revenues. We expect this program to continue to hold traction, resulting in recurring revenues over a span of three to five years.

Service and other revenues for the years ended December 31, 20202022 and 20192021 were $2,485,411$26,010,003 and $2,708,568,$12,233,147, respectively, a decreasean increase of $223,157 (8%$13,776,856 (113%), due to the following factors:

Cloud revenues generated by the video solutions operating segment were $954,873$1,471,860 and $749,713$1,055,965 for the years ended December 31, 20202022 and 2019,2021, respectively, an increase of $205,160 (27%$415,895 (39%). We have experiencedcontinue to experience increased interest in our cloud solutions for law enforcement primarily due to the deployment of our cloud-based EVO-HD in-car system and our next generation body-worn camera products, which contributed to our increased cloud revenues in the year ended December 31, 2020.2022. We expect this trend to continue for 20212023 as the migration from local storage to cloud storage continues in our customer base.
RevenuesVideo solutions operating segment revenues from extended warranty services were $1,173,169$692,017 and $1,414,308$978,018 for the years ended December 31, 20202022 and 2019,2021, respectively, aan decrease of $241,139 (17%$286,001 (29%). We have many customers that have purchased extended warranty packages, primarilyThis correlates with the decrease in our DVM-800 premium service program. However, the fallout from the COVID-19 pandemic and related restrictions on travel adversely affected our sales of DVM-800 hardware systems resulting in a decrease in their sales of 33% in the 2020 period compared to 2019.associated extended warranty.
InstallationOur new entertainment operating segment generated service revenues were $180,319totaling $15,272,697 and $255,149$7,922,523 for the years ended December 31, 20202022 and 2019,2021, respectively, a decreasean increase of $74,830 (29%$7,350,174 (93%). InstallationThe Company completed the acquisitions of Goody Tickets, LLC and TicketSmarter, LLC in the third quarter of 2021, thus resulting in the new revenue stream for the Company during the last fourth months of 2021 and twelve months ended December 31, 2022. TicketSmarter collects fees on transactions administered through the TicketSmarter.com platform for the buying and selling of tickets for live events throughout the country. This increase reflects a full twelve months of service revenues tendby our entertainment operating segment, which we hope will continue to vary more than other servicepresent a strong revenue types and are dependent on larger customer implementations. The Covid-19 pandemic travel restrictions also limited our ability to provide onsite installation services in 2020 as compared to 2019.outlook moving forward.
SoftwareOur new revenue non-warranty repaircycle management operating segment generated service revenues totaling $7,886,107 and other revenues were $177,050 and $289,398$1,630,048 for the years ended December 31, 20202022 and 2019,2021, respectively, a decreasean increase of $112,348 (39%$6,256,059 (384%). Software revenues were $64,493Our revenue cycle management operating segment has completed four acquisitions since formation in 2020 comparedJune 2021, thus resulting in the new service revenue stream added in the twelve months ended December 31, 2022. Our revenue cycle management operating segment provides revenue cycle management solutions and back-office services to $106,155 in 2019 and non-warranty repairs were $48,896 in 2020 comparedhealthcare organizations throughout the country. We expect our revenue cycle management segment to $99,647 in 2019. Situational security event fees were $48,600 in 2020 comparedcontinue to $64,800 in 2019.present a strong revenue outlook moving forward.

Total revenues for the years ended December 31, 20202022, and 20192021 were $10,514,868$37,009,895 and $10,441,364,$21,413,434, respectively, an increase of $73,504 (1%$15,596,461 (73%), due to the reasons noted above.

2623
 

Cost of Product Revenue

CostOverall cost of product revenue on units sold for the years ended December 31, 20202022, and 20192021 was $5,739,572$14,372,115 and $6,577,347,$8,635,047, respectively, a decreasean increase of $837,775 (13%$5,737,068 (66%). CostOverall cost of goods sold for products as a percentage of product revenues for the years ended December 31, 20202022, and 20192021 were 71%131% and 85%94%, respectively. This improvementCost of products sold by operating segment is as follows:

  Years Ended December 31, 
  2022  2021 
Cost of Product Revenues:        
Video Solutions $8,332,484  $6,197,061 
Revenue Cycle Management      
Entertainment  6,039,631   2,437,986 
Total Cost of Product Revenues $14,372,115  $8,635,047 

The increase in cost of goods sold for our video solutions segment products is due to numerous factors including a sizeable increase in the allowance for excess and obsolete inventory, mostly surrounding the personal protective equipment product line. Cost of product sold as a percentage of product revenues is due to the Company moving to new and smaller warehouse facilities during June 2020, resulting in manufacturing efficiencies during the year ended December 31, 2020. Additionally, the improvement in cost as a percentage of revenues is attributable to the new product lines, including ThermoVU™ and Shield™, which the Company introduced in 2020 and have higher margins than our legacy products.

Cost of service and other revenue for the years ended December 31, 2020 and 2019 was $712,702 and $631,388, respectively, an increase of $81,314 (13%). The increase in service and other cost of goods sold is primarily duevideo solutions segment increased to an increase in the cost of service and other revenues sold as a percentage of service and other revenues to 29%154% for the year ended December 31, 20202022 as compared to 23%97% for the year ended December 31, 2019 offset by the 13% decrease in service and other revenues for the 2020 period compared to the 2019 period. 2021.

The increase in theentertainment operating segment cost of service and other revenuesproduct sold as a percentage of service and other revenues is attributable to inefficiencies and additional expenses related to service technicians performing installation and other software related services due to the effectsSeptember 1, 2021 acquisition of the COVID-19 pandemic.

TotalTicketSmarter, resulting in a full twelve months of cost of sales as a percentage ofproduct revenues decreased to 61% for the year ended December 31, 2020 from 69%2022, and an increase to cost of product revenue of $3,601,645 for the year ended December 31, 2019. We believe our gross margins will continue2022 compared to improve$2,437,986 for the year ended December 31, 2021. Cost of product sold as we continuea percentage of product revenues for the entertainment segment increased to improve revenue levels, continue108% for the year ended December 31, 2022 as compared to reduce product warranty issues and add higher margin revenues from cloud-based and other services.87% for the year ended December 31, 2021.

We recorded $1,960,351$5,489,541 and $4,144,013$3,353,458 in reserves for obsolete and excess inventories atfor the years ended December 31, 20202022 and 2019,2021, respectively. Total raw materials and component parts were $3,186,426$4,509,165 and $4,481,611 at$3,062,046 for the years ended December 31, 20202022 and 2019,2021, respectively, an increase of $1,447,119 (47%). Finished goods balances were $7,816,618 and $10,512,579 for the years ended December 31, 2022 and December 31, 2021, respectively, a decrease of $1,295,185 (29%). We scrapped older version inventory component parts that were mostly or fully reserved during the year ended December 31, 2020 which was the primary cause for the decrease. Finished goods balances were $6,974,291 and $4,906,956 at December 31, 2020 and December 31, 2019, respectively, an increase of $2,067,335 (42%$2,695,961 (26%) which was attributable to accumulatinga reduction in inventory for the new Shieldvideo solutions product lines and ThermoVu product lines.a large decrease in ticket inventory for the newly acquired entertainment segment. The decreaseincrease in the inventory reserve is primarily due to the scrapping of older version legacy products that were mostly or fully reserved during the year 2020 as a result of moving our warehouse and office location. The remaining reserve for inventory obsolescence is generally provided for the level of excess component parts of the older versions of our PCBprinted circuit boards and the phase out of our DVM-750, DVM-500 Plus, DVM-500 and LaserAlly legacy products.products, ThermoVu products, and personal protective equipment. Additionally, the Company determined a reasonable reserve for inventory held at the ticket operating segment, in which some inventory items sell below cost or go unsold, thus having to be fully written-off following the event date. We believe the reserves are appropriate given our inventory levels atas of December 31, 2020.2022.

Cost of Service Revenue

Overall cost of service revenue sold for the years ended December 31, 2022, and 2021 was $20,315,839 and $7,114,612, respectively, an increase of $13,201,227 (186%). Overall cost of goods sold for services as a percentage of service revenues for the years ended December 31, 2022, and 2021 were 78% and 58%, respectively. Cost of service revenues by operating segment is as follows:

  Years Ended December 31, 
  2022  2021 
Cost of Service Revenues:        
Video Solutions $1,170,081  $874,219 
Revenue Cycle Management  4,582,630   1,109,001 
Entertainment  14,563,128   5,131,392 
Total Cost of Service Revenues $20,315,839  $7,114,612 

24

The increase in cost of service revenues for our video solutions segment is commensurate with the increase in service revenues in the year ended December 31, 2022 compared to the year ended December 31, 2021. Cost of service revenues as a percentage of service revenues for the video solutions segment increased to 41% for the year ended December 31, 2022 as compared to 33% for the year ended December 31, 2021.

The increase in revenue cycle management operating segment cost of service revenue is due to the four completed acquisitions of medical billing companies in late 2021 and early 2022. Cost of service revenues as a percentage of product revenues for the revenue cycle management operating segment decreased to 58% for the year ended December 31, 2022 as compared to 68% for the year ended December 31, 2021.

The increase in entertainment operating segment cost of service revenues is due to the September 1, 2021 acquisition of TicketSmarter, resulting in an increase to cost of service revenue to $14,563,128 for the year ended December 31, 2022, compared to $5,131,392 for the year ended December 31, 2021. Cost of service revenues as a percentage of service revenues for the entertainment increased to 95% for the year ended December 31, 2022 as compared to 65% for the year ended December 31, 2021.

Gross Profit

Gross

Overall gross profit for the years ended December 31, 20202022 and 20192021 was $4,062,594$2,321,941 and $3,232,629,$5,663,775, respectively, an increasea decrease of $829,965 (26%$3,341,833 (59%). Gross profit by operating segment was as follows:

  Years Ended December 31, 
  2022  2021 
Gross Profit:        
Video Solutions $(1,250,278) $2,002,345 
Revenue Cycle Management  3,303,477   521,047 
Entertainment  268,742   3,140,383 
Total Gross Profit $2,321,941  $5,663,775 

The increaseoverall decrease is attributable to the 1% overall increase in revenuescost of goods sold across our video and entertainment segments for the year ended December 31, 2020 coupled with2022, as there was an improvementoverall increase in the overall cost of sales as a percentage of overall revenues to 61%94% for the year ended December 31, 20202022 from 69%74% for the year ended December 31, 2019.2021. Our goal is to improve our margins to 60% over the longer term based on the expected margins ofgenerated by our new recent revenue cycle management and entertainment operating segments together with our video solutions operating segment and its expected margins from our EVO-HD, DVM-800, VuLink, FirstVU HD, ThermoVuTM,FirstVu Pro, FirstVu II, ShieldTM disinfectants and our cloud evidence storage and management offering, ifprovided that they gain traction in the marketplace and subject to a normalizing economy in the wake of the COVID-19 pandemic.marketplace. In addition, if revenues from these productsthe video solutions segment increase, we will seek to further improve our margins from themthis segment through economies of scaleexpansion and more efficientlyincreased efficiency utilizing fixed manufacturing overhead components. We plan to continue our initiative to more efficient management of our supply chain through outsourcing production, quantity purchases and more effective purchasing practices.

27

Selling, General and Administrative Expenses

Selling,

Overall selling, general and administrative expenses were $11,726,245$32,055,199 and $9,265,410$20,424,685 for the years ended December 31, 20202022 and 2019,2021, respectively, an increase of $2,460,835 (27%$11,630,514 (57%). The increase was primarily attributable to a patent litigation settlementthe recent acquisitions completed in the first quarter of $6.0 million we received during 2019 that did not recur in 2020. Exclusive2022 and third quarter of the 2019 patent litigation settlement; our2021. Our selling, general and administrative expenses as a percentage of sales decreased to 112%87% for 20202022 compared to 146%95% in the same period in 2019. 2021.

The significant components of selling, general and administrative expenses are as follows:

  Year ended December 31, 
  2022  2021 
Research and development expense $2,290,293  $1,930,784 
Selling, advertising and promotional expense  9,312,204   5,717,824 
Professional fees and expense  3,297,895   1,513,862 
Executive, sales, and administrative staff payroll  6,544,711   3,288,360 
Other  10,610,096   7,973,855 
Total $32,055,199  $20,424,685 

25

The significant components of selling,Selling, general and administrative expenses by operating segment are as follows:

  Year ended December 31, 
  2020  2019 
Research and development expense $1,842,800  $2,005,717 
Selling, advertising and promotional expense  2,607,242   3,652,434 
Stock-based compensation expense  1,462,270   2,112,090 
Professional fees and expense  990,975   1,533,679 
Executive, sales, and administrative staff payroll  2,449,690   3,083,021 
Patent litigation settlement  -   (6,000,000)
Other  2,373,987   2,878,469 
Total $11,726,964  $9,265,410 
  Years Ended December 31, 
  2022  2021 
Selling, general and administrative expenses:        
Video Solutions $9,950,263  $6,231,254 
Revenue Cycle Management  2,575,592   427,284 
Entertainment  1,681,997   2,904,951 
Corporate  17,847,347   10,861,196 
Total selling, general and administrative expenses $32,055,199  $20,424,685 

Research and development expense. We continueOur video solutions operating segment continues to focus on bringing new products to market, including updates and improvements to current products. Our research and development expenses totaled $1,842,800$2,290,293 and $2,005,717$1,930,784 for the years ended December 31, 20202022 and 2019,2021, respectively, a decreasean increase of $162,917 (9%$359,509 (19%). We employed 1521 engineers at December 31, 20202022 compared to 1617 engineers at December 31, 2019,2021, most of whom are dedicated to research and development activities for new products and primarily the ThermoVuTM, ShieldTM,FirstVu Pro, FirstVu II, QuickVu docking stations, EVO-HD and non-mirror based DVM-250 that can be located in multiple places in a vehicle. We expect our research and development activities will continue to trend higher in future quarters as we continue to expand our product offerings based on our new EVO-HD product platform and we continue to outsource more development projects. We consider our research and development capabilities and new product focus to be a competitive advantage and will continue to invest in this area on a prudent basis and consistent with our financial resources.

Selling, advertising and promotional expenses. Selling, advertising and promotional expenseexpenses totaled $2,607,242$9,312,204 and $3,652,434$5,717,824 for the years ended December 31, 20202022 and 2019,2021, respectively, a decreasean increase of $1,045,192 (40%$3,594,380 (63%). Salesman salaries and commissions for our video solutions segment represent the primary components of these costs and were $1,616,267$1,643,563 and $2,632,729$1,605,034 for the years ended December 31, 20202022 and 2019,2021, respectively, a decreaseslight increase of $1,016,432 (63%$38,529 (2%). The effective commission rate was 15.4%4% for the year ended December 31, 20202022 compared to 25.2%8% for the year ended December 31, 2019.2021. We reducedincreased the number of salesmen in our law enforcement and commercial channels in early 2020 and decreased travel expenses in 20202022 compared to 2019,2021, thus leading to an increase in sales commissions paid during the year ended December 31, 2022. Further, our recent acquisitions require minimal salespeople, due to the impact of Covid-19 restrictions. In addition, we are utilizing third-party distributors as a major component of our new Shieldtheir specific service offerings and ThermoVU sales channel.platforms.

 

Promotional and advertising expenses totaled $990,975$7,668,641 during the year ended December 31, 20202022 compared to $1,533,679$4,112,790 during the year ended December 31, 2019, a decrease2021, an increase of $542,704 (35%$3,555,851 (86%). The overall decreaseincrease is primarily attributable to our 2019 sponsorship of2022 sponsorships within NASCAR and the ultimate suspensionIndyCar, along with TicketSmarter’s very active approach to sponsorship and advertising, as they are continuing to build a brand and gaining recognition. TicketSmarter accounted for $4,024,748 of the 2020 NASCAR season during 2020, a reduction in attendance at trade shows as a result of the COVID-19 pandemic, altered by our sponsorship of several events to promote our new Shieldtotal promotional and ThermoVU product lines including the Indianapolis 500 race that occurred in August 2020.

28

Stock-based compensation expense. Stock based compensationadvertising expense totaled $1,462,270 and $2,112,090 for the years ended December 31, 2020 and 2019, respectively, a decrease of $649,820 (31%). The decrease is primarily due to the decreased amortization during the year ended December 31, 2020 related to the restricted stock granted during 2020 and 2019 to our officers, directors, and other employees. We relied more on stock-based compensation in 2019 as we attempted to reduce cash expenses; however, in 2020 we attempted to reduce all expenses due to the impact of COVID-19.2022.

 

Professional fees and expense. Professional fees and expenses totaled $990,256$3,297,895 and $1,533,679$1,513,862 for the years ended December 31, 20202022 and 2019,2021, respectively, a decreasean increase of $543,423 (35%$1,784,033 (118%). The decreaseincrease in professional fees is primarily attributable to increased legal and other fees in connection with strategic transactions and acquisitions during the year ended December 31, 2022 paired with other current due diligence items and opportunities the Company is exploring. Additionally, board fees, audit fees, and expenses relatedservice fees that also attribute to the termination of the Axon lawsuit and the resolution of the WatchGuard and PGA lawsuits. We resolved the PGA lawsuit on April 17, 2019 and the associated cost was accrued as of December 31, 2019 and the WatchGuard lawsuit was settled on May 13, 2019. On June 17, 2019, the U.S. District Court granted Axon’s Motion for Summary Judgment and accepted Axon’s position that it did not infringe on the ‘452 Patent and dismissed the lawsuit in its entirety. We appealed the U.S. District Court’s ruling and on April 22, 2020, a three-judge panel of the United States Court of Appeals for the Tenth Circuit denied our appeal and affirmed the U.S. District Court’s previous decision to grant Axon summary judgment. The Company filed a motion requesting a rehearing in front of the Court of Appeals which motion was also denied on June 9, 2020.this increase.

 

The Company had until November 7, 2020 to decide whether it would appeal the U.S. District Court’s and Court of Appeals’ decisions to the United States Supreme Court. Our spending on legal fees on the Axon case has slowed during 2020 as we waited for the appeal to be heard. The Company has decided not to appeal the decisions to the United States Supreme Court and to abandon the lawsuit against Axon which reduced the amount of legal expenses for 2020 as compared to 2019.

Executive, sales and administrative staff payroll. Executive, sales and administrative staff payroll expenses totaled $2,449,690$6,544,711 and $3,083,021$3,288,360 for the years ended December 31, 20202022 and 2019,2021, respectively, a decreasean increase of $633,331 (21%$3,256,351 (99%). The primary reason for the decreaseincrease in executive, sales and administrative staff payroll was a reduction in our technical support staffing in response to the COVID-19 pandemic and the Company expects such reductions to continue to reduce related staff expenses during the balance of 2020. The COVID-19 pandemic has significantly impacted the Company’s new event security business channel in 2020 as many sporting venues were closed including those served by these service technicians. In addition, several membersrecent formation of the Company’srevenue cycle management accepted reductions inand entertainment operating segments and their cash compensation in 2020 to help the Company’s liquidity position in lightacquisitions of the COVID-19 pandemic.medical billing companies and TicketSmarter which occurred in late 2021 and early 2022. These recent acquisitions resulted in additional payroll expenses with expanded executive positions, sales, and administrative staff numbers compared to 2021.

26

 

Other. Other selling, general and administrative expenses totaled $2,373,987$10,610,096 and $2,878,469$7,973,855 for the years ended December 31, 20202022 and 2019,2021, respectively, a decreasean increase of $504,482 (17%$2,636,241 (33%). The decreaseincrease in other expenses in 2020the year ended December 31, 2022 compared to 2019the same period in 2021 is primarily attributable to lower contract employeethe increased expenses related to the two new operating segments and their acquisitions, and associated operating expenses, completed during the year ended December 31, 2022, that were not relevant to the year ended December 31, 2021. Additionally, this increase is also attributable to an increase in travel costs resulting fromand increased insurance costs, primarily in general liability and related coverages which premiums have been increased throughout the COVID-19 pandemic offset by increases in the Company’s insurance costs.marketplace.

 

Operating Loss

 

For the reasons previously stated, our operating loss was $7,663,651$29,733,258 and $6,032,781$14,760,910 for the years ended December 31, 20202022 and 2019,2021, respectively, aan increase of $1,630,870 (27%$14,972,348 (101%). Operating loss as a percentage of revenues decreasedworsened to 73%80% in 20202022 from 58%69% in 2019.2021.

 

Interest and Other Income

 

Interest income increaseddecreased to $47,893$131,025 for the year ended December 31, 20202022, from $37,410$310,200 in 2019,2021, which reflectedreflects our overall higherdecline in our cash and cash equivalent levels in 20202022 compared to 2019.2021. The Company raised significant amountscompany has completed five acquisitions and numerous other capital expenditures since the beginning of 2021, leading to the decrease in cash through the closing of several underwritten public offerings and the exercise of outstanding common stock purchase warrants during 2020, which generated additionalbalances: thus, leading to a decrease in interest income for the period.

Interest Expense

We incurred interest expenses of $37,196 and $28,600 during the years ended December 31, 2022 and 2021, respectively. The increase is attributable to the contingent earn-out notes associated with the four Nobility Healthcare acquisitions, currently at a total balance of $777,840 for the four notes, with interest rates of 3.00% per annum.

Change in 2020 whenFair Value of Short-Term Investments

We recognized a loss on change in fair value of short-term investments totaling $84,818 and $101,645 during the years ended December 31, 2022 and 2021, respectively. Such short-term investments are included in cash and cash equivalents as they contain original maturities of ninety (90) days or less. The decrease reflects our overall lower cash and cash equivalent levels in 2022 compared to 2019.2021.

Change in Fair Value of Warrant Derivative Liabilities

During 2021, the Company issued detachable warrants to purchase a total of 2,127,500 shares of Common Stock in association with the two registered direct offerings previously described. The underlying warrant agreement terms provide for net cash settlement outside the control of the Company in the event of tender offers under certain circumstances. As such, the Company is required to treat these warrants as derivative liabilities which are valued at their estimated fair value at their issuance date and at each reporting date with any subsequent changes reported in the condensed consolidated statement of operations as the change in fair value of warrant derivative liabilities. The change in fair value of the warrant derivative liabilities during year ended December 31, 2022 totaled $6,726,638, compared to $36,664,907 for the year ended December 31, 2021, which was recognized as a gain on the Consolidated Statements of Operations.

2927
 

Interest Expense

We incurred interest expense of $342,379 and $43,373 during the years ended December 31, 2020 and 2019, respectively. The increase was attributable to higher interest-bearing debt balances outstanding in 2020 as compared to 2019. We had secured convertible notes outstanding in 2020 represented by the $1.667 million principal amount of notes issued on April 17, 2020 and by the $2.778 million principal amount of notes issued on August 5, 2019, both of which bore interest at 8% per annum, and both of which were paid off during 2020. In addition, we issued an aggregate of $300,000 principal amount of an unsecured promissory note on December 23, 2019 bearing interest at 8% per annum on the outstanding principal balance which was paid off during 2020.

On May 12, 2020 the Company received $150,000 in additional loan funding under the Economic Injury Disaster Loans (“EIDL”) program administered by the Small Business Administration (“SBA”). Under the terms of the EIDL promissory note, interest accrues on the outstanding principal at the rate of 3.75% per annum. The term of the EIDL promissory note is thirty years and monthly principal and interest payments are deferred for twelve months after the date of disbursement and total $731.00 per month thereafter.

Change in Fair Value of Secured ConvertibleContingent Consideration Promissory Notes and Earn-Out Agreements

We elected to account for

During the secured convertible notesyear ended December 31, 2021, the Company issued a contingent consideration earn-out agreement in connection with the Stock Purchase Agreement between TicketSmarter, Inc., Goody Tickets, LLC and TicketSmarter of $3,700,000. Management determined that the actual Measurement Period EBITDA generated by TicketSmarter was less than 70% of the Projected EBITDA threshold provided in such an agreement. Therefore, no TicketSmarter earn-out payments were issued on April 17, 2020 on their fair value basis.due under such agreement. Therefore, we determined the fair value of the secured convertible notes ascontingent consideration earn-out agreement was reduced to zero, and the resulting gain of their issuance date of April 17, 2020 and through June 12, 2020, when they were paid$3,700,000 was reported in full. The change in fair value from their issuance date of April 17, 2020 to their pay-off date was $887,807, which was recognized as a charge in theour Consolidated StatementStatements of Operations for the year ended December 31, 2020.2021. There was no gain recorded for the year ended December 31, 2022.

 

We elected to account forOn June 30, 2021, Nobility Healthcare, a subsidiary of the secured convertible notes that wereCompany, issued a contingent consideration promissory note (the “June Contingent Note”) in August 2019connection with a stock purchase agreement between Nobility Healthcare and a private company (the “June Seller”) of $350,000. Principal payments, since its inception, on its fair value basis. Therefore, we determined thethis contingent consideration promissory note totaled $113,617. The estimated fair value of the secured convertible notesnote at December 31, 2022 is $176,456, representing a decrease in its estimated fair value of $27,139 as compared to its estimated fair value as of their issuance date on December 31, 2019 until they were paid in full March 3, 2020. The change in fair value from December 31, 2019 to their pay-off date was $412,445, which was recognized as2021. Therefore, the Company recorded a chargegain of $27,139 and $32,789 in the Consolidated StatementStatements of Operations for the years ended December 31, 2022 and December 31, 2021, respectively.

On August 31, 2021, Nobility Healthcare, issued another contingent consideration promissory note (the “August Contingent Payment Note”) in connection with a stock purchase agreement between Nobility Healthcare and a private company (the “August Sellers”) of $650,000. Principal payments, since its inception, on this contingent consideration promissory note totaled $292,953. The estimated fair value of the August Contingent Note at December 31, 2020. The change2022 is $388,954, representing an increase in its estimated fair value fromof $31,907 as compared to is estimated fair value as of December 31, 2021. Therefore, the issuance dateCompany recorded a loss of August 5, 2019$31,907 and $-0- in the Consolidated Statements of Operations for the years ended December 31, 2022 and December 31, 2019 was $519,821, which was recognized2021, respectively.

On January 1, 2022, Nobility Healthcare issued another contingent consideration promissory note (the “January Contingent Payment Note”) in connection with a stock purchase agreement between Nobility Healthcare and a private company (the “January Sellers”) of $750,000. Principal payments, since its inception, on this contingent consideration promissory note totaled $120,833. The estimated fair value of the January Contingent Note at December 31, 2022 is $208,083, representing a decrease in its estimated fair value of $421,085 as compared to its estimated fair value as of the inception date. Therefore, the Company recorded a chargegain of $421,085 and $-0- in the Consolidated StatementStatements of Operations for the years ended December 31, 2022 and December 31, 2021, respectively.

On February 1, 2022, Nobility Healthcare issued another contingent consideration promissory note (the “February Contingent Payment Note”) in connection with an asset purchase agreement between Nobility Healthcare and a private company (the “February Sellers”) of $105,000. The estimated fair value of the February Contingent Note at December 31, 20192022 is $4,346, representing a decrease in its estimated fair value of $100,654 as compared to its estimated fair value as of the inception date. Therefore, the Company recorded a gain of $100,654 and $-0- in the Consolidated Statements of Operations for the years ended December 31, 2022 and December 31, 2021, respectively.

 

Change in Fair ValueGain on Extinguishment of Proceeds Investment AgreementDebt

 

We recordedrecognized a gain (loss) representing the change in fair valueon extinguishment of proceeds investment agreement of $5,250,000debt totaling $-0- and $(3,358,000)$10,000 during the years ended December 31, 20202022 and 2019, respectively.

We elected to account for the PIA that was entered into in July 2018 on its fair value basis. Therefore, we determined the fair value of the 2018 PIA as of December 31, 2020, and 2019 to be $0 and $6,500,000,2021, respectively. During the year ended December 31, 2019, we settled our patent infringement litigation with WatchGuard and2021 the Company was notified that its $10,000 EIDL advance received a lump sum payment of $6.0 million as further described in Note 12, “Commitments and Contingencies,” to our consolidated financial statements. In accordance with the terms of the PIA, we remitted the $6.0 million as a principal payment toward our minimum return payment obligations under the PIA. The change in fair value from December 31, 2019 to December 31, 2020Payroll Protection Program (the “PPP”) Loan was $5,250,000, which was recognized as a loss in the Consolidated Statement of Operations at December 31, 2020.

On July 20, 2020, the Company and BKI executed the Termination Agreement. Under the terms of the Termination Agreement, the parties agreed to terminate the PIA and to release each other from any further liability under the PIA obligation.

Under the terms of the Termination Agreement, upon payment of $1,250,000 by the Company to BKI, both parties agreed to terminate the PIA and to release each other from any further liability thereunder. Such $1,250,000 payment was made on July 22, 2020. In addition to the $1,250,000 payment, the Company further agreed to pay BKI the following: (a) a contingent payment in the amount of $2,750,000 following the closing of an asset purchase, membership interest purchase, or similar transaction between the Company and a specified third-party (the “Purchase Transaction”) and (b) any and all future proceeds received from Watchguard and its successors and assigns by the Company for WatchGuard’s use of the ‘292 Patent and the ‘452 Patent. For clarity, the Company and BKI further agreed that the payment of the contingent payment would only be due and payable upon the closing of the specified Purchase Transaction and the relevant contingent payment portion of the Termination Agreement, and any obligations stemming therefrom, would automatically terminate if the specified Purchase Transaction is abandoned prior to its closing, including its failure to close within three years from the date of the Termination Agreement.

30

The parties abandoned the Purchase Transaction during the year ended December 31, 2020 and, therefore, the contingent payment obligation automatically terminated as the specified Purchase Transaction was abandoned prior to its closing. Furthermore, the Company does not anticipate any future recoveries from Watchguard and its successors and assigns relative to WatchGuard’s use of the ‘292 Patent or ‘452 Patent. As a result, the PIA obligation was extinguished upon the payment of the $1,250,000 required under the Termination Agreement.

Secured Convertible Debentures Issuance Expenses

We elected to account for and record our $1.667 million principal amount of secured convertible notes on April 17, 2020 on a fair value basis. Accordingly, we were required to expense the related issuance costs to other expense in the consolidated statements of operations. Such costs totaled $34,906 for the year ended December 31, 2020 and primarily included related legal and accounting fees.

We elected to account for and record our $2.778 million principal amount of secured convertible notes on August 5, 2019 on a fair value basis. Accordingly, we were required to expense the related issuance costs to other expense in the consolidated statements of operations. Such costs totaled $89,148 for the year ended December 31, 2019 and primarily included related legal and accounting fees.

Gain on Extinguishment of Debt

As discussed in Note 7,“Debt Obligations,” on May 4, 2020 the Company received a $1,418,900 promissory note under the SBA’s PPP Loan through the CARES Act. On December 10, 2020, we were informed that the Company’s SBA Loan had beenfully forgiven, less the EIDL Advance received, thus the remaining balance has been released resulting in a gain on extinguishment of debt.

In accordance with ASC Topic No. 470, “Debt – Modifications and Extinguishments” (Topic 470), the transaction noted above was determined to be an extinguishment of the existing debt. As a result, we recorded a gain on the extinguishment of debt in the amount of $1,417,413, which is included in “Gain on Extinguishment of Debt” in our Consolidated Statements of Operations.Operations for the year ended December 31, 2021, and further resulting in $-0- for the year ended December 31, 2022.

 

Income Gain on Extinguishment of Warrant Derivative Liabilities

We recognized a gain on the extinguishment of warrant derivative liabilities of $3,624,794 and $-0- during the year ended December 31, 2022 and December 31, 2021, respectively. This is in connection with the Warrant Exchange Agreements executed by the Company on August 23, 2022.

Income/(Loss) before Income Tax Benefit

 

As a result of the above, we reported a lossnet income/(loss) before income tax benefit of $2,625,881($18,873,758) and $10,005,713$25,530,961 for the years ended December 31, 20202022 and 2019,2021, respectively, an improvementa decline of $7,379,832 (74%$44,404,719 (174%).

Income Tax Benefit

We recorded an income tax benefit of $-0- for the years ended December 31, 20202022 and 2019,2021, respectively. The effective tax rate for both 20202022 and 20192021 varied from the expected statutory rate due to our continuing to provide a 100% valuation allowance on net deferred tax assets. We determined that it was appropriate to continue the full valuation allowance on net deferred tax assets as of December 31, 20202022 and 20192021 primarily because of the recurring operating losses.

We have further determined to continue providing a full valuation reserve on our net deferred tax assets as of December 31, 2020.2022. During 2020,2022, we increaseddecreased our valuation reserve on deferred tax assets by $405,000$17,220,000 whereby our deferred tax assets continue to be fully reserved due to our recent operating losses.

We had approximately $76,070,000$113,315,000 of federal net operating loss carryforwards and $1,795,000 of research and development tax credit carryforwards as of December 31, 20202022 available to offset future net taxable income.

Net Income/(Loss)

As a result of the above, we reported a net income/(loss) of ($18,873,758) and $25,530,961 for the years ended December 31, 2022 and 2021, respectively, a decline of $44,404,719 (174%).

Net Income Attributable to Noncontrolling Interests of Consolidated Subsidiary

The Company owns a 51% equity interest in its consolidated subsidiary, Nobility Healthcare. As a result, the noncontrolling shareholders or minority interest is allocated 49% of the income/loss of Nobility Healthcare which is reflected in the statement of income (loss) as “net income (loss) attributable to noncontrolling interests of consolidated subsidiary”. We reported net income (loss) attributable to noncontrolling interests of consolidated subsidiary of $407,933 and $56,453 for the years ended December 31, 2022 and 2021, respectively.

28

Loss on Redemption – Series A & B Convertible Redeemable Preferred Stock

 

During the year ended December 31, 2022, the Company redeemed 1,400,000 shares of Series A & 100,000 shares of Series B Preferred Stock, for a redemption price of $15,750,000, with a $13,365,000 carrying amount, resulting in a $2,385,000 loss on redemption.

Net LossIncome/(Loss) Attributable to Common Stockholders

 

As a result of the above, we reported a net lossesincome/(loss) of $2,625,881($21,666,691) and $10,005,713$25,474,508 for the years ended December 31, 20202022 and 2019,2021, respectively, an improvementa decline of $7,379,832 (74%$47,141,199 (185%).

31

Basic and Diluted LossIncome/(Loss) per Share

The basic and diluted lossincome/(loss) per share was $0.12($8.50) and $0.87$10.14 for the years ended December 31, 20202022 and 2019,2021, respectively, for the reasons previously noted. All outstanding stock options and common stock purchase warrants were considered antidilutive and therefore excluded from the calculation of diluted loss per share for the years ended December 31, 20202022 and 20192021 because all potentially dilutive securities during 2022 had exercise prices in excess of the market value of the company’s common stock and because of the net loss reported for each period.2022.

Liquidity and Capital Resources

Overall:

Management’s Liquidity Plan - The Company has historically raised capital in the form of equityWe have experienced net losses and debt instrumentscash outflows from private and public sourcesoperating activities since inception. Based upon our current operating forecast, we anticipate that we will need to supplement its needs for funds to support its business operational and strategic plans. In addition, during 2019, the Company settled one of its patent infringement cases and received a lump sum payment of $6.0 million, which it used to pay its obligations under the PIA agreement, and on July 20, 2020, the Company and BKI executed a Termination Agreement which terminated the PIA and released the parties from any further liability under the PIA obligation upon payment of $1,250,000 by the Company to BKI. Such $1,250,000 payment was made on July 22, 2020 and the PIA obligation was extinguished, as more fully described in Note 7, “Debt Obligations”. In recent years the Company has accessed the public and private capital markets to raise funding through the issuance of debt and equity. In that regard, the Company raised $12.8 million in underwritten public offerings of Common Stock, $5.2 million through the exercise of common stock purchase warrants and options, $1.6 million through the issuance of promissory notes under the SBA’s PPP and EIDL programs, raised $1.5 million through the issuance of secured convertible notes and $419,000 in unsecured promissory notes and detachable warrants during the year ended December 31, 2020. These debt and equity raises were utilized to fund its operations during 2020. Management believes that it now has adequate liquidity for the foreseeable future from recent issuances of equity in 2021 through the utilization of the Company’s shelf registration statement on Form S-3 (File No. 333-239419), which was initially filed with the SEC on June 25, 2020, and was declared effective on July 2, 2020 (the “Shelf Registration Statement”).

Shelf Registration Statement on Form S-3 - The Shelf Registration Statement allows the Company to offer and sell, from time to time in one or more offerings, any combination of our Common Stock, debt securities, debt securities convertible into Common Stock or other securities in any combination thereof, rights to purchase shares of Common Stock or other securities in any combination thereof, warrants to purchase shares of Common Stock or other securities in any combination thereof or units consisting of Common Stock or other securities in any combination thereof having an aggregate initial offering price not exceeding $125,000,000. The Company has utilized the Shelf Registration Statement for two recent offerings of its securities, as described as follows:

Registered Direct Offering - On January 14, 2021, the Company, pursuant a securities purchase agreement, closed a registered direct offering (the “January Offering”) of (i) 2,800,000 shares of Common Stock, (ii) pre-funded warrants to purchase up to 7,200,000 of Common Stock at an exercise price of $0.01 per share, issuable to investors whose purchase of shares of Common Stock would otherwise result in such investor, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the holder, 9.99%) of the Company’s outstanding Common Stock immediately following the consummation of the January Offering; and (iii) common stock purchase warrants (“January Warrants”) to purchase up to an aggregate of 10,000,000 shares of Common Stock, which are exercisable for a period of five years after issuance at an initial exercise price $3.25 per share, subject to certain adjustments, as provided in the January Warrants. The January Offering was conducted pursuant to a placement agency agreement, dated January 11, 2021 (the “January Placement Agency Agreement”), between the Company and Kingswood Capital Markets, division of Benchmark Investments, Inc. (the “Placement Agent”). The combined offering price of each share of Common Stock and accompanying January Warrant in the January Offering was $3.095.

Pursuant to the terms of the January Placement Agency Agreement, the Company agreed not to, for a period of 90 days after the date of the January Placement Agency Agreement, with certain exceptions, unless it has obtained the prior written consent of the Placement Agent, (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company; (ii) file or cause to be filed any registration statement with the SEC relating to the offering of any shares of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company; (iii) complete any offering of debt securities of the Company, or (iv) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of capital stock of the Company.

32

The Company received approximately $29,013,000 in net proceeds from the January Offering after deducting the discounts, commissions and other estimated offering expenses payable by the Company. The Company plans to use the net proceeds from the January Offering for working capital, product development, order fulfillment and for general corporate purposes.
Registered Direct Offering - On February 1, 2021, the Company, pursuant a securities purchase agreement closed a registered direct offering (the “February Offering”) of (i) 3,250,000 shares of Common Stock, (ii) pre-funded warrants to purchase up to 11,050,000 of Common Stock at an exercise price of $0.01 per share, issuable to investors whose purchase of shares of Common Stock would otherwise result in such investor, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the holder, 9.99%) of the Company’s outstanding Common Stock immediately following the consummation of the February Offering; and (iii) common stock purchase warrants (“February Warrants”) to purchase up to an aggregate of 14,300,000 shares of Common Stock, which are exercisable for a period of five years after issuance at an initial exercise price $3.25 per share, subject to certain adjustments, as provided in the Warrants. The February Offering was conducted pursuant to a placement agency agreement, dated January 28, 2021 (the “February Placement Agency Agreement”), between the Company and the Placement Agent. The combined offering price of each share of Common Stock and accompanying February Warrant in the February Offering was $2.80.
Pursuant to the terms of the February Placement Agency Agreement, the Company has agreed not to, for a period of 90 days after the date of the February Placement Agency Agreement, with certain exceptions, unless it has obtained the prior written consent of the Placement Agent, (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company; (ii) file or cause to be filed any registration statement with the SEC relating to the offering of any shares of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company; (iii) complete any offering of debt securities of the Company, or (iv) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of capital stock of the Company.
The Company received approximately $37,447,100 in net proceeds from the February Offering after deducting the discounts, commissions and other estimated offering expenses payable by the Company. The Company plans to use the net proceeds from the February Offering for working capital, product development, order fulfillment and for general corporate purposes.

33

Management believes that it has adequate funding to support its business operations for the foreseeable future as a result of the funds raised by the January Offering and the February Offering.

The Company has increased its addressable market to non-law enforcement customers and obtained new non-law enforcement contracts in 2020 and 2019, which contracts include recurring revenue during the period from 2020 to 2023. The Company believes that its quality control and cost cutting initiatives, expansion to non-law enforcement sales channels and new product introduction will eventually restore positive operating cash flows and/or raise additional capital in the short-term to fund operations, meet our customary payment obligations and profitability, although itotherwise execute our business plan over the next 12 months. We are continuously in discussions to raise additional capital, which may include a variety of equity and debt instruments; however, there can offerbe no assurancesassurance that our capital raising initiatives will be successful. Our recurring losses and level of cash used in this regard. The extent to which our future operating results are affected by the COVID-19 pandemic will largely depend on future developments which cannot be accurately predicted, including the duration and scope of the pandemic, governmental and business responses to the pandemic and the impact on the global economy, our customers’ demand for our products and services, andoperations, along with uncertainties concerning our ability to provideraise additional capital, raise substantial doubt about our products and services, particularlyability to continue as a result of our employees working remotely and/or the closure of certain offices and facilities. While these factors are uncertain, we believe that the COVID-19 pandemic and/or the perception of its effects will have a material adverse effect on our business, financial condition, results of operations and cash flows.going concern.

On March 3, 2020, the Company consummated an underwritten public offering of 2,521,740 shares of common stock (the “March Offering”). The shares of Common Stock in the March Offering were sold at a public offering price of $1.15 per share. The gross proceeds to the Company from the March Offering, before deducting underwriting discounts and commissions and other estimated offering expenses, and assuming the underwriters would not exercise their over-allotment option, were approximately $2.9 million. The net proceeds to the Company from the offering, after deducting underwriting discounts and commissions and the non-accountable expense reimbursement, but before deducting other expenses in connection with the offering, and assuming the underwriters would not exercise their over-allotment option, were approximately $2.67 million. The Company intends to use the net proceeds from this offering to fund the repayment of debt and for general corporate purposes.

We had warrants outstanding exercisable to purchase 3,388,364 shares of Common Stock at a weighted average exercise price $6.24 per share outstanding as of December 31, 2020. In addition, there are Common Stock options outstanding exercisable to purchase 838,313 shares of Common Stock at an average price of $3.20 per share. We could potentially use such outstanding warrants to provide near-term liquidity if we could induce their holders to exercise their warrants by adjusting/lowering the exercise price on a temporary or permanent basis if the exercise price was below the then market price of our Common Stock, although we can offer no assurances in this regard. Ultimately, we must restore profitable operations and positive cash flows to provide liquidity to support our operations and, if necessary, to raise capital on commercially reasonable terms in 2021, although we can offer no assurances in this regard.

On June 4, 2020, the Company consummated an underwritten public offering (the “First June Offering”) of 3,090,909 shares of Common Stock. The First June Offering was conducted pursuant to an underwriting agreement, dated June 2, 2020 (the “First June Underwriting Agreement”), between the Company and Aegis Capital Corp., as representative of the underwriters (the “Underwriter”), at a public offering price of $1.65 per share, for gross proceeds of approximately $5.1 million, before deducting underwriting discounts and other offering expenses. Pursuant to the First June Underwriting Agreement, the Company granted the Underwriters a forty-five (45)-day option to purchase up to an additional 463,636 shares of Common Stock at the public offering price, less underwriting discounts and commissions, to cover over-allotments, if any (the “First June Option Shares”). On June 8, 2020, the Underwriters fully exercised their over-allotment option to acquire the First June Option Shares at $1.65 per share, and the offering of the First June Option Shares closed on June 8, 2020. The exercise of such over-allotment option resulted in additional gross proceeds, before deducting underwriting discounts and commissions and other estimated offering expenses, of $764,999.40, which the Company used for working capital purposes throughout the year.

On June 10, 2020, the Company consummated an underwritten public offering (the “Second June Offering”) of 2,325,581 shares of Common Stock. The Second June Offering was conducted pursuant to the terms of an underwriting agreement, dated June 8, 2020 (the “Second June Underwriting Agreement”), with the Underwriter, at a public offering price of $2.15 per share, for gross proceeds of approximately $5.0 million, before deducting underwriting discounts and other offering expenses. The Underwriters also fully exercised their over-allotment option, under the terms of the Second June Underwriting Agreement, to acquire an additional 213,953 shares of Common Stock (the “Second June Option Shares”) at the public offering price, for additional gross proceeds of $459,998.95, before deducting underwriting discounts and other offering expenses. The Company used the net proceeds from the Second June Offering for working capital purposes throughout the year.

The First June Offering and the Second June Offering were registered pursuant to the Company’s effective shelf registration statement on Form S-3 (File No. 333-225227), which was initially filed with the SEC on May 25, 2018, and was declared effective on June 6, 2018, and the related base prospectus included in such registration statement, as supplemented by the prospectus supplement dated June 2, 2020.

Our Common Stock is currently listed on The Nasdaq Capital Market.Market. In order to maintain our listing, we must satisfy minimum financial and other continued listing requirements and standards, including those regarding director independence and independent committee requirements, minimum stockholders’ equity, minimum share price, and certain corporate governance requirements. There can be no assurances that we will be able to comply with the applicable listing standards. See “Nasdaq Listing” below.

We had $4,361,758$3,532,199 of available cash and equivalents and net working capital of $14,109,500$11,447,313 as of December 31, 2020.2022. Net working capital as of December 31, 20202022, included approximately $1.7$6.1 million of accounts receivable and $8.2other receivables and $6.8 million of current inventory.

34

Cash, cash equivalents: As of December 31, 2020,2022, we had cash and cash equivalents with an aggregate balance of $4,361,758, an increase$3,532,199, a decrease from a balance of $359,685 at$32,007,792 for the year December 31, 2019.2021. Summarized immediately below and discussed in more detail in the subsequent subsections are the main elements of the $4,002,073$28,475,593 net increasedecrease in cash during the year ended December 31, 2020:2022:

 Operating activities:$13,274,715 18,580,385 of net cash used inoperating activities. Net cash used in operating activities was $13,274,715$18,580,385 and $1,124,373$17,825,108 for the years ended December 31, 20202022 and 2019,2021, respectively, a deterioration of $12,150,342.$755,277. The deterioration is attributable to the net loss incurred for 2020,2022, the non-cash gain attributable to the change in value of the PIA obligation, the usage of cash to increase inventory,warrant derivative liability, increased accounts receivable and other operating assets and the reduction of accounts payable during the year ended December 31, 20202022 compared to the same period in 2019.2021.
    
 Investing activities:$1,499,189 2,940,591 of net cash used ininvesting activities. Cash used in investing activities was $1,499,189$2,940,591 and $266,144$19,124,379 for the years ended December 31, 20202022 and 20192021 respectively. In 20202022, we incurred costs for the purchase of an aircraft for our BirdVu Jets subsidiary, further building improvements, the closing of one business acquisition and one asset acquisition. In 2021 we incurred costs for: (i) the purchase of aan office and warehouse building; (ii) the build out of the new leased office and warehouse space; (iii) the tooling of new products; (iv) patent applications on our proprietary technology utilized in our new products and included in intangible assets; and (v) a $250,000 investment the Company made in a private company; and (vi) issuanceclosing of $800,000 in secured notes in other companies.three acquisitions during the year ended December 31, 2021, compared to only two, smaller acquisitions during the year ended December 31, 2022.

29

 Financing activities: 
Financing activities$6,954,617 :$18,775,977 of net cash provided byused in financing activities. Cash used in financing activities was $18,775,977$6,954,617 for the year ended December 31, 20202022, compared to cash provided by $1,848,605financing activities of $64,595,521 for the year ended December 31, 2019.2021. In 2020,2022, we utilized over $4.0 million on the stock repurchase program, $2.4 million for completion of the preferred stock transaction, as well as over $0.5 million on payments of contingent consideration promissory notes related to the revenue cycle management segment. In 2021, we closed severaltwo underwritten public offerings of our Common Stock, which generated $12.8$66.6 million of cash we received total proceeds of $5.2 million from the exerciseand repurchased and cancelled shares of common stock purchase warrants and we received a total of $1.6 million in borrowings under the PPP and EIDL programs administered by the SBA. In April 2020, we received net proceeds of $1,500,000 from the issuance of the convertible notes with detachable common stock purchase warrants. In addition, we received $419,000 in proceeds from the issuance of unsecured promissory notes payable during the year ended December 31, 2020. These 2020 financing cash inflows were offset by the extinguishment of the PIA obligation and the repayment of principal on the secured convertible notes and unsecured promissory notes. During 2019, we received $2,500,000 in proceeds from the issuance of convertible debt and $1,564,000 of proceeds from the exercise of common stock purchase warrants offset by the $6 million payment on the PIA.approximately $1.98 million.

 

The net result of these activities was an increasea decrease in cash of $4,002,073$28,475,593 to $4,361,758$3,532,199 for the year ended December 31, 2020.2022.

 

Commitments:

We had $4,361,758$3,532,199 of cash and cash equivalents and net positive working capital $14,109,500$11,447,313 as of December 31, 2020.2022. Accounts receivable and other receivable balances represented $1,705,461$6,120,578 of our net working capital atas of December 31, 2020.2022. We intend to collect our outstanding receivables on a timely basis and reduce the overall level during 2021,2023, which would help to provide positive cash flow to support our operations during 2021.2023. Inventory represented $8,202,274$6,839,406 of our net working capital atas of December 31, 2020 and finished goods represented $6,974,291 of total current and non-current inventory.2022. We are actively managing the level of inventory and our goal is to reduce such level during 20212023 by our sales activities, the increase of which should provide additional cash flow to help support our operations during 2021.2023.

 

Capital Expenditures. We had no material commitments for capital expenditures atOn December 6, 2021, the Board authorized the repurchase of up to $10.0 million of the Company’s outstanding common stock under the specified terms of a share repurchase program (the “Program”). During the year ended December 31, 2020 however, on February 24, 20212022, the Company entered intorepurchased 186,299 shares of its common stock for $4,026,523, in accordance with the Program.

On June 30, 2022, the Board elected to terminate the Program, effective immediately. The Program began in December 2021, with the Company purchasing a contracttotal of 273,041 shares at a cost of $6,001,602 through its termination on June 30, 2022.

The Company’s revenue cycle management segment completed its third medical billing company acquisition using approximately $1.2 in cash for the portion of the purchase price during 2022. The acquisition of the medical billing company included a contingent consideration promissory note payable to purchase a 71,361 square foot building located in Lenexa, Kansas,the sellers of $750,000 at closing, which is intended to servemanagement estimated its fair value of $208,083 as of December 31, 2022.

In addition, the Company’s office and warehouse needs. The building containsrevenue cycle management segment completed its fourth medical billing asset acquisition using approximately 30,000 square foot$230,000 in cash for a portion of office space and the remainder warehouse space. The total purchase price. The acquisition of the fourth medical billing asset purchase price is approximately $5.3 million and is expectedincluded a contingent consideration promissory note payable to close on or around May 1, 2021.the sellers with an estimated fair value of $105,000 at closing which management estimated its fair value of $4,346 as of December 31, 2022.

3530
 

 

Lease commitments. On May 13, 2020, the Company entered into an operating lease for new warehouse and office space, which will serveserved as its new principal executive office and primary business location.location prior to the April 30 purchase and sale agreement. The original lease agreement was amended on August 28, 2020 to correct the footage under lease and monthly payment amounts resulting from such correction. The lease terms, as amended include no base rent for the first nine months and monthly payments ranging from $12,398 to $14,741 thereafter, with a termination date of December 31, 2026. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related to its new location. The Company took possession of the leased facilities on June 15, 2020. The remaining lease term for the Company’s office and warehouse operating lease as of December 31, 20202022 was seventy-oneforty-eight months. The Company’s previous office and warehouse space lease expired in April 2020 and the Company paid holdover rent for the time period until it moved to and commenced occupying the new space on June 15, 2020.

The Company entered into an operating lease with a third party in October 2019 for copiers used for office and warehouse purposes. The terms of the lease include 48 monthly payments of $1,598 with a maturity date of October 2023. The Company has the option to Purchase thepurchase such equipment at maturity for its estimated fair market value at that point in time. The remaining lease term for the Company’s copier operating lease as of December 31, 20202022 was 34ten months.

On June 30, 2021, the Company completed the acquisition of its first medical billing company, through Nobility Healthcare. Upon completion of this acquisition, Nobility Healthcare became responsible for the operating lease for the seller’s office space. The lease terms include monthly payments ranging from $2,648 to $2,774 thereafter, with a termination date in July 2024. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related to this location. The remaining lease term for the Company’s office and warehouse operating lease as of December 31, 2022 was nineteen months.

On August 31, 2021, the Company completed the acquisition of its second acquired medical billing company, through Nobility Healthcare. Upon completion of this acquisition, Nobility Healthcare became responsible for the operating lease for the seller’s office space. The lease terms include monthly payments ranging from $11,579 to $11,811 thereafter, with a termination date in March 2023. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related to this location. The Company took possession of the leased facilities on September 1, 2021. The remaining lease term for the Company’s office and warehouse operating lease as of December 31, 2022 was three months. The Company plans to relocate the revenue cycle management operating segment acquired operations to existing owned or leased facilities upon termination of this operating lease.

On September 1, 2021, the Company completed the acquisition of Goody Tickets, LLC and TicketSmarter, LLC through TicketSmarter. Upon completion of this acquisition, the Company became responsible for the operating lease for TicketSmarter’s office space. The lease terms include monthly payments ranging from $7,211 to $7,364 thereafter, with a termination date of December 2022. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related to this location. The Company took possession of the leased facilities on September 1, 2021. The Company signed a six month extension for the lease, extending the remaining lease term for the Company’s office and the remaining lease term for the Company’s warehouse operating lease as of December 31, 2022 was six months.

On January 1, 2022, the Company completed the acquisition of a private medical billing company, through its revenue cycle management segment. Upon completion of this acquisition, the Company became responsible for the operating lease for the seller’s office space. The lease terms include monthly payments ranging from $4,233 to $4,626, with a termination date of June 2025. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related to this location. The Company took possession of the leased facilities on January 1, 2022. The remaining lease term for the Company’s office and warehouse operating lease as of December 31, 2022, was thirty months.

Lease expense related to the office spacespaces and copier operating leases was recorded on a straight-line basis over the lease term. Total lease expense under the twofive operating leases was approximately $349,079$547,609 for the year ended December 31, 2020.2022.

The weighted-average remaining lease term related to the Company’s lease liabilities as of December 31, 2022 and December 31, 2021 was 3.3 years and 3.8 years, respectively.

31

The discount rate implicit within the Company’s operating leases was not generally determinable, and therefore, the Company determined the discount rate based on its incremental borrowing rate on the information available at commencement date. As of commencement date, the operating lease liabilities reflect a weighted average discount rate of 8%.

The following sets forth the operating lease right of use assets and liabilities as of December 31, 2020:2022:

Assets:        
Operating lease right of use assets $753,175  $782,129 
        
Liabilities:        
Operating lease obligations-current portion $113,484  $294,617 
Operating lease obligations-less current portion $723,272  $555,707 
Total operating lease obligations $836,756  $850,324 

Following are the minimum lease payments for each year and in total.

Year ending December 31:      
2021 $175,249 
2022  184,145 
2023  184,241  $349,811 
2024  171,642   245,761 
Thereafter  333,705 
2025  196,462 
2026  175,113 
Total undiscounted minimum future lease payments  1,048,982   967,147 
Imputed interest  (212,226)  (116,823)
Total operating lease liability $836,756  $850,324 

36

Litigation.

From time to time, we are notified that we may be a party to a lawsuit or that a claim is being made against us. It is our policy to not disclose the specifics of any claim or threatened lawsuit until the summons and complaint are actually served on us. After carefully assessing the claim, and assuming we determine that we are not at fault or we disagree with the damages or relief demanded, we vigorously defend any lawsuit filed against us. We record a liability when losses are deemed probable and reasonably estimable. When losses are deemed reasonably possible but not probable, we determine whether it is possible to provide an estimate of the amount of the loss or range of possible losses for the claim, if material for disclosure. In evaluating matters for accrual and disclosure purposes, we take into consideration factors such as our historical experience with matters of a similar nature, the specific facts and circumstances asserted, the likelihood of our prevailing, the availability of insurance, and the severity of any potential loss. We reevaluatere-evaluate and update accruals as matters progress over time.

While the ultimate resolution is unknown, we do not expect that these lawsuits will individually, or in the aggregate, have a material adverse effect to our results of operations, financial condition or cash flows. However, the outcome of any litigation is inherently uncertain and there can be no assurance that any expense, liability or damages that may ultimately result from the resolution of these matters will be covered by our insurance or will not be in excess of amounts recognized or provided by insurance coverage and will not have a material adverse effect on our operating results, financial condition or cash flows. See Item 3, “Legal Proceedings,” of this Annual Report on Form 10-K for information on our litigation.

Nasdaq Listing.

On July 11, 2019, we were officially notified by The Nasdaq Stock Market LLC that, for the previous 30 consecutive business days, the minimum Market Value of Listed Securities (the “MVLS”) for our Common Stock was below the $35 million minimum MVLS requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2) (the “MVLS Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), we had 180 calendar days, or until January 7, 2020, to regain compliance with the MVLS Rule, or in the alternative, the minimum stockholders’ equity requirement of $2,500,000. To regain compliance with the MVLS Rule, the minimum MVLS for our Common Stock must have been at least $35 million for a minimum of 10 consecutive business days at any time during this 180-day period. If we failed to regain compliance with either the MVLS Rule or the minimum stockholders’ equity requirement by January 7, 2020, we could have been delisted from Nasdaq.

On January 8, 2020, we received a determination letter (the “Letter”) from the staff of The Nasdaq Stock Market LLC (the “Staff”) stating that we had not regained compliance with the MVLS Standard, since our Common Stock was below the $35 million minimum MVLS requirement for continued listing on Nasdaq under the MLVS Rule and had not been at least $35 million for a minimum of 10 consecutive business days at any time during the 180-day grace period granted to us. Pursuant to the Letter, unless we requested a hearing to appeal this determination by 4:00 p.m. Eastern Time on January 15, 2020, our Common Stock would have been delisted from the Nasdaq Capital Market, trading of our Common Stock would have been suspended at the opening of business on January 17, 2020, and a Form 25-NSE would have been filed with the SEC, which would have removed our Common Stock from listing and registration on The Nasdaq Stock Market LLC.

On January 13, 2020, we requested a hearing before the Nasdaq Hearings Panel (the “Panel”) to appeal the Letter and a hearing was set for February 20, 2020. In anticipation of such hearing, we were asked to provide the Panel with a plan to regain compliance with the minimum MLVS requirement under the MLVS Rule, which needed to include a discussion of the events that we believe will enable us to timely regain compliance with the minimum MLVS requirement, or in the alternative, the minimum shareholders’ equity requirement. On January 21, 2020, we submitted a compliance plan that we believed was sufficient to permit us to regain compliance with the minimum stockholders’ equity requirement. On February 20, 2020, we appeared before the Panel to discuss our plan to regain compliance, including, but not limited to, complying with Nasdaq Listing Rule 5550(b)(1), which is the minimum stockholdersequity standard for continued listing, which requires that companies listed on the Nasdaq Capital Market maintain a minimum of $2,500,000 in stockholders’ equity (“Rule 5550(b)(1)”). On March 6, 2020, we received written notice from the Panel indicating that, based on the plan of compliance that we had presented at such hearing, the Panel granted our request for the continued listing of our Common Stock on Nasdaq, subject to, among other things, us keeping the Staff updated on the progress of our compliance plan and ultimately being able to evidence shareholder equity in an amount greater than or equal to $2,500,000 in accordance with Rule 5550(b)(1) no later than June 30, 2020. During this time, our Common Stock remained listed and trading on the Nasdaq Capital Market.

37

On June 4, 2020 and June 10, 2020, we consummated underwritten public offerings identified above and raised aggregate gross proceeds of approximately $11.3 million, before underwriting discounts and commissions and other estimated expenses of such offerings. As a result of such offerings, we achieved compliance withRule 5550(b)(1) and on June 18, 2020 we received written notice from the Staff stating that we had regained compliance with such rule and the matter is now closed.

On April 22, 2020, we received a written notification from The Nasdaq Stock Market LLC indicating that we were not in compliance with Nasdaq Listing Rule 5550(a)(2), as the closing bid price for our Common Stock was below $1.00 per share for the last thirty (30) consecutive business days. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), we were granted a 180-calendar day compliance period to regain compliance with the minimum bid price requirement. Subsequently, the 180-day grace period to regain compliance with such minimum bid price requirement under applicable Nasdaq Stock Market LLC rules was extended due to the global market impact caused by COVID-19. More specifically, The Nasdaq Stock Market LLC stated that the compliance periods for any company previously notified about non-compliance would be suspended effective April 16, 2020, through June 30, 2020. On July 1, 2020, companies not in compliance would receive the balance of any pending compliance period exception to come back into compliance with such minimum bid price requirement. As a result of this extension, we had until December 28, 2020, to regain compliance with such minimum bid price requirement. During the compliance period, our Common Stock would still continue to be listed and traded on the Nasdaq Capital Market. To regain compliance, the closing bid price of the Common Stock had to have met or exceeded $1.00 per share for at least ten (10) consecutive business days by December 28, 2020. On June 11, 2020, our Common Stock met such minimum bid price requirement, as the closing sale price of our Common Stock had equaled or exceeded $1.00 per share on the Nasdaq Capital Market at the close of each trading day since May 29, 2020, and we received written notice from the Staff stating that the Company regained compliance with such requirement and the matter is now closed.

401 (k) Plan. The Company sponsors a 401(k) retirement savings plan for the benefit of its employees. The plan, as amended, requires the Company to provide 100% matching contributions for employees, who elect to contribute up to 3% of their compensation to the plan and 50% matching contributions for employee’s elective deferrals on the next 2% of their contributions. The Company made matching contributions totaling $110,491$223,084 and $108,688$127,293 for the years ended December 31, 20202022 and 2019,2021, respectively. Each participant is 100% vested at all times in employee and employer matching contributions.

Consulting and Distributor Agreements. The Company entered into an agreement that required it to make monthly payments that will be applied to future commissions and/or consulting fees to be earned by the provider. The agreement is with a limited liability company (“LLC”) that is minority owned by a relative of the Company’s chief financial officer. Under the agreement, dated January 15, 2016 and as amended on February 13, 2017, the LLC provides consulting services for developing a new distribution channel outside of law enforcement for its body-worn camera and related cloud storage products to customers in the United States. The Company advanced amounts to the LLC against commissions ranging from $5,000 to $6,000 per month plus necessary and reasonable expenses for the period through June 30, 2017, which can be automatically extended based on the LLC achieving minimum sales quotas. The agreement was renewed in January 2017 for a period of three years, subject to yearly minimum sales thresholds that would allow the Company to terminate the contract if such minimums are not met. As of December 31, 2020, the Company had advanced a total of $274,731 pursuant to this agreement which has been fully reserved for a net advance of $-0-. The minimum sales threshold was not met, and the Company discontinued all advances, although the contract has not been formally terminated. However, the exclusivity provisions of the agreement have been terminated.

On June 1, 2018, the Company entered into an agreement with an individual that required it to make monthly payments that will be applied to future commissions and/or consulting fees to be earned by the provider. Under the agreement, the individual provides consulting services for developing new distribution channels both inside and outside of law enforcement for its in-car and body-worn camera systems and related cloud storage products to customers within and outside the United States. The Company was required to advance amounts to the individual as an advance against commissions of $7,000 per month plus necessary and reasonable expenses for the period through August 31, 2018, which was extended to December 31, 2018 by mutual agreement of the parties at $6,000 per month. The parties have mutually agreed to further extend the arrangement on a monthly basis at $5,000 per month. The Company had advanced a total of $53,332 pursuant to this agreement, until September 2020 when the agreement was mutually terminated, thus as of December 31, 2020 the Company had advanced $-0- pursuant to this agreement.

3832
 

Critical Accounting PoliciesEstimates

Our significant accounting policies are summarized in Note 1, “Nature of Business and Summary of Significant Accounting Policies,” to our consolidated financial statements. While the selection and application of any accounting policy may involve some level of subjective judgments and estimates, we believe the following accounting policies are the most critical to our financial statements, potentially involve the most subjective judgments in their selection and application, and are the most susceptible to uncertainties and changing conditions:

Revenue Recognition / Allowance for Doubtful Accounts;
Allowance for Excess and Obsolete Inventory;
Goodwill and other intangible assets;

Warranty Reserves;

Stock-based Compensation Expense;
Fair value of warrants;
Fair value of assets and liabilities acquired in business combinations;
Accounting for Income Taxes; and
   
 Allowance for Excess and Obsolete Inventory;

Redeemable Preferred Stock.

Warranty Reserves;
Stock-based Compensation Expense; and
Accounting for Income Taxes.

Revenue Recognition / Allowances for Doubtful Accounts. Revenue is recognized for the shipment of products or delivery of service when all five of the following conditions are met:

(i)Identify the contract with the customer;
(ii)Identify the performance obligations in the contract;
(iii)Determine the transaction price;
(iv)Allocate the transaction price to the performance obligations in the contract; and
(v)Recognize revenue when a performance obligation is satisfied.

We consider the terms and conditions of the contract and our customary business practices in identifying our contracts under ASC 606. We determine we have a contract when the customer order is approved, we can identify each party’s rights regarding the services to be transferred, we can identify the payment terms for the services, we have determined the customer has the ability and intent to pay and the contract has commercial substance. At contract inception we evaluate whether the contract includes more than one performance obligation. We apply judgment in determining the customer’s ability and intent to pay, which is based on a variety of factors, including the customer’s historical payment experience or, in the case of a new customer, credit and financial information pertaining to the customer.

Performance obligations promised in a contract are identified based on the services and the products that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the services and the products is separately identifiable from other promises in the contract. Our performance obligations consist of (i) products, (ii) professional services, and (iii) extended warranties.

39

The transaction price is determined based on the consideration to which we expect to be entitled in exchange for transferring services to the customer. Variable consideration is included in the transaction price if, in our judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. None of our contracts contain a significant financing component.

33

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on the relative standalone selling price (“SSP”).

Revenue for our video solutions segment is recognized at the time the related performance obligation is satisfied by transferring the control of the promised service to a customer. Revenue is recognized when control of the service is transferred to the customer, in an amount that reflects the consideration that we expect to receive in exchange for our services. We generate all our revenue from contracts with customers.

Revenue for our revenue cycle management segment is recorded on a net basis, as its primary source of revenue is its end-to-end service fees. These service fees are reported as revenue monthly upon completion of our performance obligation to provide the agreed upon services.

Revenue for our entertainment segment is recorded on a gross or net basis based on management’s assessment of whether we are acting as a principal or agent in the transaction. The determination is based upon the evaluation of control over the event ticket, including the right to sell the ticket, prior to its transfer to the ticket buyer.

We sell our tickets held in inventory, which consists of one performance obligation, being to transfer control of an event ticket to the buyer upon confirmation of the order. We act as the principal in these transactions as we own the ticket at the time of sale, therefore we control the ticket prior to transferring to the customer. In these transactions, revenue is recorded on a gross basis based on the value of the ticket and is recognized when an order is confirmed. Payment is typically due upon delivery of the ticket.

We also act as an intermediary between buyers and sellers through the online secondary marketplace. Revenues derived from this marketplace primarily consist of service fees from entertainment operations, and consists of one primary performance obligation, which is facilitating the transaction between the buyer and seller, being satisfied at the time the order has been confirmed. As we do not control the ticket prior to the transfer, we act as an agent in these transactions. Revenue is recognized on a net basis, net of the amount due to the seller when an order is confirmed, the seller is then obligated to deliver the tickets to the buyer per the seller’s listing. Payment is due at the time of sale.

We review all significant, unusual, or nonstandard shipments of productproducts or delivery of services as a routine part of our accounting and financial reporting process to determine compliance with these requirements. Extended warranties are offered on selected products, and when a customer purchases an extended warranty, the associated proceeds are treated as contract liability and recognized over the term of the extended warranty.

OurFor our video solutions segment, our principal customers are state, local, and federal law enforcement agencies, which historically have been low risks for uncollectible accounts. However, we have commercial customers and international distributors that present a greater risk for uncollectible accounts than such law enforcement customers and we consider a specific reserve for bad debts based on their individual circumstances. OurAs of December 31, 2022, our historical bad debts have been negligible, with less than $258,000$286,000 charged off as uncollectible on cumulative revenues of $238.9$256.3 million since we commenced deliveries duringin 2006.

For our entertainment segment, our customers are mainly online visitors that pay at the time of the transaction, and we collect the service fees charged with the transaction. Thus, leading to minimal risk for uncollectible accounts, to which we then consider a specific reserve for bad debts based on their individual circumstances. As we continue to learn more about the collectability related to this recent acquisition, we will track historical bad debts and continue to assess appropriate reserves.

For our revenue cycle management segment, our customers are mainly medium to large healthcare organizations that are charged monthly upon the execution of our services. Being these customers are healthcare organizations with minimal risk for uncollectible accounts, we consider a specific reserve for bad debts based on their individual circumstances. As we continue to learn more about the collectability related to this recently added segment, we will track historical bad debts and continue to assess appropriate reserves.

34

As of December 31, 2020,2022, and 2019,2021, we had provided a reserve for doubtful accounts of $123,224$152,736 and $123,224,$113,234, respectively.

We periodically perform a specific review of significant individual receivables outstanding for risk of loss due to uncollectability. Based on such review, we consider our reserve for doubtful accounts to be adequate as of December 31, 2020.2022. However, should the balance due from any significant customer ultimately become uncollectible then our allowance for bad debts will not be sufficient to cover the charge-off and we will be required to record additional bad debt expense in our statement of operations.

Allowance for Excess and Obsolete Inventory. We record valuation reserves on our inventory for estimated excess or obsolete inventory items. The amount of the reserve is equal to the difference between the cost of the inventory and the estimated market value based upon assumptions about future demand and market conditions. On a quarterly basis, management performs an analysis of the underlying inventory to identify reserves needed for excess and obsolescence. Management uses its best judgment to estimate appropriate reserves based on this analysis. In addition, we adjust the carrying value of inventory if the current market value of that inventory is below its cost.

Inventories consisted of the following atas of December 31, 20202022 and 2019:2021:

 December 31, 2020  December 31, 2019  December 31, 2022  December 31, 2021 
Raw material and component parts $3,186,426  $4,481,611  $4,509,165  $3,062,046 
Work-in-process  1,907   35,858   3,164    
Finished goods  6,974,291   4,906,956 
Finished goods – video solutions  6,846,091   8,410,307 
Finished goods – entertainment  970,527   2,102,272 
Subtotal  10,162,625   9,424,425   12,328,947   13,574,625 
Reserve for excess and obsolete inventory  (1,960,351)  (4,144,013)
Reserve for excess and obsolete inventory – video solutions  (5,230,261)  (3,353,458)
Reserve for excess and obsolete inventory – entertainment  (259,280)  (561,631)
Total inventories $8,202,274  $5,280,412  $6,839,406  $9,659,536 

40

We balance the need to maintain strategic inventory levels to ensure competitive delivery performance to our customers against the risk of inventory obsolescence due to changing technology and customer requirements. As reflected above, our inventory reserves represented 19.3%44.5% of the gross inventory balance atas of December 31, 2020,2022, compared to 38.2%28.8% of the gross inventory balance atas of December 31, 2019.2021. We had $1,960,351$5,489,541 and $4,144,013$3,915,089 in reserves for obsolete and excess inventories atas of December 31, 20202022 and 2019,2021, respectively. Total raw materials and component parts were $3,186,427$4,506,709 and $4,481,611 at$3,062,046 as of December 31, 20202022 and 2019,2021, respectively, an increase of $1,444,663 (47%). Finished goods balances were $7,816,618 and $10,512,579 as of December 31, 2022 and 2021, respectively, a decrease of $1,295,185 (29%). During June 2020, the Company moved to new and smaller warehouse facilities and during the move sorted through its entire inventory and disposed of all excess and obsolete inventory rather than moving such distressed products to the new location which contributed to the significant decrease in the cost of raw materials and component parts. We scrapped older version inventory component parts that were mostly or fully reserved in 2020, which was the primary cause for the decrease in total raw materials and component parts. Finished goods balances were $6,974,291 and $4,906,956 at December 31, 2020 and 2019, respectively, an increase of $2,067,335 (42%$2,695,961 (26%). The increasedecrease in finished goods was primarily attributable to accumulatingdeclining inventory for the new Shield product line, our new body-worn cameras and ThermoVU product lines.docking stations, along with a decline in inventory from our entertainment segment, acquired in September 2021. The decreaseincrease in the inventory reserve is primarily due to the scrapping of older version legacy products that were mostly or fully reserved during 2020 as a result of moving our warehouse and office location. The remaining reserve for inventory obsolescence is generally provided for the level of component parts of the older versions of our printed circuit boards and the phase out of our DVM-750, DVM-500 Plus, and LaserAlly legacy products.products, ThermoVu products, and personal protective equipment. Additionally, the Company determined a reasonable reserve for inventory held at the ticket operating segment, in which some inventory items sell below cost or go unsold, thus having to be fully written-off following the event date. We believe the reserves are appropriate given our inventory levels atas of December 31, 2020.2022.

If actual future demand or market conditions are less favorable than those projected by management or significant engineering changes to our products that are not anticipated and appropriately managed, additional inventory write-downs may be required in excess of the inventory reserves already established.

35

Goodwill and other intangible assets. When we acquire a business, we determine the fair value of the assets acquired and liabilities assumed on the date of acquisition, which may include a significant amount of intangible assets such as customer relationships, software and content, as well as goodwill. When determining the fair values of the acquired intangible assets, we consider, among other factors, analyses of historical financial performance and an estimate of the future performance of the acquired business. The fair values of the acquired intangible assets are primarily calculated using an income approach that relies on discounted cash flows. This method starts with a forecast of the expected future net cash flows for the asset and then adjusts the forecast to present value by applying a discount rate that reflects the risk factors associated with the cash flow streams. We consider this approach to be the most appropriate valuation technique because the inherent value of an acquired intangible asset is its ability to generate future income. In a typical acquisition, we engage a third-party valuation expert to assist us with the fair value analyses for acquired intangible assets.

Determining the fair values of acquired intangible assets requires us to exercise significant judgment. We select reasonable estimates and assumptions based on evaluating a number of factors, including, but not limited to, marketplace participants, consumer awareness and brand history. Additionally, there are significant judgments inherent in discounted cash flows such as estimating the amount and timing of projected future cash flows, the selection of discount rates, hypothetical royalty rates and contributory asset capital charges. Specifically, the selected discount rates are intended to reflect the risk inherent in the projected future cash flows generated by the underlying acquired intangible assets.

Determining an acquired intangible asset’s useful life also requires significant judgment and is based on evaluating a number of factors, including, but not limited to, the expected use of the asset, historical client retention rates, consumer awareness and trade name history, as well as any contractual provisions that could limit or extend an asset’s useful life.

The Company’s goodwill is evaluated in accordance with FASB ASC Topic 350, which requires goodwill to be assessed for impairment at least annually and whenever events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable. In addition, an impairment evaluation of our amortizable intangible assets may also be performed if events or circumstances indicate potential impairment. Among the factors that could trigger an impairment review are current operating results that do not align with our annual plan or historical performance; changes in our strategic plans or the use of our assets; restructuring charges or other changes in our business segments; competitive pressures and changes in the general economy or in the markets in which we operate; and a significant decline in our stock price and our market capitalization relative to our net book value.

When performing our annual assessment of the recoverability of goodwill, we initially perform a qualitative analysis evaluating whether any events or circumstances occurred or exist that provide evidence that it is more likely than not that the fair value of any of our reporting units is less than the related carrying amount. If we do not believe that it is more likely than not that the fair value of any of our reporting units is less than the related carrying amount, then no quantitative impairment test is performed. However, if the results of our qualitative assessment indicate that it is more likely than not that the fair value of a reporting unit is less than its respective carrying amount, then we perform a two-step quantitative impairment test.

Evaluating the recoverability of goodwill requires judgments and assumptions regarding future trends and events. As a result, both the precision and reliability of our estimates are subject to uncertainty. Among the factors that we consider in our qualitative assessment are general economic conditions and the competitive environment; actual and projected reporting unit financial performance; forward-looking business measurements; and external market assessments. To determine the fair values of our reporting units for a quantitative analysis, we typically utilize detailed financial projections, which include significant variables, such as projected rates of revenue growth, profitability and cash flows, as well as assumptions regarding discount rates, the Company’s weighted average cost of capital and other data.

Our most recent annual impairment test of goodwill conducted as of December 31, 2022, indicated no impairment. Subsequent to completing our 2022 annual impairment test, no events or changes in circumstances were noted that required an interim goodwill impairment test. Note 1 — Nature of Business and Summary of Significant Accounting Policies and Note 8 — Goodwill and Other Intangible Assets in the Notes to Consolidated Financial Statements provide additional information regarding the Company’s goodwill and other intangible assets.

36

Warranty Reserves. We generally provide up to a two-year parts and labor standard warranty on our products to our customers. Provisions for estimated expenses related to product warranties are made at the time products are sold. These estimates are established using historical information on the nature, frequency, and average cost of claims. We actively study trends of claims and take action to improve product quality and minimize claims. Our warranty reserves were increased to $31,845$15,694 as of December 31, 20202022 compared to $17,838$13,742 as of December 31, 20192021 as we begin to slow our warranty exposures through the roll-off of DVM-750 and DVM-800 units from warranty coverage. Standard warranty exposure on the DVM-800 and DVM-250plus are the responsibility of the contract manufacturers, which reduced our overall warranty exposure as these are very popular products in our line. There is a risk that we will have higher warranty claim frequency rates and average cost of claims than our history has indicated on our legacy mirror products on our new products for which we have limited experience. Actual experience could differ from the amounts estimated requiring adjustments to these liabilities in future periods.

Stock-based Compensation Expense. We grant stock options to our employees and directors and such benefits provided are share-based payment awards which require us to make significant estimates related to determining the value of our share-based compensation. Our expected stock-price volatility assumption is based on historical volatilities of the underlying stock that are obtained from public data sources and there were 255,0001,250 stock options granted during the year ended December 31, 2020.2022.

If factors change and we develop different assumptions in future periods, the compensation expense that we record in the future may differ significantly from what we have recorded in the current period. There is a high degree of subjectivity involved when using option pricing models to estimate share-based compensation. Changes in the subjective input assumptions can materially affect our estimates of the fair valuesvalue of our share-based compensation. Certain share-based payment awards, such as employee stock options, may expire worthlessworthlessly or otherwise result in zero intrinsic value compared to the fair values originally estimated on the grant date and reported in our financial statements. Alternatively, values may be realized from these instruments that are significantly in excess of the fair values originally estimated on the grant date and reported in our financial statements. Although the fair value of employee share-based awards is determined using an established option pricing model, that value may not be indicative of the fair value observed in a willing buyer/willing seller market transaction. In addition, we account for forfeitures as they occur.

Accounting for Income Taxes. Accounting for income taxes requires significant estimates and judgments on the part of management. Such estimates and judgments include, but are not limited to, the effective tax rate anticipated to apply to tax differences that are expected to reverse in the future, the sufficiency of taxable income in future periods to realize the benefits of net deferred tax assets and net operating losses currently recorded and the likelihood that tax positions taken in tax returns will be sustained on audit.

41

As required by authoritative guidance, we record deferred tax assets or liabilities based on differences between financial reporting and tax bases of assets and liabilities using currently enacted rates that will be in effect when the differences are expected to reverse. Authoritative guidance also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that all or some portion of the deferred tax asset will not be realized. As of December 31, 2019,2022, cumulative valuation allowances in the amount of $23,740,000$34,200,000 were recorded in connection with the net deferred income tax assets. Based on a review of our deferred tax assets and recent operating performance, we determined that our valuation allowance should be increased by $855,000$17,220,000 to a balance of $24,595,000$34,200,000 to fully reserve our deferred tax assets at December 31, 2020.2022. We determined that it was appropriate to continue to provide a full valuation reserve on our net deferred tax assets as of December 31, 20202022, because of the overall net operating loss carryforwards available. We expect to continue to maintain a full valuation allowance until we determine that we can sustain a level of profitability that demonstrates our ability to realize these assets. To the extent we determine that the realization of some or all of these benefits is more likely than not based upon expected future taxable income, a portion or all of the valuation allowance will be reversed. Such a reversal would be recorded as an income tax benefit and, for some portion related to deductions for stock option exercises, an increase in shareholders’ equity.

As required by authoritative guidance, we have performed a comprehensive review of our portfolio of uncertain tax positions in accordance with recognition standards established by the FASB, an uncertain tax position represents our expected treatment of a tax position taken in a filed tax return or planned to be taken in a future tax return, that has not been reflected in measuring income tax expense for financial reporting purposes. We have no recorded liability as of December 31, 20202022, representing uncertain tax positions.

37

We have generated substantial deferred income tax assets related to our operations primarily from the charge to compensation expense taken for stock options, certain tax credit carryforwards and net operating loss carryforwards. For us to realize the income tax benefit of these assets, we must generate sufficient taxable income in future periods when such deductions are allowed for income tax purposes. In some cases where deferred taxes were the result of compensation expense recognized on stock options, our ability to realize the income tax benefit of these assets is also dependent on our share price increasing to a point where these options have intrinsic value at least equal to the grant date fair value and are exercised. In assessing whether a valuation allowance is needed in connection with our deferred income tax assets, we have evaluated our ability to generate sufficient taxable income in future periods to utilize the benefit of the deferred income tax assets. We continue to evaluate our ability to use recorded deferred income tax asset balances. If we fail to generate taxable income for financial reporting in future years, no additional tax benefit would be recognized for those losses, since we will not have accumulated enough positive evidence to support our ability to utilize net operating loss carryforwards in the future. Therefore, we may be required to increase our valuation allowance in future periods should our assumptions regarding the generation of future taxable income not be realized.

Redeemable Preferred Stock. Preferred stock may be classified as a liability, temporary equity (i.e., mezzanine equity) or permanent equity. In order to determine the appropriate classification, an evaluation of the cash redemption features is required.  Where there exists an absolute right of redemption presently or in the future, the preferred stock would be classified as a liability. If redemption is contingently redeemable upon the occurrence of an event that is outside of the issuer’s control, it should be classified as mezzanine equity. The probability that the redemption event will occur is irrelevant. If no redemption features exist, or if a contingent redemption feature is within the Company’s control, the preferred stock would be considered equity.

Inflation and Seasonality

Inflation has not materially affected us during the past fiscal year.year; however, we believe that it is likely to have significant impact to all of our operating segments in 2023 and beyond. We do not believe that our business is seasonal in nature; however, we generally generate higher revenues during the second half of the calendar year compared to the first half.

Item 7a.Quantitative and Qualitative Disclosures About Market Risk.

Not applicable.

Item 8.Financial Statements and Supplementary Data.

Our financial statements are included in this Annual Report on Form 10-K commencing on page F-1.

Item 9.Changes in and Disagreements Withwith Accountants on Accounting and Financial Disclosure.

None.

42

Item 9A.Controls and Procedures.

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures to provide reasonable assurance of achieving the control objectives, as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based on their evaluation as of December 31, 2020,2022, the end of the period covered by this Annual Report on Form 10-K, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective atas of December 31, 2022 due to the reasons described below.

In connection with the audit of our consolidated financial statements as of December 31, 2022 and 2021, we identified a reasonable assurance levelmaterial weakness in our internal control over financial reporting related to ensurethe timely detection of potential accounting misstatements. The company believes that the information requiredincrease in acquisition activities resulted in a temporary gap of accounting resources during the year ended December 31, 2022. To address these deficiencies, the Company will implement additional procedures designed to be disclosed inaccelerate the tempo of upwardly reporting subsidiaries and the visibility of receipt of reports filed or submitted underby the Exchange Act, including this Annual Report on Form 10-K, was recorded, processed, summarized and reported within the time periods specifiedparent company to allow for ample opportunities for review procedures in the SEC’s rules and forms, and was accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.reporting process.

38

Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;
Provide reasonable assurance that the transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and
Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

The SEC guidance allows companies to exclude acquisitions from management’s report on internal control over financial reporting for the first year after the acquisition. During 2022, the Company completed one business acquisition and one asset acquisition within the revenue cycle management segment. Due to the timing of the transaction, management has excluded the transaction from our annual evaluation of internal control over financial reporting. The preliminary total revenue of this acquisition represents less than 10% of our consolidated revenues for the year ended December 31, 2022.

In connection with the filing of this Annual Report on Form 10-K, our management assessed the effectiveness of our internal control over financial reporting as of December 31, 2020.2022. In making this assessment, our management used the criteria set forth by 2013 Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our assessment using the framework in 2013 Internal Control – Integrated Framework, management believes that, as of December 31, 2020,2022, our internal control over financial reporting is not effective.

 

43

Material Weakness

In connection with the audit of our consolidated financial statements as of December 31, 2022 and 2021, we identified a material weakness in our internal control over financial reporting related to timely review and detection of potential accounting misstatements, which in the aggregate, constitute a material weakness.

 

Remediation Activities

As part of our plan to remediate this material weakness, we are performing a full review of our internal control procedures. We have implemented, and plan to continue to implement, new controls and new processes. We have hired and plan to continue to hire additional qualified personnel and establish more robust processes to support our internal control over financial reporting, including clearly defined roles and responsibilities. The Company anticipates time being required to complete the implementation and to assess and ensure the sustainability of these controls. The material weakness will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.

Changes in Internal Control Over Financial Reporting

ThereWe have completed the process of integrating our recent business acquisition, which was acquired at the beginning of 2022, into our overall internal control over financial reporting process. Other than this integration, there have been no changes in our internal control over financial reporting during the year ended December 31, 2020,2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We are continually monitoring and assessing our internal controls to ensure the appropriate design and operating effectiveness.

Item 9B.Other Information.

None.

Item 9C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

Not applicable.

39

PART III

Item 10.Directors, Executive Officers and Corporate Governance.

Information

Directors

The names of the members of our Board of Directors and certain information about them as of the date of this Annual Report on Form 10-K are set forth below:

Name of Board of Director Member (4) Positions Age Director
Since
Stanton E. Ross Chairman, President and Chief Executive Officer 61 2005
Leroy C. Richie (1)(2)(3) Lead Independent Director, Chairman of the Nominating Committee and Compensation Committee and attorney 81 2005
Daniel F. Hutchins (1) Independent Director; Chairman of Audit Committee 67 2007
Michael J. Caulfield (1)(2)(3) Independent Director 67 2016

(1)Member of Audit Committee
(2)Member of Compensation Committee
(3)Member of Nominating Committee
(4)The address of each executive officer and director listed is 14001 Marshall Drive, Lenexa, Kansas 66215.

The Board has determined that Messrs. Richie, Hutchins, and Caulfield are “independent directors,” as defined by the rules and listing standards of The Nasdaq Stock Market LLC (“Nasdaq”). In making this determination, the Board considered the transactions and relationships disclosed under “Certain Relationships and Related Transactions” below.

Stanton E. Ross has served as Chairman, President and Chief Executive Officer (“CEO”) since September 2005. From March 1992 to June 2005, Mr. Ross was the Chairman and President of American Noble Gas Inc. (formerly known as Infinity Energy Resources, Inc.), a publicly held oil and gas exploration and development company (“AMGAS”) and served as an officer and director of each of AMGAS’s subsidiaries. He resigned from all his positions with AMGAS in June 2005, except Chairman, but was reappointed President in October 2006. From 1991 until March 1992, he founded and served as President of Midwest Financial, a financial services corporation involved in mergers, acquisitions, and financing for corporations in the Midwest. From 1990 to 1991, Mr. Ross was employed by Duggan Securities, Inc., an investment banking firm in Lenexa, Kansas, where he primarily worked in corporate finance. From 1989 to 1990, he was employed by Stifel, Nicolaus & Co., a member of the New York Stock Exchange, where he was an investment executive. From 1987 to 1989, Mr. Ross was self-employed as a business consultant. From 1985 to 1987, Mr. Ross was President and founder of Kansas Microwave, Inc., which developed a radar detector product. From 1981 to 1985, he was employed by Birdview Satellite Communications, Inc., which manufactured and marketed home satellite television systems, initially as a salesman and later as National Sales Manager. Mr. Ross estimates he devoted most of his time to Digital Ally and the balance to AMGAS in 2020. In late 2007, AMGAS sold a substantial portion of its operating assets and has not required a substantial amount of his time since such point. Mr. Ross holds no public company directorships other than with the Company and AMGAS and has not held any others during the previous five years. The Company believes that Mr. Ross’s broad entrepreneurial, financial, and business expertise and his experience with micro-cap public companies and his role as President and Chief Executive Officer give him the qualifications and skills to serve as a Director.

40

Leroy C. Richie has been the Lead Independent Director of Digital Ally since September 2005. He is also the Chairman of the Compensation Committee and Nominating Committee and a member of the Audit Committee. Since June 1, 1999, Mr. Richie has been a director of AMGAS. Additionally, until 2017, Mr. Richie served as a member of the board of directors of Columbia Mutual Funds, (or mutual fund companies acquired by or merged with Columbia Mutual Funds), a family of investment companies managed by Ameriprise Financial, Inc. From 2004 to 2015, he was of counsel to the Detroit law firm of Lewis & Munday, P.C. From 2007 to 2014, Mr. Richie served as a member of the board of directors of OGE Energy Corp. He holds no other public directorships and has not held any others during the previous five years. Until 2019, Mr. Richie served as the Vice-Chairman of the Board of Trustees and Chairman of the Compensation Committee for the Henry Ford Health System, in Detroit. Mr. Richie was formerly Vice President of Chrysler Corporation and General Counsel for automotive legal affairs, where he directed all legal affairs for its automotive operations from 1986 until his retirement in 1997. Before joining Chrysler, he was an associate with the New York law firm of White & Case (1973-1978) and served as director of the New York office of the Federal Trade Commission (1978-1983). Mr. Richie received a B.A. from City College of New York, where he was valedictorian, and a J.D. from the New York University School of Law, where he was awarded an Arthur Garfield Hays Civil Liberties Fellowship. The Company believes that Mr. Richie’s extensive experience as a lawyer and as an officer or director of public companies gives him the qualifications and skills to serve as a Director.

Daniel F. Hutchins was elected a Director in December 2007. He serves as Chairman of the Audit Committee and is the Board’s financial expert. Mr. Hutchins, a Certified Public Accountant, was a Principal with the accounting firm of Hutchins & Haake, LLC until his retirement on July 1, 2021. Mr. Hutchins currently serves as a director and the Chief Financial Officer of AMGAS, of which Mr. Ross is the Chairman and President. Mr. Hutchins has served as an instructor for the Becker CPA exam with the Keller Graduate School of Management and has over 18 years of teaching experience preparing CPA candidates for the CPA exam. He has over 40 years of public accounting experience, including five years with Deloitte & Touche, LLP. He has served on the boards of various non-profit groups and is a member of the American Institute of Certified Public Accountants. Mr. Hutchins earned his Bachelor of Business Administration degree in Accounting at Washburn University in Topeka, Kansas. Mr. Hutchins holds no other public company directorships and has not held any others during the previous five years. The Company believes that Mr. Hutchins’ significant experience in finance and accounting gives him the qualifications and skills to serve as a Director.

Michael J. Caulfield was elected a Director in May 2016. He is a member of the Audit Committee, Compensation Committee and Nominating Committee. He served as Vice President – Strategic Development of the Company from June 1, 2009 to January 11, 2012. Mr. Caulfield was most recently (2012-2016) a Vice-Chairman at Teneo Holdings, LLC, a global advisory firm where he was responsible for the firm’s investment banking relationships with a broad range of industrial companies. From 2006 to 2009, Mr. Caulfield served as a Managing Director at Banc of America Securities (“BAS”), where he was responsible for the merger, acquisition, divestiture and restructuring advisory services for a number of large public and private companies. He was also in charge of BAS’s global investment banking activities involving the Safety, Security, Engineering and Construction Industries. Prior to joining BAS, Mr. Caulfield spent six years (2000-2006) as a Managing Director with Morgan Stanley in New York City, leading that global investment banking firm’s efforts in the Aerospace and Defense Industries. He was also responsible for the investment banking relationships with a number of Morgan Stanley’s largest clients. From 1989 to 2000, he worked at General Electric Capital Corp., where he served as a Managing Director and head of the Corporate Finance Group. In this capacity, he advised GE Capital and the industrial divisions of General Electric on such issues as capital structuring, mergers and acquisitions, and private equity transactions. Mr. Caulfield received an MBA from the Wharton School of the University of Pennsylvania and a B.S. Degree from the University of Minnesota. The Company believes that Mr. Caulfield’s significant experience in investment banking and the public market gives him the qualifications and skills to serve as a Director.

Our Directors are elected annually and hold office until the next annual meeting of our stockholders or until their successors are elected and qualified. Officers are elected annually and serve at the discretion of the Board of Directors. There is no family relationship between any of our directors, director nominees and executive officers. Board vacancies are filled by a majority vote of the Board.

41

Board of Directors and Committee Meetings

Our Board of Directors held four meetings and acted a number of times by unanimous consent resolutions during the fiscal year ended December 31, 2022. Each of our directors attended at least 75% of the meetings of the Board of Directors and the committees on which he served in the fiscal year ended December 31, 2022. Our directors are expected, absent exceptional circumstances, to attend all Board meetings and meetings of committees on which they serve and are also expected to attend our annual meeting of stockholders. All directors then in office attended the 2022 annual meeting of stockholders.

Committees of the Board of Directors

Our Board of Directors currently has four committees: an Audit Committee, a Compensation Committee and a Nominating Committee. Each committee has a written charter approved by the Board of Directors outlining the principal responsibilities of the committee. These charters are also available on the Investor Relations page of our website. All of our directors, other than our Chairman and Chief Executive Officer, have met in executive sessions without management present on a regular basis in 2022 and year-to-date 2023.

Audit Committee

Our Audit Committee appoints the Company’s independent auditors, reviews audit reports and plans, accounting policies, financial statements, internal controls, audit fees, and certain other expenses and oversees our accounting and financial reporting process. Specific responsibilities include selecting, hiring and terminating our independent auditors; evaluating the qualifications, independence and performance of our independent auditors; approving the audit and non-audit services to be performed by our auditors; reviewing the design, implementation, adequacy and effectiveness of our internal controls and critical accounting policies; overseeing and monitoring the integrity of our financial statements and our compliance with legal and regulatory requirements as they relate to financial statements or accounting matters; reviewing any earnings announcements and other public announcements regarding our results of operations in conjunction with management and our public auditors; conferring with management and the independent auditors regarding the effectiveness of internal controls, financial reporting processes and disclosure controls; consulting with management and the independent auditors regarding Company policies governing financial risk management; reviewing and discussing reports from the independent auditors on critical accounting policies used by the Company; establishing procedures, as required under applicable law, for the receipt, retention and treatment of complaints received by the Company regarding accounting, internal accounting controls or auditing matters and the confidential and anonymous submission by employees of concerns regarding questionable accounting or auditing matters; reviewing and approving related-person transactions in accordance with the Company’s policies and procedures with respect to related-person transactions and applicable rules; reviewing the financial statements to be included in our Annual Report on Form 10-K; discussing with management and the independent auditors the results of the annual audit and the results of quarterly reviews and any significant changes in our accounting principles; and preparing the report that the SEC requires in our annual proxy statement.

The Audit Committee is comprised of three Directors, each of whom is independent, as defined by the rules and regulations of the SEC and Nasdaq Rule 5605(a)(2). The Audit Committee held four meetings during the year ended December 31, 2022. The members of our Audit Committee are Daniel F. Hutchins (Chairman), Leroy C. Richie and Michael J. Caulfield. The Board of Directors determined that Mr. Hutchins qualifies as an “audit committee financial expert,” as defined under the applicable rules and listing standards of Nasdaq and SEC rules and regulations and is independent as noted above.

42

Under the Sarbanes-Oxley Act of 2002, all audit and non-audit services performed by the Company’s independent registered public accounting firm must be approved in advance by the Audit Committee to assure that such services do not impair the auditor’s independence from the Company. Accordingly, the Audit Committee has adopted an Audit and Non-Audit Services Pre-Approval Policy (the “Policy”) that sets forth the procedures and the conditions pursuant to which services to be performed by the independent auditors are to be pre-approved. Pursuant to the Policy, certain services described in detail in the Policy may be pre-approved on an annual basis together with pre-approved maximum fee levels for such services. The services eligible for annual pre-approval consist of services that would be included under the categories of Audit Fees, Audit-Related Fees and Tax Fees in the table, as well as services for limited review of actuarial reports and calculations. If not pre-approved on an annual basis, proposed services must otherwise be separately approved prior to being performed by the independent registered public accounting firm. In addition, any services that receive annual pre-approval but exceed the pre-approved maximum fee level also will require separate approval by the Audit Committee prior to being performed. The Audit Committee may delegate authority to pre-approve audit and non-audit services to any member of the Audit Committee but may not delegate such authority to management.

Compensation Committee

Our Compensation Committee assists our Board of Directors in determining the development plans and compensation of our officers, directors and employees. Specific responsibilities include approving the compensation and benefits of our executive officers; reviewing the performance objectives and actual performance of our officers; administering our stock option and other equity compensation plans; and reviewing and discussing with management the compensation discussion and analysis that the SEC requires in our future Form 10-Ks and proxy statements.

Our Compensation Committee is comprised of three Directors, whom the Board considers to be independent under the applicable rules and listing standards of Nasdaq and SEC rules and regulations. The members of our Compensation Committee are Leroy C. Richie (Chairman) and Michael J. Caulfield. The Compensation Committee held two meetings and acted several times by unanimous written consent resolutions during the year ended December 31, 2022. Mr. Ross, our Chief Executive Officer, does not participate in the determination of his own compensation or the compensation of directors. However, he makes recommendations to the Compensation Committee regarding the amount and form of the compensation of the other executive officers is incorporated hereinand key employees, and he often participates in the Compensation Committee’s deliberations about such persons’ compensation. Thomas J. Heckman, our Chief Financial Officer (“CFO”), also assists the Compensation Committee in its deliberations regarding executive officer, director and employee compensation. No other executive officers participate in the determination of the amount or the form of the compensation of executive officers or directors. The Compensation Committee does not utilize the services of an independent compensation consultant to assist in its oversight of executive and director compensation.

Nominating Committee

Our Nominating Committee assists our Board of Directors by referenceidentifying and recommending individuals qualified to become members of our Board of Directors, reviewing correspondence from our stockholders, and establishing, evaluating, and overseeing our corporate governance guidelines. Specific responsibilities include the following: evaluating the composition, size and governance of our Board of Directors and its committees and making recommendations regarding future planning and appointing directors to our definitivecommittees; establishing a policy for considering stockholder nominees for election to our Board of Directors; and evaluating and recommending candidates for election to our Board of Directors.

43

Our Nominating Committee strives for a Board composed of individuals who bring a variety of complementary skills, expertise, or background and who, as a group, will possess the appropriate skills and experience to oversee our business. The diversity of the members of the Board relates to the selection of its nominees. While the Committee considers diversity and variety of experiences and viewpoints to be important factors, it does not believe that a director nominee should be chosen or excluded solely or largely because of race, color, gender, national origin or sexual orientation or identity. In selecting a director nominee for recommendation to our Board, our Nominating Committee focuses on skills, expertise or background that would complement the existing members on the Board. Accordingly, although diversity may be a consideration in the Committee’s process, the Committee and the Board of Directors do not have a formal policy regarding the consideration of diversity in identifying director nominees.

When the Nominating Committee has either identified a prospective nominee or determined that an additional or replacement director is required, the Nominating Committee may take such measures as it considers appropriate in connection with its evaluation of a director candidate, including candidate interviews, inquiry of the person or persons making the recommendation or nomination, engagement of an outside search firm to gather additional information, or reliance on the knowledge of the members of the Board of Directors or management. In its evaluation of director candidates, including the members of the Board eligible for re-election, the Nominating Committee considers a number of factors, including: the current size and composition of the Board of Directors, the needs of the Board of Directors and the respective committees of the Board, and such factors as judgment, independence, character and integrity, age, area of expertise, diversity of experience, length of service and potential conflicts of interest.

The Nominating Committee of the Board selects director nominees and recommends them to the full Board of Directors. In relation to such nomination process, the Nominating Committee:

determines the criteria for the selection of prospective directors and committee members;
reviews the composition and size of the Board and its committees to ensure proper expertise and diversity among its members;
evaluates the performance and contributions of directors eligible for re-election;
determines the desired qualifications for individual directors and desired skills and characteristics for the Board;
identifies persons who can provide needed skills and characteristics;
screens possible candidates for Board membership;
reviews any potential conflicts of interests between such candidates and the Company’s interests; and
shares information concerning the candidates with the Board and solicits input from other directors.

The Nominating Committee has specified the following minimum qualifications that it believes must be met by a nominee for a position on the Board: the highest personal and professional ethics and integrity; proven achievement and competence in the nominee’s field and the ability to exercise sound business judgment; skills that are complementary to those of the existing Board; the ability to assist and support management and make significant contributions to our success; the ability to work well with the other directors; the extent of the person’s familiarity with the issues affecting our business; an understanding of the fiduciary responsibilities that are required of a member of the Board of Directors; and the commitment of time and energy necessary to diligently carry out those responsibilities. A candidate for director must agree to abide by our Code of Ethics and Conduct.

44

After completing its evaluation, the Nominating Committee makes a recommendation to the full Board of Directors as to the persons who should be nominated to the Board, and the Board of Directors determines the nominees after considering the recommendation and report of the Committee.

Our Nominating Committee is comprised of two Directors, whom the Board considers to be independent under the applicable rules and listing standards of Nasdaq and SEC rules and regulations. The Nominating Committee held one meeting during the year ended December 31, 2022. The members of our Nominating Committee are Leroy C. Richie (Chairman) and Michael J. Caulfield.

Board of Directors’ Role in the Oversight of Risk Management

We face a variety of risks, including credit, liquidity, and operational risks. In fulfilling its risk oversight role, our Board of Directors focuses on the adequacy of our risk management process and overall risk management system. Our Board of Directors believes that an effective risk management system will (i) adequately identify the material risks that we face in a timely manner; (ii) implement appropriate risk management strategies that are responsive to our risk profile and specific material risk exposures; (iii) integrate consideration of risk and risk management into our business decision-making; and (iv) include policies and procedures that adequately transmit necessary information regarding material risks to senior executives and, as appropriate, to the Board or relevant committee.

The Board of Directors has designated the Audit Committee to take the lead in overseeing risk management at the Board of Directors level. Accordingly, the Audit Committee schedules time for periodic review of risk management, in addition to its other duties. In this role, the Audit Committee receives reports from management, independent registered public accounting firm, outside legal counsel, and other advisors, and strives to generate serious and thoughtful attention to our risk management process and system, the nature of the material risks we face, and the adequacy of our policies and procedures designed to respond to and mitigate these risks.

Although the Board of Directors has assigned the primary risk oversight to the Audit Committee, it also periodically receives information about our risk management system and the most significant risks that we face. This is principally accomplished through Audit Committee reports to the Board of Directors and summary versions of the briefings provided by management and advisors to the Audit Committee.

In addition to the formal compliance program, our Board of Directors and the Audit Committee encourage management to promote a corporate culture that understands risk management and incorporates it into our overall corporate strategy and day-to-day business operations. Our risk management structure also includes an ongoing effort to assess and analyze the most likely areas of future risk for us. As a result, the Board of Directors and the Audit Committee periodically ask our executives to discuss the most likely sources of material future risks and how we are addressing any significant potential vulnerability.

Board Leadership Structure

Our Board of Directors does not have a policy on whether the roles of Chief Executive Officer and Chairman of the Board of Directors should be separate and, if they are to be separate, whether the Chairman of the Board should be selected from the non-employee directors or be an employee. Our Board of Directors believes that it should be free to make a choice from time to time in any manner that is in the best interest of us and our stockholders. The Board of Directors believes that Mr. Ross’s service as both Chief Executive Officer and Chairman of the Board is in the best interest of us and our stockholders. Mr. Ross possesses detailed and in-depth knowledge of the issues, opportunities and challenges we face and is thus best positioned to develop agendas, with the input of Mr. Richie, the lead independent director, to ensure that the Board’s time and attention are focused on the most critical matters. His combined role enables decisive leadership, ensures clear accountability, and enhances our ability to communicate our message and strategy clearly and consistently to our stockholders, employees, customers, and suppliers, particularly during times of turbulent economic and industry conditions.

45

Our Board of Directors also believes that a lead independent director is part of an effective Board leadership structure. To this end, the Board has appointed Mr. Richie as the lead independent director. The independent directors meet regularly in executive sessions at which only they are present, and the lead independent director chairs those sessions. As the lead independent director, Mr. Richie calls meetings of the independent directors as needed; sets the agenda for meetings of the independent directors; presides at meetings of the independent directors; is the principal liaison on Board issues between the independent directors and the Chairman and between the independent directors and management; provides feedback to the Chairman and management on the quality, quantity and timeliness of information sent to the Board; is a member of the Compensation Committee that evaluates the CEO’s performance; and oversees the directors’ evaluation of the Board’s overall performance. The Nominating Committee and the Board believe that its leadership structure, which includes the appointment of a lead independent director, is appropriate because it, among other things, provides for an independent director who gives board member leadership and each of the directors, other than Mr. Ross, is independent. Our Board of Directors believes that the independent directors provide effective oversight of management.

Stockholder Communications with the Board of Directors

Stockholders may communicate with the Board of Directors by writing to us as follows: Digital Ally, Inc., attention: Corporate Secretary, 14001 Marshall Drive, Lenexa, Kansas 66215. Stockholders who would like their submission directed to a member of the Board of Directors may so specify and the communication will be forwarded as appropriate.

Policy for Director Recommendations and Nominations

Our Nominating Committee will consider candidates for Board membership suggested by Board members, management and our stockholders. The policy of our Nominating Committee is to consider recommendations for candidates to the Board of Directors from any stockholder of record in accordance with our Bylaws. A director candidate recommended by our stockholders will be considered in the same manner as a nominee recommended by a Board member, management or other sources. In addition, a stockholder may nominate a person directly for election to the Board of Directors at an annual meeting of stockholders, provided the stockholder meets the requirements set forth in our Bylaws. We do not pay a fee to any third party to identify or evaluate or assist in identifying or evaluating potential nominees.

Stockholder Recommendations for Director Nominations. Stockholder recommendations for director nominations may be submitted to the Company at the following address: Digital Ally, Inc., Attention: Corporate Secretary, 14001 Marshall Drive, Lenexa, Kansas 66215. Such recommendations will be forwarded to the Nominating Committee for consideration, provided that they are accompanied by sufficient information to permit the Board to evaluate the qualifications and experience of the nominees, and they are in time for the Nominating Committee to do an adequate evaluation of the candidate before the Annual Meeting. The submission must be accompanied by a written consent of the individual to stand for election if nominated by the Board of Directors and to serve if elected and to cooperate with a background check.

Stockholder Nominations of Directors. Our Bylaws provide that, in order for a stockholder to nominate a director at an annual meeting of stockholders, the stockholder must give timely written notice to our Secretary and such notice must be received at our principal executive offices not less than one-hundred-and-twenty (120) days before the date of our release of the proxy statement which we expect to filestockholders in connection with our previous year’s annual meeting of stockholders. Such stockholder’s notice shall include, with respect to each person whom the stockholder proposes to nominate for election as a director, all information relating to such nominee that is required under the Exchange Act, including such person’s written consent to being named in the proxy statement as a nominee and serving as a director, and cooperating with a background investigation. In addition, the stockholder must include in such notice the name and address, as they appear on our records, of the stockholder proposing the nomination of such person, and the name and address of the beneficial owner, if any, on whose behalf the nomination is made, the class and number of shares of our capital stock that are owned beneficially and of record by such stockholder of record and by the beneficial owner, if any, on whose behalf the nomination is made, and any material interest or relationship that such stockholder of record and/or the beneficial owner, if any, on whose behalf the nomination is made may respectively have in such business or with such nominee. At the request of the Board of Directors, any person nominated for election as a director shall furnish to our Secretary the information required to be set forth in a stockholder’s notice of nomination that pertains to the nominee.

To be timely in the case of a special meeting or if the date of the annual meeting is changed by more than thirty (30) days from such anniversary date, a stockholder’s notice must be received at our principal executive offices no later than 120 days afterthe close of business on the tenth (10th) day following the earlier of the day on which notice of the meeting date was mailed or public disclosure of the meeting date was made.

Compensation Committee Interlocks and Insider Participation

None of our executive officers serves, or in the past has served, as a member of the Compensation Committee. None of the members of our Compensation Committee is, or has ever been, an officer or employee of the Company.

Code of Ethics and Conduct

Our Board of Directors has adopted a Code of Ethics and Conduct that is applicable to all of our employees, officers and directors. Our Code of Ethics and Conduct is intended to ensure that our employees, officers and directors act in accordance with the highest ethical standards. The Code of Ethics and Conduct is available on the Investor Relations page of our website at http://www.digitalally.com and the Code of Ethics and Conduct was filed as an exhibit to our Annual Report on Form 10-KSB filed March 4, 2008.

46

Item 11.Executive Compensation.

The following table presents information concerning the total compensation of the Company’s Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”) and Chief Operating Officer (“COO”) and collectively with the CEO and the CFO, the “Named Executive Officers”) for services rendered to the Company in all capacities for the years ended December 31, 2020 (our “2021 Proxy Statement”).2022 and 2021, as required by Item 402(m)(2) of Regulation S-K.

Information with respectSummary Compensation Table

Name and Principal Position Year  Salary ($)  Bonus ($)  Stock awards ($)  Option awards
($) (1)
  All other compensation ($) (2)  Total ($) 
Stanton E. Ross  2021  $250,000  $250,000  $828,000(1)(3) $      —  $30,805  $1,358,805 
Chairman, CEO and President  2022  $300,000  $100,000  $374,500(6) $  $32,034  $806,534 
                             
Thomas J. Heckman  2021  $230,000  $115,000  $414,000(1)(4) $  $23,329  $782,329 
CFO, Treasurer and Secretary  2022  $120,000  $  $80,250(7) $  $16,292  $216,542 
                             
Peng Han (9)  2021  $165,000  $  $63,000(1)(5) $  $5,428  $233,428 
COO  2022  $250,000  $  $107,000(8) $  $10,576  $367,576 

(1) Represents aggregate grant date fair value pursuant to compliance with Section 16(a)ASC Topic 718 for the respective year for stock options granted. Please refer to Note 14 to the consolidated financial statements for a further description of the Exchange Act,awards and the underlying assumptions utilized to determine the amount of grant date fair value related to such grants.

(2) Amounts included in all other compensation include the following items: the employer contribution to the Company’s 401(k) Retirement Savings Plan (the “401(k) Plan”) on behalf of the named executive. We are required to provide a 100% matching contribution for all who elect to contribute up to 3% of their compensation to the plan and a 50% matching contribution for all employees’ elective deferral between 4% and 5%. The employee (i) is incorporated herein100% vested at all times in the employee contributions and employer matching contributions; (ii) receives Company paid healthcare insurance; (iii) receives Company paid contributions to health savings accounts; and (iv) receives Company paid life, accident and disability insurance. See “All Other Compensation Table” below.

(3) Stock awards include the following restricted stock granted during 2021 to Mr. Ross: 15,000 shares at $55.20 per share that vest 50% on January 6, 2022 and 50% on January 6, 2023, subject to Mr. Ross remaining an employee of the Company at that point in time.

(4) Stock awards include the following restricted stock granted during 2021 to Mr. Heckman: 7,500 shares at $55.20 per share that vest 50% on January 6, 2022 and 50% on January 6, 2023, subject to Mr. Heckman remaining an employee of the Company at that point in time.

(5) Stock awards include the following restricted stock granted during 2021 to Mr. Han: 2,500 shares at $25.20 per share that vest ratably over the two-year period ending September 20, 2023.

(6) Stock awards include the following restricted stock granted during 2022 to Mr. Ross: 17,500 shares at $21.40 per share that vest 50% on January 7, 2023 and 50% on January 7, 2024, subject to Mr. Ross remaining an employee of the Company at that point in time.

(7) Stock awards include the following restricted stock granted during 2022 to Mr. Heckman: 3,750 shares at $21.40 per share that on January 7, 2023, subject to Mr. Heckman remaining an employee of the Company at that point in time.

47

(8) Stock awards include the following restricted stock granted during 2022 to Mr. Han: 5,000 shares at $21.40 per share that vest 20% annually on the anniversary of January 7 from 2023 to 2027, subject to Mr. Han remaining an employee of the Company at that point in time.

(9) Mr. Han was appointed Chief Operating Officer on December 13, 2021, thus Mr. Han’s 2021 compensation was set by referencemanagement prior to his appointment as a named executive officer of the Company.

All Other Compensation Table

Name and Principal Position Year  

401(k) Plan

contribution

by

Company

  

Company

paid

healthcare

insurance

  

Flexible &

health

savings

account

contributions

by Company

  

Company

paid life,

accident

&

disability

insurance

  

Other

Contractual

payments

  

Total

($)

 
Stanton E. Ross  2021  $8,606  $20,556  $1,100  $543  $          -  $30,805 
Chairman, CEO and President  2022  $10,039  $20,319  $1,100  $576  $-  $32,034 
                             
Thomas J. Heckman  2021  $9,138  $12,848  $800  $543  $-  $23,329 
CFO, Treasurer and Secretary  2022  $4,800  $10,021  $895  $576  $-  $16,292 
                             
Peng Han (9)  2021  $4,885  $-  $-  $543  $-  $5,428 
COO  2022  $10,000  $-  $-  $576  $-  $10,576 

Compensation Policy. Our executive compensation plan is based on attracting and retaining qualified professionals who possess the skills and leadership necessary to enable us to achieve earnings and profitability growth to satisfy its stockholders. We must, therefore, create incentives for these executives to achieve both our and individual performance objectives using performance-based compensation programs. No one component is considered by itself, but all forms of the compensation package are considered in total. Wherever possible, objective measurements will be utilized to quantify performance, but many subjective factors still come into play when determining performance.

Compensation Components. The main elements of its compensation package consist of base salary, stock options or restricted stock awards and bonus.

Base Salary. The base salary for each executive officer is reviewed and compared to the prior year, with considerations given for increase or decrease. The review is generally on an annual basis but may take place more often in the discretion of the Compensation Committee.

On January 7, 2021, the Compensation Committee restored the annual base salaries of Stanton E. Ross, President and Chief Executive Officer, Thomas J. Heckman, Chief Financial Officer, Treasurer and Secretary, at $250,000 and $230,000, respectively for 2021.

The Compensation Committee plans to review the base salaries for possible adjustments on an annual basis. Base salary adjustments will be based on both individual and our performances and will include both objective and subjective criteria specific to each executive’s role and responsibility with us.

48

Stock Options and Restricted Stock Awards. The Compensation Committee determined stock option and restricted stock awards based on numerous factors, some of which include responsibilities incumbent with the role of each executive with us, tenure with us, as well as our performance. The vesting period of options and restricted stock is also tied, in some instances, to our performance directly related to certain executive’s responsibilities with us. The Compensation Committee determined that Messrs. Ross and Heckman were eligible for awards of stock options or restricted stock in 2021 Proxy Statement.based on their performance. Refer to the “Grants of Plan-Based Awards” table below for restricted stock awards made in 2021. The Committee also determined that Messrs. Ross, Heckman, and Han would be eligible in 2022 for awards of restricted stock or stock options.

Information with respectBonuses. The Compensation Committee determined to award bonuses to each of the executive officers in 2022 and 2021, as set forth in the foregoing table. Refer to the “Summary Compensation Table” above for the bonuses paid to Messrs. Ross and Heckman in 2022 and 2021. In fiscal 2022, Messrs. Ross and Heckman were eligible for bonuses of up to $250,000 and $120,000, respectively. Mr. Ross was awarded a partial 2022 bonus of $100,000. The Compensation Committee reviews each executive officer’s performance on a quarterly basis and determines what, if any, portion of the bonus he has earned and will be paid as of such point.

Other. In July 2008, we amended and restated our 401(k) Plan. The amended 401(k) Plan requires us to provide a 100% matching contribution for employees who elect to contribute up to 3% of their compensation to the plan and a 50% matching contribution for employees’ elective deferrals between 4% and 5%. We have made matching contributions for executives who elected to contribute to the 401(k) Plan during 2021. Each participant is 100% vested at all times in employee and employer matching contributions. As of December 31, 2022, a total of 23,120 shares of our Common Stock were held in the 401(k) Plan. Mr. Heckman, as trustee of the 401(k) Plan, holds the voting power as to the shares of our Common Stock held in the 401(k) Plan. We have no profit-sharing plan in place for our employees. However, we may consider adding such a plan to provide yet another level of compensation to our codecompensation plan.

The following table presents information concerning the grants of business conductplan-based awards to the Named Executive Officers during the year ended December 31, 2022:

Grant of Plan-Based Awards

Name Grant date 

Date

approved by

Compensation

Committee

 

All other stock

awards: Number

of shares of stock

or units:
(#) (1)

(2)(3)

  

Exercise or base

price of option

awards

($/Share)

  

Grant date fair

value of stock

awards ($) (4)

 
Stanton E. Ross                
Chairman, CEO and President January 7, 2022 January 7, 2022  17,500(1) $21.40  $374,500 
                 
Thomas J. Heckman                
CFO, Treasurer and Secretary January 7, 2022 January 7, 2022  3,750(2) $21.40  $80,250 
                 
Peng Han                
COO January 7, 2022 January 7, 2022  5,000(3) $21.40  $107,000 

(1) These restricted stock awards were made under the Digital Ally, Inc. Stock Option and ethicsRestricted Stock Plans and vest over a two-year period (50% on January 7, 2023 and 50% on January 7, 2024) contingent upon whether the individual is incorporated hereinstill employed by referenceus at that point.

49

(2) These restricted stock awards were made under the Digital Ally, Inc. Stock Option and Restricted Stock Plans and vest over a one-year period contingent upon whether the individual is still employed by us at that point.

(3) These restricted stock awards were made under the Digital Ally, Inc. Stock Option and Restricted Stock Plans and vest over a five-year period (20% on each anniversary of January 7 from 2023 to 2027) contingent upon whether the individual is still employed by us at that point.

(4) Stock awards noted represent the aggregate amount of grant date fair value as determined under ASC Topic 718. Please refer to Note 14 to the consolidated financial statements that appear in our 2021 Proxy Statement.Annual Report on Form 10-K, filed with the SEC on April 15, 2022, for a further description of the awards and the underlying assumptions utilized to determine the amount of grant date fair value related to such grants.

InformationEmployment Contracts; Termination of Employment and Change-in-Control Arrangements

We do not have any employment agreements with respectany of our executive officers. However, on December 23, 2008, we entered into retention agreements with the following executive officers: Stanton E. Ross and Thomas J. Heckman. In April 2018 we amended these agreements.

Retention Agreements - Potential Payments upon Termination or Change of Control

The following table sets forth for each named executive officer potential post-employment payments and payments on a change in control and assumes that the triggering event took place on January 1, 2023 and that the amendments to our corporate governance disclosuresthe retention agreements of each person were in effect.

Retention Agreement Compensation

Name 

Change in control

payment due based

upon successful

completion of

transaction

  

Severance payment

due based on

termination after

Change of

Control occurs

  Total 
Stanton E. Ross $125,000  $500,000  $625,000 
Thomas J. Heckman $115,000  $460,000  $575,000 
Total $240,000  $960,000  $1,200,000 

The retention agreements guarantee the executive officers’ specific payments and benefits upon a Change in Control of the Company. The retention agreements also provide for specified severance benefits if, after a Change in Control of the Company occurs, the executive officer voluntarily terminates employment for “Good Reason” or is incorporated herein by reference to our 2021 Proxy Statement.involuntarily terminated without “Cause.”

Item 11.Executive Compensation.50

InformationUnder the retention agreements, a “Change in Control” means (i) one party alone, or acting with others, has acquired or gained control over more than 50% of the voting shares of the Company; (ii) the Company merges or consolidates with or into another entity or completes any other corporate reorganization, if more than 50% of the combined voting power of the surviving entity’s securities outstanding immediately after such merger, consolidation or other reorganization is owned by persons who were not stockholders of the Company immediately prior to such merger, consolidation or other reorganization; (iii) a majority of the Board of Directors is replaced and/or dismissed by the stockholders of the Company without the recommendation of or nomination by the Company’s current Board of Directors; (iv) the Company’s Chief Executive Officer (the “CEO”) is replaced and/or dismissed by stockholders without the approval of the Board of Directors; or (v) the Company sells, transfers or otherwise disposes of all or substantially all of the consolidated assets of the Company and the Company does not own stock in the purchaser or purchasers having more than 50% of the voting power of the entity owning all or substantially all of the consolidated assets of the Company after such purchase.

“Good Reason” means either (i) a material adverse change in the executive’s status as an executive or other key employee of the Company, including without limitation, a material adverse change in the executive’s position, authority, or aggregate duties or responsibilities; (ii) any adverse change in the executive’s base salary, target bonus or benefits; or (iii) a request by the Company to materially change the executive’s geographic work location.

“Cause” means (i) the executive has acted in bad faith and to the detriment of the Company; (ii) the executive has refused or failed to act in accordance with any specific lawful and material direction or order of his or her supervisor; (iii) the executive has exhibited, in regard to employment, unfitness or unavailability for service, misconduct, dishonesty, habitual neglect, incompetence, or has committed an act of embezzlement, fraud or theft with respect to the property of the Company; (iv) the executive has abused alcohol or drugs on the job or in a manner that affects the executive’s job performance; and/or (v) the executive has been found guilty of or has plead nolo contendere to the commission of a crime involving dishonesty, breach of trust, or physical or emotional harm to any person. Prior to termination for Cause, the Company shall give the executive written notice of the reason for such potential termination and provide the executive a 30-day period to cure such conduct or act or omission alleged to provide grounds for such termination.

If any Change in Control occurs and the executive continues to be employed as of the completion of such Change in Control, upon completion of such Change in Control, as payment for the executive’s additional efforts during such Change in Control, the Company shall pay the executive a Change in Control benefit payment equal to three months of the his base salary at the rate in effect immediately prior to the Change in Control completion date, payable in a lump sum net of required tax withholdings. If any Change in Control occurs, and if, during the one-year period following the Change in Control, the Company terminates the executive’s employment without Cause or the executive submits a resignation for Good Reason (the effective date of such termination or resignation, the “Termination Date”), then:

a)The Company shall pay the executive severance pay equal to 12 months of his base salary at the higher of the rate in effect immediately prior to the Termination Date or the rate in effect immediately prior to the occurrence of the event or events constituting Good Reason, payable on the Termination Date in a lump sum net of required tax withholdings, plus all other amounts then payable by the Company to the executive less any amounts then due and owing from the executive to the Company;
b)The Company shall provide continuation of the executive’s health benefits at the Company’s expense for 18 months following the Termination Date; and
c)The executive’s outstanding employee stock options shall fully vest and be exercisable for a 90-day period following the Termination Date.

51

The executive is not entitled to the above severance benefits for a termination based on death or disability, resignation without Good Reason or termination for Cause. Following the Termination Date, the Company shall also pay the executive all reimbursements for expenses in accordance with the Company’ policies, within ten days of submission of appropriate evidence thereof by the executive.

The following table presents information concerning the outstanding equity awards for the Named Executive Officers as of December 31, 2022:

Outstanding Equity Awards at Fiscal Year-End

  Option Awards     Stock Awards 
Name 

Number of

securities

underlying

unexercised

options (#)

exercisable

(1)

  

Number of

securities

underlying

unexercised

options (#)

unexercisable

  

Equity

incentive

plan

awards:

Number of

securities

underlying

unexercised

unearned

options (#)

  

Option

exercise

price

($)

  

Option

expiration

date

  

Number

of

shares

or units

of stock

that

have

not

vested

(1)

  

Market

value

of

shares

or

units of

stock

that

have

not

vested

(2)

  

Equity

incentive

plan

awards:

Number

of

unearned

shares,

units or

other

rights

that have

not

vested

  

Equity

incentive

plan

awards:

Market

or

Payout

value of

unearned

shares,

units or

other

rights

that have

not

vested

 
Stanton E. Ross                                                                                                   
Chairman, CEO and President      -   -   -   -   25,000  $115,000   -  $- 
                                     
Thomas J. Heckman                                    
CFO, Treasurer and Secretary  -   -   -   -   -   7,500  $34,500   -  $- 
                                     
Peng Han (9)                                    
COO  -   -   -   -   -   6,250  $28,750   -  $- 

(1) These stock option and restricted stock awards were made under the Digital Ally, Inc. Stock Option and Restricted Stock Plans and vest over the prescribed period contingent upon whether the individual is still employed by the Company at that point.

(2) Market value based upon the closing market price of $4.60 on December 31, 2022.

52

The following table presents information concerning the stock options exercised and the vesting of restricted stock awards during 2021 for the Named Executive Officers for the year ended December 31, 2022:

  Option Exercises and Restricted Stock Vested 
  Option Awards  Stock Awards 
  Number of Shares acquired realized on exercise (#)  

Value realized

on exercise ($)

  

Number of

Shares

acquired on

vesting (#)

  

Value on

vesting ($)

 
Stanton E. Ross                
Chairman, CEO and President  -  $-   7,500  $160,500(1)
                 
Thomas J. Heckman                
CFO, Treasurer and Secretary  -  $-   3,750  $80,250(1)
                 
Peng Han                
COO  331  $28,520   1,250  $15,000(2)

(1)Based on the closing market price of our Common Stock of $21.40 on January 7, 2022, the date of vesting for 7,500 shares of Common Stock for Mr. Ross, and 3,750 shares of Common Stock for Mr. Heckman.
(2)Based on the closing market price of our Common Stock of $12.00 on September 20, 2022, the date of vesting for 1,250 shares of Common Stock for Mr. Han.

The number of stock options and restricted stock awards that an employee, director, or consultant may receive under our Plans (defined below under “Information Regarding Plans and Other Arrangements Not Subject to Security Holder Action”) is in the discretion of the administrator and therefore cannot be determined in advance. The Board of Directors’ policy in 2022 was to grant officers an award of 17,500 restricted shares of Common Stock to our CEO/President and 3,750 restricted shares of Common Stock to our CFO/Treasurer and each non-employee director an award of options to purchase 5,000 shares of Common Stock, all subject to vesting requirements.

The following table sets forth (a) the aggregate number of shares of Common Stock subject to options granted under the Plans during the year ended December 31, 2022 and (b) the average per share exercise price of such options.

Stock Options and Restricted Stock Grants

Name of Individual or Group

Number of Restricted

Shares of Common

Stock Granted

Number of

Options

Granted

Average per

Share Exercise

Price

Stanton E. Ross, Chairman of the Board of Directors, CEO & President17,500-$-
Leroy C. Richie, Director--$-
Daniel F. Hutchins, Director--$-
Michael J. Caulfield, Director--$-
Thomas J. Heckman, Vice President, CFO, Treasurer & Secretary3,750-$-
Peng Han5,000-$-
All executive officers, as a group26,250-$-
All directors who are not executive officers, as a group--$-
All employees who are not executive officers, as a group5,500-$-

Director Compensation

Our non-employee directors received the stock option grants noted in the “Director Compensation” table below for their service on the Board of Directors in 2022, including on the Audit, Nominating and Compensation Committees.

In July 2021, we granted to Messrs. Richie, Caulfield and Hutchins each options exercisable to acquire 5,000 shares of Common Stock at an exercise price of $33.40 per share for their service on the Board of Directors until the next annual meeting of stockholders with vesting to occur ratably through May 31, 2022, provided each person has remained a director at such dates.

Director compensation for the year ended December 31, 2022 was as follows:

Director Compensation

Name 

Fees earned or paid in

cash ($)

  

Stock

awards
($)

  

Option

awards
($)

  Total
($)
 
Stanton E. Ross, Chairman of the Board of Directors (1) $  $  $  $ 
Leroy C. Richie $95,000  $  $  $95,000 
Daniel F. Hutchins $90,000  $  $  $90,000 
Michael J. Caulfield $87,917  $  $  $87,917 

(1)As a Named Executive Officer, Mr. Ross’s compensation and option awards are fully reflected in the “Summary Compensation” table, and elsewhere under “Executive Compensation.” He did not receive compensation, stock awards or options for his services as a director.

53

Stock Option and Restricted Stock Grants to Directors

Name Number of Restricted Shares of Common Stock Granted  Number of Options Granted      Average per Share Exercise Price     
Stanton E. Ross, Chairman of the Board of Directors  -   -  $- 
Leroy C. Richie, Director  -   5,000  $33.40 
Daniel F. Hutchins, Director  -   5,000  $33.40 
Michael J. Caulfield, Director  -   5,000  $33.40 

Securities Authorized for Issuance Under Equity Compensation Plans

Our Board of Directors adopted the 2005 Stock Option and Restricted Stock Plan (the “2005 Plan”) on September 1, 2005. The 2005 Plan authorized us to reserve 15,625 shares of our executive officersCommon Stock for issuance upon exercise of options and grant of restricted stock awards. The 2005 Plan terminated in 2015 with 1,078 shares of Common Stock reserved for awards that are now unavailable for issuance. Stock options granted under the 2005 Plan that remain unexercised and outstanding as of December 31, 2022 total 284.

On January 17, 2006, our Board adopted the 2006 Stock Option and Restricted Stock Plan (the “2006 Plan”). The 2006 Plan authorizes us to reserve 9,375 shares of Common Stock for future grants under it. The 2006 Plan terminated in 2016 with 2,739 shares of Common Stock reserved for awards that are now unavailable for issuance. Stock options granted under the 2006 Plan that remain unexercised and outstanding as of December 31, 2022 total 531.

On January 24, 2007, our Board adopted the 2007 Stock Option and Restricted Stock Plan (the “2007 Plan”). The 2007 Plan authorizes us to reserve 9,375 shares of Common Stock for future grants under it. The 2007 Plan terminated in 2017 with 4,733 shares of Common Stock reserved for awards that are now unavailable for issuance. There are no stock options granted under the 2007 Plan that remain unexercised and outstanding as of December 31, 2022.

On January 2, 2008, our Board adopted the 2008 Stock Option and Restricted Stock Plan (the “2008 Plan”). The 2008 Plan authorizes us to reserve 6,250 shares of Common Stock for future grants under it. The 2008 Plan terminated in 2018 with 2,025 shares of Common Stock reserved for awards that are now unavailable for issuance. There are no stock options granted under the 2008 Plan that remain unexercised and outstanding as of December 31, 2022.

On March 18, 2011, our Board adopted the 2011 Stock Option and Restricted Stock Plan (the “2011 Plan”). The 2011 Plan authorizes us to reserve 3,125 shares of Common Stock for future grants under it. At December 31, 2022, there were 438 shares of Common Stock reserved for awards available for issuance under the 2011 Plan. Stock options granted under the 2011 Plan that remain unexercised and outstanding as of December 31, 2022 total 50.

On March 22, 2013, our Board adopted the 2013 Stock Option and Restricted Stock Plan (the “2013 Plan”). The 2013 Plan was amended on March 28, 2014 and November 14, 2014 to increase the number of shares of Common Stock authorized and reserved for issuance under the 2013 Plan to a total of 15,000. At December 31, 2022, there were no shares of Common Stock reserved for awards available for issuance under the 2013 Plan. Stock options granted under the 2013 Plan that remain unexercised and outstanding as of December 31, 2022 total 1,000.

On March 27, 2015, our Board of Directors adopted the 2015 Stock Option and Restricted Stock Plan (the “2015 Plan”). The 2015 Plan was amended on February 25, 2016 and May 31, 2017 to increase the number of shares of Common Stock authorized and reserved for issuance under the 2015 Plan to a total of 62,500. At December 31, 2022, there were no shares of Common Stock reserved for awards available for issuance under the 2015 Plan, as amended. Stock options granted under the 2015 Plan that remain unexercised and outstanding as of December 31, 2022 total 6,500.

54

On April 12, 2018, our Board of Directors adopted the 2018 Stock Option and Restricted Stock Plan (the “2018 Plan”). The 2018 Plan was amended on May 21, 2019 to increase the number of shares of Common Stock authorized and reserved for issuance under the 2018 Plan to a total of 87,500. At December 31, 2022, there were 31,275 shares of Common Stock reserved for awards available for issuance under the 2018 Plan. Stock options granted under the 2018 Plan that remain unexercised and outstanding as of December 31, 2022 total 17,000.

Our Board of Directors adopted the 2020 Stock Option and Restricted Stock Plan (the “2020 Plan”) on June 30, 2020 and the Company’s stockholders approved the 2020 Plan at the Annual Meeting held on September 9, 2020. The Company’s stockholders approved an amendment to the 2020 Plan at the Annual Meeting held on June 22, 2021 which increased the number of shares of Common Stock authorized and reserved for issuance under the 2020 Plan to a total of 125,000. At December 31, 2022, there were 12,042 shares of Common Stock reserved for awards available for issuance under the 2020 Plan. Stock options granted under the 2020 Plan that remain unexercised and outstanding as of December 31, 2022 total 29,000.

Our Board of Directors adopted the 2022 Stock Option and Restricted Stock Plan (the “2022 Plan”) on October 28, 2022 and the Company’s stockholders approved the 2022 Plan at the Annual Meeting held on December 7, 2022. The number of shares of Common Stock authorized and reserved for issuance under the 2022 Plan totals 125,000. At December 31, 2022, there were no shares of Common Stock reserved for awards available for issuance under the 2022 Plan. Stock options granted under the 2022 Plan that remain unexercised and outstanding as of December 31, 2022 total 125,000.

The 2005 Plan, 2006 Plan, 2007 Plan, 2008 Plan, 2011 Plan, 2013 Plan, 2015 Plan, 2018 Plan, 2020 Plan, and 2022 Plan are collectively referred to as the “Plans.”

The Plans authorize us to grant (i) to the key employees incentive stock options (except for the 2007 Plan) to purchase shares of Common Stock and non-qualified stock options to purchase shares of Common Stock and restricted stock awards, and (ii) to non-employee directors and consultants’ non-qualified stock options and restricted stock. The Compensation Committee of our Board (the “Compensation Committee”) administers the Plans by making recommendations to the Board or determinations regarding the persons to whom options or restricted stock should be granted and the amount, terms, conditions and restrictions of the awards.

The Plans allow for the grant of incentive stock options (except for the 2007 Plan), non-qualified stock options and restricted stock awards. Incentive stock options granted under the Plans must have an exercise price at least equal to 100% of the fair market value of the Common Stock as of the date of grant. Incentive stock options granted to any person who owns, immediately after the grant, stock possessing more than 10% of the combined voting power of all classes of our stock, or of any parent or subsidiary corporation, must have an exercise price at least equal to 110% of the fair market value of the Common Stock on the date of grant. Non-statutory stock options may have exercise prices as determined by our Compensation Committee.

The Compensation Committee is incorporated hereinalso authorized to grant restricted stock awards under the Plans. A restricted stock award is a grant of shares of the Common Stock that is subject to restrictions on transferability, risk of forfeiture and other restrictions and that may be forfeited in the event of certain terminations of employment or service prior to the end of a restricted period specified by referencethe Compensation Committee.

We have filed various registration statements on Form S-8 and amendments to our 2021 Proxy Statement.previously filed Form S-8’s with the Securities and Exchange Commission (the “SEC”), which registered a total of 408,750 shares of Common Stock issued or to be issued underlying the awards under the Plans.

 

The following table sets forth certain information regarding the Plans as of December 31, 2022:

Equity Compensation Plan Information

Plan category Number of securities to be issued upon exercise of outstanding options, warrants and rights (a)  Weighted-average exercise price of outstanding options, warrants and rights (b)  Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (c) 
Equity compensation plans approved by stockholders  53,950  $45.80   408,750 
Equity compensation plans not approved by stockholders    $    
Total all plans  53,950  $45.80   408,750 

55

Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

InformationThe following table sets forth, as of March 31, 2023, information regarding beneficial ownership of our Common Stock for:

each person, or group of affiliated persons, known by us to beneficially own more than 5% of our Common Stock;
each of our executive officers;
each of our directors; and
all of our current executive officers and directors as a group

Beneficial ownership is determined according to the rules of the SEC and generally means that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power of that security, including securities that are currently exercisable or exercisable within sixty (60) days of March 31, 2023. Except as indicated by the footnotes below, we believe, based on the information furnished to us, that the persons named in the table below have sole voting and investment power with respect to securityall shares of Common Stock shown that they beneficially own, subject to community property laws where applicable.

Common Stock subject to securities currently exercisable or exercisable within sixty (60) days of March 31, 2023 are deemed to be outstanding for computing the percentage ownership of certainthe person holding such securities and the percentage ownership of any group of which the holder is a member but are not deemed outstanding for computing the percentage of any other person.

Unless otherwise indicated, the address of each beneficial owners and management and related stockholder matters,owner listed in the table below is incorporated herein by reference to our 2021 Proxy Statement.c/o Digital Ally, Inc., 14001 Marshall Drive., Lenexa, KS 66215.

  Number of Shares of Common
Stock Beneficially Owned (1)
  % of Total
Voting
 
  Shares  %  Power 
5% or Greater Stockholders:            
None         
Executive Officers and Directors:            
Stanton E. Ross(2)  116,065   4.2%  4.2%
Leroy C. Richie(3)  18,211   *   * 
Daniel F. Hutchins(4)  17,885   *   * 
Michael J. Caulfield(5)  16,393   *   * 
Thomas J. Heckman(6)  76,687   2.8%  2.8%
Peng Han(7)  13,781   *   * 
             
All executive officers and directors as a group (five individuals)  259,022   9.2%  9.2%

*Represents less than 1%.
(1)Based on 2,755,170 shares of Common Stock issued and outstanding as of March 31, 2023 and, with respect only to the ownership by all executive officers and directors as a group.
(2)Mr. Ross’s total shares of Common Stock include 26,250 restricted shares that are subject to forfeiture to us.
(3)Mr. Richie’s total shares of Common Stock include 16,250 shares of Common Stock to be received upon the exercise of vested options.

Information about our Plans is incorporated herein by reference to Part II, Item 5 of this Annual Report on Form 10-K.

(4)Mr. Hutchins’ total shares of Common Stock include 16,250 shares of Common Stock to be received upon the exercise of vested options.
(5)Mr. Caulfield’s total shares of Common Stock include 16,250 shares of Common Stock to be received upon the exercise of vested options.
(6)Mr. Heckman’s total shares of Common Stock include (i) 3,750 restricted shares that are subject to forfeiture to us and (ii) 23,120 shares of Common Stock held in the Company’s 401(k) Plan (on December 31, 2022) as to which Mr. Heckman has voting power as trustee of the 401(k) Plan.
(7)Mr. Han’s total shares of Common Stock include (i) 10,250 restricted shares that are subject to forfeiture to us and (ii) 331 shares of Common Stock to be received upon the exercise of vested options.

56

Item 13.Certain Relationships and Related Transactions, and Director Independence.

InformationTransactions with respectManaging Member of Nobility Healthcare

On January 27, 2022, the Board of Directors appointed Christian J. Hoffmann, III as a member of the Board, effective immediately. Mr. Hoffmann is a principal owner and manager of Nobility, LLC which is currently the managing member of our consolidated subsidiary Nobility Healthcare, LLC.

The Company has advanced a total of $158,384 in the form of a working capital loan to certain relationshipsNobility, LLC in order to fund capital expenditures necessary for the initial growth of the joint venture during 2022. The outstanding balance of the working capital loan was $138,384 as of December 31, 2022 and related transactions,the Company anticipates full repayment of this advance during the year ended December 31, 2023. The Company paid distributions to the noncontrolling in consolidated subsidiary totaling $15,692 and director independence is incorporated herein by reference to our$-0-, for the years ended December 31, 2022 and 2021, Proxy Statement.respectively.

On August 1, 2022, Mr. Hoffmann resigned as a member of the Board, effective immediately. He remains as a principal owner and manager of Nobility, LLC.

Item 14.Principal AccountingAccountant Fees and Services.

InformationThe following table is a summary of the fees billed to us by RBSM LLP for the fiscal years ended December 31, 2022 and 2021:

Fee Category 

Fiscal

2022 fees

  

Fiscal

2021 fees

 
Audit fees $327,415  $189,250 
Audit-related fees     61,500 
Tax fees      
All other fees      
Total fees $327,415  $250,750 

Audit Fees. Such amount consists of fees billed for professional services rendered in connection with respectthe audit of our annual financial statements and review of the interim financial statements included in our quarterly reports. It also includes services that are normally provided by our independent registered public accounting firms in connection with statutory and regulatory filings or engagements.

Audit-Related Fees. Consists of fees billed for assurance and related services that are reasonably related to the performance of the audit or review of our financial statements and are not reported under “Audit Fees.” These services include employee benefit plan audits, consents issued for certain filings with the SEC, accounting consultations in connection with acquisitions, attest services that are not required by statute or regulation, and consultations concerning financial accounting and reporting standards.

Tax Fees. Tax fees paidconsist of fees billed for professional services related to tax compliance, tax advice and tax planning. These services include assistance regarding federal, state and international tax compliance, tax audit defense, customs and duties, mergers and acquisitions, and international tax planning.

All Other Fees. Consists of fees for products and services other than the services reported above.

Pre–Approval Policy of Services Performed by Independent Registered Public Accounting Firm. The Audit Committee’s policy is to pre–approve all audit and non–audit related services, tax services and other services. Pre–approval is generally provided for up to one year, and any pre–approval is detailed as to the particular service or category of services and is generally subject to a specific budget. The Audit Committee has delegated the pre–approval authority to its chairperson when expedition of services is necessary. The independent registered public accounting firm and management are required to periodically report to the full Audit Committee regarding the extent of services provided by our principal accountants is incorporated herein by referencethe independent registered public accounting firm in accordance with this pre–approval and the fees for the services performed to our 2021 Proxy Statement.date.

4457
 

PART IV

Item 15.Exhibits and Financial Statement Schedules.

(a)The following documents are filed as part of this Annual Report on Form 10-K:

1.Consolidated Financial Statements:
The consolidated financial statements required to be included in Part II, Item 8, Financial Statements and Supplementary Data, begin on Page F-1 and are submitted as a separate section of this Annual Report on Form 10-K.
2.Financial Statement Schedules:
All schedules are omitted because they are not applicable or are not required, or because the required information is included in the consolidated financial statements or notes in this Annual Report on Form 10-K.
3.Exhibits:

Exhibit

Number

 Description of Exhibit   Description of Exhibit  
2.1 Plan of Merger among Vegas Petra, Inc., a Nevada corporation, and Digital Ally, Inc., a Nevada corporation, and its stockholders, dated November 30, 2004. (1) Agreement and Plan of Merger. (19)
3.1(i)(a) Amended and Restated Articles of Incorporation of Digital Ally, Inc. (see the Amended and Restated Articles of Incorporation included in the Plan of Merger, filed as Exhibit 2.1 hereto). (1) Articles of Incorporation. (19)
3.1(i)(b) Articles of Merger. (19)
3.1(i)(c) Certificate of Amendment to Digital Ally, Inc.’s Articles of Incorporation.  (22)
3.1(i)(d) Certificate of Amendment to Articles of Incorporation of Digital Ally, Inc. (23)
3.1(ii) Certificate of Change of Digital Ally, Inc., dated August 24, 2012. (5) Bylaws (19)
3.1(iii) Certificate of Amendment of Digital Ally, Inc., dated July 27, 2018. (20)
3.2(i) Amended and Restated Bylaws of Digital Ally, Inc. (1)  
3.2(ii) Amendment to Amended and Restated Bylaws of Digital Ally, Inc. (19)
3.3 Audit Committee Charter dated September 22, 2005. (1)
3.4 Compensation Committee Charter, dated September 22, 2005 (1)
3.5 Nominating Committee Charter dated December 27, 2007. (2)
3.6 Corporate Governance Guidelines (3)
3.7 Nominating and Governance Charter, Amended and Restated as of February 25, 2010. (4)
3.8 Strategic Planning Committee Charter dated June 28, 2009. (4)
3.9 Certificate of Change Pursuant to NRS 78.209 of Digital Ally, Inc. (5)
4.1 Form of Common Stock Certificate. (6) Form of Common Stock Certificate. 

*

4.2 Form of Common Stock Purchase Warrant. (6) Form of Series A-1 Warrant. (6)
4.3 Form of Series A Common Stock Purchase Warrant. (7) Form of Common Stock Purchase Warrant. (7)
4.4 Form of Series B Common Stock Purchase Warrant. (7) Common Stock Purchase Warrant of Digital Ally, Inc. (8)
4.5 Form of Series C Common Stock Purchase Warrant. (7) Form of Common Stock Purchase Warrant (10)
4.6 Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934  Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 

*

5.1 Opinion of Quarles & Brady, LLP (17)
10.1 2005 Stock Option and Restricted Stock Plan. (6) 2005 Stock Option and Restricted Stock Plan. (2)
10.2 2006 Stock Option and Restricted Stock Plan. (6) 2006 Stock Option and Restricted Stock Plan. (2)
10.3 Form of Stock Option Agreement (ISO and Non-Qualified) 2005 Stock Option Plan. (6) Form of Stock Option Agreement (ISO and Non-Qualified) 2005 Stock Option Plan. (2)
10.4 Form of Stock Option Agreement (ISO and Non-Qualified) 2006 Stock Option Plan. (6) Form of Stock Option Agreement (ISO and Non-Qualified) 2006 Stock Option Plan. (2)
10.5 2007 Stock Option and Restricted Stock Plan. (8)
10.6 Form of Stock Option Agreement (ISO and Non-Qualified) 2007 Stock Option Plan. (2)
10.7 Amendment to 2007 Stock Option and Restricted Stock Plan. (2)
10.8 2008 Stock Option and Restricted Stock Plan. (2)
10.9 Form of Stock Option Agreement (ISO and Non-Qualified) 2008 Stock Option Plan. (2) Forms of Restricted Stock Agreement for 2005, 2006, 2007 and 2008 Stock Option and Restricted Stock Plans. (3)
10.10 Forms of Restricted Stock Agreement for 2005, 2006, 2007 and 2008 Stock Option and Restricted Stock Plans. (9)
10.11 2011 Stock Option and Restricted Stock Plan (10) 2011 Stock Option and Restricted Stock Plan (4)
10.12 Form of Stock Option Agreement for 2011 Stock Option and Restricted Stock Plan (10) Form of Stock Option Agreement for 2011 Stock Option and Restricted Stock Plan (4)
10.13 Amended and Restated 2015 Stock Option and Restricted Stock Plan (5)
10.14 Form of 2015 Stock Option and Restricted Stock Plan Restricted Stock Grant Agreement. *
10.15 

Digital Ally, Inc. 2018 Stock Option and Restricted Stock Plan.

 (9)
10.16 Form of 2018 Stock Option and Restricted Stock Plan Restricted Stock Grant Agreement. *
10.17 Digital Ally, Inc. 2020 Stock Option and Restricted Stock Plan. (11)
10.18 Amendment to Digital Ally, Inc. 2020 Stock Option and Restricted Stock Plan. (14)
10.19 

Form of 2020 Stock Option and Restricted Stock Plan Restricted Stock Grant Agreement.

 

*

10.20 Digital Ally, Inc. 2022 Stock Option and Restricted Stock Plan. (21)
10.21 Form of 2022 Stock Option and Restricted Stock Plan Restricted Stock Grant Agreement under the 2022 Stock Option and Restricted Stock Plan. (24)
10.22 Proceeds Investment Agreement, dated as July 31, 2018, by and between Digital Ally, Inc. and Brickell Key Investments LP (8)
10.23 Letter Agreement, dated as July 31, 2018, by and between Digital Ally, Inc. and Brickell Key Investments LP (8)
10.24 Form of Securities Purchase Agreement, dated as of January 11, 2021, by and between the Company and the Investors. (12)
10.25 Form of Placement Agency Agreement, dated January 27, 2021, by and between the Company and Kingswood Capital Markets, division of Benchmark Investments, Inc. (13)

 

4558
 

 

10.13 Amended and Restated 2015 Stock Option and Restricted Stock Plan (11)
10.14 Common Stock Purchase Warrant (12)
10.15 Form of Series A-1 Warrant (13)
10.16 Form of Series A-2 Warrant (13)
10.17 Form of Series A-3 Warrant (13)
10.18 Form of Common Stock Purchase Warrant (14)
10.19 Common Stock Purchase Warrant of Digital Ally, Inc. (15)
10.20 Proceeds Investment Agreement, dated as July 31, 2018, by and between Digital Ally, Inc. and Brickell Key Investments LP (15)
10.21 Letter Agreement, dated as July 31, 2018, by and between Digital Ally, Inc. and Brickell Key Investments LP (15)
10.22 Digital Ally, Inc. 2018 Stock Option and Restricted Stock Plan (16)
10.23 Form of Common Stock Purchase Warrant. (18)
10.24 Form of Wholesale Distribution Agreement, dated April 3, 2020. (22)
10.25 Form of Placement Agency Agreement, dated January 11, 2021, by and between the Company and Kingswood Capital Markets, division of Benchmark Investments, Inc. (23)
10.26 Form of Securities Purchase Agreement, dated as of January 11, 2021, by and between the Company and the Investors. (23)
10.27 Form of Placement Agency Agreement, dated January 27, 2021, by and between the Company and Kingswood Capital Markets, division of Benchmark Investments, Inc. (24)
10.28 Form of Securities Purchase Agreement, dated as of January 27, 2021, by and between the Company and the Investors. (24)
14.1 Code of Ethics and Code of Conduct. (2)
21.1 Subsidiaries of Registrant (21)
23.1 Consent of RBSM LLP *
23.3 Consent of Quarles & Brady LLP (included in Exhibit 5.1)* (17)
24.1 Power of Attorney *
31.1 Certificate of Stanton E. Ross, Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *
31.2 Certificate of Thomas J. Heckman, Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *
10.26 Form of Securities Purchase Agreement, dated as of January 27, 2021, by and between the Company and the Investors. (13)
10.27 Commercial Real Estate Sales Contract, dated February 24, 2021, between the Company and DDG Holding, LLC. (15)
10.28 Form of Operating Agreement of Nobility Healthcare, LLC, dated June 1, 2021 (16)
10.29 Warrant Exchange Agreement, dated August 19, 2021, by and among the Company and the warrant holders who are signatories thereto. (17)
10.30 Unit Purchase Agreement, dated September 2, 2021 (18)
10.31 Form of Exchange Agreement. (19)
10.32 Form of Securities Purchase Agreement between Digital Ally, Inc. and the investors thereto. (20)
10.33 Form of Registration Rights Agreement by and among Digital Ally, Inc. and the investors named therein. (20)
14.1 Code of Ethics and Code of Conduct. (1)
21.1 Subsidiaries of Registrant *
23.1 Consent of RBSM LLP *
24.1 Power of Attorney *
31.1 Certificate of Stanton E. Ross, Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *
31.2 Certificate of Thomas J. Heckman, Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *
32.1 Certificate of Stanton E. Ross, Chief Executive Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 *
32.2 Certificate of Thomas J. Heckman, Chief Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 *

46

32.1101.INSCertificate of Stanton E. Ross, Chief Executive Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
32.2Certificate of Thomas J. Heckman, Chief Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*

101.INSInline XBRL Instance Document **
101.SCHInline XBRL Taxonomy Schema **
101.CALInline XBRL Taxonomy Calculation Linkbase **
101.LABInline XBRL Taxonomy Label Linkbase **
101.PREInline XBRL Taxonomy Presentation Linkbase **
104Cover Page Interactive Data File (embedded within the Inline XBRL document)

*Filed herewith.

** The XBRL related information in Exhibit 101 to this Annual Report on Form 10-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that Section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.

 (1)Filed as an exhibit to the Company’s Form SB-2, filed October 16, 2006, No. 333-138025.
(2)Filed as an exhibit to the Company’s Annual Report on Form 10KSB for the Year ended December 31, 2007.
 (3)(2)Filed as an exhibit to the Company’s Current Report onOctober 2006 Form 8-K dated November 20, 2009.SB-2.
 (4)(3)Filed as an exhibit to the Company’s Annual Report on Form 10K for the Year ended December 31, 2009.
 (5)(4)Filed as an exhibit to the Company’s Form 8-K filed August 30, 2012.
(6)Filed as an exhibit to the Company’s October 2006 Form SB-2.
(7)Filed as an exhibit to the Company’s Form 8-K filed July 17, 2015
(8)Filed as an exhibit to the Company’s Form S-8, filed October 23, 2007, No. 333-146874.
(9)Filed as an exhibit to the Company’s Annual Report on Form 10K for the Year ended December 31, 2009.
(10)Filed as an exhibit to the Company’s Form 8-K filed June 1, 2011.
 (11)(5)Filed as an exhibit to the Company’s Form S-8 filed May 23, 2016.
 (12)(6)Filed as an exhibit to the Company’s Form S-8 filed January 3, 2017.
(13)Filed as an exhibit to the Company’s Form 8-K filed August 25, 2017.
 (14)(7)Filed as an exhibit to the Company’s Form 8-K filed April 4, 2018.
 (15)(8)Filed as an exhibit to the Company’s Form 8-K filed August 2, 2018.
 (16)(9)Filed as an exhibit to the Company’s Registration Statement on Form S-8 filed August 20, 2018.
 (17)(10)Filed as an Exhibit 5.1 to the October 2006 Form SB-2.
(18)Filed as an exhibit to the Company’s Form 8-K filed August 5, 2019.
 (19)(11)Filed as an exhibit to the Company’s Form 8-K filed December 10, 2007.
(20)Filed as an exhibit to the Company’s Registration Statement on Form S-1/AS-8 filed February 7,November 16, 2020.
 (21)(12)Filed as an exhibit to the Company’s Quarterly Report on Form 10-Q for the Quarter ended June 30, 2020.
(22)Filed as an exhibit to the Company’s Form 8-K filed April 8, 2020.
(23)Filed as an exhibit to the Company’s Form 8-K filed January 12, 2021.
 (24)(13)Filed as an exhibit to the Company’s Form 8-K filed January 28, 2021.

 (b)(14)Filed as Appendix A to the Company’s Definitive Proxy Statement on Schedule 14A filed April 27, 2021.
(15)Filed as an exhibit to the Company’s Form 8-K filed May 3, 2021.
(16)Filed as an exhibit to the Company’s Form 8-K filed June 9, 2021.
(17)Filed as an exhibit to the Company’s Form 8-K filed August 19, 2021.
(18)Filed as an exhibit to the Company’s Form 8-K filed September 9, 2021.
(19)Filed as an exhibit to the Company’s Form 8-K filed August 23, 2022.
(20)Filed as an exhibit to the Company’s Form 8-K filed October 19, 2022.
(21)Filed as Appendix A to the Company’s Definitive Proxy Statement on Schedule 14A filed October 28, 2022.
(22)Filed as an exhibit to the Company’s Form 8-K filed 8-K filed December 8, 2022.
(23)Filed as an exhibit to the Company’s Form 8-K filed 8-K filed February 7, 2023.
(24)Filed as an exhibit to the Company’s Registration Statement on Form S-8 filed February 28, 2023.

(b)No financial statement schedules have been provided because the information is not required or is shown either in the financial statements or the notes thereto.

4759
 

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

DIGITAL ALLY, INC.,
a Nevada corporation
By:/s/ Stanton E. Ross
Stanton E. Ross
President and Chief Executive Officer

(Principal Executive Officer)

Dated:March 31, 2023

Each person whose signature appears below authorizes Stanton E. Ross to execute in the name of each such person who is then an officer or director of the registrant, and to file, any amendments to this Annual Report on Form 10-K necessary or advisable to enable the registrant to comply with the Securities Exchange Act of 1934 and any rules, regulations and requirements of the Securities and Exchange Commission in respect thereof, which amendments may make such changes in such Report as such attorney-in-fact may deem appropriate.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the Registrantregistrant and in the capacities and on the dates indicated.

Signature and TitleDate
/s/ Stanton E. RossMarch 31, 20212023
Stanton E. Ross, Director and Chief Executive Officer
/s/ Leroy C. RichieMarch 31, 20212023
Leroy C. Richie, Director
/s/ Michael J. CaulfieldMarch 31, 20212023
Michael J. Caulfield, Director
/s/ Daniel F. HutchinsMarch 31, 20212023
Daniel F. Hutchins, Director
/s/ Thomas J. HeckmanMarch 31, 20212023

Thomas J. Heckman, Chief Financial Officer, Secretary, Treasurer and

Principal Accounting Officer

(Principal Financial Officer and Principal Accounting Officer)
  

4860
 

DIGITAL ALLY, INC. AND SUBSIDIARIES

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

Page(s)
Report of Independent Registered Public Accounting Firm (PCAOB ID No: 587)F-2
Consolidated Financial Statements:
Consolidated Balance Sheets – December 31, 20202022 and 20192021F-3F-5
Consolidated Statements of Operations for the Years Ended December 31, 20202022 and 20192021F-4F-6
Consolidated Statements of Stockholders’ Equity (Deficit) for the Years Ended December 31, 20202022 and 20192021F-5F-7
Consolidated Statements of Cash Flows for the Years Ended December 31, 202092022 and 20192021F-6F-8
Notes to the Consolidated Financial StatementsF-7F-9

F-1

Report of Independent Registered Public Accounting Firm

To the Stockholders and the Board of Directors of Digital Ally, Inc.

Opinion on the Consolidated Financial StatementStatements

We have audited the accompanying consolidated balance sheets of Digital Ally, Inc. and its subsidiaries (the Company) as of December 31, 20202022 and 2019,2021, the related consolidated statements of operations, stockholders’ equity (deficit) and cash flows for each of the two years in the two year period ended December 31, 2020,2022, and the related notes (collectively referred to as the financial statement)statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 20202022 and 2019,2021, and the results of its operations and its cash flowsflow for each of the two years in the two year period ended December 31, 2020,2022, in conformity with accounting principles generally accepted in the United States of America.

The Company’s Ability to Continue as a Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has incurred substantial operating losses and will require additional capital to continue as a going concern. This raises substantial doubt about the Company’s ability to continue as a going concern. Management’s plans regarding these matters are also described in Note 1. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.

Basis for Opinion

These financial statementsstatement are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

 

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1)that (i) relate to accounts or disclosures that are material to the consolidated financial statements and (2)(ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

 

Value of Inventories

F-2

Goodwill, Indefinite Life Intangibles and Other Intangibles Impairment Assessments – Entertainment/Ticketing Reporting Unit – Refer to Notes 1, 8 and 422 to the consolidated financial statements

 

Critical Audit Matter Description

 

As discloseddescribed in Note 1 and 422 to the consolidated financial statements, inventories consistthe Company’s goodwill and indefinite life intangible asset balance was $5,886,547 and $600,000, respectively as of various components, work-in-processDecember 31, 2022. The Company also has amortizable identifiable intangible assets of $5,600,000 and finished goods,$600,000 which are being amortized over 5 years and 4 years, respectively, and are carried atrelated to the lowerEntertainment/Ticketing reporting unit. Management tests these assets annually for impairment or more frequently when potential impairment triggering events are present. Goodwill is tested for impairment by comparing the estimated fair value of cost or net realizablea reporting unit to its carrying value. Management uses a market approach to estimate the fair value with cost determined by standard cost methods, which approximateof its reporting unit. The key assumptions and estimates utilized in the first-in, first-out method. Inventory costsmarket approach primarily include material, labormarket multiples, peer group and manufacturing overhead. Management has established inventory reserves based on estimatescomparable transaction selection and selection of excess and/or obsolete inventories.relevant financial matrices for concluding the fair value of reporting unit discount rates, and future levels of revenue growth and operating margins.

 

We identifiedThe principal considerations for our determination that performing procedures relating to the inventory reserve for certain inventory products asgoodwill and intangible asset impairment assessments of the Entertainment/Ticketing reporting unit is a critical audit matter because (i) the significant judgment used by management when determining the fair value estimates of the significant estimates andreporting units; (ii) the assumptions management makes to evaluate their ability to move inventories which have been slow moving during the year. This required a high degree of subjective and complex auditor judgment, subjectivity and an increased extenteffort in performing procedures and evaluating the significant assumptions used in management’s fair value estimates; and (iii) the audit effort involved in the use of effort when performing audit procedures to evaluate the reasonableness of related assumptions, as well as the viability of management’s plans to sell this inventory, to evaluate whether inventory reserves for certain inventory products were appropriately recorded as of December 31, 2020.professionals with specialized skill and knowledge.

 

How the Critical Audit Matter Was Addressed in the Audit

 

OurAddressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements.

These procedures included, among others, (i) testing management’s process for determining the fair value estimates of the entertainment/ticketing reporting unit; (ii) testing the completeness and accuracy of the underlying data used in the market approach; and (iii) evaluating the reasonableness of the significant assumptions used by management related to market multiples, peer group and comparable transaction selection and selection of relevant financial matrices for concluding the fair value of reporting unit discount rates, and future levels of revenue growth and operating margins.
Evaluating management’s assumptions related to the future levels of revenue growth and operating margins involved evaluating whether the assumptions were reasonable considering (i) current and past performance of the reporting units; (ii) the consistency with external market and industry data; and (iii) whether these assumptions were consistent with evidence obtained in other areas of the audit.
Professionals with specialized skill and knowledge were used to assist in evaluating (i) the appropriateness of the market approach and (ii) the reasonableness of significant assumptions related to the market multiples, peer group and comparable transaction selection and selection of relevant financial matrices for concluding the fair value of reporting unit discount rates, and future levels of revenue growth and operating margins.

Goodwill and Other Intangibles arising from the acquisition of Healthcare Acquisition and Medical Billing Acquisitions – Refer to Notes 1, 8 and 21 to the consolidated financial statements

Critical Audit Matter Description

As disclosed in Note 1, Goodwill arises in connection with acquisitions. The excess purchase price over the fair value of net tangible assets and identifiable intangible assets acquired is recorded as goodwill.

As disclosed in Note 21, on June 30, 2021, August 31, 2021 and January 1, 2022 the Company completed acquisitions in accordance with the stock purchase agreement. The consideration included an initial payment of cash. In addition to the initial payment amount, the Company agreed to issue an earn-out agreement to the selling stockholders in the contingent amount of $1,750,000 that is subject to an earn-out adjustment based on difference between projected revenue and cash basis revenue collected by the Company in its normal course of business from the clients existing on the acquisition date during the measurement period. The Company gave a fair value of $1,750,000 to the earn-out on the date of acquisition which is considered a contingent liability. Auditing the accounting for the acquisition was complex due to the significant estimation uncertainty in determining the fair values of identified intangible assets, which consisted of Client Agreements $664,034 and Goodwill of $5,480,966.

F-3

Given the significant judgments made by management to estimate the intangible assets acquired, performing audit procedures related to the inventory reserve for certain inventory products included the following, among others:

● We evaluated the appropriateness and consistency of management’s methods and assumptions used in developing their estimate of the inventory reserves.

● We evaluatedevaluate the reasonableness of management’s plansestimates and strategiesassumptions required a high degree of auditor judgment and an increased effort, including the need to sell certain inventory products deemed to be slow moving and which are already partially reserved.involve our fair value specialists.

 

● We performed analysis over key product metrics, inventory turnover,How the Critical Audit Matter Was Addressed in the Audit

Addressing the matter involved performing procedures and margins, to identify and evaluate slow-moving inventory categories, negative margins, or other trends which may indicate a requirement to reserve.

evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included, among others:

 

We utilized personnel with specialized knowledge and skill in valuation to assist in; a) assessing the appropriateness of Multi-Period Excess Earnings Method - valuation methodology for the client agreements – intangible asset, b) evaluating the reasonableness of the growth rates, percent of revenues derived from acquired customers, medical loss ratio, operating costs, contributory asset charge and discount rate used in the income approach, c) evaluating the reasonableness of the assumptions and estimates used in the valuation methodologies.
Evaluate the reasonableness of management’s significant estimates and assumptions including revenue growth rates, percent of revenues derived from acquired customers, medical loss ratio, operating costs, contributory asset charge and discount rates and futures market conditions.
Evaluate if there have been events and circumstances that might indicate Goodwill has been impaired.
Professionals with specialized skill and knowledge were used to assist in evaluating (i) the appropriateness of the income approach and (ii) the reasonableness of significant assumptions.
Reviewed and assessed the appropriateness of adjustments to Goodwill, Other Intangibles and other Assets and Liabilities acquired based on changes to their estimated fair values.

/s/ RBSM LLP
We have served as the Company’s auditor since 2019.
New York, NY

March 31, 20212023

PCAOB ID Number 587

F-4
 

F-2

DIGITAL ALLY, INC.

CONSOLIDATED BALANCE SHEETS

DECEMBER 31, 20202022 AND 20192021

 2020  2019  2022 2021 
Assets                
Current assets:                
Cash and cash equivalents $4,361,758  $359,685  $3,532,199  $32,007,792 
Accounts receivable-trade, less allowance for doubtful accounts
of $123,224 – 2020 and $123,224 – 2019
  1,705,461   1,071,018 
Other Receivables (including $500,000 due from Related Parties – 2020 and $0 – 2019, refer to Note 16)  1,529,920   514,730 
Accounts receivable-trade, less allowance for doubtful accounts of $152,736 – 2022 and $113,234 – 2021  2,044,056   2,727,052 
Other receivables (including $138,384 due from related parties – 2022 and $158,384– 2021, refer to Note 19)  4,076,522   2,021,813 
Inventories, net  8,202,274   5,280,412   6,839,406   9,659,536 
Income tax refund receivable, current  -   44,650 
Prepaid expenses  2,030,693   381,090   8,466,413   9,728,782 
                
Total current assets  17,830,106   7,651,585   24,958,596   56,144,975 
                
Furniture, fixtures and equipment, net  666,800   197,063 
Intangible assets, net  392,564   413,268 
Property, plant, and equipment, net  7,898,686   6,841,026 
Goodwill and other intangible assets, net  17,872,970   16,902,513 
Operating lease right of use assets, net  753,175   122,459   782,129   993,384 
Other assets  1,154,881   532,500   5,155,681   2,107,299 
                
Total assets $20,797,527  $8,916,875  $56,668,062  $82,989,197 
                
Liabilities and Stockholders’ Equity (Deficit)        
Liabilities and Equity        
Current liabilities:                
Accounts payable $1,144,675  $2,339,985  $9,477,355  $4,569,106 
Accrued expenses  796,094   845,881   1,090,967   1,175,998 
Current portion of operating lease obligations  113,484   159,160   294,617   373,371 
Contract liabilities-current  1,647,469   1,707,943 
Unsecured promissory note payable, net of unamortized discount of $0 and $66,061, respectively  -   233,939 
Secured convertible notes at fair value – current portion  -   1,593,809 
Subordinated notes payable – current portion  11,727   - 
Contract liabilities – current  2,154,874   1,665,519 
Debt obligations – current  485,373   389,934 
Warrant derivative liabilities     14,846,932 
Income taxes payable  7,158   5,934   8,097   1,827 
                
Total current liabilities  3,720,606   6,886,651   13,511,283   23,022,687 
                
Long-term liabilities:                
Proceeds investment agreement, at fair value  -   6,500,000 
Subordinated notes payable – long term  148,273   - 
Operating lease obligation, long term  723,272   44,460 
Contract liabilities-long term  1,848,869   1,803,143 
Debt obligations – long term  442,467   727,278 
Operating lease obligation – long term  555,707   688,207 
Contract liabilities – long term  5,818,082   2,687,786 
                
Total liabilities  6,441,021   15,234,254   20,327,539   27,125,958 
                
Commitments and contingencies          -   - 
                
Stockholders’ Equity (Deficit):        
Common stock, $0.001 par value; 100,000,000 and 50,000,000 shares authorized, respectively; shares issued: 26,834,709 – 2020 and 12,079,095 – 2019  26,835   12,079 
Mezzanine equity:        
Series A Convertible Redeemable Preferred stock, $0.001 par value; shares issued: 0 – 2022 and 0 – 2021      
Series B Convertible Redeemable Preferred stock, $0.001 par value; shares issued: 0 – 2022 and 0 – 2021      
        
Equity:        
Common stock, $0.001 par value; 200,000,000 shares authorized; shares issued: 2,720,170 – 2022 and 2,545,220 – 2021  2,721   2,545 
Additional paid in capital  106,501,396   83,216,387   127,869,342   124,476,447 
Treasury stock, at cost (63,518 shares)  (2,157,225)  (2,157,226)
Noncontrolling interest in consolidated subsidiary  448,694   56,453 
Accumulated deficit  (90,014,500)  (87,388,619)  (91,980,234)  (68,672,206)
                
Total stockholders’ equity (deficit)  14,356,506   (6,317,379)
Total equity  36,340,523   55,863,239 
                
Total liabilities and stockholders’ equity (deficit) $20,797,527  $8,916,875 
Total liabilities and equity $56,668,062  $82,989,197 

See Notes to Consolidated Financial Statements.

F-3F-5

DIGITAL ALLY, INC.


CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE YEARS ENDED

DECEMBER 31, 20202022 AND 20192021

 2020  2019  2022 2021 
Revenue:                
Product $8,029,457  $7,732,796  $10,999,892  $9,180,287 
Service and other  2,485,411   2,708,568   26,010,003   12,233,147 
                
Total revenue  10,514,868   10,441,364   37,009,895   21,413,434 
                
Cost of revenue:                
Product  5,739,572   6,577,347   14,372,115   8,635,047 
Service and other  712,702   631,388   20,315,839   7,114,612 
                
Total cost of revenue  6,452,274   7,208,735   

34,687,954

   15,749,659 
                
Gross profit  4,062,594   3,232,629   2,321,941   5,663,775 
                
Selling, general and administrative expenses:                
Research and development expense  1,842,800   2,005,717   2,290,293   1,930,784 
Selling, advertising and promotional expense  2,607,242   3,652,434   9,312,204   5,717,824 
        
General and administrative expense  7,276,203   9,607,259   20,452,702   12,776,077 
Patent litigation settlement     (6,000,000)
                
Total selling, general and administrative expenses  11,726,245   9,265,410   32,055,199   20,424,685 
                
Operating loss  (7,663,651)  (6,032,781)  (29,733,258)  (14,760,910)
                
Other income (expense)        
Other income (expense):        
Interest income  47,893   37,410   131,025   310,200 
Interest expense  (342,379)  (43,373)  (37,196)  (28,600)
Change in fair value of secured convertible notes  (1,300,252)  (519,821)
Change in fair value of proceeds investment agreement  5,250,000   (3,358,000)
Other expense  (230,744)   
Change in fair value of short-term investments  (84,818)  (101,645)
Change in fair value of warrant derivative liabilities  6,726,638   36,664,907 
Change in fair value of contingent consideration promissory notes and earn-out agreements  516,970   3,732,789 
Warrant modification expense     (295,780)
Gain on the extinguishment of debt  1,417,413         10,000 
Secured convertible notes issuance expense  (34,906)  (89,148)
Gain on extinguishment of warrant derivative liabilities  3,624,794    
Gain on sale of property, plant and equipment  212,831    
                
Total other income (expense)  5,037,769   (3,972,932)
Total other income  10,859,500   40,291,871 
                
Loss before income tax expense (benefit)  (2,625,881)  (10,005,713)
Income (loss) before income tax expense (benefit)  (18,873,758)  25,530,961 
Income tax expense (benefit)            
                
Net loss $(2,625,881) $(10,005,713)
Net income (loss)  (18,873,758)  25,530,961 
                
Net loss per share information:        
Net income attributable to noncontrolling interests of consolidated subsidiary  (407,933)  (56,453)
        
Loss on redemption – Series A & B convertible redeemable preferred stock  

(2,385,000

)  

 
        
Net income (loss) attributable to common stockholders $(21,666,691) $25,474,508 
        
Net income (loss) per share attributable to common information:        
Basic $(0.12) $(0.87) $(8.50) $10.14 
Diluted $(0.12) $(0.87) $(8.50) $10.14 
                
Weighted average shares outstanding:                
Basic  21,603,635   11,478,618   2,548,549   2,511,114 
Diluted  21,603,635   11,478,618   2,548,549   2,511,114 

See Notes to Consolidated Financial Statements.

F-4F-6

DIGITAL ALLY, INC.


CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

YEARS ENDED DECEMBER 31, 20202022 AND 20192021

        Additional          
  Common Stock  Paid In  Treasury  Accumulated    
  Shares  Amount  Capital  stock  deficit  Total 
Balance, December 31, 2018  10,445,445  $10,445  $78,117,507  $(2,157,226) $(77,382,906) $(1,412,180)
                         
Stock-based compensation        2,112,090         2,112,090 
Restricted common stock grant  522,110   522   (522)         
Restricted common stock forfeitures  (5,370)  (5)  5          
Issuance of common stock upon conversion of secured convertible notes and interest  498,625   499   697,568         698,067 
Issuance of common stock In connection with issuance of secured convertible notes  89,285   89   118,660         118,749 
Issuance of common stock purchase warrants in connection with issuance of secured convertible debentures        535,739         535,739 
Issuance of common stock upon exercise of warrants  529,000   529   1,563,471         1,564,000 
Issuance of common stock purchase warrants in connection with issuance of unsecured promissory note payable        71,869         71,869 
                         
Net loss              (10,005,713)  (10,005,713)
                         
Balance, December 31, 2019  12,079,095   12,079   83,216,387   (2,157,226)  (87,388,619)  (6,317,379)
                         
Stock-based compensation        1,462,270         1,462,270 
Restricted common stock grant  846,591   846   (846)         
Restricted common stock forfeitures  (36,750)  (37)  37          
Issuance of common stock upon conversion of secured convertible notes and interest  2,624,212   2,625   3,022,060         3,024,685 
Issuance of common stock through underwritten public offering at $1.15 per share (net of offering expenses and underwriters’ discount)  2,521,740   2,522   2,499,614         2,502,136 
Issuance of common stock through underwritten public offering at $1.65 per share (net of offering expenses and underwriters’ discount)  3,554,545   3,554   5,346,859         5,350,413 
Issuance of common stock through underwritten public offering at $2.15 per share (net of offering expenses and underwriters’ discount)  2,539,534   2,540   4,974,152         4,976,692 
Issuance of common stock upon exercise of common stock purchase warrants  2,693,867   2,694   5,200,428         5,203,122 
Issuance of common stock purchase warrants in connection with issuance of secured convertible notes        721,141         721,141 
Issuance of common stock upon exercise of stock options  1,875   2   7,798         7,800 
Issuance of common stock for services rendered  10,000   10   30,690         30,700 
Issuance of common stock purchase warrants in connection with issuance of unsecured promissory note payable        20,806         20,806 
                         
Net loss              (2,625,881)  (2,625,881)
                         
Balance, December 31, 2020  26,834,709  $26,835  $106,501,396  $(2,157,225) $(90,014,500) $14,356,506 
              Noncontrolling       
        Additional     Interest in       
  Common Stock  Paid In  Treasury  consolidated  Accumulated    
  Shares  Amount  Capital  stock  subsidiary  deficit  Total 
Balance, December 31, 2020  1,341,735  $1,342  $106,526,889  $(2,157,225) $  $(90,014,500) $14,356,506 
                             
Stock-based compensation        1,605,949            1,605,949 
Restricted common stock grant  42,800   43   (43)            
Restricted common stock forfeitures  (385)                 
Issuance of common stock through registered direct offering at $61.90 per share and accompanying warrants (net of offering expenses and placement agent discount)  140,000   140   6,728,860            6,729,000 
Issuance of common stock through registered direct offering at $56.00 per share and accompanying warrants (net of offering expenses and placement agent discount)  162,500   162   6,617,438            6,617,600 
Exercise of pre-funded common stock purchase warrants at $61.90 per share  360,000   360   22,283,640            22,284,000 
Exercise of pre-funded common stock purchase warrants at $56.00 per share  552,500   552   30,939,448            30,940,000 
Issuance of pre-funded common stock purchase warrants in connection with the registered direct offerings        (1,817,548)           (1,817,548)
Issuance of common stock purchase warrants at exercise price of $65.00 per share in connection with the registered direct offerings        (49,398,510)           (49,398,510)
Issuance of common stock as consideration for acquisition  35,987   36   990,324            990,360 
Repurchase and cancellation of common stock  (86,742)  (87)          (1,974,992)  (1,975,079)
Cancellation of treasury stock  (3,176)  (3)    2,157,225      (2,157,222)   
                             
Net income              56,453   25,474,508   25,530,961 
                             
Balance, December 31, 2021  2,545,220  $2,545  $124,476,447  $  $56,453  $(68,672,206) $55,863,239 
Balance  2,545,220  $2,545  $124,476,447  $  $56,453  $(68,672,206) $55,863,239 
                             
Stock-based compensation        1,282,757            1,282,757 
Restricted common stock grant  35,750   36   (36)            
Restricted common stock forfeitures  (3,250)  (3)  3             
Distribution to noncontrolling interest in consolidated subsidiary              (15,692)     (15,692)
Issuance of common stock under rule 144 restrictions related to contemplated spin-off transaction  25,000   25   (25)            
Repurchase and cancellation of common stock  (186,299)  (186)           (4,026,337)  (4,026,523)
Issuance of common stock through warrant exchange agreement  303,750   304   4,495,196            4,495,500 
Loss on redemption of Series A and Series B Preferred Stock        (2,385,000)           (2,385,000)
                             
Net income (loss)              407,933   (19,281,691)  (18,873,758)
                             
Balance, December 31, 2022  2,720,171  $2,721  $127,869,342  $  $448,694  $(91,980,234) $36,340,523 
Balance  2,720,171  $2,721  $127,869,342  $  $448,694  $(91,980,234) $36,340,523 

See Notes to Consolidated Financial Statements.

F-5F-7

DIGITAL ALLY, INC.


CONSOLIDATED STATEMENTS OF CASH FLOWS

YEARS ENDED DECEMBER 31, 20202022 AND 20192021

 2020  2019  2022 2021 
Cash Flows From Operating Activities:        
Net loss $(2,625,881) $(10,005,713)
Adjustments to reconcile net loss to net cash flows used in operating activities:        
Cash Flows from Operating Activities:        
Net income (loss) $(18,873,758) $25,530,961 
Adjustments to reconcile net income (loss) to net cash flows used in operating activities:        
Depreciation and amortization  250,156   390,151   2,176,679   822,489 
Gain on sale of property, plant and equipment  

(212,831

)   
Stock based compensation  1,462,270   2,112,090   1,282,757   1,605,949 
Issuance of common stock for services  30,700    
Amortization of debt discount  86,867   5,808 
Provision for doubtful accounts receivable     60,000   (39,502)  9,990 
Interest paid through issuance of common stock  99,945   50,000 
Provision for doubtful lease receivable  140,448    
Gain on extinguishment of debt  (1,417,413)       (10,000)
Secured convertible debentures issuance expense  34,906   89,148 
Change in fair value of secured convertible debentures  1,300,252   519,821 
Change in fair value of proceeds investment agreement  (5,250,000)  3,358,000 
Change in fair value of contingent consideration promissory notes and earn-out agreements  (516,970)  (3,732,789)
Change in fair value of warrant derivative liability  (6,726,638)  (36,664,907)
Gain of extinguishment of warrant derivative liabilities  (3,624,794)   
Warrant modification expense     295,780 
Provision for inventory obsolescence  275,690   856,242   1,574,453   1,954,738 
Change in operating assets and liabilities:                
(Increase) decrease in:                
Accounts receivable – trade  (634,443)  716,868   722,498  (29,838)
Accounts receivable – other (including related party)  (1,015,191)  (132,318)  (2,195,157)  (693,992)
Inventories  (3,197,552)  862,406   1,245,677  (1,431,080)
Prepaid expenses  (1,649,603)  48,313   1,293,080  (3,839,458)
Income tax refund receivable  44,650   45,350 
Operating lease right of use assets  (630,716)  378,292   328,772   180,497 
Other assets  177,619   (275,751)  (3,048,382)  (738,466)
Increase (decrease) in:                
Accounts payable  (1,195,310)  1,555,386   4,709,030  (1,907,608)
Accrued expenses  (41,274  (1,234,786)  (112,896)  166,874 
Income taxes payable  1,224   2,245   6,270  (5,331)
Operating lease obligations  633,136   (297,131)  (328,772)  (195,884 
Contract liabilities  (14,747)  (228,794)  3,619,651   856,967 
                
Net cash used in operating activities  (13,284,715)  (1,124,373)  (18,580,385)  (17,825,108)
                
Cash Flows from Investing Activities:                
Purchases of furniture, fixtures and equipment  (621,860)  (204,013)
Additions to intangible assets  (77,329)  (62,131)
Issuance of notes receivable  (800,000)   
Purchases of property, plant and equipment  (2,068,508)  (6,428,225)
Proceeds from sale of property, plant and equipment  609,559    
Purchases of intangible assets  (116,990)  (1,189,132)
Proceeds from sale of intangible assets  18,975    
Cash paid for acquisition of Medical Billing Company    (1,026,508)
Cash paid for acquisition of Medical Billing Company    (2,270,000)
Cash paid for acquisition of Medical Billing Company  

(1,153,627

)  

 
Cash paid for asset acquisition of Medical Billing Company  

(230,000

)  

 
Cash paid for acquisition of TicketSmarter    (8,615,514)
Collection of notes receivable     405,000 
                
Net cash used in investing activities  (1,499,189)  (266,144)  (2,940,591)  (19,124,379)
                
Cash Flows from Financing Activities:                
Proceeds from unsecured promissory note payable, related party  319,000    
Proceeds from unsecured promissory note payable  100,000   300,000 
Proceeds from PPP/EIDL Loans  1,568,900    
Repayment of proceeds investment agreement  (1,250,000)  (6,000,000)
Proceeds from issuance of common stock and warrants, net of issuance costs  12,829,241    
Proceeds from secured convertible debentures  1,500,000   2,500,000 
Secured convertible debenture issuance expense  (34,906)  (89,148)
Principal payments on related party note payable  (319,000)   
Principal payment on unsecured notes payable  (400,000)  (123,457)
Principal payment on secured convertible debentures  (748,180)   
Proceeds from issuance of common stock upon exercise of warrants  5,203,122   1,564,000 
Proceeds from exercising stock options  7,800    
Proceeds from issuance of common stock upon exercise of pre-funded warrants     53,224,000 
Net proceeds from sale of common stock in registered direct offerings     13,346,600 
Repurchase and cancellation of common stock  (4,026,523)  (1,975,079)
Distribution to noncontrolling interest in consolidated subsidiary  (15,692)   
Principal payment on contingent consideration promissory notes  (527,402)   
Proceeds from issuance of Series A & B convertible redeemable preferred shares, net of issuance costs  13,365,000    
Redemption of Series A & B convertible redeemable preferred shares  (15,750,000)   
                
Net cash (used in) provided by financing activities  18,775,977   (1,848,605)
Net cash provided by (used in) financing activities  (6,954,617)  64,595,521 
                
Net increase (decrease) in cash and cash equivalents  4,002,073   (3,239,122)  (28,475,593)  27,646,034 
Cash, cash equivalents, beginning of year  359,685   3,598,807   32,007,792   4,361,758 
                
Cash, cash equivalents, end of year $4,361,758  $359,685  $3,532,199  $32,007,792 
                
Supplemental disclosures of cash flow information:                
Cash payments for interest $128,911  $30,937  $49,070  $ 
                
Cash payments for income taxes $4,776  $3,755  $8,730  $1,224 
                
Supplemental disclosures of non-cash investing and financing activities:                
Restricted common stock grant $846  $522  $61  $43 
                
Restricted common stock forfeitures $37  $5  $3  $ 
                
Impact of Adoption of ASC 842 - obtaining right of use asset for lease liability $  $500,751 
Issuance of contingent consideration earn-out agreement for business acquisitions $750,000  $3,700,000 
                
Amounts allocated to common stock purchase warrants in connection with proceeds from secured convertible debentures $741,947  $535,739 
Issuance of contingent consideration promissory note for business acquisitions $  $1,000,000 
                
Issuance of common stock upon conversion of secured convertible notes $2,924,740  $648,067 
Issuance of contingent consideration promissory note for asset acquisitions $105,000  $ 
                
Issuance of common stock related to the issuance of secured convertible notes $  $118,749 
Assets acquired in business acquisitions $190,631  $6,324,189 
                
Amounts allocated to common stock purchase warrants in connection with issuance of unsecured promissory note payable $  $71,869 
Identifiable intangible assets acquired in business acquisitions $  $6,800,000 
        
Goodwill acquired in business acquisitions $2,100,000  $9,931,547 
        
Liabilities assumed in business acquisitions $387,005  $5,453,353 
        
ROU and lease liability recorded on extension of lease $

42,403

  $ 
        
Common stock issued as consideration for business acquisitions $  $990,360 
        
Amounts allocated to initial measurement of warrant derivative liabilities in connection to the warrants and pre-funded warrants $  $51,216,058 
        
Issuance of common stock through warrant exchange agreement $4,495,500  $ 
        
Cancellation of treasury stock $  $2,157,225 

See Notes to Consolidated Financial Statements.

F-6F-8

DIGITAL ALLY, INC.


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1. NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Business:

Digital Ally, Inc. (with its wholly-owned subsidiaries, Digital Ally International, Inc. and Shield Products, LLC collectively, “Digital Ally,” “Digital,” and the “Company”) produces digital video imaging, storage products and disinfectant and related safety products for use in law enforcement, security and commercial applications. The Company’s products include, among others; in-car digital video/audio recorders contained in a rear-view mirror for use in law enforcement and commercial fleets; a system that provides its law enforcement customers with audio/video surveillance from multiple vantage points and hands-free automatic activation of body-worn cameras and in-car video systems; a miniature digital video system designed to be worn on an individual’s body; and cloud storage solutions. The Company has recently added two new lines of branded products: (1) the ThermoVu™ line, which is a line of self-contained temperature monitoring stations that provides alerts and controls facility access when an individual’s temperature exceeds a pre-set threshold and (2) the Shield™ disinfectant and cleanser line, which is for use against viruses and bacteria and which we began offering to the Company’s law enforcement and commercial customers beginning late in the second quarter of 2020. Both product lines are manufactured by third parties. In addition, the Company has active research and development programs to adapt its technologies to other applications. It can integrate electronic, radio, computer, mechanical, and multi-media technologies to create unique solutions to address needs in a variety of other industries and markets, including mass transit, school bus, taxicab and the military. The Company sells its products to law enforcement agencies, private security customers and organizations, and consumer and commercial fleet operators through direct sales domestically and third-party distributors internationally.

The Company was originally incorporated in Nevada on December 13, 2000 as Vegas Petra, Inc. and had no operations until 2004. On November 30, 2004, Vegas Petra, Inc. entered into a Plan of Merger with Digital Ally, Inc., at which time the merged entity was renamed Digital Ally, Inc. (such merged entity, the “Predecessor Registrant”).

On August 23, 2022 (the “Effective Time”), the Predecessor Registrant merged with and into its wholly owned subsidiary, DGLY Subsidiary Inc., a Nevada corporation (the “Registrant”), pursuant to an agreement and plan of merger, dated as of August 23, 2022 (the “Merger Agreement”), between the Predecessor Registrant and the Registrant, with the Registrant as the surviving corporation in the merger (such transaction, the “Merger”). At the Effective Time, Articles of Merger were filed with the Secretary of State of the State of Nevada, pursuant to which the Registrant was renamed “Digital Ally, Inc.” and, by operation of law, succeeded to the assets, continued the business and assumed the rights and obligations of the Predecessor Registrant immediately prior to the Merger. Under the Nevada Revised Statutes, shareholder approval was not required in connection with the Merger Agreement or the transactions contemplated thereby.

At the Effective Time, pursuant to the Merger Agreement, (i) each outstanding share of Predecessor Registrant’s common stock, par value $0.001 per share (the “Predecessor Common Stock”) automatically converted into one share of common stock, par value $0.001 per share, of the Registrant (“Registrant Common Stock”), (ii) each outstanding option, right or warrant to acquire shares of Predecessor Common Stock converted into an option, right or warrant, as applicable, to acquire an equal number of shares of Registrant Common Stock under the same terms and conditions as the original options, rights or warrants, and (iii) the directors and executive officers of the Predecessor Registrant were appointed as directors and executive officers, as applicable, of the Registrant, each to serve in the same capacity and for the same term as such person served with the Predecessor Registrant immediately before the Merger.

The business of the Registrant, Digital Ally, Inc. (with its wholly-owned subsidiaries, Digital Ally International, Inc., Shield Products, LLC, Digital Ally Healthcare, LLC, TicketSmarter, Inc., Worldwide Reinsurance, Ltd., Digital Connect, Inc., BirdVu Jets, Inc., Kustom 440, Inc., and its majority-owned subsidiary Nobility Healthcare, LLC, collectively, “Digital Ally,” “Digital,” and the “Company”), is divided into three reportable operating segments: 1) the Video Solutions Segment, 2) the Revenue Cycle Management Segment and 3) the Ticketing Segment. The Video Solutions Segment is our legacy business that produces digital video imaging, storage products, disinfectant and related safety products for use in law enforcement, security and commercial applications. This segment includes both service and product revenues through our subscription models offering cloud and warranty solutions, and hardware sales for video and health safety solutions. The Revenue Cycle Management Segment provides working capital and back-office services to a variety of healthcare organizations throughout the country, as a monthly service fee. The Ticketing Segment acts as an intermediary between ticket buyers and sellers within our secondary ticketing platform, ticketsmarter.com, and we also acquire tickets from primary sellers to then sell through various platforms. The accounting guidance on Segment Reporting establishes standards for reporting information regarding operating segments in annual financial statements and requires selected information of those segments to be presented in financial statements. Such required segment information is included in Note 23.

 

Reverse Stock Split

On February 6, 2023, the Company filed a Certificate of Amendment to its Articles of Incorporation, as amended, with the Secretary of State of the State of Nevada to effect a 1-for-20 reverse stock split (the “Reverse Stock Split”) of the shares of its common stock. The Reverse Stock Split was effective as of time of filing. No fractional shares were issued in connection with the Reverse Stock Split. Any fractional shares of our Common Stock that would have otherwise resulted from the Reverse Stock Split were rounded up to the nearest whole number. In connection with the Reverse Stock Split, the board of directors of the Company approved appropriate and proportional adjustments to all outstanding securities or other rights convertible or exercisable into shares of the Company’s common stock, including, without limitation, all preferred stock, warrants, options, and other equity compensation rights. All historical share and per-share amounts reflected throughout the Company’s consolidated financial statements and other financial information in this Report have been adjusted to reflect the Reverse Stock Split as if the split occurred as of the earliest period presented. The par value per share of the Company’s common stock was not affected by the Reverse Stock Split.

F-9

The following is a summary of the Company’s Significant Accounting Policies:

Basis of Consolidation:Consolidation:

The accompanying financial statements include the consolidated accounts of Digital Ally, and its wholly-owned subsidiaries, Digital Ally International, Inc., Shield Products, LLC, Digital Ally Healthcare, LLC, TicketSmarter, Inc., Worldwide Reinsurance, Ltd., Digital Connect, Inc., BirdVu Jets, Inc., Kustom 440, Inc., and Shield Products,its majority-owned subsidiary Nobility Healthcare, LLC. All intercompany balances and transactions have been eliminated during consolidation.

The Company formed Digital Ally International, Inc. during August 2009 to facilitate the export sales of its products. The Company formed Shield Products, LLC in May 2020 to facilitate the sales of its Shield™ line of disinfectant/cleanser products and ThermoVu™ThermoVu® line of temperature monitoring equipment. The Company formed Nobility Healthcare, LLC (“Nobility Healthcare”) in June 2021 to facilitate the operations of its revenue cycle management solutions and back-office services for healthcare organizations. The Company formed TicketSmarter, Inc. upon its acquisition of Goody Tickets, LLC and TicketSmarter, LLC, to facilitate its global ticketing operations. The Company formed Worldwide Reinsurance Ltd., which is a captive insurance company domiciled in Bermuda. It will provide primarily liability insurance coverage to the Company for which insurance may not be currently available or economically feasible in today’s insurance marketplace. The Company formed Digital Connect, Inc. and BirdVu Jets, Inc. for travel and transportation purposes in 2022. The Company formed Kustom 440, Inc. in 2022 to create unique entertainment experiences directly for consumers.

Fair Value of Financial Instruments:Instruments:

The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and subordinated notes payable approximate fair value because of the short-term nature of these items. The Company accounts for its secured convertible debentures and proceeds investment agreement on a fair value basis.

Revenue Recognition:Recognition:

The Company applies the provisions of Accounting Standards Codification (ASC) 606-10, Revenue from Contracts with Customers, and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to its customers in an amount reflecting the consideration to which it expects to be entitled. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.

F-7

The Company has two different revenue streams, product and service, represented through its three segments. The Company reports all revenues on a gross basis, other than service revenues from the Company’s entertainment and revenue cycle management segments, Revenues generated by all segments are reported net of sales taxes.

Video Solutions

The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with the customer. In situation where sales are to a distributor, the Company had concluded its contracts are with the distributor as the Company holds a contract bearing enforceable rights and obligations only with the distributor. As part of part of its consideration for the contract, the Company evaluates certain factors including the customers’ ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it expects to be entitled. As the Company’s standard payment terms are less than one year, it has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. The product price as specified on the purchase order is considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Revenue is recognized when control of the product is transferred to the customer (i.e. when the Company’s performance obligations is satisfied), which typically occurs at shipment. Further in determining whether control has been transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Customers do not have a right to return the product other than for warranty reasons for which they would only receive repair services or replacement product.products. The Company has also elected the practical expedient under ASC 340-40-25-4 to expense commissions for product sales when incurred as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.

The Company sells its products and services to law enforcement and commercial customers in the following manner:

F-10
 Sales to domestic customers are made direct to the end customer (typically a law enforcement agency or a commercial customer) through its sales force, which is composed of its employees. Revenue is recorded when the product is shipped to the end customer.
Sales to international customers are made through independent distributors who purchase products from the Company at a wholesale price and sell to the end user (typically law enforcement agencies or a commercial customer) at a retail price. The distributor retains the margin as its compensation for its role in the transaction. The distributor generally maintains product inventory, customer receivables and all related risks and rewards of ownership. Accordingly, upon application of steps one through five above, revenue is recorded when the product is shipped to the distributor consistent with the terms of the distribution agreement.
Repair parts and services for domestic and international customers are generally handled by its inside customer service employees. Revenue is recognized upon shipment of the repair parts and acceptance of the service or materials by the end customer.

Sales taxes collected on products sold are excluded from revenues and are reported as accrued expenses in the accompanying balance sheets until payments are remitted.

Service and other revenue is comprised of revenues from extended warranties, repair services, cloud revenue and software revenue. Revenue is recognized upon shipment of the product and acceptance of the service or materials by the end customer for repair services. Revenue for extended warranty, cloud service or other software-based products is over the term of the contract warranty or service period. A time-elapsed method is used to measure progress because the Company transfers control evenly over the contractual period. Accordingly, the fixed consideration related to these revenues is generally recognized on a straight-line basis over the contract term, as long as the other revenue recognition criteria have been met.

F-8

Contracts with some of the Company’s customers contain multiple performance obligations that are distinct and accounted for separately. The transaction price is allocated to the separate performance obligations on a relative standalone selling price (“SSP”). The Company determined SSP for all the performance obligations using observable inputs, such as standalone sales and historical pricing. SSP is consistent with the Company’s overall pricing objectives, taking into consideration the type of service being provided. SSP also reflects the amount the Company would charge for the performance obligation if it were sold separately in a standalone sale. Multiple performance obligations consist of product, software, cloud subscriptions and extended warranties.

The Company’s multiple performance obligations may include future in-car or body-worn camera devices to be delivered at defined points within a multi-year contract, and in those arrangements, the Company allocates total arrangement consideration over the life of the multi-year contract to future deliverables using management’s best estimate of selling price.

Revenue Cycle Management

The Company reports revenue cycle management revenues on a net basis, as its primary source of revenue is its end-to-end service fees which is generally determined as a percentage of the invoice amounts collected. These service fees are reported as revenue monthly upon completion of the Company’s performance obligation to provide the agreed upon service.

Entertainment

The Company reports ticketing revenue on a gross or net basis based on management’s assessment of whether the Company is acting as a principal or agent in the transaction. The determination is based upon the evaluation of control over the event ticket, including the right to sell the ticket, prior to its transfer to the ticket buyer.

The Company sells tickets held in inventory, which consists of one performance obligation, being to transfer control of an event ticket to the buyer upon confirmation of the order. The Company acts as the principal in these transactions as the ticket is owned by the Company at the time of sale, therefore controlling the ticket prior to transferring to the customer. In these transactions, revenue is recorded on a gross basis based on the value of the ticket and is recognized when an order is confirmed. Payment is typically due upon delivery of the ticket.

The Company also acts as an intermediary between buyers and sellers through online secondary marketplace. Revenues derived from this marketplace primarily consist of service fees from ticketing operations, and consists of one primary performance obligation, which is facilitating the transaction between the buyer and seller, being satisfied at the time the order has been confirmed. As the Company does not control the ticket prior to the transfer, the Company acts as an agent in these transactions. Revenue is recognized on a net basis, net of the amount due to the seller when an order is confirmed, the seller is then obligated to deliver the tickets to the buyer per the seller’s listing. Payment is due at the time of sale.

 

F-11

Other

Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract and are reported separately as current liabilities and non-current liabilities in the Consolidated Balance Sheets. Such amounts consist of extended warranty contracts, prepaid cloud services and prepaid installation services and are generally recognized as the respective performance obligations are satisfied. During the year ended December 31, 2020,2022, the Company recognized revenue of $1.6$2.4 million related to its contract liabilities at January 1, 2020. Total contract liabilities consist of the following:liabilities. Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract and are reported separately as current liabilities and non-current liabilities in the Consolidated Balance Sheets. Such amounts consist of extended warranty contracts, prepaid cloud services and prepaid installation services and are generally recognized as the respective performance obligations are satisfied. Total contract liabilities consist of the following:

SCHEDULE OF CONTRACT LIABILITIES

 December 31, 2022 
 December 31, 2020  December 31, 2019  December 31, 2021 Additions/Reclass Recognized Revenue December 31, 2022 
Contract liabilities, current $1,647,469  $1,707,943  $1,665,519  $1,478,479  $989,124  $2,154,874 
Contract liabilities, non-current  1,848,869   1,803,143   2,687,786   4,560,600   1,430,304   5,818,082 
                        
Total contract liabilities $3,496,338  $3,511,086 
 $4,353,305  $6,039,079  $2,419,428  $7,972,956 

  December 31, 2021 
  December 31, 2020  Additions/Reclass  Recognized Revenue  December 31, 2021 
Contract liabilities, current $1,647,469  $696,936  $678,886  $1,665,519 
Contract liabilities, non-current  1,848,869   2,432,884   1,593,967   2,687,786 
                 
  $3,496,338  $3,129,820  $2,272,853  $4,353,305 

Sales returns and allowances aggregated $26,069$118,027 and $134,825$45,298 for the years ended December 31, 20202022 and 2019,2021, respectively. Obligations for estimated sales returns and allowances are recognized at the time of sales on an accrual basis. The accrual is determined based upon historical return rates adjusted for known changes in key variables affecting these return rates.

Revenues for the years ended December 31, 2020 and 2019 were derived from the following sources:

  Year ended December 31, 
  2020  2019 
DVM-800 $2,499,588  $3,756,544 
ThermoVU  1,466,306    
Shield disinfectants/sanitizers  176,918    
Repair and service  1,331,071   1,505,849 
FirstVu HD  1,383,822   1,264,457 
DVM-250 Plus  339,008   1,133,557 
Cloud service revenue  937,218   754,586 
VuLink  170,415   140,392 
EVO  931,889   287,012 
Accessories and other revenues  1,278,633   1,598,967 
  $10,514,868  $10,441,364 

F-9

Use of Estimates:Estimates:

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Management utilizes various other estimates, including but not limited to, determining the estimated lives of long-lived assets, determining the potential impairment of long-lived assets, the fair value of warrants, options, proceeds investment agreement and convertible debt, the recognition of revenue, inventory valuation reserve, fair value of assets and liabilities acquired in a business combination, incremental borrowing rate on leases, the valuation allowance for deferred tax assets and other legal claims and contingencies. The results of any changes in accounting estimates are reflected in the financial statements in the period in which the changes become evident. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the period that they are determined to be necessary.

Cash and cash equivalents:equivalents:

Cash and cash equivalents include funds on hand, in bank and short-term investments with original maturities of ninety (90) days or less.

Cash and cash equivalents that are restricted as to withdrawal or use under The following table shows the terms of the secured convertible debentures are presented as restricted cash separate fromCompany’s cash and cash equivalents onby significant investment category as of December 31, 2022 and 2021:

SCHEDULE OF SHORT TERM INVESTMENTS

  December 31, 2022 
  Adjusted
Cost
  Realized
Gains
  Realized
Losses
  Fair Value 
Demand deposits $897,745  $  $  $897,745 
Short-term investments with original maturities of 90 days or less (Level 1):                                  
Money market funds  2,634,454         2,634,454 
                 
  $3,532,199  $  $  $3,532,199 

F-12

  December 31, 2021 
  Adjusted
Cost
  Unrealized
Gains
  Unrealized
Losses
  Fair Value 
Demand deposits $5,031,246  $  $  $5,031,246 
Short-term investments with original maturities of 90 days or less (Level 1):                           
Money market funds  14,928,526         14,928,526 
Mutual funds  12,079,901      (31,881)  12,048,020 
                 
  $32,039,673  $  $(31,881) $32,007,792 

The Company maintains its cash and cash equivalents in banks insured by the accompanyingFederal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with numerous major financial institutions. At December 31, 2022 and 2021, the uninsured balance sheet.amounted to $2,495,189 and $29,836,142, respectively.

Accounts Receivable:Receivable:

Accounts receivable are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on a weekly basis. The Company determines the allowance for doubtful accounts by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history, and current economic conditions.

Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when received.

A trade receivable is considered to be past due if any portion of the receivable balance is outstanding for more than thirty (30) days beyond terms. No interest is charged on overdue trade receivables.

Inventories:Goodwill and Other Intangibles:

Inventories consistGoodwill - In connection with acquisitions, the Company applies the provisions of electronic parts, circuitry boards, camera parts and ancillary parts (collectively, “components”)ASC 805, Business Combinations, work-in-process and finished goods, and are carried atusing the loweracquisition method of cost or market, with cost determined by standard cost methods, which approximate the first-in, first-out method. Inventory costs include material, labor and manufacturing overhead. Service inventories that exceed the estimated requirements for the next 12 months based on recent usage levels are reported as other long-term assets. Management has established inventory reserves based on estimates ofaccounting. The excess and/or obsolete current and non-current inventory.

Manufacturing inventory is reviewed for obsolescence and excess quantities on a quarterly basis, based on estimated future use of quantities on hand, which is determined based on past usage, planned changes to products and known trends in markets and technology. Changes in support plans or technology could have a significant impact on obsolescence.

To support our world-wide service operations, we maintain service spare parts inventory, which consists of both consumable and repairable spare parts. Consumable service spare parts are used within our service business to replace worn or damaged parts in a system during a service call and are generally classified in current inventory as our stock of this inventory turns relatively quickly. However, if there has been no recent usage for a consumable service spare part, but the part is still necessary to support systems under service contracts, the part is considered to be non-current and included within non-current inventories within our consolidated balance sheet. Consumables are charged to cost of goods sold when issued during the service call.

F-10

As these service parts agepurchase price over the related product group’s post-production service life, we reduce the net carryingfair value of our repairable spare part inventory on the consolidated balance sheet to account for the excess that builds over the service life. The post-production service life of our systems is generally seven to twelve yearsnet tangible assets and at the end of twelve years, the carrying value for these parts in our consolidated balance sheet is reduced to zero. We also perform periodic monitoring of our installed base for premature end of service life events and expense, through cost of sales, the remaining net carrying value of any related spare parts inventory in the period incurred.

Furniture, fixtures and equipment:

Furniture, fixtures and equipment is stated at cost net of accumulated depreciation. Additions and improvements are capitalized while ordinary maintenance and repair expenditures are charged to expense as incurred. Depreciationidentifiable intangible assets acquired is recorded by the straight-line method over the estimated useful life of the asset, which ranges from three to ten years. Amortization expense on capitalized leases is includedas goodwill. In accordance with depreciation expense. The costASC 350, Intangibles - Goodwill and accumulated depreciation related to assets sold or retired are removed from the accounts and any gain or loss is credited or charged to income.

Intangible assets:

Intangible assets include deferred patent costs and license agreements. Legal expenses incurred in preparation of patent application have been deferred and will be amortized over the useful life of granted patents. Costs incurred in preparation of applications that are not granted will be charged to expense at that time. The Company has entered into several sublicense agreements under which it has been assigned the exclusive rights to certain licensed materials used in its products. These sublicense agreements generally require upfront payments to obtain the exclusive rights to such material. The Company capitalizes the upfront payments as intangible assets and amortizes such costs over their estimated useful life on a straight-line method.

Leases:

The Company determines if an arrangement contains a lease at inception. For arrangements whereOther, the Company is the lessee, the Company will evaluate whether to accountassesses goodwill for the lease as an operating or finance lease. Operating leases are included in the right of use assets (ROU) and operating lease liabilities on the consolidated balance sheetimpairment annually as of December 31, 2020. Finance leases wouldand more frequently if events and circumstances indicate that goodwill might be included in furniture, fixturesimpaired.

Goodwill impairment testing is performed at the reporting unit level. Goodwill is assigned to reporting units at the date the goodwill is initially recorded. Once goodwill has been assigned to reporting units, it no longer retains its association with a particular acquisition, and equipment, netall of the activities within a reporting unit, whether acquired or internally generated, are available to support the value of the goodwill.

Traditionally, goodwill impairment testing is a two-step process. Step one involves comparing the fair value of the reporting units to its carrying amount. If the carrying amount of a reporting unit is greater than zero and long-term debt and finance lease obligations onits fair value is greater than its carrying amount, there is no impairment. If the balance sheet.reporting unit’s carrying amount is greater than the fair value, the second step must be completed to measure the amount of impairment, if any. Step two involves calculating an implied fair value of goodwill. The Company hadhas adopted ASU 2017-04 which simplifies subsequent goodwill measurement by eliminating step two from the goodwill impairment test. As a result, the Company compares the fair value of a reporting unit with its respective carrying value and recognizes an impairment charge for the amount by which the carrying amount exceeded the reporting unit’s fair value.

F-13

The Company determines the fair value of its reporting units using the market approach. Under the market approach, we estimate the fair value based on multiples of comparable public companies and precedent transactions. Significant estimates in the market approach include: identifying similar companies with comparable business factors such as size, growth, profitability, risk and return on investment, and assessing comparable revenue and operating leasesincome multiples in estimating the fair value of the reporting unit.

Long-lived and Other Intangible Assets - The Company periodically assesses potential impairments of its long-lived assets in accordance with the provisions of ASC 360, Accounting for copiersthe Impairment or Disposal of Long-lived Assets. An impairment review is performed whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. The Company groups its assets at the lowest level for which identifiable cash flows are largely independent of the cash flows of the other assets and liabilities. The Company has determined that the lowest level for which identifiable cash flows are available is the operating segment level.

Factors considered by the Company include, but are not limited to, significant underperformance relative to historical or projected operating results; significant changes in the manner of use of the acquired assets or the strategy for the overall business; and significant negative industry or economic trends. When the carrying value of a long-lived asset may not be recoverable based upon the existence of one or more of the above indicators of impairment, the Company estimates the future undiscounted cash flows expected to result from the use of the asset and its officeeventual disposition. If the sum of the expected future undiscounted cash flows and warehouse space at December 31, 2020 but no financing leases.

ROU assets and lease liabilities are recognizedeventual disposition is less than the carrying amount of the asset, the Company recognizes an impairment loss. An impairment loss is reflected as the amount by which the carrying amount of the asset exceeds the fair value of the asset, based on the presentfair value of the future minimum lease payments over the lease term at commencement date.if available, or discounted cash flows, if fair value is not available. The Company usesassessed potential impairments of its incremental borrowing rate based on the information available at the commencement date in determining the operating lease liabilities if the operating lease does not provide an implicit rate. Lease terms may include the option to extend when Company is reasonably certainlong-lived assets as of December 31, 2022 and concluded that the option will be exercised. Lease expense for operating leases is recognized on a straight-line basis over the lease term.there was no impairment.

The Company elected to apply the short-term lease measurement and recognition exemption in which ROU assets and lease liabilities are not recognized for short term leases.

Secured convertible debentures:

The Company has elected to record its debentures at fair value. Accordingly, the debentures are marked-to-market at each reporting date with the change in fair value reported as a gain (loss) in the Consolidated Statement of Operations. All issuance costs related to the debentures were expensed as incurred in the Consolidated Statement of Operations.

F-11

Proceeds investment agreement:

The Company has elected to record its proceeds investment agreement at its fair value. Accordingly, the proceeds investment agreement will be marked-to-market at each reporting date with the change in fair value reported as a gain (loss) in the Consolidated Statement of Operations. All issuance costs related to the proceeds investment agreement were expensed as incurred in the Consolidated Statement of Operations.

Senior Convertible Notes:

The Company has elected to record its senior convertible notes at its fair value. Accordingly, the senior convertible notes will be marked-to-market at each reporting date with the change in fair value reported as a gain (loss) in the Consolidated Statement of Operations. All issuance costs related to the senior convertible notes were expensed as incurred in the Consolidated Statement of Operations.

Long-Lived Assets:

Long-lived assets such as furniture, fixturesproperty, plant and equipment and purchased intangible assets subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If the carrying value of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques, including discounted cash flow models, quoted market values and third-party appraisals, as considered necessary.

Warranties:Intangible assets include deferred patent costs and license agreements. Legal expenses incurred in preparation of patent application have been deferred and will be amortized over the useful life of granted patents. Costs incurred in preparation of applications that are not granted will be charged to expense at that time. The Company has entered into several sublicense agreements under which it has been assigned the exclusive rights to certain licensed materials used in its products. These sublicense agreements generally require upfront payments to obtain the exclusive rights to such material. The Company capitalizes the upfront payments as intangible assets and amortizes such costs over their estimated useful life on a straight-line method.

Inventories:

Inventories for the video solutions segment consist of electronic parts, circuitry boards, camera parts and ancillary parts (collectively, “components”), work-in-process and finished goods. Finished goods that are manufactured and assembled by the Company are carried at the lower of cost or net realizable value, with cost determined by standard cost methods, which approximate the first-in, first-out method. Inventory costs include material, labor and manufacturing overhead. Inventories for the entertainment segment consists of tickets to live events purchased, which are held at lower of cost or net realizable value, and written-off after the event has occurred. Event tickets for the entertainment segment are carried at lower of cost or net realizable value, and fully written off at the time the event occurs if the ticket is unsold and remaining in inventory after the completion of the event. Management has established inventory reserves based on estimates of excess and/or obsolete current inventory.

Manufacturing inventory for the video solutions segment is reviewed for obsolescence and excess quantities on a quarterly basis, based on estimated future use of quantities on hand, which is determined based on past usage, planned changes to products and known trends in markets and technology. Changes in support plans or technology could have a significant impact on obsolescence.

To support our world-wide service operations for the video solutions segment, we maintain service spare parts inventory, which consists of both consumable and repairable spare parts. Consumable service spare parts are used within our service business to replace worn or damaged parts in a system during a service call and are generally classified in current inventory as our stock of this inventory turns relatively quickly. However, if there has been no recent usage for a consumable service spare part, but the part is still necessary to support systems under service contracts, the part is considered to be non-current and included within non-current inventories within our consolidated balance sheet. Consumables are charged to cost of goods sold when issued during the service call.

F-14

As these service parts age over the related product group’s post-production service life, we reduce the net carrying value of our repairable spare part inventory on the consolidated balance sheet to account for the excess that builds over the service life. The post-production service life of our systems is generally seven to twelve years and, at the end of twelve years, the carrying value for these parts in our consolidated balance sheet is reduced to zero. We also perform periodic monitoring of our installed base for premature end of service life events and expense, through cost of sales, the remaining net carrying value of any related spare parts inventory in the period incurred.

Property, plant and equipment:

Property, plant and equipment is stated at cost net of accumulated depreciation. Additions and improvements are capitalized while ordinary maintenance and repair expenditures are charged to expense as incurred. Depreciation is recorded by the straight-line method over the estimated useful life of the asset, which ranges from three to thirty years, other than the infinite useful life of land. Amortization expense on capitalized leases is included with depreciation expense. The cost and accumulated depreciation related to assets sold or retired are removed from the accounts and any gain or loss is credited or charged to income.

Leases:

The Company determines if an arrangement contains a lease at inception. For arrangements where the Company is the lessee, the Company will evaluate whether to account for the lease as an operating or finance lease. Operating leases are included in the right of use assets (ROU) and operating lease liabilities on the consolidated balance sheet as of December 31, 2022. Finance leases would be included in property, plant and equipment, net and long-term debt and finance lease obligations on the balance sheet. The Company had operating leases for copiers and its office and warehouse space at December 31, 2022 but no financing leases.

ROU assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. The Company uses its incremental borrowing rate based on the information available at the commencement date in determining the operating lease liabilities if the operating lease does not provide an implicit rate. Lease terms may include the option to extend when Company is reasonably certain that the option will be exercised. Lease expense for operating leases is recognized on a straight-line basis over the lease term.

The Company elected to apply the short-term lease measurement and recognition exemption in which ROU assets and lease liabilities are not recognized for short term leases.

Warranties:

The Company’s video solutions segment products carry explicit product warranties that extend up to two years from the date of shipment. The Company records a provision for estimated warranty costs based upon historical warranty loss experience and periodically adjusts these provisions to reflect actual experience. Accrued warranty costs are included in accrued expenses. Extended warranties are offered on selected products and when a customer purchases an extended warranty the associated proceeds are treated as contract liabilities and recognized over the term of the extended warranty.

F-15

Shipping and Handling Costs:Costs:

Shipping and handling costs video solutions segment for outbound sales orders totaled $74,721$70,749 and $65,312$79,763 for the years ended December 31, 20202022 and 2019,2021, respectively. Such costs are included in selling, general and administrative expenses in the Consolidated Statements of Operations.

Advertising Costs:Costs:

Advertising expense video solutions segment and entertainment segments includes costs related to trade shows and conventions, promotional material and supplies, and media costs. Advertising costs are expensed in the period in which they are incurred. The Company incurred total advertising expenseexpenses of approximately $990,975$7,668,641 and $1,019,707$4,110,032 for the years ended December 31, 20202022 and 2019,2021, respectively. Such costs are included in selling, advertising and promotional expenses in the Consolidated Statements of Operations.

Income Taxes:Taxes:

Deferred taxes are provided for by the liability method in which deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

F-12

The Company applies the provisions of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) No. 740 - Income Taxes that provides a framework for accounting for uncertainty in income taxes and provided a comprehensive model to recognize, measure, present, and disclose in its financial statements uncertain tax positions taken or expected to be taken on a tax return. It initially recognizes tax positions in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions are initially and subsequently measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and all relevant facts. Application requires numerous estimates based on available information. The Company considers many factors when evaluating and estimating its tax positions and tax benefits, and it recognized tax positions and tax benefits may not accurately anticipate actual outcomes. As it obtains additional information, the Company may need to periodically adjust its recognized tax positions and tax benefits. These periodic adjustments may have a material impact on its Consolidated Statements of Operations.

The Company’s policy is to record estimated interest and penalties related to the underpayment of income taxes as income tax expense in the Consolidated Statements of Operations. There was no interest expense related to the underpayment of estimated taxes during the years ended December 31, 20202022 and 2019.2021. There were no penalties in 20202022 and 2019.2021.

The Company is subject to taxation in the United States and various states. As of December 31, 2020,2022, the Company’s tax returns filed for 2017, 2018,2019, 2020 and 20192021 and to be filed for 20202022 are subject to examination by the relevant taxing authorities. With a few exceptions, as of December 31, 2020,2022, the Company is no longer subject to Federal, state, or local examinations by tax authorities for taxable years before 2017.prior to 2019.

Research and Development Expenses:Expenses:

The Company expenses all research and development costs as incurred.incurred, which is generally incurred by the video solutions segment. Development costs of computer software to be sold, leased, or otherwise marketed are subject to capitalization beginning when a product’s technological feasibility has been established and ending when a product is available for general release to customers. In most instances, the Company’s products are released soon after technological feasibility has been established. Costs incurred subsequent to achievement of technological feasibility were not significant, and software development costs were expensed as incurred during 20202022 and 2019.2021.

F-16

Warrant Derivative Liabilities:

In accordance with FASB ASC 815-40, Derivatives and Hedging: Contracts in an Entities Own Equity, entities must consider whether to classify contracts that may be settled in its own stock, such as warrants to purchase shares of Common Stock, Purchase Warrants:

The Company hasas equity of the entity or as an asset or liability. If an event that is not within the entity’s control could require net cash settlement, then the contract should be classified as an asset or a liability rather than as equity. We have determined because the terms of the warrants issued during the first quarter of 2021, and remain outstanding, include a provision that entitles all the warrant holders to receive cash for their warrants in the event of a qualifying cash tender offer, while only certain of the holders of the underlying shares of common stock purchasewould be entitled to cash, our warrants outstanding that are accounted forshould be classified as equity based on their relativeliability measured at fair value, with changes in fair value each period reported in earnings. Volatility in the price of our common stock may result in significant changes in the value of the derivatives and are not subject to re-measurement.resulting gains and losses on our statement of operations.

Stock-Based Compensation:Compensation:

The Company grants stock-based compensation to its employees, board of directors and certain third-party contractors. Share-based compensation arrangements may include the issuance of options to purchase common stock in the future or the issuance of restricted stock, which generally are subject to vesting requirements. The Company records stock-based compensation expense for all stock-based compensation granted based on the grant-date fair value. The Company recognizes these compensation costs on a straight-line basis over the requisite service period of the award.

The Company estimates the grant-date fair value of stock-based compensation using the Black-Scholes valuation model. Assumptions used to estimate compensation expense are determined as follows:

Expected term is determined using the contractual term and vesting period of the award;
Expected volatility of award grants made in the Company’s plan is measured using the weighted average of historical daily changes in the market price of the Company’s common stock over the period equal to the expected term of the award;
Expected dividend rate is determined based on expected dividends to be declared;
Risk-free interest rate is equivalent to the implied yield on zero-coupon U.S. Treasury bonds with a maturity equal to the expected term of the awards; and
Forfeitures are accounted for as they occur.

F-13

SegmentsSegment Reporting

The accounting guidance on Segment Reporting establishes standards for reporting information regarding operating segments in annual financial statements and requires selected information of Business:

those segments to be presented in financial statements. Operating segments are identified as components of an enterprise for which separate discrete financial information is available for evaluation by the chief operating decision maker (the Company’s Chief Executive Officer or “CODM”) in making decisions on how to allocate resources and assess performance. The CompanyCompany’s three operating segments are Video Solutions, Revenue Cycle Management, and Entertainment, each of which has determinedspecific personnel responsible for that business and reports to the CODM. Corporate expenses capture the Company’s corporate administrative activities, is also to be reported in the segment information. Therefore, its operations are comprisedeliminated in consolidation and is not considered a separate business segment for financial reporting purposes.

Contingent Consideration

In circumstances where an acquisition involves a contingent consideration arrangement that meets the definition of one reportable segment:a liability under the saleFinancial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity, the Company recognizes a liability equal to the fair value of digital audiothe contingent payments the Company expects to make as of the acquisition date. The Company remeasures this liability each reporting period and video recordingrecords changes in the fair value through the consolidated statement of operations.

F-17

Repurchase and speed detection devices. ForCancellation of Shares

From time to time, the Company’s Board of Directors (the “Board”) may authorize share repurchases of common stock. Shares repurchased under Board authorizations are held in treasury for general corporate purposes and cancelled when it is determined appropriate by management. The Company accounts for repurchases of common stock under the cost method. Shares repurchased and cancelled during the period were recorded as a reduction to stockholders’ equity. See further discussion of the Company’s share repurchase program in Note 18–Stockholders’ Equity.

Non-Controlling Interests

Non-controlling interests in the Company’s Consolidated Financial Statements represent the interest in subsidiaries held by venture partners. The venture partners hold noncontrolling interests in the Company’s consolidated subsidiary Nobility Healthcare, LLC. Since the Company consolidates the financial statements of all wholly-owned and majority owned subsidiaries, the noncontrolling owners’ share of each subsidiary’s results of operations are deducted and reported as net income attributable to noncontrolling interest in the Consolidated Statements of Operations.

Redeemable Preferred Stock

Preferred stock may be classified as a liability, temporary equity (i.e., mezzanine equity) or permanent equity. In order to determine the appropriate classification, an evaluation of the cash redemption features is required.  Where there exists an absolute right of redemption presently or in the future, the preferred stock would be classified as a liability. If redemption is contingently redeemable upon the occurrence of an event that is outside of the issuer’s control, it should be classified as mezzanine equity. The probability that the redemption event will occur is irrelevant. If no redemption features exist, or if a contingent redemption feature is within the Company’s control, the preferred stock would be considered equity.

Lease Receivable

Lease receivable are carried at the original invoice amount less the total payments received pertaining to each individual customer’s lease agreement. These agreements range from three to five years and are removed from lease receivables upon termination of the agreement. The Company determines if an allowance for doubtful accounts by regularly evaluating individual customer lease receivables and considering a customer’s financial condition, credit history, and current economic conditions. No allowance was deemed necessary for the year ended December 31, 2020 and 2019, sales by geographic area were as follows:

  Year ended December 31, 
  2020  2019 
Sales by geographic area:        
United States of America $10,425,494  $10,251,259 
Foreign  89,374   190,105 
  $10,514,868  $10,441,364 

Sales to customers outside of the United States are denominated in U.S. dollars. All Company assets are physically located within the United States.2022.

 

Reclassification of Prior Year PresentationNotes Receivable

 

Certain prior year amounts have been reclassifiedNotes receivable are carried at the original note amount less an estimate made for consistencydoubtful receivables based on a review of all outstanding notes on a quarterly basis. The Company determines the allowance for doubtful accounts by regularly evaluating each note receivable and considering the borrower’s financial condition, credit history, and current economic conditions. The Company entered into a promissory note, through its entertainment segment, as part of a co-marketing agreement, with the current year presentation. These reclassifications had no effecta principal amount of $3,000,000. Principal payment, since its inception, on the reported resultsthis promissory note totaled $1,401,660 as of operations.December 31, 2022, resulting in a remaining balance of $1,598,340 maturing December 31, 2023.

New Accounting Standards

In 2020, FASB issued ASU No. 2020-06 to simplify the accounting for convertible debt instruments as the current accounting guidance was determined to be unnecessarily complex and difficult to navigate. The ASU primarily does three things: (1) The ASU eliminates the beneficial conversion feature model and the cash conversion model. The elimination of these models will result in more convertible instruments (convertible debt instruments or convertible preferred stock instruments) being reported as a single liability instrument. The ASU also makes targeted improvements to the related disclosures, (2) The ASU eliminates certain settlement conditions that are required to qualify for derivative scope exception which will allow for less equity contracts to be accounted for as a derivative and (3) The ASU aligns the diluted EPS calculation for convertible instruments by requiring the use of the if-converted method and requiring share settlement be included in the calculation when the contract includes an option of cash or share settlement. ASU No. 2020-06 is effective for fiscal years beginning after December 15, 2021 with early adoption permitted for fiscal years beginning after December 15, 2020. Based on a preliminary analysis,The Company adopted this update for the Company does not expect the adoption of this new accounting standard will have a significant impactquarter ended March 31, 2021, with no material effect on the Company’s financial position and results of operations.financials.

In 2020, FASB issued ASU No. 2020-01 which represents a consensus of the Emerging Issues Task Force and it clarifies certain items related to ASU 2016-01, Financial Instruments—Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The ASU (1) clarifies that when an entity is either applying the equity method or upon discontinuing the equity method it should consider observable price changes in orderly transactions for the identical or a similar investment with the same issuer for valuing basis of the investment and (2) clarifies that when determining the accounting for certain forward contracts and purchased options an entity should not consider, whether upon settlement or exercise, if the underlying securities would be accounted for under the equity method or fair value option. ASU No. 2020-01 is effective for fiscal years beginning after December 15, 2020 with early adoption permitted. Based on a preliminary analysis,The Company adopted this update for the Company does not expect the adoption of this new accounting standard will have a significant impactquarter ended March 31, 2021, with no material effect on the Company’s financial position and results of operations.financials.

F-14

In December 2019, the FASB issued ASU No. 2019-12, Income Taxes - simplifying the accounting for income taxes (Topic 740), which is meant to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740, Income Taxes. The amendment also improves consistent application and simplifies GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The adoption of this standard did not have a significant impact on the Company’s financial position and results of operations.

F-18

 

In February 2016, the FASB issued Accounting Standard Update (“ASU”) 2016-02, Leases (“Topic 842”). The guidance requires lessees to put most leases on their balance sheets but recognize expenses on their income statements in a manner similar to today’s accounting. Lessees initially recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term. The lease liability is measured at the present value of the lease payments over the lease term. The right-of-use asset is measured at the lease liability amount, adjusted for lease prepayments, lease incentives received and the lessee’s initial direct costs. The standard is effective for public business entities for annual reporting periods beginning after December 15, 2018, and interim periods within that reporting period, which is the first quarter of 2019 for the Company.

The Company adopted the new guidance on January 1, 2019 using the optional transitional method and elected to use the package of three practical expedients which allows the Company not to reassess whether contracts are or contain leases, lease classification and whether initial direct costs qualify for capitalization. The Company has completed its assessment of the impact of the standard and determined that the only lease that the Company held was an operating lease for its office and warehouse space. Upon adoption of the standard, the Company recorded Right of Use (ROU) assets of approximately $501,000 and lease liabilities of approximately $582,000 related to it office and warehouse space operating leases. The Company also removed deferred rent of approximately $81,000 when adopting the new guidance.

For financial liabilities measured using the fair value option in ASC 825, ASU 2016-01, Financial Instruments — Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, issued in January 2016, requires entities to recognize the changes in fair value of liabilities caused by a change in instrument specific credit risk (own credit risk) in other comprehensive income. The ASU is effective for calendar-year public business entities beginning in 2018. For all other calendar-year entities, it is effective for annual periods beginning in 2019 and interim periods beginning in 2020. Entities can early adopt certain provisions of the new standard, including this provision related to financial liabilities measured under the fair value option. We have considered this guidance and its impact on this debt accounted for at fair value. Based on discussions with our valuation expert and knowledge of the Company there was no change in valuation caused by a change in the Company’s credit risk during the period ending December 31, 2020.

ASU 2018-09, Codification improvements, clarifies the accounting for a debt extinguishment when the fair value option is elected. Upon extinguishment an entity shall include in net income the cumulative amount of the gain or loss previously recorded in other comprehensive income for the extinguished debt that resulted from changes in instrument-specific credit risk. The ASU is effective for calendar-year public business entities beginning in 2019. For all other calendar-year entities, it is effective for annual periods beginning in 2020 and interim periods beginning in 2021. Early adoption is permitted for any fiscal year or interim period for which an entity’s financial statements have not yet been issued or have not been made available to be issued. We have considered this guidance and its impact on this debt accounted for at fair value. Based on discussions with our valuation expert and knowledge of the Company there was no change in valuation caused by a change in the Company’s credit risk during the period ending December 31, 2020. Since there is no change accounted for as a change in Credit Risk (included in other comprehensive income/loss) there is no impact to the Company’s financial statements from this new guidance.

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments – Credit Losses” to improve information on credit losses for financial assets and net investment in leases that are not accounted for at fair value through net income. ASU 2016-13 replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses. In April 2019 and May 2019, the FASB issued ASU No. 2019-04, “Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments” and ASU No. 2019-05, “Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief” which provided additional implementation guidance on the previously issued ASU. In November 2019, the FASB issued ASU 2019-10, “Financial Instruments - Credit Loss (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842),” which defers the effective date for public filers that are considered small reporting companies (“SRC”) as defined by the Securities and Exchange Commission to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Since the Company is an SRC, implementation is not needed until January 1, 2023. The Company will continue to evaluate the effect of adopting ASU 2016-13 will have on the Company’s consolidated financial statements.

Going Concern Matters and Management’s Plans

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company incurred substantial operating losses in the years ended December 31, 2022 and December 31, 2021 primarily due to reduced gross margins caused by a combination of competitors’ introduction of newer products with more advanced features together with significant price cutting of their products and the recent acquisitions with much smaller margins than the video solutions segment, historically. The Company incurred operating losses of approximately $29.7 million for the year ended December 31, 2022 and $14.8 million during the year ended December 31, 2021 and it had an accumulated deficit of $92.0 million as of December 31, 2022. In recent years the Company has accessed the public and private capital markets to raise funding through the issuance of debt and equity. In that regard, the Company raised approximately $66.6 million in the year ended December 31, 2021 through two underwritten public offerings. These equity raises were utilized to fund its operations and acquisitions. Management expects to continue this pattern until it achieves positive cash flows from operations, although it can offer no assurance in this regard.

The Company will have to restore positive operating cash flows and profitability over the next year and/or raise additional capital to fund its operational plans, meet its customary payment obligations and otherwise execute its business plan. There can be no assurance that it will be successful in restoring positive cash flows and profitability, or that it can raise additional financing when needed, and obtain it on terms acceptable or favorable to the Company.

The Company has increased its contract liabilities to nearly $8.0 million as of December 31, 2022, which results in recurring revenue during the period of 2023 to 2026. The Company believes that its quality control and cost cutting initiatives, expansion to non-law enforcement sales channels and new product introduction will eventually restore positive operating cash flows and profitability, although it can offer no assurances in this regard.

The Company has significantly cut costs in its entertainment segment through the removal of several large partnerships and sponsorships. These were not yielding the results management expected; thus, it is not expected that these costs with significantly hinder total revenues in 2023 and beyond.

In addition to the initiatives described above, the Board of Directors is conducting a review of a full range of strategic alternatives to best position the Company for the future including, but not limited to, the sale of all or certain assets, properties or groups of properties or individual businesses or merger or combination with another company. The result of this review may also include the continued implementation of the Company’s business plan. There can be no assurance that any additional transactions or financings will result from this process.

Based on the uncertainties described above, the Company believes its business plan does not alleviate the existence of substantial doubt about its ability to continue as a going concern within one year from the date of the issuance of these consolidated financial statements. The accompanying consolidated financial statements do not include any adjustments related to the recoverability and classification of asset amounts or the classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

F-15F-19

In August 2018, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement, to improve the effectiveness of disclosures. The amendments remove, modify, and add certain disclosure requirements in Topic 820, “Fair Value Measurement.” The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The amendments are effective for fiscal years beginning after December 15, 2019. Early adoption is permitted, including adoption in an interim period. Furthermore, an entity is permitted to early adopt any removed or modified disclosures upon issuance of the update and delay adoption of the additional disclosures until their effective date. The Company is currently evaluating the effects the adoption of ASU 2018-13 will have on the disclosures.

In August 2018, the FASB issued ASU No. 2018-15, Intangible-Goodwill and Other Internal-Use Software (Subtopic 350-40), or ASU 2018-15. ASU 2018-15 updates guidance regarding accounting for implementation costs associated with a cloud computing arrangement that is a service contract. The amendments under ASU 2018-15 are effective for interim and annual fiscal periods beginning after December 15, 2019, with early adoption permitted. The Company does not expect the adoption of ASU 2018-15 to have a material impact on its financial statements.

In December 2019, the FASB issued ASU No. 2019-12, Income Taxes - simplifying the accounting for income taxes (Topic 740), which is meant to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740, Income Taxes. The amendment also improves consistent application and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. We do not expect the adoption of this standard to have a significant impact on our financial position and results of operations.

NOTE 2. CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS

Financial instruments that potentially subject the Company to concentrations of credit risk consist of accounts receivable. Sales to domestic customers are typically made on credit and the Company generally does not require collateral while sales to international customers require payment before shipment or backing by an irrevocable letter or credit. The Company performs ongoing credit evaluations of its customers’ financial condition and maintains an allowance for estimated losses. Accounts are written off when deemed uncollectible and accounts receivable are presented net of an allowance for doubtful accounts. The allowance for doubtful accounts totaled $123,224$152,736 as of December 31, 20202022 and $123,224$113,234 as of December 31, 2019.2021.

The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000$250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. At December 31, 20202022 and 2019,2021, the uninsured balance amounted to $3,653,192$2,495,189 and $-0-$29,836,142, respectively. The Company uses primarily a network of unaffiliated distributors for international sales and an employee-based direct sales force for domestic sales. No international distributor individually exceeded 10% of total revenues and norevenues. No one individual customer receivable balance exceeded 10% of total accounts receivable for the years endedas of December 31, 2020 and 2019.2022.

The CompanyCompany’s video solutions segment purchases finished circuit boards and other proprietary component parts from suppliers located in the United States and on a limited basis from Asia. Although the Company obtains certain of these components from single source suppliers, it generally owns all tooling and management has located alternative suppliers to reduce the risk in most cases to supplier problems that could result in significant production delays. The Company has not historically experienced significant supply disruptions from any of its principal vendors and does not anticipate future supply disruptions. The Company acquires most of its components on a purchase order basis and does not have long-term contracts with its suppliers.

F-16

NOTE 3. ACCOUNTS RECEIVABLE – ALLOWANCE FOR DOUBTFUL ACCOUNTS

The allowance for doubtful accounts receivable was comprised of the following for the years ended December 31, 20202022 and 2019:2021:

SCHEDULE OF ALLOWANCE FOR DOUBTFUL ACCOUNTS

 December 31, 2020  December 31, 2019  December 31, 2022 December 31, 2021 
Beginning balance $123,224  $70,000  $113,234  $123,224 
Provision for bad debts  

   60,000   126,018   7,154 
Charge-offs to allowance, net of recoveries     (6,776)  (86,516)  (17,144)
Ending balance $123,224  $123,224  $152,736  $113,234 

NOTE 4. INVENTORIESOTHER RECEIVABLES

Other receivables were the following at December 31, 2022 and December 31, 2021:

SCHEDULE OF OTHER RECEIVABLES

  December 31,
2022
  December 31,
2021
 
Notes receivable $1,598,340  $470,000 
Lease receivable  2,339,799   1,376,518 
Other  138,383   175,295 
Total other assets $4,076,522  $2,021,813 

Notes receivable increased by over $1.1 million at December 31, 2022 compared to December 31, 2021, primarily due to a note receivable issued by the Company during 2022. The Company entered into a promissory note, through its entertainment segment, as part of a co-marketing agreement, with a principal amount of $3,000,000. Principal payment, since its inception, on this promissory note totaled $1,401,660 as of December 31, 2022, resulting in a remaining balance of $1,598,340 maturing December 31, 2023. Lease receivable increased by nearly $1.0 million primarily due to increased sales under the Company’s subscription model during 2022. The Company determines if an allowance for doubtful accounts by regularly evaluating notes receivable and individual customer lease receivables, by considering a customer’s financial condition, credit history, and current economic conditions. No allowance was deemed necessary for the year ended December 31, 2022. Other receivables relate to a related party receivable further described in Note 19.

NOTE 5. INVENTORIES

Inventories consisted of the following at December 31, 20202022 and 2019:2021:

SCHEDULE OF INVENTORIES

  December 31, 2020  December 31, 2019 
Raw material and component parts $3,186,426  $4,481,611 
Work-in-process  1,907   35,858 
Finished goods  6,974,291   4,906,956 
Subtotal  10,162,625   9,424,425 
Reserve for excess and obsolete inventory  (1,960,351)  (4,144,013)
Total inventories $8,202,274  $5,280,412 
  December 31, 2022  December 31, 2021 
Raw material and component parts– video solutions segment $4,509,165  $3,062,046 
Work-in-process– video solutions segment  3,164    
Finished goods – video solutions segment  6,846,091   8,410,307 
Finished goods – entertainment segment  970,527   2,102,272 
Subtotal  12,328,947   13,574,625 
Reserve for excess and obsolete inventory– video solutions segment  (5,230,261)  (3,353,458)
Reserve for excess and obsolete inventory – entertainment segment  (259,280)  (561,631)
Total inventories $6,839,406  $9,659,536 

Finished goods inventory includes units held by potential customers and sales agents for test and evaluation purposes. The cost of such units totaled $138,263$171,071 and $80,711$153,976 as of December 31, 20202022 and 2019,2021, respectively.

F-20

NOTE 5. FURNITURE, FIXTURES6. PREPAID EXPENSES

Prepaid expenses were the following at December 31, 2022 and 2021:

SCHEDULE OF PREPAID EXPENSE

  December 31,
2022
  December 31,
2021
 
Prepaid inventory $6,110,321  $6,546,100 
Prepaid advertising  1,931,628   2,455,527 
Other  424,464   727,155 
Total prepaid expenses $8,466,413  $9,728,782 

Prepaid expenses decreased by nearly $1.3 million primarily due to a decline in prepaid inventory purchases and advertising expenses in 2022.

NOTE 7. PROPERTY, PLANT AND EQUIPMENT

Furniture, fixturesProperty, plant and equipment consisted of the following at December 31, 20202022 and 2019:2021:

SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT

 Estimated Useful Life December 31, 2020  December 31, 2019  Estimated
Useful Life
 December 31,
2022
 December 31,
2021
 
Building 30 years $422,441  $  25 years $4,537,037  $4,909,478 
Office furniture, fixtures and equipment 3-10 years  232,472   397,795 
Land Infinite  739,734   789,734 
Office furniture, fixtures, equipment, and aircraft 3-20 years  2,048,169   493,652 
Warehouse and production equipment 3-5 years  96,415   210,700  3-7 years  51,302   65,948 
Demonstration and tradeshow equipment 2-5 years  107,241   252,001  3-7 years  72,341   82,337 
Leasehold improvements 2-5 years  289,865   163,170 
Building improvements 5-7 years  1,334,374   911,940 
Rental equipment 1-3 years  71,548   93,923  1-3 years     8,584 
Total cost  1,219,983   1,117,591     8,782,957   7,261,673 
Less: accumulated depreciation and amortization  (553,183)  (920,528)    (884,271)  (420,647)
                  
Net furniture, fixtures and equipment $666,800  $197,063 
Net property, plant and equipment   $7,898,686  $6,841,026 

Depreciation and amortization of furniture, fixturesproperty, plant and equipment aggregated $62,048$614,121 and $254,491$258,999 for the years ended December 31, 20202022 and 2019,2021, respectively. The cost and accumulated depreciation related to assets sold or retired are removed from the accounts and any gain or loss is credited or charged to income. The Company retired fixed assets during 20202022 totaling $519,468,$549,104 resulting in a gain on sale of assets of $212,831 for the year ended December 31, 2022 on the Company’s Consolidated Statement of Operations. The Company retired fixed assets during 2021 totaling $391,535 all of which were fully depreciated resulting in no gain or loss for the year ended December 31, 2020.2021.

F-17F-21

NOTE 6.8. GOODWILL AND OTHER INTANGIBLE ASSETS

Intangible assets consisted of the following at December 31, 20202022 and 2019:2021:

SCHEDULE OF INTANGIBLE ASSETS

  December 31, 2020  December 31, 2019 
  Gross value  Accumulated amortization  Net carrying value  Gross value  Accumulated amortization  Net carrying value 
Amortized intangible assets:                        
Licenses $104,099  $52,872  $51,227  $73,893  $41,785  $32,108 
Patents and Trademarks  264,490   135,236   129,254   542,420   326,220   216,200 
                         
   368,589   188,108   180,481   616,313   368,005   248,308 
                         
Unamortized intangible assets:                        
Patents and trademarks pending  212,083      212,083   164,960      164,960 
                         
Total $580,672  $188,108  $392,564  $781,273  $368,005  $413,268 
  December 31, 2022  December 31, 2021 
  Gross
value
  Accumulated
amortization
  Net
carrying
value
  Gross
value
  Accumulated
amortization
  Net
carrying
value
 
Amortized intangible assets:                        
Licenses (video solutions segment) $211,183  $80,378  $130,805  $194,286  $65,578  $128,708 
Patents and trademarks (video solutions segment)  472,077   305,021   167,056   493,945   233,471   260,474 
Sponsorship agreement network (entertainment segment)  5,600,000   1,493,333   4,106,667   5,600,000   373,333   5,226,667 
SEO content (entertainment segment)  600,000   200,000   400,000   600,000   50,000   550,000 
Personal seat licenses (entertainment
segment)
  180,081   8,001   172,080   201,931   2,244   199,687 
Client agreements (revenue cycle management segments)  999,034   126,864   872,170          
                         
   8,062,375   2,213,597   5,848,778   7,090,162   724,626   6,365,536 
                         
Indefinite life intangible assets:                        
Goodwill (entertainment and revenue cycle management segments)  11,367,514      11,367,514   9,931,547      9,931,547 
Trade name (entertainment segment)  600,000      600,000   600,000      600,000 
Patents and trademarks pending
(video solutions segment)
  56,678      56,678   5,430      5,430 
                         
Total $20,086,567  $2,213,597  $17,872,970  $17,627,139  $724,626  $16,902,513 

Patents and trademarks pending will be amortized beginning at the time they are issued by the appropriate authorities. If issuance of the final patent or trademark is denied, then the amount deferred will be immediately charged to expense.

Amortization expense for the years ended December 31, 20202022 and 20192021 was $188,108$1,562,558 and $135,660,$563,490, respectively. Estimated amortization for intangible assets with definite lives for the next five years ending December 31, 2022, and thereafter is as follows:

SCHEDULE OF ESTIMATED AMORTIZATION FOR INTANGIBLE ASSETS

Year ending December 31:      
2021 $89,478 
2022  63,909 
2023  1,950  $1,486,473 
2024  1,510   1,435,915 
2025 and thereafter  23,634 
 $180,481 
2025  1,343,420 
2026  859,438 
2027 and thereafter  723,532 
Total $5,848,778 

F-22

NOTE 9. OTHER ASSETS

Other assets were the following at December 31, 2022 and December 31, 2021:

SCHEDULE OF OTHER ASSETS

  December 31,
2022
  December 31,
2021
 
Lease receivable $4,700,923  $1,921,021 
Sponsorship network  116,828   30,752 
Other  337,930   155,526 
Total other assets $5,155,681  $2,107,299 

 

NOTE 7. 10. DEBT OBLIGATIONS

Debt obligations is comprised of the following:

SUMMARY OF DEBT OBLIGATIONS

 December 31, 2020  December 31, 2019  December 31,
2022
 December 31,
2021
 
Economic injury disaster loan (EIDL) $150,000  $  $150,000  $150,000 
Payroll protection program loan (PPP)  10,000    
2019 Secured convertible notes, at fair value     1,593,809 
2018 Proceeds investment agreement, at fair value     6,500,000 
Unsecured promissory note payable, less unamortized discount of $-0- and $66,061 at December 31, 2020 and 2019, respectively     233,939 
Contingent consideration promissory note – Nobility Healthcare Division Acquisition  388,955   317,212 
Contingent consideration promissory note – Nobility Healthcare Division Acquisition  176,456   650,000 
Contingent consideration promissory note – Nobility Healthcare Division Acquisition  208,083    
Contingent consideration promissory note – Nobility Healthcare Division Acquisition  4,346    
Debt obligations  160,000   8,327,748   927,840   1,117,212 
Less: current maturities of debt obligations  11,727   1,827,748   485,373   389,934 
Debt obligations, long-term $148,273  $6,500,000  $442,467  $727,278 

F-18

Debt obligations mature as follows as of December 31, 2020:2022:

SCHEDULE OF MATURITY OF DEBT OBLIGATIONS

 December 31, 2020  December 31,
2022
 
2021 $6,218 
2022  6,206 
2023  3,166  $485,374 
2024  3,286   297,971 
2025 and thereafter  141,124 
2025  3,412 
2026  3,542 
2027 and thereafter  137,541 
        
Total $160,000  $927,840 

2020 Small Business Administration Notes.

On May 4, 2020, the Company issued a promissory note in connection with the receipt of the PPP Loan of $1,418,900 under the SBA’s PPP Program under the CARES Act. The PPP Loan has a two-year term and bears interest at a rate of 1.0% per annum. Monthly principal and interest payments are deferred for nine months after the date of disbursement and total $79,850.57 per month thereafter. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. The promissory note contains events of default and other provisions customary for a loan of this type. The PPP provides that the PPP Loan may be partially or wholly forgiven if the funds are used for certain qualifying expenses as described in the CARES Act. The Company intends to use the majority of the PPP Loan amount for qualifying expenses and to apply for forgiveness of the PPP Loan in accordance with the terms of the CARES Act. The Company is in process of applying for forgiveness of the PPP Loan. On December 10, 2020, the Company was fully forgiven of its $1,418,900 PPP Loan, thus we recorded a gain on the extinguishment of debt in the amount of $1.4 million in the line item “Gain on Extinguishment of Debt” in our Consolidated Statements of Operations.

On May 12, 2020, the Company received $150,000$150,000 in loan funding from the SBA under the EIDL program administered by the SBA, which program was expanded pursuant to the recently enacted CARES Act. The EIDL is evidenced by an unsecured promissory note, dated May 8, 2020, in the original principal amount of $150,000$150,000 with the SBA, the lender.

Under the terms of the note issued under the EIDL program, interest accrues on the outstanding principal at the rate of 3.75%3.75% per annum. The term of such note is thirty years, though it may be payable sooner upon an event of default under such note. Monthly principal and interest payments arebegan in November 2022, after being deferred for twelvethirty months after the date of disbursement and total $731.00$731.00 per month thereafter. Such note may be prepaid in part or in full, at any time, without penalty. The Company granted the secured party a continuing interest in and to any and all collateral, including but not limited to tangible and intangible personal property.

2020 Secured ConvertibleContingent Consideration Promissory Notes.

On April 17, 2020,June 30, 2021, Nobility Healthcare, a subsidiary of the Company, entered intoissued a securitiescontingent consideration promissory note (the “June Contingent Note”) in connection with a stock purchase agreement with several accredited investors providingbetween Nobility Healthcare and a private company (the “June Seller”) of $350,000. The Contingent Note has a three-year term and bears interest at a rate of 3.00% per annum. Quarterly principal and interest payments are deferred for six months and is due in equal quarterly installments on the issuanceseventh business day of (i) the Company’s 8% secured convertible notes due April 16, 2021 with aeach quarter. The principal face amount of $1,666,666, which convertible notes are,the June Contingent Note is subject to certain conditions, convertible into 1,650,164 sharesan earn-out adjustment, being the difference between the $975,000 (the “June Projected Revenue”) and the cash basis revenue (the “June Measurement Period Revenue”) collected by the June Seller in its normal course of business from the clients existing on June 30, 2021, during the period from October 1, 2021 through September 30, 2022 (the “June Measurement Period”) measured on a quarterly basis and annualized as of the Company’s common stock, at a price per sharerelevant period. If the June Measurement Period Revenue is less than the June Projected Revenue, such amount will be subtracted from the principal balance of $1.01 (the “2020 Convertible Notes”), and (ii) five-year warrants to purchase an aggregate of 1,237,624 shares of Common Stock at an exercise price of $1.31, which warrants are immediately exercisable upon issuance andthis June Contingent Note on a cashless basis ifdollar-for-dollar basis. If the Warrants have not been registered 180 days afterJune Measurement Period Revenue is more than the dateJune Projected Revenue, such amount will be added to the principal balance of issuance.this June Contingent Note on a dollar-for-dollar basis. In no event will the principal balance of this June Contingent Note become a negative number. The accredited investors purchasedmaximum downward earn-out adjustment to the foregoing securities for an aggregate cash purchase priceprincipal balance will be to zero. There are no limits to the increases to the principal balance of $1,500,000.

Under the purchase agreement, the convertible notes and warrants contain provisions whereby the accredited investors are prohibited from exercising their rights to convert the notes or exercise the warrants if,June Contingent Note as a result of such conversion or exercise, such holder, together with its affiliates, would own more than 4.99%the earn-out adjustments.

F-23

The June Contingent Payment Note is considered to be additional purchase price, therefore the estimated fair value of the total number of shares ofcontingent liability is recorded as a liability at the Company’s common stock outstanding immediately after giving effect to such exercise. However, the investors may increase or decrease such percentage to any other percentage not in excess of 9.99%, provided that any increase in such percentage shall not be effective until 61 days after such notice to the Company.

F-19

The Company elected to account for the secured convertible notes onacquisition date and the fair value basis.is considered part of the consideration paid for the acquisition. Management has recorded the contingent consideration promissory note at its estimated fair value of $350,000 at the acquisition date. Principal payments, since its inception, on this contingent consideration promissory note totaled $113,617. The estimated fair value of the June Contingent Note at December 31, 2022 is $176,456, representing a decrease in its estimated fair value of $27,139 as compared to its estimated fair value as of December 31, 2021. Therefore, the Company recorded a gain of $27,139 and $32,789 in the Consolidated Statements of Operations for the years ended December 31, 2022 and December 31, 2021, respectively.

On August 31, 2021, Nobility Healthcare, issued another contingent consideration promissory note (the “August Contingent Payment Note”) in connection with a stock purchase agreement between Nobility Healthcare and a private company (the “August Sellers”) of $650,000. The August Contingent Payment Note has a three-year term and bears interest at a rate of 3.00% per annum. Quarterly principal and interest payments are deferred for six months and is due in equal quarterly installments on the seventh business day of each quarter. The principal amount of the August Contingent Payment Note is subject to an earn-out adjustment, being the difference between the $3,000,000 (the “August Projected Revenue”) and the cash basis revenue (the “August Measurement Period Revenue”) collected by the August Sellers in its normal course of business from the clients existing on September 1, 2021, during the period from December 1, 2021 through November 30, 2022 (the “August Measurement Period”) measured on a quarterly basis and annualized as of the relevant period. If the August Measurement Period Revenue is less than the August Projected Revenue, such amount will be subtracted from the principal balance of this August Contingent Payment Note on a dollar-for-dollar basis. If the August Measurement Period Revenue is more than the August Projected Revenue, such amount will be added to the principal balance of this August Contingent Payment Note on a dollar-for-dollar basis. In no event will the principal balance of this August Contingent Payment Note become a negative number. The maximum downward earn-out adjustment to the principal balance will be to zero. There are no limits to the increases to the principal balance of the August Contingent Payment Note as a result of the earn-out adjustments.

The August Contingent Payment Note is considered to be additional purchase price, therefore the estimated fair value of the contingent liability is recorded as a liability at the acquisition date and the fair value is considered part of the consideration paid for the acquisition. Management has recorded the contingent consideration promissory note at its estimated fair value of $650,000 at the acquisition date. Principal payments, since its inception, on this contingent consideration promissory note totaled $292,953. The estimated fair value of the August Contingent Note at December 31, 2022 is $388,954, representing an increase in its estimated fair value of $31,907 as compared to is estimated fair value as of December 31, 2021. Therefore, the Company recorded a loss of $31,907 and $-0- in the Consolidated Statements of Operations for the years ended December 31, 2022 and December 31, 2021, respectively.

On January 1, 2022, Nobility Healthcare issued another contingent consideration promissory note (the “January Contingent Payment Note”) in connection with a stock purchase agreement between Nobility Healthcare and a private company (the “January Sellers”) of $750,000. The January Contingent Payment Note has a two-and-a-half-year term and bears interest at a rate of 3.00% per annum. Quarterly principal and interest payments are deferred for seven months and is due in equal quarterly installments on the tenth business day of each quarter. The principal amount of the January Contingent Payment Note is subject to an earn-out adjustment, being the difference between $3,500,000 (the “January Projected Revenue”) and the cash basis revenue (the “January Measurement Period Revenue”) collected by the January Sellers in its normal course of business from the clients existing on January 1, 2022, during the period from April 1, 2022 through March 31, 2023 (the “January Measurement Period”) measured on a quarterly basis and annualized as of the relevant period. If the January Measurement Period Revenue is less than the January Projected Revenue, such amount will be subtracted from the principal balance of this January Contingent Payment Note on a dollar-for-dollar basis. If the January Measurement Period Revenue is more than the January Projected Revenue, such amount will be added to the principal balance of this January Contingent Payment Note on a dollar-for-dollar basis. In no event will the principal balance of this January Contingent Payment Note become a negative number. The maximum downward earn-out adjustment to the principal balance will be a reduction to zero. There are no limits to the increases to the principal balance of the January Contingent Payment Note as a result of the earn-out adjustments.

F-24

The January Contingent Payment Note is considered to be additional purchase price, therefore the estimated fair value of the contingent liability is recorded as a liability at the acquisition date and the fair value is considered part of the consideration paid for the acquisition. Management has recorded the contingent consideration promissory note at its estimated fair value of $750,000 at the acquisition date. Principal payments, since its inception, on this contingent consideration promissory note totaled $120,833. The estimated fair value of the January Contingent Note at December 31, 2022 is $208,083, representing a decrease in its estimated fair value of $421,085 as compared to its estimated fair value as of the inception date. Therefore, the Company recorded a gain of $421,085 and $-0- in the Consolidated Statements of Operations for the years ended December 31, 2022 and December 31, 2021, respectively.

On February 1, 2022, Nobility Healthcare issued another contingent consideration promissory note (the “February Contingent Payment Note”) in connection with an asset purchase agreement between Nobility Healthcare and a private company (the “February Sellers”) of $105,000. The February Contingent Payment Note has a three-year term and bears interest at a rate of 3.00% per annum. Quarterly principal and interest payments are deferred for seven months and are due in equal quarterly installments on the tenth business day of each quarter. The principal amount of the February Contingent Payment Note is subject to an earn-out adjustment, being the difference between $440,000 (the “February Projected Revenue”) and the cash basis revenue (the “February Measurement Period Revenue”) collected by the February Sellers in its normal course of business from the clients existing on February 1, 2022, during the period from May 1, 2022 through April 30, 2023 (the “February Measurement Period”) measured on a quarterly basis and annualized as of the relevant period. If the February Measurement Period Revenue is less than the February Projected Revenue, such amount will be subtracted from the principal balance of this February Contingent Payment Note on a dollar-for-dollar basis. If the February Measurement Period Revenue is more than the February Projected Revenue, such amount will be added to the principal balance of this February Contingent Payment Note on a dollar-for-dollar basis. In no event will the principal balance of this February Contingent Payment Note become a negative number. The maximum downward earn-out adjustment to the principal balance will be a reduction to zero. There are no limits to the increases to the principal balance of the February Contingent Payment Note as a result of the earn-out adjustments.

The February Contingent Payment Note is considered to be additional purchase price, therefore the estimated fair value of the contingent liability is recorded as a liability at the acquisition date and the fair value is considered part of the consideration paid for the acquisition. Management has recorded the contingent consideration promissory note at its estimated fair value of $105,000 at the acquisition date. The estimated fair value of the February Contingent Note at December 31, 2022 is $4,346, representing a decrease in its estimated fair value of $100,654 as compared to its estimated fair value as of the inception date. Therefore, the Company recorded a gain of $100,654 and $-0- in the Consolidated Statements of Operations for the years ended December 31, 2022 and December 31, 2021, respectively.

Contingent consideration earn-out Agreement – TicketSmarter Acquisition

On September 1, 2021, TicketSmarter, Inc., a subsidiary of the Company, issued a contingent consideration earn-out agreement (the “TicketSmarter Earn-Out”) in connection with the Stock Purchase Agreement between TicketSmarter, Inc., Goody Tickets, LLC and TicketSmarter, LLC (“TicketSmarter”) of up to $4,244,400 with a fair value at acquisition of $3,700,000. The TicketSmarter Earn-Out shall be payable with ninety percent (90%) readily available funds and ten percent (10%) in stock consideration. The principal amount of the TicketSmarter Earn-Out is subject to an earn-out adjustment, being the difference between the $2,896,829 (the “Projected EBITDA”) and the actual EBITDA (the “Measurement Period EBITDA”) generated by TicketSmarter in its normal course of business, during the period from September 1, 2021 through December 31, 2021 (the “Measurement Period”). If the Measurement Period EBITDA is less than seventy percent (70%) of the Projected EBITDA, there will be zero contingent payment. If the Measurement Period EBITDA is between seventy percent (70%) and one hundred percent (100%) of the Projected EBITDA, then a fractional amount of the contingent payment will be paid out. If the Measurement Period EBITDA is more than the Projected EBITDA, the full principal balance of this TicketSmarter Earn-Out will be paid out. In no event will the principal balance of this TicketSmarter Earn-Out become a negative number. The maximum downward earn-out adjustment to the earn-out balance will be to reduce the balance to zero.

F-25

The contingent consideration earn-out is considered to be additional purchase price, therefore the estimated fair value of the contingent liability is recorded as a liability at the acquisition date and the fair value is considered part of the consideration paid for the acquisition. Management has recorded the contingent consideration earn-out at its estimated fair value of $3,700,000 at the acquisition date. Management determined that the actual Measurement Period EBITDA generated by TicketSmarter was less than 70% of the Projected EBITDA threshold. Therefore, no TicketSmarter Earn-Out payments amounts were due under the agreement. Therefore, the fair value of the secured convertible notescontingent consideration earn-out agreement was reduced to zero, and the common stock purchase warrants which yielded estimated fair valuesresulting gain of the secured convertible notes including their embedded derivatives$-0- and the detachable common stock purchase warrants. The following represents the resulting fair value as determined on April 17, 2020, the date$3,700,000 was reported in our Consolidated Statements of origination:

Secured convertible notes $778,859 
Common stock purchase warrants  721,141 
     
Gross cash proceeds $1,500,000 

During the year ended December 31, 2020, the holders of the 2020 Convertible Notes exercised their right to convert principal balances aggregating $1,665,666 into equity. In addition, on June 12, 2020, the Company exercised its right to prepay in cash the remaining outstanding principal balance aggregating $1,000. There remains no outstanding 2020 Convertible notes as of December 31, 2020 as a result of these conversions and prepayments.

Under the fair value basis, the Company determines the fair value of the secured convertible notes and adjusts the carrying value of the secured convertible notes at each reporting date with the resulting charge or credit being reflected in the consolidated statement of operations. Following is an analysis of the activity in the secured convertible notes during the year ended December 31, 2020:

Amount
Balance at December 31, 2019$
Issuance of 2020 convertible notes at fair value778,859
Principal repaid during the period by issuance of common stock(1,665,666)
Principal repaid during the period by payment of cash(1,000)
Change in fair value of secured convertible note during the period887,807
Balance at December 31, 2020$

Following is a range of certain estimates and assumptions utilized as of the April 17, 2020 issuance date to determine the fair value of secured convertible notes:

  April 17, 2020 
  Assumptions 
Volatility – range  90%
Risk-free rate  0.36%
Contractual term  1.0 years 
Stock price $0.92 
Debt yield  132.2%

Under the fair value basis, legal, accounting, and miscellaneous costs directly related to the issuance of the secured convertible notes are charged to expense as incurred. A total of $34,906 and $-0- of such issuance costs were charged to operations duringOperations for the years ended December 31, 20202022 and 2019, respectively.

2019 Secured Convertible Notes.

On August 5, 2019, the Company, entered into a securities purchase agreement with several accredited investors providing for the issuance of (i) the Company’s 8% secured convertible notes due August 4, 2020 with a principal face amount of $2,777,777.78, which convertible notes are, subject to certain conditions, convertible into 1,984,126 shares of the Company’s common stock, at a price per share of $1.40; (ii) five-year warrants to purchase an aggregate of 571,428 shares of Common Stock at an exercise price of $1.8125, which warrants are immediately exercisable upon issuance and on a cashless basis if the Warrants have not been registered 180 days after the date of issuance; and (iii) the issuance of shares of common stock equal to 5% of the aggregate purchase price of the convertible notes, with an aggregate value of $125,000 (the “Commitment Shares”). The accredited investors purchased the foregoing securities for an aggregate cash purchase price of $2,500,000.

F-20

Pursuant to the purchase agreement, an aggregate of $1,153,320 in principal amount of convertible notes (the “Registered Notes”), the conversion shares underlying the Registered Notes and all of the Commitment Shares were issued to the accredited investors in a registered direct offering pursuant to a prospectus supplement to the Company’s currently effective shelf registration statement on Form S-3. Accordingly, $1,153,320 in original principal amount of our convertible notes were issued as Registered Notes pursuant to the shelf registration statement and therefore freely tradable.

In a related transaction and in accordance with the purchase agreement, the Company issued to the accredited investors in a concurrent private placement pursuant to an exemption from the registration requirements of the Securities Act provided in Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder, (1) the remaining aggregate of $1,624,457.78 in principal amount of convertible notes, (2) the shares of common stock issuable from time to time upon conversion of such convertible notes, and (3) the common shares underlying the common stock purchase warrants. On September 5, 2019, the Company filed a Registration Statement on Form S-1 covering the securities issued in the concurrent private placement including an aggregate of $1,624,457.78 in principal amount of previously non-registered convertible notes, the shares of common stock issuable from time to time upon conversion of such non-registered convertible notes and the common stock underlying the common stock purchase warrants. Such Registration Statement on Form S-1 was declared effective by the Securities and Exchange Commission on September 12, 2019.

In connection with the purchase agreement, the Company and its subsidiary entered into a security agreement, dated as of August 5, 2019, with the investors, pursuant to which the Company and its subsidiary granted a security interest in, among other items, the Company and its subsidiary’s accounts, chattel paper, documents, equipment, general intangibles, instruments and inventory, and all proceeds, as set forth in the security agreement. In addition, pursuant to an intellectual property security agreement, dated as of August 5, 2019, the Company granted a continuing security interest in all of the Company’s right, title and interest in, to and under certain of the Company’s trademarks, copyrights and patents. In addition, the Company’s subsidiary jointly and severally agreed to guarantee and act as surety for the Company’s obligation to repay the convertible notes pursuant to a subsidiary guarantee.

Under the purchase agreement, the convertible notes and warrants contain provisions whereby the accredited investors are prohibited from exercising their rights to convert the notes or exercise the warrants if, as a result of such conversion or exercise, such holder, together with its affiliates, would own more than 4.99% of the total number of shares of the Company’s common stock outstanding immediately after giving effect to such exercise. However, the investors may increase or decrease such percentage to any other percentage not in excess of 9.99%, provided that any increase in such percentage shall not be effective until 61 days after such notice to the Company.

The Company elected to account for the secured convertible notes on the fair value basis. Therefore, the Company determined the fair value of the (1) secured convertible notes, (2) the Commitment Shares and (3) the common stock purchase warrants which yielded estimated fair values of the secured convertible notes including their embedded derivatives, the Commitment Shares and the detachable common stock purchase warrants. The following represents the resulting fair value as determined on August 5, 2019, the date of origination:

Secured convertible notes $1,845,512 
Common stock issued as Commitment Shares  118,749 
Common stock purchase warrants  535,739 
     
Gross cash proceeds $2,500,000 

F-21

Under the fair value basis, the Company determines the fair value of the secured convertible notes and adjusts the carrying value of the secured convertible notes at each reporting date with the resulting charge or credit being reflected in the consolidated statement of operations. Following is an analysis of the activity in the secured convertible notes during the years ended December 31, 2020 and 2019:2021, respectively.

  Amount 
Balance at December 31, 2018   
Issuance of convertible notes on August 5, 2019, at fair value  1,845,512 
Principal repaid during the period by issuance of common stock  (648,067)
Principal repaid during the period by payment of cash  (123,457)
Change in fair value of secured convertible note during the period  519,821 
     
Balance at December 31, 2019 $1,593,809 
Principal repaid during the period by issuance of common stock  (1,259,074)
Principal repaid during the period by payment of cash  (747,180)
Change in fair value of secured convertible note during the period  412,445 
     
Balance at December 31, 2020 $ 

Following is a range of certain estimates and assumptions utilized as of December 31, 2020 to determine the fair value of secured convertible notes:

  

December 31,

2019

 
  Assumptions 
Volatility – range  115%
Risk-free rate  1.60%
Contractual term  0.6 years 
Calibrated stock price $1.06 
Debt yield  123.6%

Under the fair value basis, legal, accounting, and miscellaneous costs directly related to the issuance of the secured convertible notes are charged to expense as incurred. A total of $-0- and $89,148 of such issuance costs were charged to operations during the years ended December 31, 2020 and 2019, respectively.

2018 Proceeds Investment Agreement.

On July 31, 2018, the Company entered into a Proceeds Investment Agreement (the “PIA Agreement”) with Brickell Key Investments LP (“BKI”), pursuant to which BKI funded an aggregate of $500,000 (the “First Tranche”) to be used (i) to fund the Company’s litigation proceedings relating to the infringement of certain patent assets listed in the PIA Agreement and (ii) to repay the Company’s existing debt obligations and for certain working capital purposes set forth in the PIA Agreement. Pursuant to the PIA Agreement, BKI was granted an option to provide the Company with an additional $9.5 million, at BKI’s sole discretion (the “Second Tranche”). On August 21, 2018, BKI exercised its option on the Second Tranche for $9.5 million which completed the $10 million funding.

Pursuant to the PIA Agreement and in consideration for the $10 million in funding, the Company agreed to assign to BKI (i) 100% of all gross, pre-tax monetary recoveries paid by any defendant(s) to the Company or its affiliates agreed to in a settlement or awarded in judgment in connection with the patent assets, plus any interest paid in connection therewith by such defendant(s) (the “Patent Assets Proceeds”), up to the minimum return (as defined in the Agreement) and (ii) if BKI has not received its minimum return by the earlier of a liquidity event (as defined in the Agreement) and July 31, 2020, then the Company agreed to assign to BKI 100% of the Patent Asset Proceeds until BKI has received an amount equal to the minimum return on $4.0 million.

Pursuant to the PIA Agreement, the Company granted BKI (i) a senior security interest in the Patent Assets, the claims (as defined in the Agreement) and the Patent Assets Proceeds until such time as the minimum return is paid, in which case, the security interest on the patent assets, the claims and the Patent Assets Proceeds will be released, and (ii) a senior security interest in all other assets of the Company until such time as the minimum return is paid on $4.0 million, in which case, the security interest on such other assets will be released.

F-22

The security interest is enforceable by BKI if the Company is in default under the PIA Agreement which would occur if (i) the Company fails, after five (5) days’ written notice, to pay any due amount payable to BKI under the PIA Agreement, (ii) the Company fails to comply with any provision of the PIA Agreement or any other agreement or document contemplated under the PIA Agreement, (iii) the Company becomes insolvent or insolvency proceedings are commenced (and not subsequently discharged) with respect to the Company, (iv) the Company’s creditors commence actions against the Company (which are not subsequently discharged) that affect material assets of the Company, (v) the Company, without BKI’s consent, incurs indebtedness other than immaterial ordinary course indebtedness up to $500,000, (vi) the Company fails, within five (5) business days following the closing of the second tranche, to fully satisfy its obligations to certain holders of the Company’s senior secured convertible promissory notes listed in the PIA Agreement and fails to obtain unconditional releases from such holders as to the Company’s obligations to such holders and the security interests in the Company held by such holders or (vii) there is an uncured non-compliance of the Company’s obligations or misrepresentations by the Company under the PIA Agreement.

Under the PIA Agreement, the Company issued BKI a warrant to purchase up to 465,712 shares of the Company’s common stock, par value $0.001 per share (the “PIA Warrant”), at an exercise price of $2.60 per share provided that the holder of the PIA Warrant will be prohibited from exercising the PIA Warrant if, as a result of such exercise, such holder, together with its affiliates, would own more than 4.99% of the total number of shares of the Company’s common stock outstanding immediately after giving effect to such exercise. However, such holder may increase or decrease such percentage to any other percentage not in excess of 9.99%, provided that any increase in such percentage shall not be effective until 61 days after such notice to the Company. The PIA Warrant is exercisable for five years from the date of issuance and is exercisable on a cashless exercise basis if there is no effective registration statement. No contractual registration rights were given.

The Company elected to account for the PIA on the fair value basis. Therefore, the Company determined the fair value of the PIA and PIA Warrants which yielded estimated fair values of the PIA including their embedded derivatives and the detachable PIA Warrants as follows:

Proceeds investment agreement $9,067,513 
Common stock purchase warrants  932,487 
     
Gross cash proceeds $10,000,000 

The Company utilized a probability weighted present value of expected patent asset proceeds for the litigation involving both Axon and WatchGuard (see Note 12 – Commitments and Contingencies) which involved estimates of the amount and timing of the expected patent asset proceeds from the alleged patent infringement. The fair value of the PIA is updated for actual and estimated activity affecting the probability weighted present value of expected patent asset proceeds at each reporting date with the change charged/credited to operations. Following is a range of certain estimates and assumptions utilized as of December 31, 2019 to probability weighted present value of expected patent asset proceeds for the litigation involving both Axon and WatchGuard:

December 31,

2019

Discount rate3.0% - 16.6%
Expected term to patent asset proceeds payment0.58 years - 4 years
Probability of success5.9% - 38.5%
Estimated minimum return payable to BKI$21 million
Negotiation discount43.3%

During 2019, the Company settled its patent infringement litigation with WatchGuard whereby it received a lump-sum payment of $6.0 million as further described in Note 12. In accordance with the terms of the PIA, the Company remitted the $6.0 as a principal payment toward its minimum return payment obligations under the PIA. The Company recorded the receipt of the $6,000,000 settlement as Patent litigation settlement income in the accompanying consolidated statement of operations.

F-23

On July 20, 2020, the Company and BKI executed a Termination Agreement and Mutual Release (the “Termination Agreement”). Under the terms of the Termination Agreement the parties agreed to terminate the PIA and to release each other from any further liability under the PIA obligation.

Under the terms of the Termination Agreement, upon payment of $1,250,000 by the Company to BKI both parties agreed to terminate the PIA and to release each other from any further liability thereunder. Such $1,250,000 payment was made on July 22, 2020. In addition to the $1,250,000 payment, the Company further agreed to pay BKI the following: (a) a contingent payment in the amount of $2,750,000 following the closing of an asset purchase, membership interest purchase, or similar transaction between the Company and a specified third-party (the “Purchase Transaction”) and (b) any and all future proceeds received from Watchguard and its successors and assigns by the Company for WatchGuard’s use of U.S. Patent Nos. 8,781,292 and 9,253,452. For clarity, the Company and BKI further agreed that the payment of the contingent payment would only be due and payable upon the closing of the specified Purchase Transaction and the relevant contingent payment portion of the Termination Agreement, and any obligations stemming therefrom, would automatically terminate if the specified Purchase Transaction is abandoned prior to its closing, including its failure to close within three years from the date of the Termination Agreement.

The parties abandoned the Purchase Transaction during the year ended December 31, 2020 and therefore, the contingent payment obligation automatically terminated as the specified Purchase Transaction was abandoned prior to its closing. Furthermore, the Company does not anticipate any future recoveries from Watchguard and its successors and assigns relative to WatchGuard’s use of U.S. Patent Nos. 8,781,292 and 9,253,452. As a result, the PIA obligation was extinguished upon the payment of the $1,250,000 required under the Termination Agreement.

The following represents activity in the PIA during the years ended December 31, 2020 and 2019:

Beginning balance as of January 1, 2019 $9,142,000 
Repayment of obligation  (6,000,000)
Change in the fair value during the period  3,358,000 
Ending balance as of December 31, 2019 $6,500,000 
     
Beginning Balance as of January 1, 2020 $6,500,000 
Repayment of obligation  (1,250,000)
Change in fair value during the period  (5,250,000)
Ending balance as of December 31, 2020 $- 

Unsecured Promissory Note Payable.

On December 23, 2019, the Company, borrowed $300,000 under an unsecured note payable to a private, third-party lender. The promissory note bears interest at the rate of 8% per annum with principal and accrued interest payable on or before its maturity date of March 31, 2020. The Company granted the lender warrants exercisable to purchase a total of 107,000 shares of its common stock at an exercise price of $1.40 per share until December 23, 2024. When determining the fair value of these warrants, the assumptions utilized in the Black-Scholes model include the expected volatility of stock price of 86%, discount rate of 1.75%, and expected dividends of 0%. The Company allocated $71,869 of the proceeds of the promissory note to additional paid-in-capital, which represented the grant date relative fair value of the warrants issued to the lender. The discount will be amortized to interest expense ratably over the term of the promissory note which approximates the effective interest method. The amortization of discount resulted in $66,061 and $5,808 of the discount amortized to interest expense during the years ended December 31, 2020 and 2019, respectively.

On January 17, 2020, the Company borrowed $100,000 under an unsecured note payable to a private, third-party lender. The promissory note bore interest at the rate of 8% per annum with principal and accrued interest payable on or before its maturity date of April 17, 2020. The Company granted the lender warrants exercisable to purchase a total of 35,750 shares of its common stock at an exercise price of $1.40 per share until January 17, 2025. When determining the fair value of these warrants, the assumptions utilized in the Black-Scholes model include the expected volatility of stock price of 86%, discount rate of 2%, and expected dividends of 0%. The Company allocated $20,806 of the proceeds of the promissory note to additional paid-in-capital, which represented the grant date relative fair value of the warrants issued to the lender. The note was repaid in full on March 12, 2020 and the discount was amortized to interest expense through the date of payment. The amortization of discount resulted in $20,806 of the discount amortized to interest expense during the year ended December 31, 2020.

F-24

Unsecured Promissory Notes Payable – Related party

During February and April 2020, the Company borrowed a total of $319,000 from the Company’s Chairman, CEO & President under an unsecured promissory note bearing interest at 6% through its May 28, 2020 maturity date. The proceeds from the note were used for general corporate purposes. The principal balance and related accrued interest were paid in full during the year ended December 31, 2020. Total interest accrued and paid on this note was $5,236.

NOTE 8. 11. FAIR VALUE MEASUREMENT

In accordance with ASC Topic 820 — Fair Value Measurements and Disclosures (“ASC 820”), the Company utilizes the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets, liabilities or a group of assets or liabilities, such as a business.

ASC 820 utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:

Level 1 — Quoted prices in active markets for identical assets and liabilities
Level 2 — Other significant observable inputs (including quoted prices in active markets for similar assets or liabilities)
Level 3 — Significant unobservable inputs (including the Company’s own assumptions in determining the fair value)

The following table represents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of December 31, 20202022 and 2019.2021.

SCHEDULE OF FINANCIAL ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON RECURRING BASIS

  December 31, 2022 
  Level 1  Level 2  Level 3  Total 
Liabilities:                
Warrant derivative liabilities $  $  $  $ 
Contingent consideration promissory notes and contingent consideration earn-out agreement        777,840   777,840 
  $  $  $777,840  $777,840 

  December 31, 2021 
  Level 1  Level 2  Level 3  Total 
Liabilities:                
Warrant derivative liabilities $  $  $14,846,932  $14,846,932 
Contingent consideration promissory notes and contingent consideration earn-out agreement        967,212   967,212 
  $  $  $15,814,144  $15,814,144 

F-26
 December 31, 2020
Level 1Level 2Level 3Total
Liabilities:
Secured convertible debentures$$$$
Proceeds investment agreement
$$$$

  December 31, 2019 
  Level 1  Level 2  Level 3  Total 
Liabilities:                
Secured convertible debentures $  $  $1,593,809  $1,593,809 
Proceeds investment agreement        6,500,000   6,500,000 
  $  $  $8,093,809  $8,093,809 

F-25

The following table represents the change in Level 3 tier value measurements:

SCHEDULE OF FAIR VALUE MEASUREMENTS CHANGE IN LEVEL 3 INPUTS

  2019  2020       
  Secured  Secured  Proceeds    
  Convertible  Convertible  Investment    
  Notes  Notes  Agreement  Total 
             
Balance, December 31, 2018 $  $  $9,142,000  $9,142,000 
                 
Principal payments made on debentures        (6,000,000)  (6,000,000)
                 
New secured convertible debentures  1,845,512         1,845,512 
                 
Conversion of secured convertible debentures  (648,067)        (648,067)
                 
Repayment of 2019 secured convertible notes  (123,457)     ��  (123,457)
                 
Change in fair value of secured convertible debentures and proceeds investment agreement  519,821      3,358,000   3,877,821 
                 
Balance, December 31, 2019 $1,593,809  $  $6,500,000  $8,093,809 
                 
Issuance of secured convertible debt     778,859      778,859 
                 
Conversion of secured convertible debentures  (1,259,074)  (1,665,666)     (2,924,740)
                 
Repayment of proceeds investment agreement        (1,250,000)  (1,250,000)
                 
Repayment of secured convertible notes  (747,180)  (1,000)     (748,180)
                 
Change in fair value of secured convertible debentures and proceeds investment agreement  412,445   887,807   (5,250,000)  (3,949,748)
                 
Balance, December 31, 2020 $  $  $  $ 
  Contingent
Consideration
Promissory Notes and Earn-Out Agreement
  Warrant Derivative
Liabilities
 
       
Balance, December 31, 2021 $967,212  $14,846,932 
         
Issuance of contingent consideration promissory note - Revenue Cycle Management Segment Business Acquisition  750,000    
         
Issuance of contingent consideration promissory note - Revenue Cycle Management Segment Asset Acquisition  105,000    
         
Change in fair value of warrant derivative liabilities     (6,726,638)
         
Gain on extinguishment of warrant derivative liabilities     (3,624,794)
         
Issuance of common stock through warrant exchange agreement     (4,495,500)
         
Principal payments on contingent consideration promissory notes – Revenue Cycle Management Acquisitions  (527,402)   
         
Change in fair value of contingent consideration promissory notes - Revenue Cycle Management Acquisitions  (516,970)   
         
Balance, December 31, 2022 $777,840  $ 

NOTE 9. 12. ACCRUED EXPENSES

Accrued expenses consisted of the following at December 31, 20202022 and 2019:2021:

SCHEDULE OF ACCRUED EXPENSES

 December 31, 2020  December 31, 2019  December 31,
2022
 December 31,
2021
 
Accrued warranty expense $31,845  $17,838  $15,694  $13,742 
Accrued litigation costs  250,000   295,000   247,984   250,000 
Accrued sales commissions  38,294   28,480   55,000   30,213 
Accrued payroll and related fringes  199,850   233,254   504,020   453,858 
Accrued insurance     78,579 
Accrued sales returns and allowances  26,069   18,258   118,026   45,298 
Accrued sales taxes  53,627   50,136 
Accrued taxes  46,408   180,486 
Other  196,409   124,336   103,835   202,401 
 $796,094  $845,881 
Total accrued expenses $1,090,967  $1,175,998 

Accrued warranty expense was comprised of the following for the years ended December 31, 20202022 and 2019:2021:

SCHEDULE OF ACCRUED WARRANTY EXPENSE

 2020  2019  2022 2021 
Beginning balance $17,838  $195,135  $13,742  $31,845 
Provision for warranty expense  123,474   47,355   71,734   92,202 
Charges applied to warranty reserve  (109,468)  (224,651)  (69,782)  (110,305)
                
Ending balance $31,845  $17,838  $15,694  $13,742 

F-26F-27

 

NOTE 10. 13. INCOME TAXES

The components of income tax provision (benefit) for the years ended December 31, 20202022, and 20192021 are as follows:

SCHEDULE OF COMPONENTS OF INCOME TAX PROVISION (BENEFIT)

  2020   2019  2022 2021 
Current taxes:                                
Federal $  $  $  $ 
State            
                
Total current taxes            
Deferred tax provision (benefit)            
                
Income tax provision (benefit) $  $  $  $ 

A reconciliation of the income tax (provision) benefit at the statutory rate of 21% for the years ended December 31, 20202022, and 20192021 to the Company’s effective tax rate is as follows:

SCHEDULE OF RECONCILIATION OF INCOME TAX (PROVISION) BENEFIT

 2020  2019  2022 2021 
U.S. Statutory tax rate  21.0%  21.0%  21.0%  21.0%
State taxes, net of Federal benefit  5.1%  5.1%  6.0%  5.1%
Stock based compensation  (1.9)%  (2.6)%  (1.5)%  (0.9)%
Change in valuation reserve on deferred tax assets  (32.6)%  (22.4)%  (91.2)%  (26.7)%
Forgiveness of Payroll Protection Plan loan  11.3%  %
Termination of warrant derivative liabilities  57.0%  %

Contingent consideration for acquisition

  

4.1

%  %
Other, net  (2.9)%  (1.1)%  4.6%  (0.3)%
                
Income tax (provision) benefit  %  %  %  %

The effective tax rate for the years ended December 31, 2022, and 2021 varied from the expected statutory rate due to the Company continuing to provide a 100% valuation allowance on net deferred tax assets. The Company determined that it was appropriate to continue the full valuation allowance on net deferred tax assets as of December 31, 2022, primarily because of the current year operating losses.

Significant components of the Company’s deferred tax assets (liabilities) as of December 31, 20202022 and 20192021 are as follows:

SCHEDULE OF SIGNIFICANT COMPONENTS OF DEFERRED TAX ASSETS (LIABILITIES)

 2020  2019  2022 2021 
Deferred tax assets:                
Stock-based compensation $765,000  $605,000  $510,000  $705,000 
Start-up costs  115,000   115,000   110,000   115,000 
Inventory reserves  510,000   1,080,000   1,355,000   875,000 
Uniform capitalization of inventory costs  85,000   85,000   70,000   85,000 
Allowance for doubtful accounts receivable  35,000   90,000   40,000   30,000 
Equipment depreciation  255,000   240,000 
Property, plant and equipment depreciation  290,000   285,000 
Deferred revenue  915,000   915,000   1,965,000   1,135,000 
Debt and PIA obligations carried at fair value     1,045,000 
Accrued litigation reserve  60,000   65,000 
Accrued expenses  120,000   110,000   50,000   35,000 
Net operating loss carryforward  19,855,000   17,515,000   27,940,000   21,240,000 
Research and development tax credit carryforward  1,795,000   1,795,000   1,795,000   1,795,000 
State jobs credit carryforward  230,000   230,000   230,000   230,000 
Charitable contributions carryforward  60,000   55,000   95,000   100,000 
                
Total deferred tax assets  24,740,000   23,880,000   34,510,000   26,695,000 
Valuation reserve  (24,595,000)  (23,740,000)  (34,200,000)  (16,980,000)
                
Total deferred tax assets  145,000   140,000   310,000   9,715,000 
Deferred tax liabilities:        
Warrant derivative liabilities    (9,495,000 
Intangible assets  (165,000)  (75,000 
Domestic international sales company  (145,000)  (140,000)  (145,000)  (145,000)
        
Total deferred tax liabilities  (145,000)  (140,000)  (310,000)  (9,715,000)
                
Net deferred tax assets (liability) $  $  $  $ 

F-28

The valuation allowance on deferred tax assets totaled $24,595,000$34,200,000 and $23,740,000$16,980,000 as of December 31, 20202022, and 2019,2021, respectively. The Company records the benefit it will derive in future accounting periods from tax losses and credits and deductible temporary differences as “deferred tax assets.” In accordance with ASC 740, “Income Taxes,” the Company records a valuation allowance to reduce the carrying value of our deferred tax assets if, based on all available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.

F-27

The Company has incurred operating losses in 2020 and 20192022 but generated income 2021 and it continues to be in a three-year cumulative loss position at December 31, 20202022 and 2019.2021. Accordingly, the Company determined there was not sufficient positive evidence regarding its potential for future profits to outweigh the negative evidence of our three-year cumulative loss position under the guidance provided in ASC 740. Therefore, it determined to increase our valuation allowance by $855,000 to$17,220,000 but continue to fully reserve its deferred tax assets at December 31, 2020.2022. The Company expects to continue to maintain a full valuation allowance until it determines that it can sustain a level of profitability that demonstrates its ability to realize these assets. To the extent the Company determines that the realization of some or all of these benefits is more likely than not based upon expected future taxable income, a portion or all of the valuation allowance will be reversed. Such a reversal would be recorded as an income tax benefit and, for some portion related to deductions for stock option exercises, an increase in shareholders’ equity.

AtAs of December 31, 2020,2022, the Company had available approximately $76,070,000$113,315,000 of Federal net operating loss carryforwardscarry-forwards available to offset future taxable income generated. Such tax net operating loss carryforwardscarry-forwards expire between 20262024 and 2040.2042, with $63,726,000of the tax net operating loss carry-forwards have an indefinite life since the enactment of the Tax Cuts and Jobs Act of 2017. In addition, the Company had research and development tax credit carryforwardscarry-forwards totaling $1,795,000 $1,795,000 available as of December 31, 2020,2022, which expire between 2023 and 2037.2039.

The Internal Revenue Code contains provisions under Section 382 which limit a company’s ability to utilize net operating loss carry-forwards in the event that it has experienced a more than 50% change in ownership over a three-year period. Current estimates prepared by the Company indicate that due to ownership changes which have occurred, approximately $765,000$765,000 of its net operating loss and $175,000$175,000 of its research and development tax credit carryforwardscarry-forwards are currently subject to an annual limitation of approximately $1,151,000,$1,151,000 and may be further limited by additional ownership changes which may occur in the future. As stated above, the net operating loss and research and development credit carryforwards carry-forwards expire between 2023 and 2037,2039, allowing the Company to potentially utilize all of the limited net operating loss carry-forwards during the carryforwardcarry-forward period.

As discussed in Note 1, “Summary of Significant Accounting Policies,” tax positions are evaluated in a two-step process. The Company first determines whether it is more likely than not that a tax position will be sustained upon examination. If a tax position meets the more-likely-than-not recognition threshold, it is then measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. Management has identified no tax positions taken that would meet or exceed these thresholds and therefore there are no gross interest, penalties and unrecognized tax expense/benefits that are not expected to ultimately result in payment or receipt of cash in the consolidated financial statements.

F-29

The effective tax rate for the years ended December 31, 20202022, and 20192021 varied from the expected statutory rate due to the Company continuing to provide a 100% valuation allowance on net deferred tax assets. The Company determined that it was appropriate to continue the full valuation allowance on net deferred tax assets as of December 31, 20202022, primarily because of the current year operating losses.

The Company’s federal and state income tax returns are closed for examination purposes by relevant statute and by examination for 20162018 and all prior tax years.

NOTE 11. 14. OPERATING LEASE

On May 13, 2020, the Company entered into an operating lease for new warehouse and office space, which will serveserved as its new principal executive office and primary business location.location prior to the April 30 purchase and sale agreement. The original lease agreement was amended on August 28, 2020 to correct the footage under lease and monthly payment amounts resulting from such correction. The lease terms, as amended include no base rent for the first nine months and monthly payments ranging from $12,398$12,398 to $14,741$14,741 thereafter, with a termination date of December 2026.2026. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related to its new location. The Company took possession of the leased facilities on June 15, 2020. The remaining lease term for the Company’s office and warehouse operating lease as of December 31, 20202022 was seventy-one months. The Company’s previous office and warehouse space lease expired in April 2020 and the Company paid holdover rent for the time period until it moved to and commenced occupying the new space on June 15, 2020.forty-eight months.

F-28

The Company entered into an operating lease with a third party in October 2019 for copiers used for office and warehouse purposes. The terms of the lease include 48 monthly payments of $1,598$1,598 with a maturity date of October 2023.2023. The Company has the option to Purchase thepurchase such equipment at maturity for its estimated fair market value at that point in time. The remaining lease term for the Company’s copier operating lease as of December 31, 20202022 was 34 months.ten months.

On June 30, 2021, the Company completed the acquisition of its first medical billing company, through Nobility Healthcare. Upon completion of this acquisition, Nobility Healthcare became responsible for the operating lease for the seller’s office space. The lease terms include monthly payments ranging from $2,648 to $2,774 thereafter, with a termination date in July 2024. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related to this location. The remaining lease term for the Company’s office and warehouse operating lease as of December 31, 2022 was nineteen months.

On August 31, 2021, the Company completed the acquisition of its second acquired medical billing company, through Nobility Healthcare. Upon completion of this acquisition, Nobility Healthcare became responsible for the operating lease for the seller’s office space. The lease terms include monthly payments ranging from $11,579 to $11,811 thereafter, with a termination date in March 2023. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related to this location. The Company took possession of the leased facilities on September 1, 2021. The remaining lease term for the Company’s office and warehouse operating lease as of December 31, 2022 was three months. The Company plans to relocate the revenue cycle management operating segment acquired operations to existing owned or leased facilities upon termination of this operating lease.

On September 1, 2021, the Company completed the acquisition of Goody Tickets, LLC and TicketSmarter, LLC through TicketSmarter. Upon completion of this acquisition, the Company became responsible for the operating lease for TicketSmarter’s office space. The lease terms include monthly payments ranging from $7,211 to $7,364 thereafter, with a termination date of December 2022. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related to this location. The Company took possession of the leased facilities on September 1, 2021. The Company signed a six-month extension for the lease, extending the remaining lease term for the Company’s office and the remaining lease term for the Company’s warehouse operating lease as of December 31, 2022 was six months.

On January 1, 2022, the Company completed the acquisition of a private medical billing company, through its revenue cycle management segment. Upon completion of this acquisition, the Company became responsible for the operating lease for the seller’s office space. The lease terms include monthly payments ranging from $4,233 to $4,626, with a termination date of June 2025. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related to this location. The Company took possession of the leased facilities on January 1, 2022. The remaining lease term for the Company’s office and warehouse operating lease as of December 31, 2022, was thirty months.

F-30

Lease expense related to the office spacespaces and copier operating leases werewas recorded on a straight-line basis over their respectivethe lease terms.term. Total lease expense under the twofive operating leases was approximately $349,079$547,609 for the year ended December 31, 2020.2022.

The weighted-average remaining lease term related to the Company’s lease liabilities as of December 31, 2022 and December 31, 2021 was 3.3 years and 3.8 years, respectively.

The discount rate implicit within the Company’s operating leases was not generally determinable, and therefore, the Company determined the discount rate based on its incremental borrowing rate on the information available at commencement date. As of commencement date, the operating lease liabilities reflect a weighted average discount rate of 8%.

The following sets forth the operating lease right of use assets and liabilities as of December 31, 2020:2022:

SCHEDULE OF OPERATING LEASES RIGHT OF USE ASSETS AND LIABILITIES

Assets:       
Operating lease right of use assets $753,175  $782,129 
        
Liabilities:        
Operating lease obligations-current portion $113,484  $294,617 
Operating lease obligations-less current portion $723,272  $555,707 
Total operating lease obligations $836,756  $850,324 

The components of lease expense were as follows for the year ended December 31, 2020:

Selling, general and administrative expenses$349,079

Following are the minimum lease payments for each year and in total.

SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS

Year ending December 31:      
2021 $175,249 
2022  184,145 
2023  184,241  $349,811 
2024  171,642   245,761 
Thereafter  333,705 
2025  196,462 
2026  175,113 
Total undiscounted minimum future lease payments  1,048,982   967,147 
Imputed interest  (212,226)  (116,823)
Total operating lease liability $836,756  $850,324 

NOTE 12. 15. COMMITMENTS AND CONTINGENCIES

COVID-19 pandemic

The COVID-19 pandemic represents a fluid situation that presents a wide range of potential impacts of varying durations for different global geographies, including locations where we have offices, employees, customers, vendors and other suppliers and business partners.

Like most US-based businesses, the COVID-19 pandemic and efforts to mitigate the same began to have impacts on our business in March 2020. By that time, much of our first fiscal quarter was completed. During the year ended December 31, 2020, we observed recent decreases in demand from certain customers, including primarily our law-enforcement and commercial customers.

F-29

Given the fact that our products are sold through a variety of distribution channels, we expect our sales will experience more volatility as a result of the changing and less predictable operational needs of many customers as a result of the COVID-19 pandemic. We are aware that many companies, including many of our suppliers and customers, are reporting or predicting negative impacts from COVID-19 on future operating results. Although we observed significant declines in demand for our products from certain customers during the year ended December 31, 2020, we believe that it remains too early for us to know the exact impact COVID-19 will have on the long-term demand for our products. We also cannot be certain how demand may shift over time as the impacts of the COVID-19 pandemic may go through several phases of varying severity and duration.

In light of broader macro-economic risks and already known impacts on certain industries that use our products and services, we have taken, and continue to take targeted steps to lower our operating expenses because of the COVID-19 pandemic. We continue to monitor the impacts of COVID-19 on our operations closely and this situation could change based on a significant number of factors that are not entirely within our control and are discussed in this and other sections of this annual report on Form 10-K. We do not expect there to be material changes to our assets on our balance sheet or our ability to timely account for those assets. Further, in connection with the preparation of this annual report on Form 10-K and the financial statements contained herein, we reviewed the potential impacts of the COVID-19 pandemic on goodwill and intangible assets and have determined there to be no material impact at this time. We have also reviewed the potential impacts on future risks to the business as it relates to collections, returns and other business-related items.

To date, travel restrictions and border closures have not materially impacted our ability to obtain inventory or manufacture or deliver products or services to customers. However, if such restrictions become more severe, they could negatively impact those activities in a way that would harm our business over the long term. Travel restrictions impacting people can restrain our ability to assist our customers and distributors as well as impact our ability to develop new distribution channels, but at present we do not expect these restrictions on personal travel to be material to our business operations or financial results. We have taken steps to restrain and monitor our operating expenses and therefore we do not expect any such impacts to materially change the relationship between costs and revenues.

Like most companies, we have taken a range of actions with respect to how we operate to assure we comply with government restrictions and guidelines as well as best practices to protect the health and well-being of our employees and our ability to continue operating our business effectively. To date, we have been able to operate our business effectively using these measures and to maintain all internal controls as documented and posted. We also have not experienced challenges in maintaining business continuity and do not expect to incur material expenditures to do so. However, the impacts of COVID-19 and efforts to mitigate the same have remained unpredictable and it remains possible that challenges may arise in the future.

The actions we have taken so far during the COVID-19 pandemic include, but are not limited to:

Requiring all employees who can work from home to work from home;
Increasing our IT networking capability to best assure employees can work effectively outside the office; and
For employees who must perform essential functions in one of our offices:
Having employees maintain a distance of at least six feet from other employees whenever possible;
Having employees work in dedicated shifts to lower the risk all employees who perform similar tasks might become infected by COVID-19;
Having employees stay segregated from other employees in the office with whom they require no interaction; and
Requiring employees to wear masks while they are in the office whenever possible.

F-30

We currently believe revenue for the year ending December 31, 2021 may decline year over year due to the conditions noted. In April 2020, we implemented a COVID-19 mitigation plan designed to further reduce our operating expenses during the pandemic. Actions taken to date include work hour and salary reductions for senior management. These cost reductions are in addition to the significant restructuring actions we initiated in the first quarter of 2020. Based on our current cash position, our projected cash flow from operations and our cost reduction and cost containment efforts to date, we believe that we will have sufficient capital and or have access to sufficient capital through public and private equity and debt offerings to sustain operations for a period of one year following the date of this filing. If business interruptions resulting from the COVID-19 pandemic were to be prolonged or expanded in scope, our business, financial condition, results of operations and cash flows would be negatively impacted. We will continue to actively monitor this situation and will implement actions necessary to maintain business continuity.

Litigation.

From time to time, we are notified that we may be a party to a lawsuit or that a claim is being made against us. It is our policy to not disclose the specifics of any claim or threatened lawsuit until the summons and complaint are actually served on us. After carefully assessing the claim, and assuming we determine that we are not at fault or we disagree with the damages or relief demanded, we vigorously defend any lawsuit filed against us. We record a liability when losses are deemed probable and reasonably estimable. When losses are deemed reasonably possible but not probable, we determine whether it is possible to provide an estimate of the amount of the loss or range of possible losses for the claim, if material for disclosure. In evaluating matters for accrual and disclosure purposes, we take into consideration factors such as our historical experience with matters of a similar nature, the specific facts and circumstances asserted, the likelihood of our prevailing, the availability of insurance, and the severity of any potential loss. We reevaluate and update accruals as matters progress over time.

On May 31, 2022, the Company filed a lawsuit against Culp McAuley, Inc. (“defendant”) in the United States District Court for the District of Kansas. The lawsuit arises from the defendant’s multiple breaches of its obligations to the Company. The Company seeks monetary damages and injunctive relief based on certain conduct by the defendant. On July 18, 2022, the defendant filed its Answer to the Company’s Verified Complaint and included Counterclaims alleging breach of contract and seeking monetary damages. On August 8, 2022, the Company filed its Reply and Affirmative Defenses to the Counterclaims by, among other things, denying the allegations and any and all liability. We have not concluded that a material loss related to the allegations is probable, nor have we accrued a liability related to these claims. Although we believe a loss could be reasonably possible (as defined in ASC 450), we do not have sufficient information to determine the amount or range of reasonably possible loss with respect to the potential damages given that the dispute is yet to enter the discovery process. We will continue to vigorously pursue these claims, and we continue to believe that we have valid grounds for recovery of the disputed deliverables. However, there can be no assurances as to the outcome of the dispute.

F-31

While the ultimate resolution is unknown, based on the information currently available, we do not expect that these lawsuits will individually, or in the aggregate, have a material adverse effect to our results of operations, financial condition or cash flows. However, the outcome of any litigation is inherently uncertain and there can be no assurance that any expense, liability or damages that may ultimately result from the resolution of these matters will be covered by our insurance or will not be in excess of amounts recognized or provided by insurance coverage and will not have a material adverse effect on our operating results, financial condition or cash flows.

AxonNotice of Delisting

On July 7, 2022, the Company, received a written notification (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company owns U.S. Patent No. 9,253,452 (the “ ‘452 Patent’ ”), which generally coversthat it was not in compliance with the automatic activation and coordination of multiple recording devices in response to a triggering event, such as a law enforcement officer activating the light barminimum bid price requirement for continued listing on the vehicle.

The Company filed suit on January 15, 2016 inNasdaq Capital Market, as set forth under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”), because the U.S. District Courtclosing bid price of the Company’s common stock was below $1.00 per share for the District of Kansas (Case No: 2:16-cv-02032) against Axon, alleging willful patent infringement against Axon’s body camera product line and Signal auto-activation product.previous thirty (30) consecutive business days. The Company is seeking both monetary damages and a permanent injunction against Axon for infringementNotice has no immediate effect on the listing of the ‘452 Patent.Common Stock, which will continue to trade uninterrupted on the Nasdaq Capital Market under the ticker “DGLY.”

In December 2016 and January 2017, Axon filed two petitions for Inter Partes Review (“IPR”) againstPursuant to Nasdaq Listing Rule 5810(c)(3)(A), the ‘452 Patent. The United States Patent and Trademark Office (“USPTO”) rejected both of Axon’s petitions. Axon is now statutorily precludedCompany has been granted 180 calendar days from filing any more IPR petitions against the ‘452 Patent.

The District Court litigation in Kansas was temporarily stayed following the filingdate of the petitions for IPR. However, on November 17, 2017, the Federal District Court of Kansas rejected Axon’s requestNotice, or until January 3, 2023 (the “Compliance Period”), to maintain the stay. With this significant ruling, the parties will now proceed towards trial. Since litigation has resumed, the Court has issued a claim construction order (also called a Markman Order) where it sidedregain compliance with the Company on all disputes and denied Axon’s attempts to limitMinimum Bid Price Requirement. If at any time during the scopeCompliance Period, the bid price of the claims. FollowingCommon Stock closes at or above $1.00 per share for a minimum of ten (10) consecutive business days, Nasdaq will provide the Markman Order,Company with written confirmation of compliance with the Court set all remaining deadlines inMinimum Bid Price Requirement and the case. Fact discovery closed on October 8, 2018, and a Final Pretrial Conference took place on January 16, 2019. The parties filed motions for summary judgment on January 31, 2019.matter will be closed.

F-31

On June 17, 2019,February 23, 2023, the Court granted Axon’s motion for summary judgmentCompany received notice from Nasdaq confirming that Axon did not infringe on the Company’s patent and dismissed the case. Importantly, the Court’s ruling did not find that Digital’s ‘452 Patent was invalid. It also did not address any other issue, such as whether Digital’s requested damages were appropriate, and it did not impact the Company’s ability to file additional lawsuits to hold other competitors accountable for patent infringement. This ruling solely related to an interpretation of the claims as they relate to Axon and was unrelated to the supplemental briefing Digital recently filed on its damages claim and the WatchGuard settlement. Those issues are separate and the judge’s ruling on summary judgment had nothing to do with Digital’s damages request. The Company has filed an appeal to this rulingcured its bid price deficiency and has asked the appellate court to reverse this decision.

The Company filed an opening appeal brief on August 26, 2019fully regained compliance with the U.S. Court of Appeals for the Tenth Circuit (the “Court of Appeals”), appealing the U.S. District Court’s granting of Axon’s motion for summary judgment. Axon responded by filing a responsive brief on November 6, 2019 and we then filed a reply brief responding to Axon on November 27, 2019. The Court of Appeals scheduled oral arguments on our appeal of the U.S. District Court’s summary judgment ruling on April 6, 2020. This appeal was intended to address the Company’s position that the U.S. District Court incorrectly dismissed our claims against Axon. If the Court of Appeals overturns the ruling of the U.S. District Court, the case will be remanded to the U.S District Court before a new judge. On March 12, 2020, the panel of judges for the Court of Appeals issued an order cancelling the oral arguments previously set for April 6, 2020, having determined that the appeal will be decided solely based on the parties’ briefs. On April 22, 2020, a three-judge panel of the United States Court of Appeals denied our appeal and affirmed the District Court’s previous decision to grant Axon summary judgment. On May 22, 2020, we filed a petition for panel rehearing requesting that we be granted a rehearing of our appeal of the U.S. District Court’s summary judgment ruling. Furthermore, we requested that we be given an opportunity to make our case through oral argument in front of the three-judge panel of the Court of Appeals, which was also denied. The Company has abandoned its right to any further appeals.Minimum Bid Price Requirement.

WatchGuardGeneral

On May 27, 2016, the Company filed suit against WatchGuard, (Case No. 2:16-cv-02349-JTM-JPO) alleging patent infringement based on WatchGuard’s VISTA Wi-Fi and 4RE In-Car product lines.

On May 13, 2019, the parties resolved the dispute and executed a settlement agreement in the form of a Release and License Agreement. The litigation has been dismissed as a result of this settlement.

The Release and License Agreement encompasses the following key terms:

WatchGuard paid Digital Ally a one-time, lump settlement payment of $6,000,000.
Digital Ally granted WatchGuard a perpetual covenant not to sue if WatchGuard’s products incorporate agreed-upon modified recording functionality. Digital Ally also granted WatchGuard a license to the ‘292 Patent and the ‘452 Patent (and related patents, now existing and yet-to-issue) through December 31, 2023. The parties agreed to negotiate in good faith to attempt to resolve any alleged infringement that occurs after the license period expires.
The parties further agreed to release each other from all claims or liabilities pre-existing the settlement.
As part of the settlement, the parties agreed that WatchGuard made no admission that it infringed any of Digital Ally’s patents.

Upon receipt of the $6,000,000 the parties filed a joint motion to dismiss the lawsuit with the court, which was granted.

F-32

General

401 (k) Plan. The Company sponsors a 401(k) retirement savings plan for the benefit of its employees. The plan, as amended, requires it to provide 100% matching contributions for employees, who elect to contribute up to 3% of their compensation to the plan and 50% matching contributions for employee’s elective deferrals on the next 2% of their contributions.contributions. The Company made matching contributions totaling $110,491$223,084 and $108,688$127,293 for the years ended December 31, 20202022 and 2019,2021, respectively. Each participant is 100% vested at all times in employee and employer matching contributions.

Consulting and Distributor Agreements. The Company entered into an agreement that required it to make monthly payments that will be applied to future commissions and/or consulting fees to be earned by the provider. The agreement is with a limited liability company (“LLC”) that is minority owned by a relative of the Company’s chief financial officer. Under the agreement, dated January 15, 2016 and as amended on February 13, 2017, the LLC provides consulting services for developing a new distribution channel outside of law enforcement for its body-worn camera and related cloud storage products to customers in the United States. The Company advanced amounts to the LLC against commissions ranging from $5,000 to $6,000 per month plus necessary and reasonable expenses for the period through June 30, 2017, which can be automatically extended based on the LLC achieving minimum sales quotas. The agreement was renewed in January 2017 for a period of three years, subject to yearly minimum sales thresholds that would allow the Company to terminate the contract if such minimums are not met. As of December 31, 2020, the Company had advanced a total of $274,731 pursuant to this agreement which has been fully reserved for a net advance of $-0-. The minimum sales threshold was not met, and the Company discontinued all advances, although the contract has not been formally terminated. However, the exclusivity provisions of the agreement have been terminated.

On June 1, 2018 the Company entered into an agreement with an individual that required it to make monthly payments that will be applied to future commissions and/or consulting fees to be earned by the provider. Under the agreement, the individual provides consulting services for developing new distribution channels both inside and outside of law enforcement for its in-car and body-worn camera systems and related cloud storage products to customers within and outside the United States. The Company was required to advance amounts to the individual as an advance against commissions of $7,000 per month plus necessary and reasonable expenses for the period through August 31, 2018, which was extended to December 31, 2018 by mutual agreement of the parties at $6,000 per month. The parties have mutually agreed to further extend the arrangement on a monthly basis at $5,000 per month. The Company had advanced a total of $53,332 pursuant to this agreement, until September of 2020 when the agreement was mutually terminated, thus as of December 31, 2020 the Company had advanced $-0- pursuant to this agreement.

NOTE 13. 16. STOCK-BASED COMPENSATION

The Company recorded pretaxpre-tax compensation expense related to the grant of stock options and restricted stock issued of $1,462,270$1,282,757 and $2,112,090$1,605,949 for the years ended December 31, 20202022 and 2019,2021, respectively.

F-32

As of December 31, 2020,2022, the Company had adopted nineten separate stock option and restricted stock plans: (i) the 2005 Stock Option and Restricted Stock Plan (the “2005 Plan”), (ii) the 2006 Stock Option and Restricted Stock Plan (the “2006 Plan”), (iii) the 2007 Stock Option and Restricted Stock Plan (the “2007 Plan”), (iv) the 2008 Stock Option and Restricted Stock Plan (the “2008 Plan”), (v) the 2011 Stock Option and Restricted Stock Plan (the “2011 Plan”), (vi) the 2013 Stock Option and Restricted Stock Plan (the “2013 Plan”), (vii) the 2015 Stock Option and Restricted Stock Plan (the “2015 Plan”), (viii) the 2018 Stock Option and Restricted Stock Plan (the “2018 Plan”) and, (ix) the 2020 Stock Option and Restricted Stock Plan (the “2020 Plan”).., and (x) the 2022 Stock Option and Restricted Stock Plan (the “2022 Plan”). The 2005 Plan, 2006 Plan, 2007 Plan, 2008 Plan, 2011 Plan, 2013 Plan, 2015 Plan, 2018 Plan, 2020 Plan and 20202022 Plan are referred to as the “Plans.”

These Plans permit the grant of stock options or restricted stock to its employees, non-employee directors and others for up to a total of 5,675,000333,750 shares of common stock. The 2005 Plan terminated during 2015 with 19,6781,078 shares not awarded or underlying options, which shares are now unavailable for issuance. Stock options granted under the 2005 Plan that remain unexercised and outstanding as of December 31, 20202022 total 7,563.284. The 2006 Plan terminated during 2016 with 25,8492,739 shares not awarded or underlying options, which shares are now unavailable for issuance. Stock options granted under the 2006 Plan that remain unexercised and outstanding as of December 31, 20202022 total 39,750.531. The 2007 Plan terminated during 2017 with 89,6514,733 shares not awarded or underlying options, which shares are now unavailable for issuance. StockThere are no stock options granted under the 2007 Plan that remain unexercised and outstanding as of December 31, 2020 total 5,000.2022. The 2008 Plan terminated during 2018 with 9,2492,025 shares not awarded or underlying options, which shares are now unavailable for issuance. StockThere are no stock options granted under the 2008 Plan that remain unexercised and outstanding as of December 31, 2020 total 31,250.2022.

F-33

Our Board of Directors adopted the 2020 Stock Option and Restricted Stock Plan (the “2020 Plan”) on SeptemberJune 30, 2020 and the Company’s stockholders approved the 2020 Plan at the Annual Meeting held on September 9, 2020. The Company’s stockholders approved an amendment to the 2020 Plan authorizes us to issue 1,500,000at the Annual Meeting held on June 22, 2021 which increased the number of shares of Common Stock upon exerciseauthorized and reserved for issuance under the 2020 Plan to a total of options and grant of restricted stock awards.125,000. A total of 438,341112,958 options and restricted stock have been granted under the 2020 Plan to date. The 2020 Plan also authorizes us to grant (i) to the key employees’ incentive stock options to purchase shares of Common Stock and non-qualified stock options to purchase shares of Common Stock and restricted stock awards and (ii) to non-employee directors and consultants non-qualified stock options and restricted stock.

Our Board of Directors adopted the 2022 Stock Option and Restricted Stock Plan (the “2022 Plan”) on October 28, 2022 and the Company’s stockholders approved the 2022 Plan at the Annual Meeting held on December 7, 2022. The number of shares of Common Stock authorized and reserved for issuance under the 2022 Plan totals 125,000. The 2022 Plan also authorizes us to grant (i) to the key employees’ incentive stock options to purchase shares of Common Stock and non-qualified stock options to purchase shares of Common Stock and restricted stock awards and (ii) to non-employee directors and consultants non-qualified stock options and restricted stock.

The Company believes that such awards better align the interests of our employees with those of its stockholders. Option awards have been granted with an exercise price equal to the market price of its stock at the date of grant with such option awards generally vesting based on the completion of continuous service and having ten-year contractual terms. These option awards typically provide for accelerated vesting if there is a change in control (as defined in the Plans). The Company has registered all shares of common stock that are issuable under its Plans with the SEC. A total of 1,064,346137,042 shares remained available for awards under the various Plans as of December 31, 2020.2022.

The fair value of each option award is estimated on the date of grant using a Black-Scholes option valuation model.

F-33

Activity in the various Plans during the years ended December 31, 20202022 and 20192021 is reflected in the following table:

SUMMARY OF STOCK OPTIONS OUTSTANDING

Options Number of
Shares
  Weighted
Average
Exercise Price
  Number of
Shares
 Weighted
Average
Exercise Price
 
Outstanding at January 1, 2019  434,012  $4.62 
Outstanding at January 1, 2021  41,916  $64.00 
Granted  180,000   3.01   15,000   33.40 
Exercised            
Forfeited  (24,887)  (13.78)  (2,613)  (232.20)
Outstanding at December 31, 2019  589,125  $3.74 
Exercisable at December 31, 2019  499,125  $3.87 
Outstanding at December 31, 2021  54,303  $47.40 
Exercisable at December 31, 2021  46,803  $49.60 

Options Number of
Shares
  Weighted
Average
Exercise Price
  Number of
Shares
 Weighted
Average
Exercise Price
 
Outstanding at January 1, 2020  589,125  $3.74 
Outstanding at January 1, 2022  54,303  $47.40 
Granted  255,000   2.09   1,250   19.60 
Exercised  (1,875)  4.16       
Forfeited  (3,937)  (12.14)  (1,603)  (80.80)
Outstanding at December 31, 2020  838,313  $3.20 
Exercisable at December 31, 2020  725,813  $3.37 
Outstanding at December 31, 2022  53,950  $45.80 
Exercisable at December 31, 2022  53,950  $45.80 

The fair value of each option award is estimated on the date of grant using a Black-Scholes option valuation model. The total estimated grant date fair value stock options issued during the year ended December 31, 20202022 and 20192021 was $415,742$22,768 and $436,217,$466,831, respectively.

The Company has utilized the following assumptions in its Black-Scholes option valuation model to calculate the estimated grant date fair value of the options during the years ended December 31, 20202022 and 2019:2021:

SCHEDULE OF FAIR VALUE OF STOCK OPTIONS ASSUMPTION

 2020 2019  2022 2021 
 Assumptions  Assumptions  Assumptions Assumptions 
Volatility – range  104%  107.6%  111.67%  113%
Risk-free rate  0.28%  2.23%  1.81%  1.30%
Contractual term  5.5 years   5.5 years 
Expected term  10.0 years   10.0 years 
Exercise price $2.09  $3.01  $19.60  $33.40 

F-34

The Plans allow for the cashless exercise of stock options. This provision allows the option holder to surrender/cancel options with an intrinsic value equivalent to the purchase/exercise price of other options exercised. There were no shares surrendered pursuant to cashless exercises during the years ended December 31, 20202022 and 2019.2021.

At December 31, 20202022 and 2019,2021, the aggregate intrinsic value of options outstanding was approximately $86,150$-0- and $-0-$-0-, respectively, and the aggregate intrinsic value of options exercisable was approximately $58,025$-0- and $-0-$-0-, respectively.

As of December 31, 2020, the unrecognized portion of stock compensation expense on all existing stock options was $183,415 and will be recognized over the next five months.

The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable options under the Company’s option plans as of December 31, 2020:2022:

SCHEDULE OF SHARES AUTHORIZED UNDER STOCK OPTION PLANS BY EXERCISE PRICE RANGE

   Outstanding options  Exercisable options 
Exercise price
range
  Number of
options
  Weighted
average
remaining
contractual life
  Number of
options
  Weighted average
remaining
contractual life
 
                   
$0.01 to $49.99   37,000   7.6 years   37,000   7.6 years 
$50.00 to $69.99   15,100   5.5 years   15,100   5.5 years 
$70.00 to $89.99   1,850   2.8 years   1,850   2.8 years 
                   
     53,950   6.8 years   53,950   6.8 years 

F-34

   Outstanding options Exercisable options 
Exercise price
range
  Number of
options
  Weighted average
remaining
contractual life
 Number of
options
  Weighted average
remaining
contractual life
 
             
$0.01 to $3.49   725,313  8.2 years  612,813   7.9 years 
$3.50 to $4.99   64,000  3.3 years  64,000   3.3 years 
$5.00 to $6.49     — years     —years 
$6.50 to $7.99   7,250  0.8 years  7,250   0.8 years 
$8.00 to $9.99   2,500  0.4 years  2,500   0.4 years 
$10.00 to $13.20   39,250  0.0 years  39,250   0.0 years 
                 
                 
     838,313  7.3 years  725,813   7.0 years 

Restricted stock grants. The Board of Directors has granted restricted stock awards under the Plans. Restricted stock awards are valued on the date of grant and have no purchase price for the recipient. Restricted stock awards typically vest over one to four years corresponding to anniversaries of the grant date. Under the Plans, unvested shares of restricted stock awards may be forfeited upon the termination of service to or employment with the Company, depending upon the circumstances of termination. Except for restrictions placed on the transferability of restricted stock, holders of unvested restricted stock have full stockholder’s rights, including voting rights and the right to receive cash dividends.

A summary of all restricted stock activity under the equity compensation plans for the years ended December 31, 20202022 and 20192021 is as follows:

SUMMARY OF RESTRICTED STOCK ACTIVITY

 Number of
Restricted
shares
  Weighted
average
grant date
fair value
  Number of
Restricted
shares
 Weighted
average
grant date
fair value
 
Nonvested balance, January 1, 2019  772,150  $3.40 
Nonvested balance, January 1, 2021  36,006  $33.80 
Granted  522,110   2.91   42,800   41.40 
Vested  (774,015)  (3.35)  (25,563)  (38.80)
Forfeited  (5,370)  (3.46)  (375)  (21.60)
Nonvested balance, December 31, 2019  514,875  $2.97 
Nonvested balance, December 31, 2021  52,869  $37.40 

F-35
  Number of
Restricted
shares
  Weighted
average
grant date
fair value
 
Nonvested balance, January 1, 2022  52,869  $37.40 
Granted  60,750   14.67 
Vested  (31,244)  (34.73)
Forfeited  (3,250)  (21.20)
Nonvested balance, December 31, 2022  79,125  $21.73 

  Number of
Restricted
shares
  Weighted
average
grant date
fair value
 
Nonvested balance, January 1, 2020  514,875  $2.97 
Granted  846,591   1.02 
Vested  (604,591)  (1.85)
Forfeited  (36,750)  (1.84)
Nonvested balance, December 31, 2020  720,125  $1.69 

The Company estimated the fair market value of these restricted stock grants based on the closing market price on the date of the grant. As of December 31, 2020,2022, there were $130,072$500,280 of total unrecognized compensation costs related to all remaining non-vested restricted stock grants, which will be amortized over the next 12forty-eight months in accordance with their respective vesting scale.

The nonvested balance of restricted stock vests as follows:

SCHEDULE OF NON-VESTED BALANCE OF RESTRICTED STOCK

Years ended Number of
shares
 
    
2021  479,250 
2022  240,875 
Years ended Number of
shares
 
    
2023  57,250 
2024  12,750 
2025  4,000 
2026  3,625 
2027  1,500 

NOTE 14. 17. COMMON STOCK PURCHASE WARRANTS

The Company has issued common stock purchase warrants in conjunction with various debt and equity issuances. The warrants are either immediately exercisable, or have a delayed initial exercise date, no more than six months from their respective issue date and allow the holders to purchase up to 3,388,36467,459 shares of common stock at $2.60$52.00 to $13.43$67.20 per share as of December 31, 2020. 2022. The warrants expire from January 22, 2021February 23, 2023 through July 31, 2023 and certain of the outstanding warrants allow for cashless exercise.

F-35

On January 14, 2021 and February 1, 2021, the Company issued warrants to purchase a total of 2,127,500 shares of Common Stock. The warrant terms provide for net cash settlement outside the control of the Company under certain circumstances in the event of tender offers. As such, the Company is required to treat these warrants as derivative liabilities which are valued at their estimated fair value at their issuance date and at each reporting date with any subsequent changes reported in the consolidated statements of operations as the change in fair value of warrant derivative liabilities. Furthermore, the Company re-values the fair value of warrant derivative liability as of the date the warrant is exercised with the resulting warrant derivative liability transitioned to change in fair value of warrant derivative liabilities through the consolidated statement of operations.

On August 19, 2021, the Company entered into a Warrant Exchange Agreement (the “Exchange Agreement”) with the Investors cancelling February Warrants exercisable for an aggregate of 384,077 shares of Common Stock in consideration for its issuance of (i) new warrants (the “Exchange Warrants”) to the Investors exercisable for an aggregate of up to 384,077 shares of Common Stock. The Company also issued warrants (the “Replacement Original Warrants”) replacing the February Warrants for the remaining shares of Common Stock exercisable thereunder, representing an aggregate of 330,923 shares of Common Stock, and extended the expiration date of the February Warrants to September 18, 2026. The Exchange Warrants provide for an initial exercise price of $65.00 per share, subject to customary adjustments thereunder, and are immediately exercisable upon issuance for cash and on a cashless basis. On the date of the exchange, the Company calculated the fair value, using the Black-Scholes method, of the cancelled February Warrants and the newly issued Exchange Warrants, the difference in fair value measurement of the respective warrants was attributed to warrant modification expense in the consolidated statement of operations.

On the date of the exchange, the February Warrants and Exchange Warrants were valued at $11,818,644 and $12,114,424 using the original and modified expiry date of the warrants, respectively, using the Black-Scholes method. The difference of $295,780 was accordingly recorded as a warrant modification expense in the consolidated statement of operations.

SCHEDULE OF WARRANT MODIFICATION

  Original terms at August 19, 2021  Modified terms at August 19, 2021 
Volatility - range  109.3%  104.7%
Risk-free rate  0.78%  0.78%
Dividend  0%  0%
Remaining contractual term  4.5 years   5.1 years 
Exercise price $65.00  $65.00 
Common stock issuable under the warrants  715,000   715,000 

On August 23, 2022, the Company entered into Warrant Exchange Agreements (the “Warrant Exchange Agreements”) with certain investors (the “Investors”), pursuant to which the Company agreed to issue to the Investors an aggregate of 303,750 shares of Common Stock in exchange for the cancellation by the Investors of the January Warrants, the Exchange Warrants and the Replacement Originals Warrants. On the date of the exchange, the Company calculated the fair value of the issuance of shares of common stock pursuant to the Warrant Exchange Agreements, attributing that value to common stock and additional paid in capital. The remaining value of the warrant derivative liability was attributed to an income from change in fair market value of warrant derivative liabilities and gain on extinguishment of warrant derivative liabilities in the consolidated statement of operations. On the date of the Warrant Exchange Agreement, using the Black-Scholes method, the fair value of the warrant derivative liability was $8.1 million, compared to $9.3 million at June 30, 2022, resulting in income from change in fair market value of warrant derivative liabilities of $1.2 million during the year ended December 31, 2022. Further, the value of the issued shares of Common Stock was $4.5 million, applied to additional paid in capital, resulting in a gain on the extinguishment of warrant derivative liabilities of $3.6 million during the year ended December 31, 2022.

  Terms at
August 23, 2022
 
Volatility - range  103.7%
Risk-free rate  3.17 - 3.36%
Dividend  0%
Remaining contractual term  3.4 - 4.1 years 
Exercise price $65.00 
Common stock issuable under the warrants  1,215,000 

F-36

Fluctuations in the Company’s stock price are a primary driver for the changes in the derivative valuations during each reporting period. As the stock price increases for each of the related derivative instruments, the value to the holder of the instrument generally increases, therefore increasing the liability on the Company’s balance sheet. Additionally, stock price volatility is one of the significant unobservable inputs used in the fair value measurement of each of the Company’s derivative instruments. The simulated fair value of these liabilities is sensitive to changes in the Company’s expected volatility. Increases in expected volatility would generally result in higher fair value measurement. A 10% change in pricing inputs and changes in volatilities and correlation factors would not result in a material change in our Level 3 fair value.

The following table summarizes information about shares issuable under warrants outstanding during the years ended December 31, 20202022 and 2019:2021:

SUMMARY OF WARRANT ACTIVITY

 Warrants  Weighted
average
exercise price
  Warrants Weighted
average
exercise price
 
Vested Balance, January 1, 2019  4,693,145  $5.40 
Vested Balance, January 1, 2021  169,418  $124.80 
Granted  678,428   1.75   2,127,500   62.20 
Exercised  (529,000)  (2.96)  (912,500)  (58.40)
Cancelled  (18,000)  (3.50)  (83,988)  (188.40)
Vested Balance, December 31, 2019  4,824,573  $5.15 
Vested Balance, December 31, 2021  1,300,430  $64.80 

  Warrants  Weighted
average
exercise price
 
Vested Balance, January 1, 2020  4,824,573  $5.15 
Granted  1,273,374   1.31 
Exercised  (2,704,583)  (1.95)
Cancelled  (5,000)  (16.50)
Vested Balance, December 31, 2020  3,388,364  $6.24 
  Warrants  Weighted
average
exercise price
 
Vested Balance, January 1, 2022  1,300,430  $64.80 
Granted      
Exercised      
Forfeited/cancelled  (1,232,971)  (65.08)
Vested Balance, December 31, 2022  67,459  $60.26 

F-36

The total intrinsic value of all outstanding warrants aggregated $-0-$-0- as of December 31, 20202022 and 2021, and the weighted average remaining term is 15.8 months.was 3.9 and 50.7 months as of December 31, 2022 and 2021, respectively.

The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable warrants to purchase shares of common sharesstock as of December 31, 2020:2022:

SUMMARY OF RANGE OF EXERCISE PRICES AND WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE OF WARRANTS 

  Outstanding and exercisable warrants   Outstanding and exercisable warrants 
Exercise priceExercise price  Number of warrants  Weighted average
remaining
contractual life
Exercise
price
 Number of
warrants
 Weighted average
remaining
contractual life
 
$2.60   465,712  2.6 years52.00   23,286   0.6 years 
$3.00   316,800  2.3 years60.00   15,840   0.3 years 
$3.36   733,333  1.9 years67.20   28,333   0.2 years 
$3.65   167,000  1.5 years
$3.75   25,753  1.6 years
$5.00   800,000  1.0 years
$13.43   879,766  0.1 years
                  
    3,388,364  1.3 years    67,459   0.3 years 

F-37

NOTE 1518 - STOCKHOLDERS’ EQUITY

Amendment to Articles of IncorporationRegistered Direct Offerings

The Company held its annual meeting of the shareholders on September 9, 2020. At such meeting a proposed amendment to the Company’s Articles of Incorporation to increase the number of authorized shares of capital stock thatOn January 14, 2021, the Company may issue from 50,000,000 to 100,000,000, of which all 100,000,000 shares shall be classified as Common Stock, was approved.

Underwritten Public Offering

On March 3, 2020, the Company entered into an underwriting agreement with Aegis Capital Corp., as the representative of the underwriters and sole book-running manager, pursuant to which the Company agreed to sell to the underwriters inconsummated a firm commitment underwritten publicregistered direct offering (the “Offering”) an aggregate of 2,521,740(i) 140,000 shares of common stock (“Shares”), (ii) pre-funded warrants to purchase up to 360,000 shares of Common Stock (the “Pre-Funded Warrants”), issuable to investors whose purchase of shares of Common Stock would otherwise result in such investor, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the holder, 9.99%) of the Company’s outstanding Common Stock immediately following the consummation of the Registered Offering (“Pre-Funded Warrants”); and (iii) common stock at a public price of $1.15 per share. The Company also granted the underwriters a forty-five (45)-day optionpurchase warrants (“Warrants”) to purchase up to an additional 378,261aggregate of 500,000 shares of common stockCommon Stock (the “Warrant Shares”), which are exercisable for a period of five years after issuance at an initial exercise price $65.00 per share, subject to cover over-allotments, if any.certain adjustments, as provided in the Warrants. The Offering was registeredconducted pursuant to a placement agency agreement, dated January 12, 2021, between the Company and Kingswood Capital Markets, division of Benchmark Investments, Inc., who acted as the exclusive placement agent in connection with the Offering pursuant to a placement agency agreement. The Shares and accompanying Warrants in the Offering were sold at a combined offering price of $61.90 per Share and accompanying Warrant and the common stock wasPre-Funded Warrants and accompanying Warrants in the Offering were sold at a combined offering price of $61.70 per Pre-Funded Warrant and accompanying Warrant.

The securities in the Offering were issued pursuant to a prospectus supplement to the Company’s effective shelf registration statement on Form S-3 (File No. 333-225227), which was initially filed with the SEC on May 25, 2018 and was declared effective on June 6, 2018.

333-239419). The underwritingplacement agency agreement contained customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Underwriters.placement agent. The Underwritersplacement agent received discounts and commissions of sevensix percent (7%(6%) of the gross cash proceeds received by the Company from the sale of the common stocksecurities sold in the Offering. In addition, theOffering and certain expenses.

The Company agreed to pay the Underwriters (a) a non-accountable expense reimbursement of 1%received approximately $28,941,000 ($29,013,000 upon full exercise of the gross proceeds received and (b) “road show” expenses, diligence fees and the fees and expenses of the Underwriters’ legal counsel not to exceed $50,000. Theprefunded warrants) in net proceeds to the Company from the Offering totaled $2,502,136, after deducting underwritingthe discounts, and commissions, and other estimated offering expenses payable by the Company. As of December 31, 2021, all pre-funded warrants have been fully exercised. The Company plans to use the net proceeds from the Offering for working capital, product development, order fulfilment and for general corporate purposes.

The Company received net proceeds from this offering as follows:

SCHEDULE OF NET PROCEEDS FROM OFFERING

Description Amount 
Net proceeds received:    
  8,666,000 
Proceeds from the sale of 140,000 shares of Common Stock at $61.90 per share $8,666,000 
Proceeds from the sale of pre-funded warrants to purchase 360,000 shares of Common Stock at $61.70 per share  22,212,000 
Less: Placement agent fees and other expenses of the offering  (1,937,000)
     
Net proceeds of the offering $28,941,000 

In conjunction with this Offering, the Company issued prefunded Common Stock purchase warrants to purchase up to 360,000 shares Common Stock at $61.90 per share ($61.70 prefunded at closing) and Common Stock purchase warrants to purchase up to 500,000 shares of Common Stock at $65.00 per share. The underlying warrant terms provide for net cash settlement outside the control of the Company under certain circumstances in the event of tender offers. As such, the Company is required to treat these warrants as derivative liabilities which are valued at their estimated fair value at their issuance date and at each reporting date with any subsequent changes reported in the consolidated statements of operations as the change in fair value of warrant derivative liabilities. Accordingly, the Company allocated a portion of the net proceeds of this offering to warrant derivative liabilities based on their estimated fair value as follows (See Notes 11 and 17):

F-37F-38

SCHEDULE OF NET PROCEEDS FROM OFFERING

Description Amount 
    
Warrant derivative liabilities $21,922,158 
Pre-funded warrant derivative liabilities  378,615 
Total allocation of the net proceeds of the offering to warrant derivative liabilities $22,300,773 

Registered Direct Offerings

On June 2, 2020, February 1, 2021, the Company entered intoconsummated an underwriting agreementregistered direct offering (the “Second Offering”) of (i) 162,500 shares of common stock (“February 2021 Shares”), (ii) pre-funded warrants to purchase up to 552,500 shares of Common Stock (the “February 2021 Pre-Funded Warrants”), issuable to investors whose purchase of shares of Common Stock would otherwise result in such investor, together with Aegis Capital Corp., asits affiliates and certain related parties, beneficially owning more than 4.99% (or, at the representativeelection of the underwriters and sole book-running manager, pursuant to which the Company agreed to sell to the underwriters in a firm commitment underwritten public offering an aggregate of 3,090,909 sharesholder, 9.99%) of the Company’s outstanding Common Stock immediately following the consummation of the Registered Offering; and (iii) common stock at a public price of $1.65 per share (the “June 2nd Offering”purchase warrants (“February 2021 Warrants”). The Company also granted the underwriters a forty-five (45)-day option to purchase up to an additional 463,636aggregate of 715,000 shares of common stockCommon Stock (the “February 2021 Warrant Shares”), which are exercisable for a period of five years after issuance at an initial exercise price $65.00 per share, subject to cover over-allotments, if any (the “June 2nd Option Shares”).certain adjustments, as provided in the February 2021 Warrants. The June 2nd Second Offering was registeredconducted pursuant to a placement agency agreement, dated January 28, 2021, between the Company and Kingswood Capital Markets, division of Benchmark Investments, Inc., who acted as the exclusive placement agent in connection with the Second Offering pursuant to a placement agency agreement. The February 2021 Shares and accompanying February 2021 Warrants in the Second Offering were sold at a combined offering price of $56.00 per February 2021 Share and accompanying February 2021 Warrant and the common stock wasFebruary 2021 Pre-Funded Warrants and accompanying February 2021 Warrants in the Offering were sold at a combined offering price of $55.80 per February 2021 Pre-Funded Warrant and accompanying February 2021 Warrant.

The securities in the Second Offering were issued pursuant to a prospectus supplement to the Company’s effective shelf registration statement on Form S-3 (File No. 333-225227), which was initially filed with the SEC on May 25, 2018 and was declared effective on June 6, 2018.

On June 8, 2020, the Underwriters fully exercised their over-allotment option to acquire the June 2nd Option Shares at $1.65 per share, and the offering of the June 2nd Option Shares closed on June 10, 2020.333-239419). The exercise of such over-allotment option resulted in additional gross proceeds, before deducting underwriting discounts and commissions and other estimated offering expenses, of $765,000, which the Company intends to use for general corporate purposes, including for compliance with certain Nasdaq continued listing requirements and continued investments in the Company’s commercialization efforts.

The underwritingplacement agency agreement contained customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Underwriters.placement agent. The Underwritersplacement agent received discounts and commissions of sevensix percent (7%(6%) of the gross cash proceeds received by the Company from the sale of the common sharessecurities sold in the June 2nd Offering. In addition, theSecond Offering and certain expenses.

F-39

The Company agreed to pay the Underwriters “road show” expenses, diligence fees and the fees and expenses of the Underwriters’ legal counsel not to exceed $30,000. The net proceeds to the Company from the June 2nd Offering totaled $5,350,413, including thereceived approximately $37,447,100 ($37,557,600 upon full exercise of the underwriter’s overallotment option andprefunded warrants) in net proceeds from the Second Offering after deducting underwritingthe discounts, and commissions, and other estimated offering expenses payable by the Company. As of December 31, 2021, all pre-funded warrants have been fully exercised. The Company plans to use the net proceeds from the Second Offering for working capital, product development, order fulfilment and for general corporate purposes.

On June 8, 2020,The Company received net proceeds from this offering as follows:

SCHEDULE OF NET PROCEEDS FROM OFFERING

DescriptionAmount
Net proceeds received:
Proceeds from the sale of 162,500 shares of Common Stock at $56.00 per share$9,100,000
Proceeds from the sale of pre-funded warrants to purchase 552,500 shares of Common Stock at $55.80 per share30,829,500
Less: Placement agent fees and other expenses of the offering(2,482,400)
Net proceeds of the offering$37,447,100

In conjunction with the Second Offering, the Company entered into an underwriting agreement with Aegis Capital Corp., as the representative of the underwriters and sole book-running manager, pursuant to which the Company agreed to sell to the underwriters in a firm commitment underwritten public offering an aggregate of 2,325,581 shares of common stock at a public price of $2.15 per share (the “June 8th Offering”). The Company also granted the underwriters a forty-five (45)-day optionissued prefunded Common Stock purchase warrants to purchase up to an additional 213,953 552,500 shares of common stock to cover over-allotments, if any (the “June 8th Option Shares”).The June 8th Offering was registered and the common stock was issued pursuant to the Company’s shelf registration statement on Form S-3 (File No. 333-225227), which was initially filed with the SEC on May 25, 2018 and was declared effective on June 6, 2018.

On June 10, 2020, the Underwriters fully exercised their over-allotment option to acquire the June 8th Option SharesStock at $2.15 $56.00 per share ($55.80 prefunded at closing) and Common Stock purchase warrants to purchase up to 715,000 shares of Common Stock at $65.00 per share. The underlying warrant terms provide for net cash settlement outside the offering of the June 8th Option Shares closed on June 10, 2020. The exercise of such over-allotment option resulted in additional gross proceeds, before deducting underwriting discounts and commissions and other estimated Offering expenses, of $460,000, which the Company intends to use for general corporate purposes, including for compliance with certain Nasdaq continued listing requirements and continued investments in the Company’s commercialization efforts.

The underwriting agreement contained customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligationscontrol of the Company under certain circumstances in the event of tender offers. As such, the Company is required to treat these warrants as derivative liabilities which are valued at their estimated fair value at their issuance date and at each reporting date with any subsequent changes reported in the Underwriters. The Underwriters received discounts and commissionsconsolidated statements of seven percent (7%)operations as the change in fair value of warrant derivative liabilities. Accordingly, the Company allocated a portion of the gross cash proceeds received by the Company from the sale of the common shares in the June 8th Offering. In addition, the Company agreed to pay the Underwriters “road show” expenses, diligence fees and the fees and expenses of the Underwriters’ legal counsel not to exceed $30,000. The net proceeds of this offering to the Company from the June 8th Offering totaled $4,976,692, including the exercise of the underwriter’s overallotment optionwarrant derivative liabilities based on their estimated fair value as follows (See Notes 11 and after deducting underwriting discounts and commissions and estimated expenses payable by the Company.17):

SCHEDULE OF NET PROCEEDS FROM OFFERING

F-38
Description Amount 
    
Warrant derivative liabilities $27,476,352 
Pre-funded warrant derivative liabilities  1,438,934 
Total allocation of the net proceeds of the offering to warrant derivative liabilities $28,915,286 

2020 Issuances2022 Issuance of Restricted Common StockStock..

On January 3, 2020,7, 2022, the board of directors approved the grant of 530,05026,250 shares of restricted common stock to officers and employees of the Company. Such shares will generally vest one-halfover various periods ranging from one to five years on January 2, 2021 and one half on January 2, 2022,the anniversary of the grant date, provided that each grantee remains an officer or employee on such dates.

On various dates in January 2022, the board of directors approved the grant of 9,500 shares of common stock to employees of the Company. Most shares will generally vest in varying amounts over the next two to five years, provided that each grantee remains an employee on such vesting dates.

Cancellation of Restricted Stock

During the year ended December 31, 2022, the Company cancelled 3,250 shares for various reasons.

Preferred Stock Transaction

 

In April 17, 2020 the Compensation Committee of the Board of Directors of the Company determined that the cash portion of the annual base salaries of the Company’s President and Chief Executive Officer, and the Company’s Chief Financial Officer, Treasurer and Secretary, would be reduced to annual rates of $150,000 each for the balance of 2020 commencing May 1, 2020.

The Committee also decided that the reduction of the base annual salaries of Company’s President and Chief Executive Officer, and the Company’s Chief Financial Officer, Treasurer and Secretary, for 2020, which totaled $69,231 and $55,384, respectively, as of May 1, 2020 was paid through the issuance of shares of restricted stock under the 2018 Stock Option and Restricted Stock Plan with the Company paying the applicable federal and state taxes on such amounts. Accordingly, the Company issued the Company’s President and Chief Executive Officer, and the Company’s Chief Financial Officer, Treasurer and Secretary 75,250 shares and 60,200 shares, respectively, effective April 17, 2020 based on a closing price of $0.92 per share on such date. In addition, on September 9, 2020 a total of 178,091 shares of restricted stock were issued to five employees in consideration for their agreement to voluntary reduce their cash compensation by a total of $165,625 with the Company paying the applicable federal and state taxes on such amounts.

On July 1, 2020,October 13, 2022, the Company, entered into a commission agreementSecurities Purchase Agreement (the “Purchase Agreement”) with certain institutional investors (the “Preferred Stock Investors”), pursuant to which the Company agreed to issue and sell, in a private placement (the “2022 Offering”), 1,400,000 shares of the Company’s Series A Convertible Redeemable Preferred Stock, par value $0.001 per share (the “Series A Preferred Stock”), and 100,000 shares of the Company’s Series B Convertible Redeemable Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”, and together with the Series A Preferred Stock, the “Preferred Stock”), at an individual who provides servicesoffering price of $9.50 per share, representing a 5% original issue discount to the stated value of $10.00 per share, for our Shieldgross aggregate proceeds of $15 million in the 2022 Offering, before the deduction of discounts, fees and ThermoVU product lines. offering expenses. The shares of Preferred Stock will, under certain circumstances, be convertible into shares of the Company’s common stock, at the option of the holders of the Preferred Stock and, in certain circumstances, by the Company. In connection with the 2022 Offering, the Company paid A.G.P./Alliance Global Partners (the “Financial Advisor”) an aggregate cash fee equal to $750,000 and reimbursed the Financial Advisor for certain of its expenses in an amount not to exceed $135,000.

Pursuant to the Purchase Agreement, the Company filed on October 17, 2022 certificates of designation (the “Certificates of Designation”) with the Secretary of the State of Nevada designating the rights, preferences and limitations of the shares of Series A Preferred Stock and Series B Preferred Stock. The Certificate of Designation for the Series A Preferred Stock provides, in particular, that the Series A Preferred Stock will have no voting rights other than the right to vote on the Amendments on an as-if-converted-to-Common-Stock basis. The Certificate of Designation for the Series B Preferred Stock provides, in particular, that the Series B Preferred Stock will have no voting rights other than the right to vote on the Amendments and each share of Series B Preferred Stock entitles the holder thereof the right to cast 2,500 votes on the Amendments.

The holders of Preferred Stock will be entitled to dividends, on an as-if converted-to-Common-Stock basis, equal to dividends actually paid, if any, on shares of Common Stock. The Preferred Stock is convertible, at the option of the holders and, in certain circumstances, by the Company, into shares of Common Stock at a conversion price of $20.00 per share. The conversion price can be adjusted pursuant to the Certificates of Designation for stock dividends and stock splits, subsequent rights offering, pro rata distributions of dividends or other distribution of its assets, or the occurrence of a fundamental transaction (as defined in the applicable Certificate of Designation).

The holders of the Series A Preferred Stock and Series B Preferred Stock have the right to require the Company to redeem their shares of the relevant series at a price per share equal to 105% of the stated value of such agreement, weshares commencing (i) after the earlier of (1) the receipt of stockholder approval of the Amendments and (2) sixty (60) days after the closing of the 2022 Offering and (ii) before the date that is ninety (90) days after such closing. The Company has the option to redeem the Series A Preferred Stock and Series B Preferred Stock at a price per share equal to 105% of the stated value of such shares commencing after the 90th day following the closing of the 2022 Offering, subject to the holders’ rights to convert the shares prior to such redemption.

The proceeds of the 2022 Offering were held in an escrow account, along with the additional amount that would be necessary to fund the 105% redemption price until the expiration of the redemption period for the Preferred Stock, as applicable, subject to the earlier payment to redeeming holders. Upon expiration of the redemption period, any proceeds remaining in the escrow account will be disbursed to the Company.

The 2022 Offering closed on October 19, 2022. In December 2022, the Company redeemed 1,400,000 shares of Series A & 100,000 shares of Series B Preferred Stock, for a redemption price of $15,750,000, with a $13,365,000 carrying amount, resulting in a $2,385,000 loss on redemption.

Issuance of Common Stock as Consideration for the Potential Spin-Off Transaction.

On December 28, 2022, the Company issued a total of 10,00025,000 shares of common stock valued at $30,700 based onas a portion of the closing market price which has been expensed duringconsideration paid for the advisory services associated with the potential spin-off transaction.

F-40

Stock Repurchase Program

On December 6, 2021, the board of directors of the Company authorized the repurchase of up to $10.0 million of the Company’s outstanding common stock under the specified terms of a share repurchase program (the “Program”). During the year ended December 31, 2020.

Shelf Registration Statement on Form S-3

On July 2, 2020, the SEC declared the Company’s shelf registration statement on Form S-3 (the “Shelf Registration Statement”) effective. The Shelf Registration Statement allows2022, the Company to offer and sell, from time to time in one or more offerings, any combinationrepurchased 186,299 shares of ourits common stock debt securities, debt securities convertible into common stock or other securitiesfor $4,026,523, in any combination thereof, rightsaccordance with the Program.

SCHEDULE OF STOCK REPURCHASE

Period Total
Number of
Shares
Purchased
  Average
Price
Paid per
Shares
  Total
Number of
Shares
Purchased as
Part of
Publicly
Announced
Program
  Maximum
Approximate
Dollar Value
of
Shares that
May Yet Be
Purchased
Under the
Program
 
December 2021  86,742  $22.80   86,742    
January 2022  34,855   22.20   34,855    
February 2022  34,649   22.40   34,649    
March 2022  24,298   21.20   24,298    
April 2022  29,774   22.80   29,774    
May 2022  35,846   21.60   35,846    
June 2022  26,878   19.20   26,878    
Total all plans  273,041  $22.00   273,041  $3,998,398 

On June 30, 2022, the board of directors of the Company elected to purchaseterminate the Program, effective immediately. The Program began in December 2021, with the Company purchasing a total of 273,041 shares at a cost of common stock or other securities in any combination thereof, warrants to purchase shares of common stock or other securities in any combination thereof or units consisting of common stock or other securities in any combination thereof having an aggregate initial offering price not exceeding $125,000,000. $6,001,602 through June 30, 2022.

Noncontrolling Interests

The Company has utilizedowns a 51% equity interest in its consolidated subsidiary, Nobility Healthcare. As a result, the shelfnoncontrolling shareholders or minority interest is allocated 49% of the income/loss of Nobility Healthcare which is reflected in the statement of (income) loss as “net (income) loss attributable to noncontrolling interests of consolidated subsidiary”. We reported net income attributable to noncontrolling interests of consolidated subsidiary of $407,933 and $56,453 for its two recent offerings as described in “Note 18. SUBSEQUENT EVENTS”.the year ended December 31, 2022 and 2021, respectively.

NOTE 16. 19. RELATED PARTY TRANSACTIONS

American Rebel Holding, Inc. Secured Promissory NotesTransactions with Managing Member of Nobility Healthcare

 

On October 1, 2020,January 27, 2022, the Company advanced $250,000 to American Rebel Holdings, Inc. (AREB) underboard of directors appointed Christian J. Hoffmann, III as a secured promissory note. The CEO, President and Chairman of AREB is the brothermember of the Company’s CEO, PresidentBoard, effective immediately. Mr. Hoffmann is a principal owner and Chairman. Such note bears interest at 8% andmanager of Nobility, LLC which is secured by allcurrently the tangible and intangible assetsmanaging member of the Company that are not currently secured by other indebtedness. our consolidated subsidiary Nobility Healthcare, LLC.

The Company also received warrants to purchase 1,250,000 shares of AREB common stock at an exercise price of $0.10 per share with a five-year term. This note had an original maturity date of January 2, 2021; however, additional provisions within the note provided for an extension of the maturity date for fourteen months due to AREB’s failure to raise $300,000 in new debt or equity financing prior to the original maturity date. Upon this extension, the AREB was obligated to make equal monthly payments of principal and interest over the extended period of the note. The required monthly payments have not been made by AREB, therefore this note is currently in default status.

F-39

On October 21, 2020, the Companyhas advanced $250,000 to American Rebel Holdings, Inc. (AREB) under a second secured promissory note. Such note bears interest at 8% and is secured by inventory manufactured and revenue/accounts receivable derived from a specific purchase order. The Company also received warrants to purchase 1,250,000 shares of AREB common stock at an exercise price of $0.10 per share with a five-year term. This note has a maturity date of April 21, 2021, subject to full repayment upon AREB closing on debt or equity financings of at least $600,000, and the receipt of revenue from the sale of inventory sold under the specific purchase order serving as collateral. The required monthly payments have not been made by AREB, therefore this note is currently in default status. On March 1, 2021, the Company advanced an additional $117,600 to AREB on terms similar to the previously issued notes.

The parties have been negotiating the terms of a Forbearance Agreement regarding the following: (a) the secured promissory note dated October 1, 2020; (b) the secured promissory note dated October 21, 2020; and (c) an advance made by the Company on March 1, 2021. The parties are attempting to arrange for a series of payments that will liquidate the outstanding balances of the two delinquent notes and the advance by no later than June 30, 2021. Based on the terms being negotiated, if AREB timely and fully complies with all of its obligations under the Forbearance Agreement, the Company would agree that AREB’s obligations to the Company in connection with the defaults would be satisfied. However, there is no assurance that the parties will agree to the terms contained in the Forbearance Agreement, and whether AREB will be able to comply with such terms.

Unsecured Promissory Notes Payable – Related party

During February and April 2020, the Company borrowed a total of $319,000 from$158,384 in the Company’s Chairman, CEO & President under an unsecured promissory note bearing interest at 6% through its May 28, 2020 maturity date.form of a working capital loan to Nobility, LLC in order to fund capital expenditures necessary for the initial growth of the joint venture during 2022. The proceeds fromoutstanding balance of the note were used for general corporate purposes. The principal balanceworking capital loan was $138,384 as of December 31, 2022 and related accrued interest were paid inthe Company anticipates full in cashrepayment of this advance during the year ended December 31, 2020. Total interest accrued 2023. The Company paid distributions to the noncontrolling in consolidated subsidiary totaling $15,692 and paid on this note was $5,236.$-0-, for the years ended December 31, 2022 and 2021, respectively.

On August 1, 2022, Mr. Hoffmann resigned as a member of the Board, effective immediately. He remains as a principal owner and manager of Nobility, LLC.

F-41

NOTE 17. 20. NET LOSSINCOME (LOSS) PER SHARE

The calculation of the weighted average number of shares outstanding and loss per share outstanding for the years ended December 31, 20202022 and 20192021 are as follows:

SCHEDULE OF WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING AND LOSS PER SHARE OUTSTANDING

 Year ended December 31,  2022 2021 
 2020  2019  Year ended December 31, 
Numerator for basic and diluted income per share – Net loss $(2,625,881) $(10,005,713)
 2022 2021 
Numerator for basic and diluted income (loss) per share – Net income (loss) attributable to common stockholders $(21,666,691) $25,474,508 
                
Denominator for basic loss per share – weighted average shares outstanding  21,603,635   11,478,618   2,548,549   2,511,114 
Dilutive effect of shares issuable upon conversion of convertible debt and the exercise of stock options and warrants outstanding            
                
Denominator for diluted loss per share – adjusted weighted average shares outstanding  21,603,635   11,478,618   2,548,549   2,511,114 
                
Net loss per share:        
Net income (loss) per share:        
Basic $(0.12) $(0.87) $(8.50) $10.14 
Diluted $(0.12) $(0.87) $(8.50) $10.14 

Basic lossincome (loss) per share is based upon the weighted average number of shares of common sharesstock outstanding during the period. For the years ended December 31, 20202022 and 2019,2021, all shares issuable upon conversion of convertible debt and the exercise of outstanding stock options and warrants were antidilutive, and, therefore, not included in the computation of diluted income (loss) per share.

NOTE 21. DIGITAL ALLY HEALTHCARE VENTURE

On June 4, 2021, Digital Ally Healthcare, a wholly-owned subsidiary of the Company, entered into a venture with Nobility LLC (“Nobility”), an eight-year-old revenue cycle management (“RCM”) company servicing the medical industry, to form Nobility Healthcare, LLC (“Nobility Healthcare”). Digital Ally Healthcare is capitalizing the venture with $13.5 million to support the venture’s business strategy to make acquisitions of RCM companies. Digital Ally Healthcare owns 51% of the venture that entitles it to 51% of the distributable cash as defined in the venture’s operating agreement plus a cumulative preferred return of 10% per annum on its invested capital. Nobility will receive a management fee and 49% of the distributable cash, subordinated to Digital Ally Healthcare’s preferred return. The venture comprises the Company’s revenue cycle management segment.

On June 30, 2021, the Company’s revenue cycle management segment completed the acquisition of a private medical billing company (the “Healthcare Acquisition”). In accordance with the stock purchase agreement, the Company’s revenue cycle management segment agreed to a non-refundable initial payment (the “Initial Payment Amount”) of $850,000. In addition to the Initial Payment Amount, the Company’s revenue cycle management segment agreed to issue a promissory note to the stockholders of the Healthcare Acquisition in the principal amount of $350,000 that is subject to an earn-out adjustment. Management’s estimate of the fair value of this Contingent Note at December 31, 2021 is $317,212. The gain associated with the adjustment in the estimated fair value of this contingent promissory note is recorded as a gain in the Consolidated Statements of Operations for the year ended December 31, 2021. Lastly, the Company’s revenue cycle management segment agreed to pay $162,552 representing the principal and accrued interest balance due under a promissory note issued to the selling shareholders prior to the acquisition closing date. The Company’s revenue cycle management segment anticipates the estimated fair value of the contingent promissory note to be paid in full, therefore, the total aggregate purchase price was determined to be approximately $1,376,509. Total acquisition related costs aggregated $164,630, which was expensed as incurred. Subsequent to the acquisition date, the Company received further information regarding the purchased assets and assumed liabilities. As a result, the initial allocation of the purchase price was adjusted by increasing accounts receivable by $75,000 with a corresponding reduction of goodwill during the year ended December 31, 2021.

F-42

The Company accounts for business combinations using the acquisition method and that the Company has early adopted the amendments of Regulation S-X dated May 21, 2020 and has concluded that this acquisition was not significant. Accordingly, the presentation of the assets acquired, historical financial statements under Rule 3-05 and related pro forma information under Article 8 of Regulation S-X, respectively, are not required to be presented. Under the acquisition method, the purchase price of the Healthcare Acquisition has been allocated to the acquired tangible and identifiable intangible assets and assumed liabilities based on their estimated fair values at the time of the Healthcare Acquisition. This allocation involves a number of assumptions, estimates, and judgments that could materially affect the timing or amounts recognized in our financial statements. Our assumptions and estimates are based upon information obtained from the management of the Company’s revenue cycle management segment. The acquisition was structured as stock purchase, therefore the excess purchase price over the fair value of net tangible assets acquired was recorded as goodwill, which will not be amortized for income tax filing purposes. The results of operations of acquired businesses are included in the consolidated financial statements from the acquisition date.

The purchase price of the Healthcare Acquisition was allocated to the tangible assets, and assumed liabilities based on their preliminary estimated fair values at the time of the Healthcare Acquisition. The preliminary and final estimated fair value of assets acquired and liabilities assumed in the Healthcare Acquisition were as follows:

SCHEDULE OF PRELIMINARY FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ACQUISITION

         
  Purchase price allocation 
Description Preliminary
as allocated
June 30, 2021
  Final
as allocated
June 30, 2022
 
Assets acquired:        
Tangible assets acquired, consisting of acquired cash, accounts receivable and right of use asset $174,351  $174,351 
Intangible assets acquired – Client Agreements $174,351  $174,351 
Intangible assets acquired – client agreements     457,079 
Goodwill  1,125,000   667,921 
Liabilities assumed consisting of a promissory note issued by the selling shareholders which was paid off at closing, net of lease liability assumed  77,158   77,158 
Liabilities assumed pursuant to stock purchase agreement  77158   77158 
Net assets acquired and liabilities assumed $1,376,509  $1,376,509 
Consideration:        
Cash paid at Healthcare Acquisition date $1,026,509  $1,026,509 
Contingent consideration earn-out agreement  350,000   350,000 
         
Total Healthcare Acquisition purchase price $1,376,509  $1,376,509 

The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives in years as of the date of acquisition:

SCHEDULE OF IDENTIFIABLE INTANGIBLE ASSETS ACQUIRED AND THEIR ESTIMATED USEFUL LIVES

  Cost  Amortization through
December 31,
2022
  Estimated
useful life
Identifiable intangible assets:          
Client agreements $457,079  $68,562  10 years

F-43

For the period from the date of the Healthcare Acquisition to June 30, 2022, the Company adjusted its preliminary fair value estimates and estimated useful lives based upon information obtained through June 30, 2022, which resulted in adjustments to the preliminary allocation of the purchase price. These adjustments primarily related to estimated identifiable intangible asset fair values of client agreements and goodwill.

During the measurement period (which is the period required to obtain all necessary information that existed at the acquisition date, or to conclude that such information is unavailable, not to exceed one year), additional assets or liabilities may be recognized, or there could be changes to the amounts of assets or liabilities previously recognized on a preliminary basis, if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of these assets or liabilities as of that date. The change in fair value of the contingent consideration is more fully described in Note 10, “Debt Obligations”.

On August 31, 2021, the Company’s revenue cycle management segment completed the acquisition of another private medical billing company (the “Medical Billing Acquisition”). In accordance with the stock purchase agreement, Nobility Healthcare agreed to a non-refundable initial payment (the “Initial Payment Amount”) of $2,270,000. In addition to the Initial Payment Amount, the Company’s revenue cycle management segment agreed to issue a contingent promissory note to the stockholders of the Medical Billing Acquisition in the principal amount of $650,000 that is subject to an earn-out adjustment. The Company’s revenue cycle management segment anticipates the estimated fair value of the contingent promissory note to be paid in full, therefore, the total aggregate purchase price was determined to be approximately $2,920,000. Total acquisition related costs aggregated $5,602, which was expensed as incurred.

The Company accounts for business combinations using the acquisition method and that the Company has early adopted the amendments of Regulation S-X dated May 21, 2020 and has concluded that this acquisition was not significant. Accordingly, the presentation of the assets acquired, historical financial statements under Rule 3-05 and related pro forma information under Article 8 of Regulation S-X, respectively, are not required to be presented. Under the acquisition method, the purchase price of the Healthcare Acquisition has been allocated to the acquired tangible and identifiable intangible assets and assumed liabilities based on their estimated fair values at the time of the Healthcare Acquisition. This allocation involves a number of assumptions, estimates, and judgments that could materially affect the timing or amounts recognized in our financial statements. Our assumptions and estimates are based upon information obtained from the management of the Company’s revenue cycle management segment. The acquisition was structured as stock purchase, therefore the excess purchase price over the fair value of net tangible assets acquired was recorded as goodwill, which will not be amortized for income tax filing purposes. The results of operations of acquired businesses are included in the consolidated financial statements from the acquisition date.

The purchase price of the Medical Billing Acquisition was allocated to the tangible assets, and assumed liabilities based on their preliminary estimated fair values at the time of the Medical Billing Acquisition. The preliminary and final estimated fair value of assets acquired, and liabilities assumed in the Medical Billing Acquisition were as follows:

SCHEDULE OF PRELIMINARY FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ACQUISITION

  Preliminary As
allocated
  Final As
allocated
 
  Purchase price
allocation
 
  Preliminary As
allocated
  Final As
allocated
 
Description September 30,
2021
  September 30,
2022
 
Assets acquired:        
Tangible assets acquired $401,547  $401,547 
Identifiable intangible assets acquired – client agreements     206,955 
Goodwill  2,920,000   2,713,045 
Liabilities assumed pursuant to stock purchase agreement  (401,547)  (401,547)
Net assets acquired and liabilities assumed $2,920,000  $2,920,000 
Consideration:        
Cash paid at Healthcare Acquisition date $2,270,000  $2,270,000 
Contingent consideration earn-out agreement  650,000   650,000 
         
Total Healthcare Acquisition purchase price $2,920,000  $2,920,000 

F-44

The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives in years as of the date of acquisition:

SCHEDULE OF IDENTIFIABLE INTANGIBLE ASSET ACQUIRED AND THEIR ESTIMATED USEFUL LIVES

  Cost  Amortization through
December 31, 2022
  Estimated
useful life
Identifiable intangible assets:          
Client agreements $206,955  $27,594  10 years

For the period from the date of the Healthcare Acquisition to August 31, 2022, the Company adjusted its preliminary fair value estimates and estimated useful lives based upon information obtained through August 31, 2022, which resulted in adjustments to the preliminary allocation of the purchase price. These adjustments primarily related to estimated identifiable intangible asset fair values of client agreements and goodwill.

During the measurement period (which is the period required to obtain all necessary information that existed at the acquisition date, or to conclude that such information is unavailable, not to exceed one year), additional assets or liabilities may be recognized, or there could be changes to the amounts of assets or liabilities previously recognized on a preliminary basis, if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of these assets or liabilities as of that date. The change in fair value of the contingent consideration is more fully described in Note 10, “Debt Obligations”.

On January 1, 2022, the Company’s revenue cycle management segment completed the acquisition of another private medical billing company (the “Medical Billing Acquisition”). In accordance with the stock purchase agreement, Nobility Healthcare agreed to a non-refundable initial payment (the “Initial Payment Amount”) of $1,153,626. In addition to the Initial Payment Amount, the Company’s revenue cycle management segment agreed to issue a contingent promissory note to the stockholders of the Medical Billing Acquisition in the principal amount of $750,000 that is subject to an earn-out adjustment. The Company’s revenue cycle management segment anticipates the estimated fair value of the contingent promissory note to be paid in full, therefore, the total aggregate purchase price was determined to be approximately $1,903,626. Total acquisition related costs aggregated $7,996, which was expensed as incurred.

The Company accounts for business combinations using the acquisition method and that the Company has early adopted the amendments of Regulation S-X dated May 21, 2020 and has concluded that this acquisition was not significant. Accordingly, the presentation of the assets acquired, historical financial statements under Rule 3-05 and related pro forma information under Article 8 of Regulation S-X, respectively, are not required to be presented. Under the acquisition method, the purchase price of the Healthcare Acquisition has been allocated to the acquired tangible and identifiable intangible assets and assumed liabilities based on their estimated fair values at the time of the Healthcare Acquisition. This allocation involves a number of assumptions, estimates, and judgments that could materially affect the timing or amounts recognized in our financial statements. Our assumptions and estimates are based upon information obtained from the management of the Company’s revenue cycle management segment. The acquisition was structured as stock purchase, therefore the excess purchase price over the fair value of net tangible assets acquired was recorded as goodwill, which will not be amortized for income tax filing purposes. The results of operations of acquired businesses are included in the consolidated financial statements from the acquisition date.

The purchase price of the Medical Billing Acquisition was allocated to the tangible assets, and assumed liabilities based on their preliminary estimated fair values at the time of the Medical Billing Acquisition. There was no change from the preliminary estimated fair value to the final estimated fair value of assets acquired, and liabilities assumed in the Healthcare Acquisition, those value were as follows:

SCHEDULE OF PRELIMINARY FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ACQUISITION

Description Amount 
Assets acquired:    
Tangible assets acquired $190,631 
Goodwill  2,100,000 
Liabilities assumed pursuant to stock purchase agreement  (387,005)
Total assets acquired and liabilities assumed $1,903,626 
Consideration:    
Cash paid at acquisition date $1,153,626 
Contingent consideration promissory note  750,000 
     
Total acquisition purchase price $1,903,626 

F-45

During the measurement period (which is the period required to obtain all necessary information that existed at the acquisition date, or to conclude that such information is unavailable, not to exceed one year), additional assets or liabilities may be recognized, or there could be changes to the amounts of assets or liabilities previously recognized on a preliminary basis, if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of these assets or liabilities as of that date. The change in fair value of the contingent consideration is more fully described in Note 10, “Debt Obligations”.

On February 1, 2022, the Company’s revenue cycle management segment completed an asset acquisition from another private medical billing company (the “Medical Billing Asset Acquisition”). In accordance with the asset purchase agreement, Nobility Healthcare agreed to a non-refundable initial payment (the “Initial Payment Amount”) of $230,000. In addition to the Initial Payment Amount, the Company’s revenue cycle management segment agreed to issue a contingent promissory note to the stockholders of the Medical Billing Asset Acquisition in the principal amount of $105,000 that is subject to an earn-out adjustment. The Company’s revenue cycle management segment anticipates the estimated fair value of the contingent promissory note to be paid in full, therefore, the total aggregate purchase price was determined to be approximately $335,000. Total acquisition related costs aggregated $10,322, which was expensed as incurred.

In accordance with ASC 805, “Business Combinations”, the acquisition method of accounting is used, and recognition of the assets acquired is at fair value as of the acquisition dates. All acquisition costs were expensed as incurred. The consideration paid has been allocated to the assets acquired based on their estimated fair values at the acquisition date. The estimate of fair values for the intangible assets acquired were agreed to by both buyer and seller. The estimated fair value of intangible assets acquired in the Medical Billing Asset Acquisition were as follows:

SCHEDULE OF PRELIMINARY FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ACQUISITION

Description Amount 
Assets acquired:    
Intangible assets acquired – client agreements $335,000 
Total assets acquired and liabilities assumed $335,000 
Consideration:    
Cash paid at acquisition date $230,000 
Contingent consideration promissory note  105,000 
     
Total acquisition purchase price $335,000 

The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives in years as of the date of acquisition:

SCHEDULE OF IDENTIFIABLE INTANGIBLE ASSETS ACQUIRED AND THEIR ESTIMATED USEFUL LIVES

  Cost  Amortization through
December 31,
2022
  Estimated
useful life
Identifiable intangible assets:          
Client agreements $335,000  $30,708  10 years

The change in fair value of the contingent consideration is more fully described in Note 10, “Debt Obligations” and will be estimated on a quarterly basis.

F-46

NOTE 22. TICKETSMARTER ACQUISITION

On September 1, 2021, Digital Ally, Inc. formed TicketSmarter, Inc. (“TicketSmarter”), through which the Company completed the acquisition of Goody Tickets, LLC, a Kansas limited liability company (“Goody Tickets”) and TicketSmarter, LLC, a Kansas limited liability company (“TicketSmarter LLC”), collectively the “TicketSmarter Acquisition”. TicketSmarter, Inc. comprises the Company’s entertainment business segment. In accordance with the stock purchase agreement, the Company agreed to an initial payment (the “Initial Payment Amount”) of $9,403,600 through a combination of cash and common stock. In addition to the Initial Payment Amount, the Company agreed to issue an earn-out agreement to the stockholders of Goody Tickets and TicketSmarter LLC in the contingent amount of $4,244,400 that is subject to an earn-out adjustment based on actual EBITDA achieved in 2021, of which the Company gave a fair value of $3,700,000 on the date of acquisition. However, following the completion of 2021, it was determined that the actual EBITDA threshold for any earn-out adjustment to be paid was not met. Thus, in accordance with U.S. GAAP, the fair value of the contingent earn-out is reduced to zero, and the associated gain related to this revaluation is recorded in our Consolidated Statements of Operations for the year ended December 31, 2021. Lastly, included in the agreement, the Company agreed to place $500,000 in escrow, subject to a working capital adjustment based on actual working capital amounts on the acquisition date as defined in the agreement, this amount was subject to disbursement 45 days following the close of the acquisition. The parties completed the working capital adjustment resulting in the Company retaining $297,726 of the escrow amount with the $202,274 released to the Sellers. The total acquisition related costs aggregated $40,625, which was expensed as incurred.

The Company accounts for business combinations using the acquisition method and that the Company has early adopted the amendments of Regulation S-X dated May 21, 2020 and has concluded that this acquisition was not significant. Accordingly, the presentation of the assets acquired, historical financial statements under Rule 3-05 and related pro forma information under Article 11 of Regulation S-X, respectively, are not required to be presented. Under the acquisition method, the purchase price of the TicketSmarter Acquisition has been allocated to Goody Tickets’ and TicketSmarter LLC’s acquired tangible and identifiable intangible assets and assumed liabilities based on their estimated fair values at the time of the TicketSmarter Acquisition. This allocation involves a number of assumptions, estimates, and judgments that could materially affect the timing or amounts recognized in our financial statements. The TicketSmarter Acquisition was structured as a stock purchase; however the parties agreed to coordinate the election to invoke IRS Section 338(h)(10) relative to this transaction for tax purposes. Therefore, the excess purchase price over the fair value of net tangible assets acquired was recorded as goodwill, which will be amortized over 15 years for income tax filing purposes. Likewise, the other acquired assets were stepped up to fair value and is deductible for income tax purposes. The results of operations of acquired businesses are included in the consolidated financial statements from the acquisition date.

The purchase price of the TicketSmarter Acquisition was allocated to Goody Tickets’ and TicketSmarter LLC’s tangible assets, goodwill, identifiable intangible assets, and assumed liabilities based on their preliminary estimated fair values at the time of the TicketSmarter Acquisition. The Company retained the services of an independent valuation firm to determine the fair value of these identifiable intangible assets. The preliminary and final estimated fair value of assets acquired, and liabilities assumed in the TicketSmarter Acquisition were as follows:

SCHEDULE OF PARLIAMENT AND FINAL ESTIMATED FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED ACQUISITION

  As allocated  Final as allocated 
  Purchase price allocation 
  As allocated  Final as allocated 
Description September 30, 2021  December 31, 2021 
Assets acquired:        
Tangible assets acquired, including $51,432 of cash acquired $7,139,930  $5,748,291 
Identifiable intangible assets acquired     6,800,000 
Goodwill  11,839,308   5,886,547 
Liabilities assumed  (5,128,964)  (5,128,964)
Liabilities assumed pursuant to stock purchase agreement  

-

5128964

   -5128964 
Net assets acquired and liabilities assumed $13,850,274  $13,305,874 
Consideration:        
Cash paid at TicketSmarter Acquisition date $8,413,240  $8,413,240 
Common stock issued as consideration for TicketSmarter Acquisition at date of acquisition  990,360   990,360 
Contingent consideration earn-out agreement  4,244,400   3,700,000 
Cash paid at closing to escrow amount  500,000   500,000 
Cash retained from escrow amount pursuant to settlement of working capital target  (297,726)  (297,726)
         
Total TicketSmarter Acquisition purchase price $13,850,274  $13,305,874 

F-47

The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives in years as of the date of acquisition:

SCHEDULE OF COMPONENTS OF IDENTIFIABLE INTANGIBLE ASSETS ACCRUED AND ESTIMATED USEFUL LIVES

  Cost  Amortization through
December 31, 2022
  Estimated
useful life
Identifiable intangible assets:          
Trademarks $600,000  $  indefinite
Sponsorship agreement network  5,600,000   1,493,333  5 years
Search engine optimization/content  600,000   200,000  4 years
           
  $6,800,000  $1,693,333   

For the period from the date of the TicketSmarter Acquisition to December 31, 2021, the Company adjusted its preliminary fair value estimates and estimated useful lives based upon information obtained through December 31, 2021, which resulted in adjustments to the preliminary allocation of the purchase price. These adjustments primarily related to estimated identifiable intangible asset fair values (primarily related to the sponsorship agreement network), the estimated fair value of the contingent earn-out agreement liability and goodwill. There were no adjustments to the allocation of the purchase price during the year ended December 31, 2022.

During the measurement period (which is the period required to obtain all necessary information that existed at the acquisition date, or to conclude that such information is unavailable, not to exceed one year), additional assets or liabilities may be recognized, or there could be changes to the amounts of assets or liabilities previously recognized on a preliminary basis, if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of these assets or liabilities as of that date. The change in fair value of the contingent consideration is more fully described in Note 10, “Debt Obligations”.

NOTE 23. SEGMENT DATA

The accounting guidance on Segment Reporting establishes standards for reporting information regarding operating segments in annual financial statements and requires selected information of those segments to be presented in financial statements. Operating segments are identified as components of an enterprise for which separate discrete financial information is available for evaluation by the chief operating decision maker (the Company’s Chief Executive Officer or “CODM”) in making decisions on how to allocate resources and assess performance. The Company’s three operating segments are Video Solutions, Revenue Cycle Management, and Entertainment, each of which has specific personnel responsible for that business and reports to the CODM. Corporate expenses capture the Company’s corporate administrative activities, is also to be reported in the segment information. The Company’s captive insurance subsidiary provides services to the Company’s other business segments and not to outside customers. Therefore, its operations are eliminated in consolidation and is not considered a separate business segment for financial reporting purposes.

F-48

The Video Solutions Segment encompasses our law, commercial, and shield divisions. This segment includes both service and product revenues through our subscription models offering cloud and warranty solutions, and hardware sales for video and health safety solutions. The Revenue Cycle Management Segment provides working capital and back-office services to a variety of healthcare organizations throughout the country, as a monthly service fee. The Entertainment Segment acts as an intermediary between ticket buyers and sellers within our secondary ticketing platform, ticketsmarter.com, and we also acquire tickets from primary sellers to then sell through various platforms.

The Company’s corporate administration activities are reported in the corporate line item. These activities primarily include expense related to certain corporate officers and support staff, certain accounting staff, expense related to the Company’s Board of Directors, stock option expense for options granted to corporate administration employees, certain consulting expenses, investor relations activities, and a portion of the Company’s legal, auditing and professional fee expenses. Corporate identifiable assets primarily consist of cash, invested cash (if any), refundable income taxes (if any), and deferred income taxes.

Summarized financial information for the Company’s reportable business segments is provided for the indicated periods and as of December 31, 2022, and December 31, 2021:

SCHEDULE OF SEGMENT REPORTING

  2022  2021 
  Years Ended December 31, 
  2022  2021 
Net Revenues:        
Video Solutions $8,252,288  $9,073,626 
Revenue Cycle Management  7,886,107   1,630,048 
Entertainment  20,871,500   10,709,760 
Total Net Revenues $37,009,895  $21,413,434 
Total net revenues $37,009,895  $21,413,434 
         
Gross Profit:        
Video Solutions $(1,250,277) $2,002,345 
Revenue Cycle Management  3,303,477   521,047 
Entertainment  268,741   3,140,383 
Total Gross Profit $2,321,941  $5,663,775 
Total gross profit $2,321,941  $5,663,774 
         
Operating Income (loss):        
Video Solutions $(9,278,721) $(4,497,196)
Revenue Cycle Management  357,705   93,763 
Entertainment  (7,369,241)  235,432 
Corporate  (13,443,001)  (10,592,909)
Total Operating Income (Loss) $(29,733,258) $(14,760,910)
Total operating income (loss) $(29,733,258) $(14,760,910)
         
Depreciation and Amortization:        
Video Solutions $769,228  $395,361 
Revenue Cycle Management  128,082    
Entertainment  1,279,369   427,128 
Total Depreciation and Amortization $2,176,679  $822,489 
Total depreciation and amortization $2,176,679  $822,489 
         
Assets (net of eliminations):        
Video Solutions $28,509,706  $25,983,348 
Revenue Cycle Management  2,201,570   934,095 
Entertainment  11,190,491   12,260,780 
Corporate  14,766,295   43,810,974 
Total Identifiable Assets $56,668,062  $82,989,197 

F-49

The segments recorded noncash items effecting the gross profit and operating income (loss) through the established inventory reserves based on estimates of excess and/or obsolete current and non-current inventory. The Company recorded a reserve for excess and obsolete inventory in the video solutions segment of $5,230,261 and a reserve for the entertainment segment of $259,280 as of December 31, 2022.

The segment net revenues reported above represent sales to external customers. Segment gross profit represents net revenues less cost of revenues. Segment operating income, which is used in management’s evaluation of segment performance, represents net revenues, less cost of revenues, less all operating expenses. Identifiable assets are those assets used by each segment in its operations. Corporate assets primarily consist of cash, property, plant and equipment, accounts receivable, inventories, and other assets.

Note 18. 24. SUBSEQUENT EVENTS

2023 Issuance of Restricted Common Stock

 

Underwritten public offering -On January 14, 2021,9, 2023, the Company consummated an underwritten public offering (the “Offering”) of (i) 2,800,000 shares of common stock (”Shares”), (ii) pre-funded warrants to purchase up to 7,200,000 of Common Stock (the “Pre-Funded Warrants”), issuable to investors whose purchase of shares of Common Stock would otherwise result in such investor, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at compensation committee (“the election of the holder, 9.99%“Compensation Committee”) of the Company’s outstanding Commonboard of directors awarded Stanton E. Ross 17,500 shares of restricted common stock that will vest one half on January 10, 2024 and one half on January 10, 2025 provided that he remains an officer on such dates. Peng Han was awarded 5,000 shares of restricted common stock that will vest 1,000 shares on January 10, 2024, January 10, 2025, January 10, 2026, January 10, 2027 and January 10, 2028 provided that he remains an officer on such dates. The Compensation Committee awarded employees a total of 12,500 shares of restricted common stock that will vest one half on January 10, 2024 and one half on January 10, 2025 provided that they remain employees on such dates.

Reverse Stock immediately followingSplit

On February 6, 2023, we filed a Certificate of Amendment to the consummationArticles of Incorporation, as amended, with the Secretary of State of the Registered Offering (“Pre-Funded Warrants”); and (iii) commonState of Nevada to effect a 1-for-20 reverse stock purchase warrants (“Warrants”split (the “Reverse Stock Split”) to purchase up to an aggregate of 10,000,000the shares of Commonour common stock. The Reverse Stock (the “Warrant Shares”), which are exercisable for a periodSplit was effective as of five years after issuance at an initial exercise price $3.25 per share, subject to certain adjustments, as provided in the Warrants. The Offering was conducted pursuant to an underwriting agreement, dated January 12, between the Company and Kingswood Capital Markets, divisiontime of Benchmark Investments, Inc. (the “Underwriters”), acted as the exclusive placement agentfiling. No fractional shares were issued in connection with the Offering pursuantReverse Stock Split. Any fractional shares of our Common Stock that would have otherwise resulted from the Reverse Stock Split were rounded up to a placement agency agreement.the nearest whole number. In connection with the Reverse Stock Split, our board approved appropriate and proportional adjustments to all outstanding securities or other rights convertible or exercisable into shares of our Common Stock, including, without limitation, all preferred stock, warrants, options, and other equity compensation rights. All historical share and per-share amounts reflected throughout our consolidated financial statements and other financial information in this Report have been adjusted to reflect the Reverse Stock Split as if the split occurred as of the earliest period presented. The par value per share of our common stock in the Offering was sold at a public offering price of $3.095 per share.

F-40

The common stock in the Offering was issued pursuant to the Company’s effective shelf registration statement on Form S-3 (File No. 333-239419). The underwriting agreement contained customary representations, warranties and agreementsnot affected by the Company, customary conditions to closing, indemnification obligations of the Company and the Underwriters. The Underwriters received discounts and commissions of six percent (6%) of the gross cash proceeds received by the Company from the sale of the common shares in the Offering and certain expenses.Reverse Stock Split.

 

Under the underwriting agreement,

Nasdaq Compliance

On February 23, 2023, the Company and its officers and directors executed lock-up agreements whereby, (a)received notice from Nasdaq confirming that the Company has agreed not to engage in the following for a period of 90 days from the date of the pricing of the Offering, (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company; (ii) file or cause to be filed any registration statementcured its bid price deficiency and has fully regained compliance with the SEC relating to the offering of any shares of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company; (iii) complete any offering of debt securities of the Company, or (iv) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of capital stock of the Company.Minimum Bid Price Requirement.

Further, pursuant to the terms of the Purchase Agreement the Company has granted to the Investors, for a period of 12 months after the closing of the Offering, the right to participate in subsequent offerings by the Company of Common Stock and Common Stock equivalents in an amount up to 50% of the amount of each such subsequent offering, on the same terms, conditions and price provided for in such subsequent offering.

The Company received approximately $29,013,000 in net proceeds from the Offering after deducting the discounts, commissions, and other estimated offering expenses payable by the Company. As of March 31, 2021, all pre-funded warrants have been fully exercised. The Company plans to use the net proceeds from the Offering for working capital, product development, order fulfillment and for general corporate purposes.

Underwritten public offering - On February 1, 2021, the Company consummated an underwritten public offering (the “Offering”) of (i) 3,250,000 shares of common stock (”Shares”), (ii) pre-funded warrants to purchase up to 11,050,000 of Common Stock (the “Pre-Funded Warrants”), issuable to investors whose purchase of shares of Common Stock would otherwise result in such investor, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the holder, 9.99%) of the Company’s outstanding Common Stock immediately following the consummation of the Registered Offering (“Pre-Funded Warrants”); and (iii) common stock purchase warrants (“Warrants”) to purchase up to an aggregate of 14,300,000 shares of Common Stock (the “Warrant Shares”), which are exercisable for a period of five years after issuance at an initial exercise price $3.25 per share, subject to certain adjustments, as provided in the Warrants. The Offering was conducted pursuant to an underwriting agreement, dated January 28, between the Company and Kingswood Capital Markets, division of Benchmark Investments, Inc. (the “Underwriters”), acted as the exclusive placement agent in connection with the Offering pursuant to a placement agency agreement. The common stock in the Offering was sold at a public offering price of $2.799 per share.

The common stock in the Offering was issued pursuant to the Company’s effective shelf registration statement on Form S-3 (File No. 333-239419). The underwriting agreement contained customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Underwriters. The Underwriters received discounts and commissions of six percent (6%) of the gross cash proceeds received by the Company from the sale of the common shares in the Offering and certain expenses.

F-41

Under the underwriting agreement, the Company and its officers and directors executed lock-up agreements whereby, (a) the Company has agreed not to engage in the following for a period of 90 days from the date of the pricing of the Offering, (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company; (ii) file or cause to be filed any registration statement with the SEC relating to the offering of any shares of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company; (iii) complete any offering of debt securities of the Company, or (iv) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of capital stock of the Company.

Further, pursuant to the terms of the Purchase Agreement the Company has granted to the Investors, for a period of 12 months after the closing of the Offering, the right to participate in subsequent offerings by the Company of Common Stock and Common Stock equivalents in an amount up to 50% of the amount of each such subsequent offering, on the same terms, conditions and price provided for in such subsequent offering.

The Company received approximately $37,587,600 in net proceeds from the Offering after deducting the discounts, commissions, and other estimated offering expenses payable by the Company. As of March 31, 2021, all pre-funded warrants have been fully exercised. The Company plans to use the net proceeds from the Offering for working capital, product development, order fulfillment and for general corporate purposes.

American Rebel Holding, Inc. Secured Promissory Notes - On October 1, 2020, the Company advanced $250,000 to American Rebel Holdings, Inc. (AREB) under a secured promissory note and on October 21, 2020, the Company advanced an additional $250,000 to American Rebel Holdings, Inc. (AREB) under a second secured promissory note. Both notes are currently in default. On March 1, 2021, the Company advanced an additional $117,600 to AREB on terms similar to the previously issued notes. See “NOTE 16. RELATED PARTY TRANSACTIONS” for further information.

The parties have been negotiating the terms of a Forbearance Agreement regarding the following: (a) the secured promissory note dated October 1, 2020; (b) the secured promissory note dated October 21, 2020; and (c) an advance made by the Company on March 1, 2021. The parties are attempting to arrange for a series of payments that will liquidate the outstanding balances of the two delinquent notes and the advance by no later than June 30, 2021. Based on the terms being negotiated, if AREB timely and fully complies with all of its obligations under the Forbearance Agreement, the Company would agree that AREB’s obligations to the Company in connection with the defaults would be satisfied. However, there is no assurance that the parties will agree to the terms contained in the Forbearance Agreement, and whether AREB will be able to comply with such terms.

Purchase of Building - On February 24, 2021 the Company entered into a contract to purchase a 71,361 square foot building located in Lenexa Kansas which is intended to serve as the Company’s office and warehouse needs. The building contains approximately 30,000 square foot of office space and the remainder warehouse space. The total purchase price is approximately $5.3 million and is expected to close on or around May 1, 2021.

*************************************

F-42F-50